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S U M M A R Y .
The use of g lycosylated haemoglobin m easurement for 
monitoring the long-term glycaemic control of diabetic 
patients is now well established. To enable this m a t e r i a l  
to be measured routinely at the Royal Sussex County Hospital, 
a method based on affinity c h romatography using an 
m- a m i n o p h enylboronate agarose was developed. This technique 
provides a simple, reproducible assay, which is inexpensive 
and allows the assay of upto 60 samples per day. A "between- 
batch" CV of 2% was achieved.
Affinity c h romatography was also used for the sepa r a t i o n 
of glycosylated plasma proteins with a "between-batch" CV of 
5%. Measurement of the protein content in the fractions 
collected from the gel was performed by the Coomassie B r i l l i a n t  
Blue method of Bradford. In this way both glyco s y l a t e d  
haemoglobin and glycosylated plasma proteins could be m e a s u r e d  
in the same sample and their individual usefulness in any 
clinical situation assessed. Investigation of patients ad m i t t e d  
to hospital after a period of poor glycaemic control con f i r m e d  
that g l y c o sylated plasma proteins with their shorter half-life, 
decreased at a far quicker rate following the onset of 
treatment, than did glycosylated haemoglobins.
Part of the clinical work showed that both g l y c o s y l a t e d  
haemoglobins and g l y c o sylated plasma proteins could be used 
to detect glucose intolerance, although glyco s y l a t e d  h a e m o g l o b i n  
measurement proved more useful as a screening test for diabetes 
mellitus p o s sibly due to its b e t t e r  precision. A t w o - y e a r  study
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of 35 pregnant diabetic patients.established' that both 
g lycosylated h aemoglobin and glycosylated plasma proteins 
me a s u r e d  in the third t r i m ester of pregnancy could be used 
with a high frequency (73.5% and 68.8%, r e s p e c i t v e l y ) to 
correctly predict macrosomia, and with a higher frequency 
(85.3% and 8M-.M-%) to predict problems at delivery. 
Investigation of both m easurements in association with 
miscarriages to diabetic patients showed abnormal glyco s y l a t e d 
plasma protein results in 3 cases. No correlation was found 
between birth weight ratios and g l y c o sylated material in 
cord b l o o d ..
A two-year study of diabetic patients attending an 
out-patient clinic showed that their overall control, in 
terms of glycosylated haemoglobin measurement, improved 
significantly during the period of study. Initial 
investigations to establish exactly what the affinity gel 
separates for both the g lycosylated haem o g l o b i n  and 
glycosylated plasma protein assay are described.
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CV coefficient of variation
SD standard deviation
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RDS respiratory distress syndrome
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CHAPTER 1.
GENERAL INTRODUCTION.
H I S T O R I C A L  BACKGROUND.
The symptoms of diabetes mellitus have been known for 
many centuries. The term diabetes is, in fact, of Greek 
origin and derives from the word me a n i n g  " p a s s e r - t h r o u g h ", 
thus describing the polydipsic and pol y u r i c  c h a racteristics 
of this syndrome. Likewise, the word mellitus is Latin for 
honey and thus expresses the association of the disease with 
glucose metabolism.
Many books outline the h i s tory of the investigations 
to show the association between insulin and diabetes m e l l i t u s  
(Faris, 1982, Ireland, Thompson and Williamson, 1980, Bloom, 
1978). As quoted, in 1682 Brunner reported t h a t  the surgical 
removal of the pancreas produced extreme thirst and polyuria, 
but not until 1889 did Mering and Minkowski demonstrate the 
re l a t ionship between diabetes and pancreatectomy. In 1869 
Paul Langerhans presented his doctoral thesis n o ting the 
presence of p r e v i o u s l y  unreported cell structures in the 
pancreas. But it was 1893 before the French h i s t ologist  
Edward Laguesse suggested a physi o l o g i c a l  role for these 
cell groups, which he named " H o t s  de Langerhans". He 
pr o p o s e d  that they were sites of "an internal secretion w h i c h  
continues throughout existence". This was confirmed by 
Hedon in the same year, as he was able to prevent the 
occurrence of diabetes in p a n c r e a t e c t o m i s e d  animals by 
grafting panc r e a t i c  tissue under their skin.
By the turn of the century there was a general awareness 
of the association between pancreatic tissue and the control 
of blood sugar levels. In 1909 Jean de Meyer named the 
h y p o g l y c a e m i c  secretion from the pancreas " i n s u l i n e " .
However, due to prot e o l y t i c  destruction and the problems this 
pre s e n t e d  to scientists, it was 1922 before Banting and Best 
obtained their active extract. This preparation was 
s uccessful in the treatment of a patient in diabetic coma 
and represents one of the most important advances in m e d i c a l 
history.
A more recent article (1982) by Marliss a c k n o w l e d g e d  
the contribution by Banting and Best to medicine, but n o t e d  
that sixty years after the discovery of insulin, it has not 
proved a total "cure" for diabetes mellitus. Indeed, 
although insulin a d m i n i stration prolongs the survival of 
diabetic individuals, many develop degenerative c o m p l i cations, 
despite different therapeutic regimes.
I N S U L I N .
Today it is generally accepted that insulin, a p a n c r e a t i c  
hormone, occupies a central role in the co-ordination and 
utilisation of available energy sources and precursors, to 
provide efficient h omeostatic control in any i n d i vidual  
(Montague, 1983). In order to understand where this m e c h a n i s m  
fails in diabetes mellitus, and the various c o n s e quences of 
that failure, it is pertinent to describe the p r o d u c t i o n  and 
action of insulin in a n o n - d i a b e t i c  individual.
Structure, Synthesis and Storage of Insulin.
Human insulin consists of two polypeptide chains, 
denoted A and B, which are joined by two disulphide bridges. 
There is an a d d i tional interchain disulphide bridge on the A 
chain. Steiner (1977) noted that these chains are found 
within proinsulin, a larger, r e l a tively inactive p r e c u r s o r  
molecule. A complex pathway, involving p r o t e o l y t i c  cleavage 
of this molecule is required to synthesise insulin, which is 
then p a c kaged within the ^-granules (in the p-cells) of the 
Islets of Langerhans, ready for secretion. The rate of insulin 
b iosynthesis is largely dependent on the e x t r a c e l l u l a r  glucose 
concentration, and when this rises above the fasting level 
there is a dramatic increase in the rate of p roinsulin 
biosynthesis.
Secretion of I n s u l i n .
There fS a wide range of p h y s i o l o g i c a l  agents which 
have been shown to affect insulin secretion, s u g g esting that 
the p-cell is equipped with a variety of distinct sensor 
systems which are able to detect and quantify each of these 
possible factors. (Table 1.1). In addition, the coupling 
between such sensor systems which results in the exocytosis 
of insulin molecules is likely to involve a variety of sign a l  
molecules. Two such molecules have been ide n t i f i e d  as 
p laying an important role in linking stimulus to secretion;
Table 1.1 P h ysiological agents which affect insulin s e c r e t i o n .
Primary S t i m u l i .
Glucose
Mannose
Leucine
Arginine
Lysine
S hort-chain fatty acids 
Long-chain fatty acids 
Acetoacetate 
B-hy d r o x y b u t y r a t e
Secondary S t i m u l i .
Glucagon 
Secretin 
Pancreozymin 
Gastrin 
Acetylcholine  
Prostaglandin E and E 
1 2
I n h i b i t o r s .
Somatostatin
Adrenaline
Noradrenaline
Table from: Montague W. Diabetes and the Endocrine Pancreas: 
A Bioc h e m i c a l  Approach. Croom Helm, 1983.
calcium and cyclic AMP. Calcium appears to be the p r i m a r y  
signal response for activating the secretory process, and 
cyclic AMP appears to modulate the size of this secretory 
response.
As blood glucose concentrations increase above 4 to 5 
mmolar the {3-cells of the pancreas respond by the b i p hasic 
release of insulin. Initially those granules nea r  the 
plasma membrane of the cell are released, then there is a 
delay while other granules containing insulin are m o v e d  to 
the surface of the cell via the m i c r o t u b u l a r  system. This 
secretory response is specific, as galactose and fructose are 
both without effect. The p-cell must therefore have a 
specific recognition unit which both senses and responds to 
changes in ex t r a c e l l u l a r  glucose concentration. This unit 
is likely to be a protein which binds glucose with a low 
affinity causing the initiation of a series of events leading 
to depolarisation of the cell and calcium entry. The rate- 
limiting enzymes of glucose m e t a b o l i s m  have been suggested 
as these units (Montague, 1983A); glucokinase and 
p h o s p h o f r u c t o k i n a s e .
The secretory response of insulin is m o d i f i e d  by both 
the circulating levels of D-glucose, certain amino acids, 
fatty acids and ketone bodies, and the e x t r a c e l l u l a r  
concentrations of a variety of hormones. Glucagon, 
p ancreozymin and secretin are all pr o d u c e d  locally in other 
cells in the p a n c reatic islets, and all potentiate the 
response of the J3-cells to glucose. This effect is 
media t e d  by the cyclic AMP system of the {3-cell. Glucagon 
is produced by the o(-cells, and has met a b o l i c  effects
opposite to those of insulin and serves to raise blood
glucose. Its production is also stimulated by some L-amino 
acids and fatty acids, but D-glucose acts as a p h y s i o l o g i c a l  
inhibitor. In this way the Islets of Langerhans play an 
essential role in r e g u lating nutrient homeostasis in man.
The |3-cell threshold for the response to D-glucose is about 
5 mmolar, but with 0(-cells suppression is not r e l ieved until 
below 4 mmolar. This results in a very narrow limit of blood 
glucose concentration in a normal individual, caused by this 
very fine hormonal balance. In combination, the cells and 
the p-cells of the pancreas are well designed as an efficient  
fuel homeostat.
A further important role in the fuel home o s t a t i c  system 
is also played by the hypothalamus, anterior p i t u i t a r y  and 
adrenal cortex. Here the c h emoreceptor functions are 
apparently confined to the central nervous system and 
interpreted by the endocrine glands as increased c o r t i c o s t e r o i d  
or catecholamine secretion. Both of these act as inhibitors, 
and have converse effects to those of insulin, serving to 
raise blood glucose. Inhibitors, such as catecholamines, have 
the ability to activate 0(-receptors on the J3-cell w h i c h  
causes inhibition of adenyl cyclase and lowers i n t r a c e l l u l a r  
cyclic AMP levels. As a consequence the secretory response 
to any stimulus is reduced.
Insulin Receptors.
Insulin receptor sites have been demonstrated in both 
the classic target cells of insulin action (adipose, muscle 
and liver) and several other cell types with no r e c o g n i s e d 
insulin response (lymphocytes and monocytes). These 
receptors r e v e r s i b l y  bind insulin with high affinity and 
specificity. The binding of insulin molecules is saturable, 
occurring rapidly until a steady state is reached. 
Dissociation also occurs rapidly. Insulin receptors are 
l ocalised as an integral part of the plasma membranes of 
these cells. When a receptor binds insulin, together they 
become i n t e r nalised by the process of e n d o c y t o s i s . Insulin 
is then r a p idly degraded but the more resistant r e c eptor 
may be cycled back to the cell membrane for reuse. The 
m e c hanism as to how the interaction between insulin and its 
receptor initiates the response is not yet understood 
(Houslay and H e y w o r t h , 1983), although a second m e s s e n g e r  
has been proposed. Again calcium and cyclic AMP are likely 
to be involved to alter protein kinase activity and t h e r e b y 
to alter enzyme phosphorylation. Regulation of the number 
of receptors may allow a cell to alter its response to 
insulin.
The p h y s i o logical effects of insulin in man occur at
-10
plasma concentrations of about 10 molar and affect 
carbohydrate, protein and lipid metabolism. When such 
fuels are in excess, following a meal, insulin promotes 
their rapid uptake and storage. When these fuels are 
subsequently required, insulin promotes their c o n t rolled 
release. In this way insulin controls h o m e o stasis of fuel 
molecules m a i n t a i n i n g  them at levels suitable for tissue 
requirements, at all times. This is of p a r t i c u l a r  importance 
for some tissues, such as erythrocytes, the retina, the 
kidney, and to a lesser extent the brain, which are 
obligatory g l u c o s e .u s e r s . Other tissues can adapt to 
different n u t r i t i o n a l  states by altering their e n e r g y  source, 
but these tissues have a constant demand for glucose.
In the fed state insulin ensures that glucose is r a p i d l y 
removed from the blood and utilised by the tissues, k e e p i n g  
to a minimum the period of h y p e r g l y c a e m i a . It pr o m o t e s  the 
storage and utilisation of glucose by muscle, adipose tissue 
and the liver. The storage of glucose by both the liver and 
muscle is achieved by the formation of glycogen, as insulin 
increases glycogen synthetase activity and inhibits 
g l ycogenolysis by reducing p hosphorylase activ i t y  . When 
the glycogen stores- are full, excess glucose is then eith e r
Fig. 1.1 To illustrate the con version of glucose to ATP
via glycolysis and the Kreb's cycle.
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oxidised for ATP synthesis via the Krebs cycle (Fig. 1.1), 
or converted via lipogenesis into fatty acids which are 
then stored in adipose tissue as triglycerides. In general, 
muscles oxidise glucose whereas liver and adipose tissue are 
sites for lipogenesis. In order to promote glucose u t i l i s a t i o n  
via glycolysis, insulin increases the activity of the rate- 
limiting enzymes, pyruvate kinase, pyruvate dehydrogenase and 
p o s sibly 6 - p h o s p h o f r u c t o - l - k i n a s e . Insulin also encourages 
lipogenesis from acetyl CoA via the activation of acetyl CoA 
carboxylase, and promotes the esteri f i c a t i o n  of n e wly formed 
fatty acids by increasing the a v a i l a b i l i t y  of glycerol 
phosphate. In addition, it may stimulate the activities of 
d i a c y l glycerol a c y l t r ansferase and g l y c e r o l p h o s p h a t e  
a c y l t r a n s f e r a s e . In the fed state insulin also ensures the 
more rapid uptake of dietary triglycerides by i n c r easing the 
activity of lipoprotein lipase. In addition fatty acids are 
not released as insulin inhibits t r iglyceride lipase, and 
ketone production by the liver is kept to a minimum. Dietary  
protein is also taken up by tissues and insulin has a g e n eral  
anabolic effect.
Insulin D e g r a d a t i o n .
J
Insulin is removed from the c i r c u lation by degradation. 
This occurs p r i m a r i l y  in the liver, but most peri p h e r a l  
tissues have the specific enzymes to degrade insulin; 
insulin protease and insulin glutathione t r a n s h y d r o g e n a s e . 
These enzymes are located within cells and degrade insulin
after it enters the cell by endocytosis. Insulin degrading 
activity in the liver changes in the fed and fasted state.
DIABETES M E L L I T U S .
As the Islets of Langerhans regulate nutrient homeostasis, 
it is not surprising that when p a n c reatic endocrine function 
is derranged this causes p r o found effects on blood nutrient 
content. In most cases there is a reduction in the hormone 
p r o duced and this is most commonly r e c o gnised in the major  
clinical condition of diabetes mellitus. Although p r i m a r y 
diabetes mellitus is a heter o g e n e o u s  syndrome r e s ulting from 
any one or combination of factors altering insulin p roduction, 
it is usually c onsidered as two major disease types; type 1 
(j u v e n i l e - o n s e t ); type 2 (m a t u r i t y - o n s e t ). Ho w e v e r  it is 
worth n o ting that these two categories are far from separate 
(Fajans, Cloutier and Crowther, 1978) even though they are 
often considered as such. Secondary diabetes mellitus can 
occur when other metabolic factors alter, which oppose the 
action of insulin, such as high levels of growth hormone.
Type 1 Diabetes M e l l i t u s .
Type 1, or insulin- d e p e n d e n t  diabetes mellitus is 
chara c t e r i s e d  by an absolute deficiency of insulin and 
massive J3-cell lesion and necrosis. In human diabetics 
there must be 80% or more loss of functional p- c e l l s  before 
the fasting insulin levels decline. As insulin is not
a dequately p r o duced by the pancreas these patients are t r e a t e d  
by the a d ministration of insulin, usually i n t r a - m u s c u l a r l y . If 
insulin is not present in sufficient quantities other hormones 
can act u n o pposed with dramatic consequences. Fasting 
h y p e r g l y c a e m i a  is a major met a b o l i c  feature, and this is used 
as one criteria for diagnosis of this disease (W H O .2nd.R e p o r t , 
1980). Fasting blood glucose rises when insulin is not 
available to facilitate the uptake of glucose by such tissues 
as muscle, liver and adipose tissue. In addition other 
hormones such, as glucagon act uno p p o s e d  to increase gly.cogenolysis 
and g l u c o n eogenesis but inhibit glycogen synthesis, gly c o l y s i s  
and lipogenesis. The liver produces r a ther than utilises 
glucose, so b l ood glucose levels rise, and when these exceed 
the renal t h r e shold (about lOmmolar) glycosuria results.
Loss of glucose in the urine causes p o l yuria due to the o s m otic  
effects of glucose. Liquid intake is increased to acco m m o d a t e  
frequent urination.
There are also dramatic changes in lipid and p r o tein  
m e t a b o l i s m  seen with untreated type 1 diabetes mellitus.
Lipolysis, proteolysis and ketogenesis all increase, w i t h  
consequent rise of fatty acids, amino acids and ketones in 
the blood. Amino acids provide the substrates for 
g l u c o n e o g e n e s i s , the fatty acids for k e t o g e n e s i s . C linically,  
as muscle and adipose tissue are lost, body w a s t i n g  ma y  be 
noted. As the c oncentration of ketones continues to rise in 
the b l ood these exceed the renal t h r e s h o l d  and k e t o n u r i a  
occurs. Acetone may be smelt on the breath. The m a jor ketone
bodies are strong acids, and so as their c o ncentration 
increases they cause the buf f e r i n g  capacity of the blood 
to fail and cause acidosis. Unless insulin is a d m i n i s t e r e d 
to a patient in this condition, the patient will die, due 
to both dehydration and acidosis which affect the central 
nervous system.
Type 2 Diabetes M e l l i t u s .
Type 2 diabetes mellitus is usually less severe than 
type 1, usually not req u i r i n g  insulin but treatment by diet 
or oral glycaemic agents alone. Fasting plasma insulin 
levels may be normal, or even increased, although there is 
a relative lack of insulin e f f icacy under certain circu m s t a n c e s  
such as after a meal. This is due to either the J3-cell 
secretory system failing to respond rapidly enough to stimuli, 
or the insulin sensitive tissues having reduced s e n s i t i v i t y  
to insulin. This t a r g e t-organ resistance to insulin is 
e xac e r b a t e d  by diet and obesity as well as by genetic, 
endocrine and nervous system factors. If the response or 
the p r o d uction of insulin is altered then p e r s istent 
h y p e r g l y c a e m i a  may result.
In chronic hyperglycaemia, due to insufficient insulin 
administration or poor dietary control in both type 1 and 
type 2 diabetes mellitus there is a less dramatic rise in 
blood glucose levels than the acute situation described e a r l i e r  
but increases are observed above those found in normal 
individuals. Although no immediate effects of this high b l o o d  
glucose are apparent, it has been shown (Engerman aJL* 1982,
Chobanian <et al. 1982) that patients who consistently have a 
high level of blood glucose are more at risk later in life 
of having ’’diabetic c o m p l i c a t i o n s ” , such as retinopathy, 
n e u r o p a t h y  and c a r d i o v a s c u l a r  disease. Aspects of the 
importance of good control will be discussed in detail later. 
The a d m i n istration and a v a i l a b i l i t y  of insulin has th e r e f o r e  
overcome the problems of an acute, p o s sibly fatal disease, 
but p o t e n t i a t e d  a chronic disorder with degenerative 
complications.
MONITORING OF CONTROL IN DIABETES M E L L I T U S .
Historically, the efficacy of treatment of diabetic 
control by insulin or diet has been m e a s u r e d  using both 
urine and b l ood samples. Initially r e d ucing substances in 
urine were mea s u r e d  by the ability of a urine sample to 
reduce a test substance (Varley, G o w enlock and Bell, 1980) 
and cause a detectable colour change. Benedicts solution  
was u s u ally used for this purpose, changing from green to 
a r e d d i sh-brown according to the amount of re d u c i n g  s u b s tance 
present. These tests could therefore be either q u a l itative 
or q uantitative depending on the degree of tec h n i c a l  a c c u r a c y  
employed. H o w ever reducing substances other than glucose, 
such as uric acid or ascorbic acid may be present in suff i c i e n t  
quantities in a urine sample to cause interference. R e d u c i n g  
substances in b l o o d  were also m e a s u r e d  after p r e c i p i t a t i o n  of 
bl ood proteins. The ability of the sample to reduce e i t h e r
alkaline cupric copper solution to cuprous oxide, or 
alkaline pot a s s i u m  ferricyanide to f e r r o c y a n i d e , was then 
me a s u r e d  either i o d o m e t r i c a l l y  or c o l o r i m e t r i c a l l y .
As m e t h o d o l o g y  improved, the specific m e a s u rement of_ 
glucose in both b l ood and urine could be achieved. 
fC l i n i s t i x ! are m a r k e t e d  by Ames Co. Ltd. Each stick has 
an area i m p r e gnated with the enzymes glucose oxidase and 
peroxidase, together with o-tolddine and a pink dye. When 
dipped in urine, any glucose present is o x i dised to gluconic 
acid and h y d rogen peroxide. O-tolidine is then o x i dised to 
give a blue colour which, in combination with the pink dye 
present, produces various shades of purple, the depth of 
colour i ndicating the c o n c e ntration of glucose in the urine 
sample. Blood glucose could also be m e a s u r e d  using similar 
biochemistry.
These were l a b o r a t o r y  tests which were, until fairly 
recently the only ones available to the clinician to aid the
clinical assessment of long-term diabetic control. They are
/
also used in the acute situation for the man a g e m e n t  o f  diabetes 
mellitus t o g ether with the m e a s urement of u r i n a r y  ketones.
For the past decade this test repertoire has increased in m a n y  
laboratories to include the m e a s u r e m e n t  of g l y c o s y l a t e d  
haemoglobins.
Discovery of G l y c o s y l a t e d  H a e m o g l o b i n s .
In 1955 Kunkel and Wallerius reported that h a e m o g l o b i n
could be s e p a rated using starch gel electrophoresis, into
both a slow (HbA ) and a fast m o v i n g  band (HbA ). Allen,
° 1
Schroeder and Balog in 1958 achieved similar separations
using a c a t i o n -exchange column, and they were further able
to resolve the fast m o ving band (HbA^) into three components
designated H b A ^ a , HbA^^, and H b A lc according to t h eir order
of elution from the column. Further studies by M c D onald
et a l . (1978) have shown H b A ^  may be further sep a r a t e d  into
two peaks, HbA, and HbA (Fig. 1.2), and more r e c ently 
J- a^ a 2
C a s t a gnogla _et ad.. (1983) separated H b A ^  into two peaks,
HbA,, and HbA.., . 
1 l b 2
The clinical significance of these faster m o v i n g  m i n o r  
haemoglobin fractions was not unde r s t o o d  until 1968 when 
Rahbar noted their presence in the blood of certain d i a betic  
patients at levels much high e r  than those found in the blood 
of n o n - d i a b e t i c  individuals. Since this study there has been 
considerable work both to identify the chemical nature of 
these peaks and to examine their clinical relevance for the 
m o n i toring of diabetic treatment.
t— ) 
0.0Normal
Hemolysate
4
3 0.6
2 0.4
0.2
0
1.4Diabetic
Hemolysate^  X  6
^  5 1.0
4 0.8
3 0.6
2 0.4
0.2
0
100 200 400300
M*
FRACTION NUMBER
F i g . 1 -2
Elution pattern of normal and diabetic h emolysates c h r o m a t o g r a p h e d
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edge of the Hb A Q peak as well as in Hb A ^ c
Bunn et al. (1979) JBC. 254, 3892.
The Chemical Nature of G l y c o s y l a t e d  H a e m o g l o b i n s .
The m a jor component of normal human red cells is HbA, 
which consists of two ^(chains and two p  chains (Of^  ) and 
comprises about 97% of the total haemoglobin. The r e m a i n d e r  
of the h aemoglobin molecules are classed as H b A 2 ( 0 ^ § A ) 
which represents about 2% of the total, and HbF ( 0 ^ ^ )  which 
represents less than 1%. These h a emoglobins differ 
g e n e t i c a l l y  from the bulk of the haem o g l o b i n  (HbA).
The m i nor h aemoglobins (HbA, , HbA.. , HbA., and HbA, )
l a l la2 lb lc
are p o s t - t r a n s l a t i o n a l  mo d i f i c a t i o n s  of HbA (Bunn, 1981). 
Recently Tegos and Beutler (1980) have shown that HbA^ also 
has components analagous to those in HbA^, but since most 
h a e m oglobin in human adults is in the HbA form, the post- 
t r a n s l a t i o n a l  forms of H b A 2 are usually con s i d e r e d  i n s i g n i f i c a n t  
and ignored. H b A ^  is the most abundant of the m i n o r  post- 
t r a n s l a t i o n a l l y  m o d i f i e d  forms of h a e m o g l o b i n  (comprising 
about 4% of the total haemoglobins in n o n - d i a b e t i c  individuals) 
(Bunn, 1981), and was thus e x t e n s i v e l y  studied to e l u c idate 
the nature of this chemical modification.
(1) The chemical nature of H b A ^ » synthesis and k i n e t i c s .
Holmquist and Schroeder (1966) showed that the
N -terminal valines of the j? -chains are blocked by an
un i d e n t i f i e d  residue containing a linkage capable of b e i n g
reduced by sodium borohydride, the pK of this group b e i n g
about 6.65. Their results i n d i cated that a Schiff' base was
formed. They d e monstrated that the b l o cking group h ad a mass
spectrum comparable with a hexose linked to the N - t e r m i n a l  
valine, although they could provide no i n f o r mation about; its
identity. Dixon (1972) reacted glucose with peptides to show
that the glyco s y l a t i n g  agent in HbA could be glucose, and
lc
that glucose could theor e t i c a l l y  react with many other amino
groups, although at a slower rate. Ho w e v e r  it was F l u c k i g e r
3
and W i n t e r h a l t e r  (1976) who provided evidence using D-(2 -H) 
glucose incubation experiments that the initial product of 
glucose and h a e m o g l o b i n  undergoes an Amadori r e a r r angement 
(Fig. 1.3). Tritium is lost from the second carbon in an 
Amadori r earrangement and so, by m e a s u r i n g  the ratio b e t ween 
^H and "^C, it can be d etermined if this r e a r r angement has 
occurred, and to what extent. Such studies indicated that 
about 91% of the initial m a t erial had undergone the 
re a r r a n g e m e n t  after 22 days and that glucose had been thus 
converted to 1-deoxy- D - f r u c t o s e  attached to the h a e m o g l o b i n  
molecule.
The term " g lycosylated h a e m o g l o b i n "  was coined as a
result of all of these investigations to indicate that
initially a conde n s a t i o n  reaction occurs b e t ween glucose and
haemoglobin (Bunn, 1981) (Fig. 1.3). Although this is the
term i n o l o g y  used in this thesis, a recent letter by Roth
(1983) drew attention to the fact that g l y c o s y l a t e d
h a e m o g l o b i n  should more correctly be called glycated
haemoglobin, as this more a c c u rately describes the amino-
linked 1 - d e o x yfructose derivative of haemoglobin. In the
case of HbA; this reaction occurs at the N - t e rminal valine 
lc
of the ^ - c hains of haem o g l o b i n  molecules. Ori g i n a l l y  an 
aldimine linkage is formed which is labile, as the p r o cess
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is reversible (Fig. 1.3). However if the avail a b i l i t y  of 
glucose remains then, by the law of mass action, a percentage 
of this Schiff base will undergo an Amadori r e a r r angement 
to the stable ketoamine form p r e v i o u s l y  described (Fig. 1.3), 
a process which is esse n t i a l l y  irreversible.
The kinetics of this two-part reaction have been studied
using various in vitro and in vivo experiments. In 1975
Koenig and Cerami showed that a haem o g l o b i n  variant e x i s t e d
in diabetic mice which could be shown to be very similar to
the HbA^^ m o i e t y  found in humans. By injecting labelled
(NaB^Hi|) r e t i c ulocytes into both norm a l  and diabetic mice
they showed that the rate of synthesis of H b A ^ c in the
diabetic animals was much faster, c o n c urring with Rahbar's
association of the molecule with diabetes. In vitro
synthesis experiments incubating suspensions of r e t i c u l o c y t e s
3
and bone marrow cells (Bunn et, ail. 1976) with ( H) leucine 
have shown that there is a slower increase in the specific 
activity incor p o r a t e d  into H b A ^  than in HbA^, strongly  
suggesting that the addition of glucose to h a e m oglobin 
occurs as a p o s t - t r a n s l a t i o n a l  modification. Also in vivo 
work by Koenig and Cerami where they injected ( ^ F e )  
transferrin..; into two individuals, showed that the specific 
activity of HbA^ rose rapidly to a ma x i m u m  in the first week 
and remained at this level, whereas the specific a c t ivity of 
H b A l c , H b A la and HbA^^ increased gradually over a p e r i o d  of 
about 60 days. This reflects the slow formation of these 
haemoglobins continuously and near l y  irreversibly from HbA 
during the life span of the red cell. Studies separating
young and old erythrocytes using density gradient techniques
support this idea as they show higher c o ncentrations of
HbA in the old cells (F i t z g i b b o n s , Koler and Jones, 1976), 
lc
although the e f f i ciency of this type of separation has been
questioned (Svendsen e_t _al. 1981) .
The in vivo synthesis of HbA after an infusion of 
---------  lc
^ F e - b o u n d  transferrin ( Svendsen .et a l . 1981) was shown to
be slow, this being consistent with the n o n - e n z y m i c  nature
of the process as p o s t u l a t e d  by Bunn ejt ad. (1975).
Mathematical models of both the in vitro and in vivo work
described indicate that the stable ketoamine form of H b A ^ c
after the Amadori r earrangement forms at a rate of about
0.006% of total Hb/ mmol glucose /24hr. (Svendsen e_t ad. 1981).
The kinetics of both the condensation reaction (reaction
rate constant k^) to form the Schiff.base, and the r e a r r a n g e m e n t
reaction (reaction rate constant k 2 ) to form the stable
ketoamine have been studied in great detail (Bunn ert a]L. 1976,
Gabbay et al. 1977, Higgins and Bunn, 1981). C y a n o b o r o h y d r i d e
was introduced into the reaction mixture of h a e m o g l o b i n  and 
14
D-( C) glucose to ensure that the Schiff base was to t a l l y
converted to the stable compound. Cyanobo r o h y d r i d e  reduces
the labile component (Fig. 1.3) but does not affect the C=0
in the stable molecule. In this way the reaction rate constant
k could be measured. The reverse reaction rate constant k ,
1 “ 1
was derived by incubating the same components but e x c l u d i n g
the cyanoborohydride. The reaction to form the stable k e t o a m i n e
was allowed to p r o ceed for 6-21 days and then H b A ^ c was
separated and quantified. These rate constants describe the
chemical m e c h anism for the formation of HbA, and can also belc
used to assess the distribution of both the labile S c h i f f  base
and the stable ketoamine in both normals and diabetics.
Most importantly they indicate that the rate of formation
of stable HbA should be directly p r o p o r t i o n a l  to the 
1 c
t ime- a v e r a g e d  concentration of glucose within the red cell.
For this reason a non- d i a b e t i c  individual having blood
glucose within n a r r o w  limits of about 3-5mmol/l will still
have a percentage of their haem o g l o b i n  converted to H b A ^ c .
This percentage though, will be consi d e r a b l y  lower than for
a diabetic patient who c o n s i stently has a higher blood
glucose concentration. In vitro experiments incubating
erythrocytes from both patients with IDDM and n o n - d i a b e t i c
controls with identical glucose c o ncentrations (Spicer e_t a l .
1979) show that HbA, is s y n t hesised at the same rate in both
lc
cases. They confirm that the p r o d uction of H b A ^  is r e l a t e d
to time, pH,glucose c o n c e n t r a t i o n 7and t emperature as it is
increased from 4-°C to 37°C.
Once the stable HbA is formed in the red cell it
lc
remains within that cell until it is removed by the
r e t i c u l o e n d o t h e l i a l  system. The average life-span of an
e rythrocyte is about 120 days and within any cell there
will be a gradual accumulation of HbA. over this period.
lc
Since the removal and synthesis of e r y t h rocytes is c o n s t a n t l y
occurring, any single m easurement of stable HbA at any
lc
point in time will reflect the t i m e - a v e r a g e d  a c c u m u l a t i o n  of 
these m o l e cules throughout the whole pop u l a t i o n  of red cells. 
As the half-life of an erythrocyte is about 60 days t h e r efore,
a single HbA m easurement should provide information about 
lc
a patients glycaemic history over the previous 3-10 weeks.
This retrospective capability of the m e a s urement is
s upported by two observations. The life-span of red cells
in some species of animals is shorter and likewise the
percentage of H b A ^ c in the n o n - d i a b e t i c  members of these
species is decreased. Similarly if a human patient has
h a e m olytic anaemia their level of g l y c o s y l a t e d  haem o g l o b i n
will be lower, and so all interpretation of HbA. results 9 r lc
should be made with the realisation that any a b n o r m a l i t y  of
an individuals red cells affecting their life-span will alter
the r e s u l t s .
(2) The chemical nature of HbA. , HbA, „ and HbA . .    lal^ la2 lb
Haney and Bunn (1976) i nvestigated the reaction of 
the sugar phosphates found in e rythrocytes with Ebh^ and 
discovered the g lycosylation rate to be about 20 times 
faster than ass o c i a t e d  with glucose. Carbon labelling 
experiments of glucose 6-phosphate showed that the incor p o r a t i o n  
of this molecule occurred at the N-te r m i n a l  of the j^-chain. 
Stevens _et a_l. (1977) showed that many sugar p h o s phates react 
more r a p idly than glucose with haemoglobin. These include 
fructose 6-phosphate, fructose 1,6-diphosphate, ribose 
5-phosphate and ribulose 5-phosphate, although glucose 
1 -phosphate and glucose 1 , 6 -diphosphate have been shown not 
to react (Dolhofer and Wieland, 1 9 7 8 ) . This would suggest that 
the rapidly reacting sugars have an aldehyde or ketone group
which is separated from a w e a k l y  charged negative group 
(Bunn, Gabbay and Gallop, 1978).
C o - c h r o m a t o g r a p h y  work (Bunn, Gabbay and Gallop, 1978, 
McDonald ejt al.. 1978) of these synthetic p o s t - t r a n s l a t i o n a l  
haemoglobins indicates that the attached molecules of HbA-^-^ 
and HbA are fructose 1 , 6-diphosphate and glucose 6-phosphate
1 0 . Z
respectively. Although these sugar phosphates react inhe r e n t l y
faster than glucose with haemoglobin, since their c o n c e n t r a t i o n s
within the red cell are consi d e r a b l y  lower this is r e f l e c t e d  in
the smaller peaks observed. (Fig. 1.2). As ne i t h e r  fructose
1,6-diphosphate or glucose 6-phosphate are e l e vated in diabetes
mellitus it is not surprising that no increase has been
observed in HbA or HbA (Bunn, Gabbay and Gallop, 1978).
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The true nature of H b A ^  has yet to be determined. K r i s h n a m o o r t h y , 
Gacon and Labie (1977) showed a c i d i fication of the m o d i f i e d  
P" chain, and a dissociation constant of the group r e s p o n s i b l e  
for this a c i d i fication which s u g g ested deamination had occurred. 
This is in direct conflict with Garrick ejt al. (1980) who show 
H b A ^  to be n e g a t i v e l y  charged, reducible with b o r o h y rdride 
and producing a positive test with th i o b a r b i t u r i c  acid.
(3) The chemical nature of glyco s y l a t e d  A ^ .
As well as the H b A ^ c peak which can be s e p a r a t e d  ’
by chroma t o g r a p h i c  means from H b A Q (Fig. 1.2) , Bunn et_ a l .
(1979) found that the leading edge of HbA also con t a i n e d
o
carbohydrate as detected by the thioba r b i t u r i c  acid test.
This "glycosylated h a e m oglobin" (GHbA ) which did not se p a r a t e
o
from the main peak r epresented about 8-10% of the total 
h aem o g l o b i n  found in non- d i a b e t i c  individuals. Bunn et al.
(1979) also showed, using parallel incubation studies with 
H glucose (bound to the second carbon atom of the glucose 
m o l e c u l e ), that both synthetic HbA, and GHbA have undergone
-LC O
A madori r e arrangements to the more stable ketoamine linkage. 
Further work shows that the glucose in G H b A Q is a t t ached to 
the amino terminus of the 0(-chains, and via £ amino groups 
of lysines on e i ther the p( or ^-chains. In all cases the 
charge characteristics are not s u f f i c i e n t l y  altered by the 
attachments to generate c h r o m a t o g r a p h i c a l l y  distinct species 
and they remain within the main peak H b A Q (Fig. 1.2).
(4-) Add i t i o n a l  factors which may affect the 
g lycosylation of h a e m o g l o b i n .
Recently two other factors which may, or m a y  not 
affect the g l y c o s ylation of h a e m o globin have been discussed; 
no t a b l y  the role of red cell p e r m e a b i l i t y  to glucose, and the 
presence, if any, of enzymes which affect the gl y c o s y l a t i o n  
process.
Higgins, Garlick and Bunn (1982) showed that 
n o n - e n z y m i c  g l ycosylation of haem o g l o b i n  in mammals was
determined by three main variables; mean plasma glucose, red 
cell life span and the red cell p e r m e a b i l i t y  to glucose. They 
were able to study this last ch a r a c t e r i s t i c  which varies in 
different species of animals. In vitro experiments where 
glucose has been incubated with extracts of e i t h e r  old or 
young red b l ood cells (Gillery et a l . 1982) have shown a
significant increase in the amount of HbA formed in the
lc
young cells in contrast to the very small amounts formed in 
the older cells. They suggested the presence in the young 
erythrocyte membranes of a factor responsible for the 
transfer of glucose, which is lost in the older cells.
Whether or not this is the case, the passage of glucose 
into the red cell either by passive or active transport 
appears to be important in the formation of g l y c o s y l a t e d  
haemoglobin. Although the nature of the factors infl u e n c i n g 
this transfer of glucose is not yet clear, it has been 
s uggested that a g l y c o c o n j u g a t e , of still unknown structure 
and under enzymic control, is involved (Gillery e_t aJL. 1982).
The presence of other enzymes which cleave the
carbohydrate from the stable form of g l y c o s y l a t e d  h a e m o g l o b i n
(Fig. 1.3) has also been s u g g ested (Lubec et_ al. 1983). In
1976 Bunn ejt al. developed equations e n c o m p a s s i n g  the rate
of synthesis and net a c cumulation of H b A n under various J lc
conditions. He used three possible m a t h e m a t i c a l  models to 
describe the process, termed "reversible," " i r r e v e r s i b l e ” and 
"slightly r eversible" and showed that his e x p e r i m e n t a l  data 
best fitted the latter category. This i n d icated that there 
was possi b l y  an enzyme present which could reverse the t r a n s f e r  
of the labile to the stable form. Recently Lubec _et al. (1983) 
have p r o duced evidence indicating that there are enzymes pr e s e n t  
in diabetic lysosomes which can cleave the bon d  be t w e e n  p r o t e i n
and carbohydrate molecules. If present, these enzymes are 
N - l - d e o x y f r u c t o  furan o s y l - g l u c o h y d r o l a s e s  and, in contrast 
to g l u c o s i d a s e s , only a few enzymes h y d r olysing glycosyl 
compounds have pre v i o u s l y  been described in mammalian systems. 
The effect and significance of that effect, if any, of these 
enzymes has yet to be investigated, but it would seem that 
although other enzymic pathways may influence g l y c o s y l a t i o n 
of haemoglobin, the n o n - e nzymic p a t h w a y  as p o s t ulated by 
Bunn e_t al^ (1979) still remains of m a jor importance. M o n n i e r  
(1983) questioned the evidence p r e s e n t e d  by Lubec e_t a_l. (1983) 
suggesting that their data was not sufficient to support the 
existence of an enzyme which can hydrolyse k e t o a m i n e - l i n k e d  
glucose. If this enzyme does not exist, then p r e s u m a b l y  the 
enzymes found in lysosomes by Lubec ejt aj.. (1983) are a s s o c i a t e d  
with another catabolic pathway which does not affect sound red 
cells.
(5) L a b i l i t y .
Now that the chemical nature of g l y c o s y l a t i o n  has 
been elucidated, it is widely accepted that there are two 
steps to the n o n - enzymic addition of glucose to a h a e m o g l o b i n  
molecule (Fig. 1.4); with the initial formation of the labile 
aldimine before the second step to the stable ketoamine 
product. The presence of these two g l y c o s y l a t e d  h a e m o g l o b i n  
fractions, together with the wide m u l titude of techniques  
used for their m e a s u rement has lead to conflicting results 
and confusion in the. literature (Svendsen et: al. 1979) when
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i n t e rpreting g lycosylated h a e m oglobin results in terms of 
clinical findings. To ensure that the usefulness of the 
glyco s y l a t e d  h aemoglobin m e a s urement is not brought into 
question, man y  workers r e c ommend the routine removal of the 
labile adduct (Daneman, Luley and Becker, 1982, C ompagnucci 
et a l . 1981).
GLYCOS Y L A T I O N  OF PROTEINS OTHER THAN H A E M O G L O B I N .
As early as 1912 Maillard (quoted by Monnier and Cerami,
|i ^
1982) suggested that chemical reactions known as bro w n i n g  
reactions occur, and that they may play an important role in 
the secondary complications observed with diabetes mellitus.
In these reactions reducing sugars attach to amino groups of 
proteins forming Schiff bases which polymerise to give a brown 
product, hence the terminology. Although the food i n d ustry 
has long recognised the importance of these reactions in the 
way they influence the a vailability of essential amino acids, 
or toxicity of food products, the m e t a b o l i c  implications have 
until quite recently been virtually ignored. However, since 
the awareness of the n o n - e n z y m i c  g l y c o sylation of h a e m o g l o b i n  
in v i v o , this has led to investigation of glyco s y l a t i o n  in 
other proteins. Subsequently interest has been shown in 
a ssessing both the effect of g l y c o sylation on the b i o l o g i c a l  
function of different proteins, and also determining w h e t h e r  
their m e a s urement is of any value in mon i t o r i n g  g l y c aemic 
control.
Gl ycosylation of Proteins - Possible Pathophy s i o l o g i c a l  
C o m p l i c a t i o n s .
Perhaps the most far reaching and c hallenging aspect of 
no n - e nzymic g l y c o s ylation is its possible role in the long 
term complications of diabetes mellitus. This post- 
translational m o d i f i c a t i o n  appears to be widespread, affecting 
many diverse tissues and proteins. The type and lon g e v i t y  of 
the protein studied should be crucial as to the effects 
observed.
The first tissue to be investigated to try and link 
n o n - e n z y m i c  glycosylation and the p a t h o l o g i c a l  sequelae of 
diabetes mellitus was the occular lens, and therefore lens . 
protein. JEn vitro studies showed that lens protein could 
become g l ycosylated to form protein aggregates which d i f f r a c t e d  
light (Monnier and Cerami, 1983). This o b s e r vation m i m i c k e d  
the _in vivo findings of the protein within the diabetic lens 
(Kasai et al. 1983). Further ill vitro g l y c o s y l a t i o n  of the 
protein caused "browning" to occur. If g l y c o s y l a t i o n  is 
oc c urringwithin the lens this will be e s s e n t i a l l y  an 
irreversible effect as lens crystallin has remarkable 
longevity. Glycosylation therefore, may be implicated in the 
development of diabetic cataracts and r e t i n o p a t h y  (Kennedy.
and Baynes, 1984).
As g l y c o s ylation of h a e m o globin is well studied, the 
investigation of possible glycosylation of the proteins of 
the red cell membrane was a logical choice. McMillan and 
Brooks (1982) studied spectrin, which is the m a j o r  p r o tein
of the inner surface of red b l ood cell membranes. This 
protein is incorporated into a network which allows the 
erythrocyte to deform and return to its original shape.
This f lexibility of form is reduced in diabetics, but as 
yet there is no evidence to suggest that this is a direct 
consequence of glycosylation. It is possible h o w e v e r  that 
glycosylation may be i ndirectly implicated through its 
inhibition of membrane protein tran s g l u t a m i d a t i o n  which is 
responsible for the removal of aged erythrocytes.
Art e r i o s c l e r o s i s  occurs at an accelerated rate in diabetes
mellitus and so the role of g l ycosylation of l i p o p roteins was
studied to see if any connection could be produced. I_n vitro
and jLn vivo g l ycosylation of both LDL and HDL has been
de m o n strated (S c h l e i c h e r , 1981) using the furosine method.
G l y c o sylation of lipoproteins was higher in diabetics than
14-in the control group. Ln vitro studies of C glucose uptake
showed that the rate of glycosylation of lipoproteins was
about 25% less than that observed for albumin. These w o r kers
argued that as the chemical modif i c a t i o n  of apo-B lysine
residues by acetylation increases the cellular uptake of LDL
and cholesterol via scavenger receptors in p e r i p h e r a l  cells,
it follows that g l y c osylated modif i c a t i o n s  of lysine re s i d u e s
may produce a similar effect. Gonen et_ aJ.. (1981) found that
in vitro g lycosylated LDL became e n c losed in human figr o b l a s t s
and so was degraded less than the control LDL. G l y c o s y l a t i o n
of LDL also impairs its ability to stimulate c holesteryl  
synthetase (Witztum e_t ajL. 1982). The implications of all of
these findings are that glyco s y l a t i o n  may alter the function 
of lipoproteins and so contribute to the problems of 
arteriosclerosis a ssociated with diabetes mellitus.
Similarly Brownlee, Vlassara and Cerami (1983) demon s t r a t e d  
that the g l y c o sylation of fibrin occurs and that this 
m o d i f ication reduces the s u s c e p tibility of fibrin to plasmin 
degradation. A c e t ylation or carbamylation at the lysine 
amino groups may cause a similar effect. The a c c u m ulation 
of fibrin within a diabetic patient may well contribute to 
vascular problems.
Chavers, E t z wiler and Michael (1981) used i m m u n o f l u o r e s c e n t  
techniques to show that there was increased deposition of 
albumin in dermal capillary membranes associated with diabetes 
mellitus^ (IDDM). ^In vitro studies of the i n corporation of 
■^C-glucose into purified rat g l o m erular basement mem b r a n e s  
(Cohen e^t aJL. 1981) indicated that increasing glucose alters 
the chemistry of t h i s ; and other basement membranes. This 
suggests that g l ycosylation may be the cause of altered 
protein m e t a b o l i s m  leading to its accumulation, and that it 
may relate to the various m i c r o a n g i o p a t h i c  sequelae a s s o c i a t e d  
with diabetes mellitus. Kohn and Schnider (1982) found that 
g l ycosylation of collagen occurs at the £f-amino group of 
lysine. They (Kohn, Cerami and M o n n i e r ? 1984) later showed 
that there was an association b e t w e e n  glycos y l a t i o n  and the 
cross-linking of collagen as found in the ageing processes.
This work was supported by Eble, Thorpe and Baynes (1983).
The cross-linking causes decreased s o l u bility of collagen in
a similar manner to that observed when albumin (Kennedy 
et a l . 1981) or lens protein (Monnier and Cerami, 1982) 
are glycosylated. For this reason Kohn and Schnider r e c o mmended 
control of glycaemia, p a r t i c u l a r l y  in periods of collagen 
synthesis. Similarly Yue et aJL. (1983) demonstrated 
glycosylation of collagen but related it to increased thermal 
rupture, or collagen stability. Bassiouny, Rosenberg and 
McDonald (1983) found that collagen altered by g l y c o s y l a t i o n 
became antigenic. Myelin, both p e r i pheral myelin and that 
of the central nervous system, have been shown to be subject 
to excessive g l ycosylation in diabetes. This work was done 
by b o r o hydride reduction followed by separation on a 
m - a m i n o p h e n y l b o r o n i c a c i d  gel, Biogel P6, which sele c t i v e l y  
retai'ns glyco s y l a t e d  amino acids. The appropriate aliquots 
of amino acids were then analysed. The g l y c o sylation of 
myelin may contribute to the functional a b n o r m a l i t y  of 
m y l e l i n a t e d  neurons a ssociated with diabetes mellitus .
(Vlassara, Brownlee and Cerami, 1983).
Short-lived proteins (eg. peptide hormones) may also 
become glycosylated. However as the process is n o n - e n z y m i c  
it is rel a t i v e l y  slow and the c o r r e sponding g l y c o s y l a t i o n  of 
these sh o r t - h a l f - l i f e - m o l e c u l e s  is likely to be so small as 
to have an insignificant effect. Glyco s y l a t i o n  of p e p tides 
and amino acids as investigated by affinity separation of 
the different sugar groups (Brownlee, Vlass a r a . a n d  Cerami,
1980) followed by specific chemical identi f i c a t i o n  m ay r e v e a l 
more about any alterations in their b i o l ogical properties.
Other aldose sugars may also react s i g n i ficantly with p r o t e i n  
amino groups. Urbanowski e_t al. (1982) d e m o n s t r a t e d  
galactosylation of albumin in asso c i a t i o n  with a child that
had g a l a c t o s a e m i a . This m o d i f ication of the protein is 
very similar to that of g l ycosylation with an Amadori 
r e a r r angement and may contribute to the complications of 
the disease.
Although there is evidence for gl y c o s y l a t i o n  of man y  
proteins which must have functional abnormalities to cause 
the observed p a t h o l o g i c a l  defects observed with diabetes, 
the evidence of the m odification actually causing these 
effects is poor. Most of the work has been performed in 
v i t r o . It is known that the b i n d i n g  of glucose to the end 
of the p chain of h a e m oglobin ( H bA^c ) decreases the b i n d i n g  
of 2,3-DPG at that site. As b i n d i n g  of 2,3-DPG serves to 
shift the o x y h a e m o g l o b i n  dissociation curve thereby r e d u c i n g  
the affinity of haem o g l o b i n  for oxygen^ it w o u l d  follow that 
high levels of HbA-^c in. vivo would result in higher oxygen 
affinity. This is not observed as there is a c o r r e s p o n d i n g  
increase of 2,3-DPG in diabetic red cells to compensate for 
this effect (Arturs on ejt al^. 1974).
The effect of reductive alkylation on the p r o p erties of 
proteins has been noted by Means and Chang (1982) and only a 
few proteins have as yet been identified as havi n g  their 
f u n c t i o n .altered by modification. These include HDL and LDL 
in humans. The overall evidence suggests that these are 
simply the early investigations into this p r oblem and as yet 
no proven connection between glycosylation and its effect on 
the function of proteins has been conc l u s i v e l y  shown. If in 
the future this were to be the case then the argument for 
stringent diabetic control w o uld be irrefutable.
Chemistry and Kinetics of Protein G l y c o s y l a t i o n .
Reactions between reducing sugars and the amino groups 
of proteins are now widely recognised, as is the natural 
occurrence of many n o n - e n z y m i c a l l y  glyco s y l a t e d  proteins.
The rate and extent of the reaction will depend on temperature, 
concentration and time of contact (Yue e_t a_l. 1980), as well 
as the ba s i c i t y  of the carbonyl group and its steric 
a c c e s s ibility (Means and Chang, 1982). The amine bas i c i t y  
appears to have little significance but its pKa value does.
For this reason the 0(-amino groups which usually have lower 
pKa values than the -amino groups should be more susc e p t i b l e 
to non- e n z y m i c  glycosylation. However, the -amino lysine 
groups are generally more accessible in proteins for 
glycosylation, h a e m o g l o b i n  being a special case. The 
importance of steric hindrance can be d e m o n s t r a t e d  by the 
fact that the addition of acyclic amines to f o r m a l d e h y d e "is 
considerably less favoured than the addition of the simple 
primary amines (Means and Chang, 1982). After the a ttachment 
of the carbonyl group to the amine an Amadori re a r r a n g e m e n t  
occurs, p r o bably followed by cyclization for s t a b ility of 
the product. Evidence for the Amadori r e a r r angement was 
pro v i d e d  by Bunn _et £Ll. (1975) who d e m o n s t r a t e d  that on 
hydrolysis albumin yielded glucose and mannose in the ratio 
o f  4:1. The amino portions of proteins are s usceptible to 
modi f i c a t i o n  by many different aldehydes; formaldehyde; 
a cetaldehyde and glucose, all of which cause "browning" at
high levels (Fantyl, Stevens and Peterson, 1982). 
C o n s equently the studies of glycosylation in a ssociation 
with diabetes may involve other molecules which bin d  to 
proteins. The attachment of acetaldehyde in alcoholics or 
the carbamylation' of proteins in association with uremia 
may also contribute to the various p a t h o logical effects 
observed.
Yue et' al. (1980) showed that plasma proteins of all 
sizes could undergo n o n - e n z y m i c  glycosylation, and that 
there was no difference between normal and diabetic plasma 
proteins. The elevation of g l y c o s y l a t e d  plas m a  proteins 
(GPP) was directly p r o p o rtional to that of g l y c o s y l a t e d  
albumin (GAlb) ('McFarland eJL cLl. 1979) but only 60-70% of 
the total g l y c o s y l a t e d  material was a t t r i butable to albumin. 
Studies of glyco s y l a t e d  proteins other than h a e m o g l o b i n  
(Day ejt ajL. 1979) by incubating human serum with t r a c e r  
amounts of labelled glucose showed a linear a c c u m u l a t i o n  of 
no n-dialysable label. Further i n vestigation ind i c a t e d  that 
the ra d i o a c t i v i t y  was a s s o ciated with three m a j o r  m o l e c u l a r  
weight proteins ; ([albumin , fclgG andiilgM.
When assessing the use of gl y c o s y l a t i o n  as a t o o l  w ith  
which to mo n i t o r  glycaemic control, both GPP and GAlb as 
well as g l y c o s y l a t e d  h a e m o g l o b i n  have been used. Do l h o f e r  
and W i e land (1980) showed a good correlation of GAlb with 
glycosylated, h a e m o globin (r=0.88, n=74) and Day <et a l .
(1980) with fasting glucose (r=0.91), i l l u s t r a t i n g  the 
i n t e r r e lationships between these various components. Since
the survival of albumin in the circulation is about 
one-sixth that of haemoglobin, it presents an oppo r t u n i t y  
to measure diabetic control over a much shorter time-span; 
of 1-2 weeks rather than 8-10 weeks. This is consistent 
with the half-life of albumin being appro x i m a t e l y  17 days 
(Schultze and Heremans, 1966). The advantage of this 
approach of assessing m e d i u m - t e r m  control is p a r t i c u l a r l y  
relevant in the more acute situations such as where control 
is being regained after coma. It could also be applicable 
to the mon i t o r i n g  of diabetic pre g n a n c y  where small 
deviations from optimum control should be detected at the 
earliest opportunity.
Several workers have shown that there are higher levels 
of GAlb (n=107) in the diabetics studied than in the controls 
(n=82). Different studies confirm the faster tur n o v e r  time 
of GAlb and GPP compared to g l y c osylated haemoglobin.
Dolhofer and Wieland (1980) found a 50% decrease in GAlb over 
20 days compared to a 15% decrease in g l y c o s y l a t e d  h a e m o g l o b i n ,  
and similarly Kennedy _et al. showed a mean decline of  35% in 
GPP in their studies whereas the g l y c o s y l a t e d  h a e m o g l o b i n  
value only fell 8%. Dolhofer, Renner and Wieland (1981), 
studying patients with either severe diabetic k e t o a c i d o s i s 
or n o n - a cidotic coma found, as they recovered, a m a r k e d  
decrease in GAlb (40% in 17 days) yet no observable change 
in glyco s y l a t e d  haem o g l o b i n  values over the same period.
Day elt al_. (1980) induced diabetes in rats wit h  varying 
severity using alloxan. Following w i t h d r a w a l  of insulin the 
half-times to reach a new steady state for glucose, GPP and 
g lyc o s y l a t e d  haemoglobin were 2, 3 and 8 days respectively.
On reinstatement of treatment the times were 2, 3.5 and 15 
days, again emphasising the different turnover times of the 
different components.
Not only is the rate of change increased, but the 
absolute rate of change in concentration of glyc o s y l a t e d 
protein has been shown to exceed that observed for h a e m o g l o b i n 
in the same amounts. With increases of upto 30% occurring 
for GAlb (Guthrow ej: _al. 1979) whereas only 20% as a m a x i m u m  
for glyco s y l a t e d  haemoglobins, this suggests that the 
measurement of GAlb may also be a more sensitive indicator 
of integrated b l ood glucose. This increased s ensitivity is 
also indicated by the observation that many diabetics that 
appear to be controlled in terms of glyco s y l a t e d  h a e m o g l o b i n  
measurement have less than satisfactory results for GPP' . 
(McFarland ejt _al. 1979). As well as p r e s e n t i n g  information' 
over a shorter time scale and po s s i b l y  being a more sensitive 
constituent than HbA^, the m easurement of g l y c o s y l a t e d  p r o t e i n s  
may circumvent problems a ssociated with HbF or h a e m olytic 
disease which affect the g lycosylated h a e m o globin measu r e m e n t .
METHODOLOGY USED FOR THE M EASUREMENT OF G L YCOSYLATED
H A E M O G L O B I N S .
There have been some excellent reviews by Bunn (1981), 
Garel ;et 'al« (1979) and, more recently Mayer and Freedman 
(1983), of the various methods em p l o y e d  for the m e a s u r e m e n t  
of glyco s y l a t e d  haemoglobins. The methods have been des c r i b e d  
and their various shortcomings outlined. Most techniques 
exploit the inherent small charge differences b e t ween HbA
o
and HbA^ ("fast haemoglobins") to achieve separation. These 
techniques include ion-exchange column chromatography, high- 
pressure liquid chroma t o g r a p h y  (HPLC), agar gel e l e c t r o p h o r e s i s  
and isoelectric focussing, and since they have the same 
underlying principle many of these methods experience s i m ilar 
problems. Other methods are based, not on charge d i f f erences  
but on the chemical removal of the attached carb o h y d r a t e  
molecule from the h aemoglobin and its quantitation via a 
colour reaction (Fluckiger and Winterhalter, 1976). These 
latter techniques therefore measure the actual g l y c o s y l a t e d  
material rather than just a separated peak or set of peaks, 
but are still prone to problems albeit different ones. This 
last category also includes immunological methods w h ich are 
as yet, not proving suitable for routine u s e .
As these current methods measure different m o i eties of 
the process of n o n e n z y m i c  ■ p o s t - t r a n s l a t i o n a l  m o d i f i c a t i o n  
of haemoglobin, then different m e t h o d o l o g i c a l  p a r a m e t e r s  and 
i n t e r f e r i n g  agents bring these differences into p e r s p e c t i v e .
Ion-exchange Column C h r o m a t o g r a p h y .
At present this is p r o bably the most widely used
technique in clinical laboratories for the m easurement of
g l y c o sylated haemoglobins. This is pro b a b l y  for two reasons.
Firstly the technique is simple, r e l a t i v e l y  easy to do and
does not require expensive equipment, secondly it was
h i s t o r i c a l l y  one of the first methods available which was
suitable for routine use. Although Allen, Schroeder and
Balog (1958) used a cation-exchange column to resolve the
faster moving haemoglobins into their constituent components
(HbA , HbA,.. and HbA, ) this technique was very time- 
l a 9 lb lc ■ J
consuming as it involved extremely long columns. Trivelli,
Ranney and Lai (1971) p r o duced a faster long column pro c e d u r e
using a Biorex 70 cation-exchange resin (sodium form) of 100
to 200 mesh size, on which most of the subsequent methods
have been based. They were able to separate H b A ^ c from the
other "fast h a emoglobins" in a suitable time scale ( a p p r o x i m a t e l y
3hr.) so that the routine measurement of HbA.. became feasible.
lc
With the growing awareness of the importance of the a s say 
for routine diabetic m o n i toring there arose a n eed for s i m p l e r  
and more rapid techniques. These were f r e q uently b a sed on the 
original method of Trivelli, Ranney and Lai (1971). I n v a r i a b l y  
the column length was shortened and although this inc r e a s e d  
the speed of separation it was at the expense of resolution, 
the process separating only the total "fast h a e m o g l o b i n "  or 
HbA^ and not its components. Kynoch and Lehmann (1977) first
reported a short column m e t h o d  which completed the s eparation
in only two and a half hours. They used a 20ml syringe
barrel (i.d.2cm) to hold a 5ml column of resin, which was
equil i b r a t e d  prior to the run with a p h o s phate buff e r  at
pH6.8. Cyanide was included in the solution used to prepare
the haemolysate prior to loading onto the column. The same
equilibration b u f f e r  was used (100ml) to remove and collect
the ’’faster moving h a e m o g l o b i n s ” from the column. Then a
further 100ml of a second phosphate b u f f e r  at pH 6.4 was
used to collect the remainder of the haemoglobin (HbA ).
o
After suitable dilutions, the absorbance at 414nm of both 
fractions was me a s u r e d  and the pro p o r t i o n  of material in the 
’’fast f r a c t i o n ” calculated. The columns were then r e - e q u i l i b r a t  
with the first buffer before reuse. The main a ttraction of 
such a technique is its simplicity, requiring only a 
s p e c t r o p h o m e t e r , and a group of columns which can be run 
simultaneously. However as large quantities of b u f f e r  are 
used and it is important that the columns do not run dry, a 
buffer r e s e rvoir must be set up for. each column.
Other methods claimed to reduce the assay time to forty 
minutes (Chou, Robinson and Siegal, 1978) and twenty mi n u t e s  
(Welch and Boucher, 1978). As well as speed these methods 
have additional advantages; requiring smaller samples and less 
cyanide for haemolysis, thereby reducing hazard to the 
operator. Nowadays several short column methods using 
disposable columns and resin, are comme r c i a l l y  available.
These include the ’’Fast H aemoglobins Test S y s t e m ” as ma r k e t e d 
by Isolab Inc. and assessed by Dix e_t al_. (1978), and the 
commonly used Biorad Kit. Comparisons have been made between 
the collective m e a s urements for all of the fast m o ving 
components as m e a s u r e d  by long columns, and the HbA_^ results 
achieved for the same samples using the shorter columns.
Abraham ejt a_l. (1978) showed these to be clinically equivalent, 
although Arnquist et_ aJL. (1981) indicated that the shorter 
columns gave lower values for glycosylation. R e c ently C a s t a g n o g l a  
e t .al. (1983) pointed out that the results from the two methods  
are only comparable when the temperature is m a i n t a i n e d  at 
p r e c i s e l y  20°C. Higher temperatures cause ov e r e s t i m a t i o n  with 
the shorter Biorad columns, and vice v e r s a . Close attention 
to temperature control has been c onsidered very important when 
ion-exchange ch r o m a t o g r a p h y  methods are used for the m e a s u r e m e n t  
of glycosylated h a e m o globins (Schellekens et_ aJ.. 1981, Simon 
and Eissler, 1980). Rosenthal (1979) re p o r t e d  that c o e f ficients 
of variation, b e t w e e n - b a t c h , could be reduced to below 2% with 
commercial kits when rigid temperature control was a d h ered to. 
Schellekens et a l . '(1981) stated that poor temp e r a t u r e  control  
affected both the results obtained from long and short columns.
Conditions for optimum chromat o g r a p h i c  sepa r a t i o n  have 
been exte n s i v e l y  studied and the effect of altered b u f f e r  
c omposition and pH on the elution c h a r a c teristics has been 
r e p o r t e d  (Jongeel and van Wissen, 1979, B o u cher et al.,1983). 
Schellekens _et a_l. (1981) recommended attention to b u f f e r  
composition, and a rela t i v e l y  constant sample loading (1.3 to
2.0 mg Hb per ml of resin). Simon and Eissler (1980)
i nvestigated the effects of c h romatographic conditions on
the separation of g l y c o s y l a t e d  haemoglobins by comparing
pur i f i e d  HbA recovery and pool results when each pa r a m e t e r  
lc
was i n d e p endently varied. They suggested that the t emperature
should be kept within 19 to 21°C, the pH of the eluting
p hosphate buffer between 6.70-6.72 and its ionicity at
0 . 0 6 - 0 . 005mM/l to ensure a good recovery of H b A ^  with the
m inimal contamination from HbA . They also found that theo J
m o l arity of the e q u i l i b r a t i o n  buffer was important and
r e c o mmended that this should be 0.07M. The precision was
also shown to improve when the absorbances were re c o r d e d  at
M-l^nm rather than 540nm. Other workers have carried out
similar studies; Jongeneel and van Wissen (1979) also
r e c o mmended close limits for the elution buffer, n a m e l y
pH6.85 and a c o ncentration of 87jnosm/kg. To correct for
possible variable recoveries due to small variations in these
parameters at least one commercial kit (Biorad) employs a
reference HbA mat e r i a l  for use with each batch o f  tests.
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Factors other than those described above have been shown 
to cause problems with ion-exchange column procedures. 
Ar t i ficial increases in the g l y c o s y l a t e d  fraction due to 
sample ageing (Gruber and Koets, 1979) and uremic c a r b a m y l a t i o n  
(Fluckiger et_ al. 1981) have been reported. Samples c o n t a i n i n g  
high levels of foetal haemoglobin (HbF), for example from 
children under years of age (Kaplan e_t slI. 1982) also y i eld
falsely high results, as the HbF coelutes with HbA^. Other 
haemoglo b i n o p a t h i e s  in which there is a p redominance of HbS 
or HbC do not affect the recovery if they are in the 
heterozygous state, although HbA must be assessed i n d e p endently 
(Aleyassine, 1979). Column ch r o m a t o g r a p h y  cannot be used at 
all with homozygous haemoglob i n o p a t h i e s .  Other factors which 
have been shown to give errant results with ion-exchange 
c h r o m a tography include severe jaundice (Simon and Cuan, 1980), 
and severe lactescence (Dix ejt al. 1979).
(1) Further mo d i f i c a t i o n s  of ion-exchange c h r o m a t o g r a p h y .
There have been a p r o g r ession of m o d i f i c a t i o n s  of 
the original method described by Trivelli, Ranney and Lai (1971) 
to achieve faster methods with better resolution, ho w e v e r  none 
avoided the need for stringent control of the assay conditions.
A natural prog r e s s i o n  was the use of HPLC. This was d e v e l o p e d  
(Davis, McDonald and Jarett, 1978) using small m esh Biorex 70 
columns and a 3 yu.1 sample size to separate and m e asure H b A ^ .  
Each run took 20 minutes and coefficients of variation of 5-10% 
were claimed. By automating HPLC Gruber and Koets, (1979) and 
Dunn, Cole and Soeldner (1979) were able to obtain superior 
precision figures for the assay of less than 2%. Although in 
his review Bunn (1981) favours column chromatography, 
parti c u l a r l y  HPLC for the meas u r e m e n t  of g l y c o s y l a t e d  
haemoglobins, there are some inherent problems for m any c l i nical 
laboratories. Most obviously many laboratories do not have
the expensive equipment required, and there still remains 
a need for stringent control of the exact operating conditions. 
Also only a single sample may be analysed at any one time, 
which is p r o h ibitive for use with large clinics. The technique 
therefore is not ideal for routine use. The main benefit of 
superior resolution probably proves more useful for research 
purposes rather than in the clinical situation (James _et_ a l . 
1981).
Other techniques to increase the speed and s pecificity
of the separation have been tried. Davis and Nicol (1978)
used centrifugation to increase the speed of elution of
m aterial to 5 minutes thereby making outpatient results at
the clinic a reality. Rosenthal, Vazquez and Seckinger (1981)
put h aemolysate into a slurry of resin which s e l e c tively
absorbs H b A ^ . By s u bsequently using a cell separator to
isolate the hbA^ fraction this could then be q u a n t i t a t e d  using
a spectrophotometer. A further method (Maquart _et a_l. 1980)
used three sequential buffers of differing saline concentration,
rather than the c onventional two phosphate b u ffer system, to
increase the specificity and so separate HbA from the column.
Very recently a letter by Rowe and G o o dland (1984) m e n t i o n e d  a
commercial kit based on ion-exchange chromatography, from
Biorad Laboratories, which offers increased s pecificity for
HbA , with prior elution of HbA., , , but at the expense of a 
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slightly longer elution time (an additional 30 min.).
Although there are various problems, short column 
ion-exchange methods or various m odifications thereof will 
probably continue to find wide acceptance in clinical 
laboratories.
(2) Labile material as m e a s u r e d  by ion-exchange 
c h r o m a t o g r a p h y .
There have been various r e c ommendations of how
best to dissociate the labile material from the stable
glyco s y l a t e d  haemoglobin fraction, prior to m e a s u rement
with ion-exchange chromatography. Most workers r e c o m m e n d  a
p r e i n cubation step with the e rythrocytes in isotonic saline.
The temperature and duration of the incubation remains in
dispute with 37°C for 6 hours (Compagnucci e_t. ad.. 1981) and
4°C for 48 hours (Daneman, Luley and Becker, 1982) both
advised. To increase the speed of the p r e i n c u b a t i o n  p r o c e d u r e
Nathan, Avezzano and Palmer (1981) developed a 30 minute
incubation step where erythrocytes were suspended in 30mM
semicarbazide and 12mM aniline at pH5.0 and 38°C. Other
workers have shown that the requirement for the rapid removal
of labile material is less complex and can be achie v e d  by
o
a djusting the glucose-free media to pH5 at 37 C. (Bannon 1982,
Bisse, Berger and Fluckiger, 1982). Goldstein (1982) c o m p a r e d
dialysis and p r e i n cubation as alternative methods for the
removal of labile material. He found that while both t e c h n i q u e s
were satisfactory to eliminate that material which r e f lects the
recent changes in blood glucose, dialysis did not give an
accurate measurement of the true ketoamine form as. it t e n d e d
to underestimate the HbA form and overestimate the HbA.
lc la+b
fractions.
Compagnucci ej: ad.. (1981) studied day-to-day variation 
in both labile and stable material in two groups of patients; 
unstable diabetics (n=7) and w e l l - c o n t r o l l e d  diabetics (n=15). 
They calculated the labile fraction as the total minus the 
stable results where these were achieved before and after 
saline incubation respectively. They found that both groups 
did not exhibit any significant d ay-to-day variation in their 
stable glyc o s y l a t e d  h aemoglobin results, but there was m a r k e d  
variation of the amount of labile m a t erial associated with 
the unstable diabetic group. This was not seen with the 
w e l l - c o n t r o l l e d  diabetics. On this basis, Compagnucci et a l . 
r e c o mmended the removal of labile material routinely for all 
situations where both unstable and w e l l - c o n t r o l l e d  diabetics 
are being m o n i t o r e d  clinically. Daneman, Luley and Becker 
(1982) also h i g h l i g h t e d  the possible relationship of labile 
fraction with diabetic instability. Arnquist ejt a3-. (1981), 
using ion-exchange showed that with 9 patients changing from 
very poor control the initial rapid decrease in HbA^ values 
was due to labile g l y c osylated h a e m o g l o b i n  and then a slower 
decrease due to the stable fraction was observed. Many 
workers have also n o ted the a ssociation between b l o o d  glucose 
of a sample and its labile fraction. (Compagnucci e_t a l .
1981, Trovati ejt aJL. 1981). When Bolli jst a^. (1981) i n c u b a t e d  
samples ill vitro with concentrations of glucose upto 21.5 m m o l / 1  
over 2 to 12 hours, the labile fraction fluctuated 1.47% 
whereas the stable fraction did not s i g n i f i c a n t l y  alter. Other 
workers have discussed the influence of a glucose load, such 
as in the oral glucose tolerance test, on the values of
labile and stable HbA-^ and there has been some d i s a g r e e m e n t
about their findings. Goebel jet aJL. (1981) found severe 
hy p e r g l y c a e m i a  over a period in excess of 6 hours was 
required in healthy subjects to increase their stable HbA^, 
whereas Scobie e_t a_l. (1981) found an increase in values of 
HbA^ 10 to 30 days after an oral glucose load of 50g.
These discrepancies are po s s i b l y  due to the labile material, 
and the removal of this fraction before the d e termination of 
stable g lycosylated h aemoglobin should be per f o r m e d  to 
circumvent similar m i s u nderstandings.
Agar Gel E l e c t r o p h o r e s i s .
In the early work of separating the "faster moving" 
haemoglobins Rahbar (1968) employed an e l e c t r o p h o r e t i c  
technique. Allen jet al_. (1979) were the first to describe 
the use of agar gel e l e c t r ophoresis for their separation 
and quantitation, a system which exploits both the 
chromatographic and electro p h o r e t i c  charac t e r i s t i c s  of the 
gel. As H b A Q carries a more positive charge than H b A ^ c it 
interacts more strongly with the fixed negative charges in
the gel leaving HbA to be swept at a faster rate towards
lc
the cathode by the e l e c t r o - e n d o s m o t i c  flow of the buffer.
The whole electr o p h o r e t i c  system is designed to emphasise
the e ndosmotic features present and so achieve a good separation.
Indeed the wide separation between the HbA and HbA, makes
o 1
agar gel e l e c t r ophoresis an attractive alternative to column 
chromatography. Only a small sample of a few .^1 is re q u i r e d  
(Menard et. ad.. 1980, Ambler, Janik and Walker, 1983), and 
several samples can be run at one time. Usually eight samples 
are run together as this is the capacity of the c o m m e r c i a l l y 
available gels as ma r k e t e d  by Corning Medical Ltd. (Thornton, 
Schellekens and Sanders, 1981). The reco m m e n d e d  conditions  
are set out by Thornton, Schellekens and Sanders using a 
citrate buff e r  of pH 6.3, p r e f a b r i c a t e d  agar plates and a 4-0 
minute electro p h o r e t i c  run. With this system the p e r c e n t a g e  
of haemoglobin in the HbA^ peak is determined by using the 
Corning M-720 densitometer, w:hich scans both peaks at 420nm 
and au t o m a t i c a l l y  integrates the area e n c losed by each.
However the inclusion of additional "background" m a t e r i a l  
(due to poor ele c t r o p h o r e t i c  technique) within the H b A Q peak 
has been known to cause slightly low results (Thornton, 
Schellekens and Sanders, 1981).
Agar gel e l e ctrophoresis has been shown to correlate 
well with b oth HPLC (Hayes ejt al. 1981) r=0.977, and ion- 
exchange column c h r o m a tography (Aleyassine, 1981) r = 0 . 9 3 1  
mini-columns) and r=0.92 (macro-columns) (Thornton, S c h e l l e k e n s  
and Sanders, 1981). The b e t w e e n - b a t c h  variation however, is
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not as precise as by HPLC (normal sample CV = 9.0%, higii 
diabetic sample CV = 4.6%) (Hayes e_t aJL.1981). Unlike column 
c h romatography it is insensitive to changes in buffer pH 
between pH 5.8 and 6.5 (Menard ejt aJL. 1980). Similarly 
changing the temperature between 4°C and 30°C has been shown 
to have little effect (Aleyassine, 1981). High levels of 
triglycerides in the sample apparently' do not cause any 
interference (Aleyassine, 1981). The technique can be used 
to detect HbS and HbC, unlike column c h r o m atography which 
u n d e r e stimates these samples, although the presence of HbF 
still causes problems. Agar gel electr o p h o r e s i s  cannot be 
used to distinguish between the intermediate labile aldimine 
and the stable ketoamine product of glycosylation. To 
remove labile ma t e r i a l  a p r e - incubation step of either 22°C 
for 12 hours (Nathan, 1981) or 37°C for 4 hours (Tibi,Young 
and Smith, 1982) have been recommended. Using these t echniques,  
Tibi, Young and Smith (1982) were able to show both an 
association between blood glucose and labile material in the 
same sample, and an i n t ra-individual variation of labile 
material within the patients studied, b e t ween -4.4% and 
+15.6% of the total glycosylated material.
The major disadvantage of the technique is that to 
achieve a reasonable rate of analysis the system relies on 
the use of a purpose built densitometer, pref e r a b l y  with 
integration facilities, and the purchase of comme r c i a l l y  
prepared agar plates. These requirements although not 
mandatory, are desirable but expensive. However the high 
throughput -.potential, together with the relative s i m p l i c i t y  
of the method and production of a visual record of the results
all combine to make this technique attractive for routine 
use in clinical laboratory, p a r t i c u l a r l y  with a large 
throughput of diabetic samples.
Isoelectric f o c u s s i n g .
Isoelectric focussing on polyac r y l a m i d e  gels was first
described by Drysdale, Righetti and Bunn, (1971). Schoos,
Sc.hoos-Barbette and Lambotte (1978) applied this technique
to thin layer gels using a high voltage and a pH gradient
to achieve a good separation of H b A n from HbA . Stickland,lc o
Perkins and Wales (1982) used isoelectric focussing for the
s eparation of g l y c o sylated h a e m o g l o b i n  and showed that using
o
20Watts at a constant temperature of 15 C for one and a half
hours, an intermediate band of "labile" m a t erial could also
be detected. This o b s e r vation was supported by M o r t e n s e n
(1980) who found this new band, which lies closely anodic to
the HbA^^ band, to be related to the blood glucose c o ncentration.
This suggests that the technique can be used to resolve labile
material and the more stable ketoamine.
To improve the separation of g l y c o s y l a t e d  h a e m o g l o b i n
from HbA still furt h e r , a m p h o t e r i c  substances were added to 
o
t r a n sform the linear pH gradient into a n o n - l i n e a r  one. By 
"flattening out" the gradient in this fashion in the correct 
region, superior separation of the desired materials, in this 
case haemoglobins, can be achieved. B e c caria e_t jil. (1978) 
used dipeptide histidy l - g l y c i n e  (pi 6.8; pI-pK=l) whereas
Jeppson, Franzen and Nilsson, (1978) used J3-alanine for
this purpose. The improved resolution gave c o r r e s p o n d i n g l y
better s e n s i tivity with i n t e r -assay CV=4.8% and i n t r a - a s s a y
CV=5.4% (Jeppson, Franzen and Nilsson, 1978).
Once separation of HbA_ from HbA has been achieved 
■ lc o
then the p r o blem remains of how to quantify the m a t e r i a l
in the two bands and t h e reby express the result as a
percentage glycosylation. A commercial system known as the
Multiphor system is m a r k e t e d  by LKB Ltd. This contains all
of the equipment n e c e s s a r y  to achieve the desired separation;
r e a d y - p r e p a r e d  plates, a tank and p o wer pack, as well as a
scanning densitometer. As an alternative to densitometry,
Jeppson, Franzen and Gaal (1980) showed that it was p o s sible
to cut out the two bands and solubilise the h a e m o g l o b i n  b e fore
reading their absorbances in a s p e c t r o p h o t o m e t e r  at 414nm.
This removes the n e c e s s i t y  for the expensive d e n s i t o m e t r i c
equipment. This technique was shown to give e q u i valent
results to that of the scanning m e t h o d  (Mortensen, 1980).
Used correctly, isoelectric focussing surpasses the
other techniques based on either charge or s i z e - d e p e n d e n t
e l e ctrophoresis in its ability to resolve similar materials.
It can resolve H b A ^ c from the other h aemoglobin components
HbA, , HbA , H b A 0 , HbS and HbF, and with the correct 
la j_b ^
conditions it allows the separate detection of labile m a t e r i a l  
(Stickland, Perkins and Wales, 1982). H o w ever the a c e t y l a t e d  
HbF migrates with H b A ^  (Simon and Cuan, 1982) and r e m a i n s  a 
problem. The interference by acet y l a t e d  materials is f u r t h e r
e x e m plified by samples from patients having high dosage 
aspirin therapy (Bridges jet aJL. 1975) where the extensive 
acetylation causes falsely high results. The major 
drawbacks with the technique are the need for expensive 
equipment, expensive materials and a high degree of 
technical skill to achieve good results. For these reasons 
isoelectric focussing probably remains more suited for 
research purposes in the i nvestigation of g lycosylated 
material, rather than as a tool for their routine measurement.
I m m u n o a s s a y .
Javid jejt a l . (1978) pu r i f i e d  HbA using the column
method of Trivelli, Ranney and Lai, (1971), and inj e c t e d
this material with suitable adjuvant into sheep to develop
an antiserum. Using this a n t i serum they were able to develop
a r a d i o i m m u n o a s s a y  which was .specific and linear t h r o ughout
the range studied (0-16% g l y c o s y l a t i o n ) . There was pa r t i a l
c r o s s - r e a c t i v i t y  ob s e r v e d  with HbA and HbA although HbF
t lb
did not interfere. The work suggests that this technique 
will provide a suitable m e t h o d  of assay for the m e a s u r e m e n t  
of different g l y c o s y l a t e d  haemoglobins using similar 
i m munological systems. At present however, there are 
difficulties with the development of such r a d i o i m m u n o a s s a y  
methods, as the antibody titres are very low.
Colorimetric T e c h n i q u e s .
The most commonly described colorimetric m e t h o d  is that 
based on the original concept by Fluckiger and W i n t e r h a l t e r  
(1976). In this meth o d  the k e t o a m i n e - l i n k e d  hexose is 
h ydr o l y s e d  with a weak (oxalic) acid (Fig. 1.5) to generate 
5-hydroxy m e t h y l f u r f u r a l , (5-HMF). This product is then 
condensed with thi o b a r b i t u r i c  acid to form a coloured adduct 
with an absorbance m a x imum at 443nm. Both stages require 
incubation. Subramanium, R a d h a k r i s h n a m u r t h y  and Berenson
(1980) optimised the conditions for hydrolysis and colour 
development for the manual assay for both g l y c o s y l a t e d 
haem o g l o b i n  and g l y c o s y l a t e d  albumin. They r e c o m m e n d e d  that 
a 16 hour h ydrolysis at 100°C in 10mol/l acetic acid should 
be used and that the m a x imal colour development with
t h iobarbituric acid could be a c h ieved after a 50min i n c u b a t i o n
o . .
at 40 C. The results are reported as a 5-HMF index e x p r e s s i n g
the n u m b e r  of micromoles of 5-HMF g e n e rated for each gm. of 
globin protein. For the calculation, the original content 
of h a e m o globin or protein in the sample must be known and 
standardised. This is usually done prior to the assay using 
the m e t h o d  of Van Kampen and Kijlstra (1961), and com m o n l y  
the original h aemoglobin content is a d j usted to 5% (W /v).
To increase the speed and therefore the usefulness of 
the technique certain adaptations of the basic m e t h o d  have 
been made. Parker et al. (1981) r e c o m m e n d e d  the use of an
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autoclave at 124 C for 60 minutes at 181b/in to accelerate
the rate of hydrolysis, and claims high rep r o d u c i b i l i t y
(CV=3%). Similarly Koch, Sidloi and Tonks (1982) used a
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pressure cooker for 20 minutes at 15 lb/in for this purpose. 
For the second stage of their m e t h o d  they used the s e m i ­
automated technique of Menez et a l . (1981) i n c o r porating 
an a u t o a nalyser system. Burrin e_t ajL. (1980) also used 
automated analysis. The precise sta n d a r d i s a t i o n  of both 
parts of the reaction is critical. For example, the 
conditions of the initial incubation affect both the formation 
and destruction of 5-HMF. This affects the m e thod of 
standardisation; only reference standards of human h a e m o g l o b i n  
or pooled h aemolysate are suitable (Postmes ejt aJ.. 1981).
The time allowed for the formation of the coloured complex 
is also critical for not only does it affect the absorbance 
maximum due to the g l y c o s y l a t e d  fraction, but it also alters 
the blank value in any individual sample (Bunn, 1981). To 
overcome this pr o b l e m  the inclusion of ind i v i d u a l  haem o l y s a t e  
blanks without colour reagent is recommended. The s e n s i t i v i t y
of the test for different sites of origin (HbA., or GHbA ) islc o
also low, causing problems for standardisation. The y i e l d  of 
HMF from H b A lc is only 30% (Bunn e_t a_l. 1979) and is p r o b a b l y  
c onsiderably less from G H b A Q .
As the assay requires very precise control o f .the 
experimental conditions its use as a routine technique is 
questionable. Although it is r elatively simple, r e q u i r i n g  
no expensive equipment or reagents, many of the reagents 
employed are poisonous and can cause p o t e ntial hazard. High
levels of glucose within the samples have been shown to 
interfere with they assay (Bunn, 1981). This interference 
has been overcome by the use of a m o d ified m e thod (Ma,
Naughton and Cameron, 1981) which includes a t r i c h l o r o a c e t i c  
acid preci p i t a t i o n  step. A l t e r n a t i v e l y  the inclusion of 
dialysis equipment in the automated systems have been r e c o m m e n d e d  
(Koch, Sidloi and T o n k s , 1982) . This though, serves to further 
reduce the sensitivity of the m e thod which may be a disadvantage. 
Problems with individual blanks and s t a n d a rdisation have already 
been mentioned.
The thioba r b i t u r i c  acid test has several advantages over 
the c h r o m a tographic and ele c t r o p h o r e t i c  techniques. Because 
it is specific for the k e t o a m i n e - l i n k e d  glucose it is not 
affected by the presence of HbF, haem o g l o b i n  variants, other 
po s t - t r a n s l a t i o n a l  m o d i f ications such as acet y l a t e d  h a e m o g l o b i n  
and, most importantly, it measures only the stable g l y c o s y l a t e d  
material (Parker e_t al_. 1981), and not the labile i n t e r m e d i a t e  
(p r e - A ^ c ) (Postmes et  aJ.. 1981). It is also e x t r e m e l y  useful 
as it has the capability of m e a s u r i n g  not only g l y c o s y l a t e d  
haemoglobin, but other g l y c o sylated proteins as well.
(Subramanium, R a d h a k r i s h n a m u r t h y  and Berenson, 1980, Parker 
et a l . 1981, Menez e_t a_l. 1981).
Nayak and P a t t a biraman (1981) followed the h y d r olysis 
and pr e c i p i t a t i o n  procedures, but used p h e n o l  followed by 
co n c e n t r a t e d  sulphuric acid for colour development, with an 
absorbance maximum at 480nm.
A totally different type of colorimetric technique was 
r ecently described by Gallop ejt a_l. (1981) for mea s u r i n g  
protein glycosylation. This was based on the fluorimetric 
meas u r e m e n t  of formaldehyde released from the molecule after 
periodate oxidation. The oxidation was carried out for 30 
minutes at room temperature with sodium periodate. Any excess 
iodate was then removed by zinc sulphate precipitation. The 
fluorimetric d e termination of the resultant formaldehyde was 
in combination with ammonium acetate and acetylacetone, using 
an excitation w a v e l e n g t h  of 410nm and an emission w a v e l e n g t h  
of 510nm. This m e t h o d  gave a good correlation with both the 
t raditional thi o b a r b i t u r i c  acid method ( r = 0 . 87) and mini ion- 
exchange columns (r=0.95). H o w ever unlike the method of 
Fluckiger and W i n t e r h a l t e r  (1976) both labile and stable 
g l y c o s y l a t e d  ma t e r i a l  are measured. As a fructose standard  
curve is used the results are defined as the absolute 
glycogroup content of the sample rather than as a percentage. 
This m e t h o d  shows promise of being a po t e n t i a l  a l t e rnative 
to the t h i o b a r b i t u r i c  acid method for the m e a s u r e m e n t  of 
g l y c o sylation in proteins other than haemoglobin.
Yet another colorimetric technique, ma r k e t e d  as the 
Glycospec S p e c t r o p h o t o m e t r i c  kit has been d e v e loped (Wallinder, 
Ronquist and Fager, 1982). This relies on the fact that 
certain o r g a n o p hosphorus compounds like inositol h e x a p h o s p h a t e  
(phytic acid) bind to the N-t e r m i n a l  of h a e m o g l o b i n  chains 
(the 2 , 3 - d i p h o s phoglycerate sites) causing s p e c t r o p h o t o m e t r i c  
changes which can be recorded. H o w ever when these sites are
already occupied with glyco s y l a t e d  molecules then this binding 
cannot occur. If sufficient phytic acid is added to 
h aemolysate to fill all the available sites then the change 
in absorbance will be inversly prop o r t i o n a l  to the glyco s y l a t i o n 
of the haemoglobin. The differences in absorbance at 560nm 
and 633nm is patients samples are recorded and interpreted 
using a graph p r e p a r e d  from standards with known HbA^ values.
The contribution of exogenous 2 , 3- d i p h o s p h o g l y c e r a t e  is very 
small (0.5%) and does not constitute a problem. Ho w e v e r  as 
the standards should contain only HbA^, they differ in their 
content of 2 , 3-diphosph o g l y c e r a t e  from the tests, and the r e f o r e 
cause a ■s m a l l .false increase in results. In spite of this a 
good correlation has been shown to exist between this, and the 
ion-exchange methods (r=0.89). Storage of samples is a p r o b l e m  
with the s p e c t r o p h o t o m e t r i c  m e thod since falsely el e v a t e d 
results are obtained; po s s i b l y  due to the failure of p h ytic 
acid to bind c ompletely to denatured haemoglobin. Like the 
ion-exchange methods the presence of HbF causes inte r f e r e n c e 
with the s p e c t r o p h o t o m e t r i c  technique.
METHODOLOGY FOR THE ASSAY OF G L Y C OSYLATED PROTEINS.
In order to investigate the effects of protein glyco s y l a t i o n 
or their clinical use, suitable methods of assay had to be 
developed. The methods for the meas u r e m e n t  of g l y c o s y l a t e d  
h a e m oglobin have already been discussed at length.
Methods for the d e t e r mination of g l y c o sylated plasma  
proteins usually fall into one of two categories; those which  
measure glyco s y l a t e d  albumin (GAlb) which has suitable l o n g e v i t y  
to become glycosylated; those w h ich measure the g l y c o s y l a t i o n  
of all proteins found in human serum or plasma (GPP). Most 
of the m e t h o d o l o g y  used is based on the colorimetric t e c h n i q u e  
where 5-HMF is generated by hydrolysis of plasma proteins and 
the subsequent colour reaction of this with t h i o b a r b i t u r i c  
acid provides a quantitative estimate of the g l y c o s y l a t i o n  of 
the protein in the sample. Ney, Colley and Pizzo (1981) have 
optimised the conditions of this reaction.
The m e a s u r e m e n t  of g l y c o s y l a t e d  albumin is s l i g h t l y  more 
complex as it requires the initial separation and p u r i f i c a t i o n  
of albumin. Dolhofer? Renner and Wi e l a n d  (1981) a c h i e v e d  this 
by using DEAE cellulose ch r o m a t o g r a p h y  and A f f i - g e l  b lue p r i o r  
to the TBA reaction. Using various m o d i f i c a t i o n s  of the 
colorimetric reaction, different coefficients of v a r i a t i o n s  
have been claimed for GPP analysis varying from less than 2.5% 
(McFarland e_t _al. 1979) to 6.3% (Yue £t_ a3.. 1980), and 9.3% 
(Johnson, Metcalf and Baker, 1982).
Column c h r o m a t o g r a p h y  has also been employed to separate
g lycosylated from n o n - g l y c o s y l a t e d  albumin (Fluckiger and
W i n t e r h a l t e r  1976,) , using a column of carbo x y m e t h y l  cellulose
eluted with a gradient of 0.01M to 0.5M sodium acetate. The
normal range quoted using this technique is 6-15% of the total
albumin is glycosylated. Guthrow et al. (1979) compared the
column and c olorimetric techniques for the m easurement of
gl y c o sylated albumin. They found that although the two
techniques gave an excellent correlation (r=0.99) more m a t e r i a l
was detected by the c olorimetric technique. They c o n c luded
that it was likely that some ma t e r i a l  was not b e ing s e p a r a t e d
c h r o m a t o g r a p h i c a l l y , an analagous situation to the finding of
GHbA . 
o
Day e_t al.' (1979) showed that the extent of p r o tein 
glycosylation was a function of. glucose concentration, time 
of exposure and temperature. In 1980 Kennedy, Mehl and Merimee 
hypo t h e s i s e d  that a d d i tional rapid g l y c o s ylation of serum 
protein could occur iji vitro at the high t e m p erature of 
hydrolysis, used in the c olorimetric technique. They d e m o n s t r a t e d  
a 24-1% increase in protein g l y c o s ylation after adding 3 0 0 mg/dl 
glucose to the sample i mmediately before hydrolysis and c o n c l u d e d  
that glucose levels in the sera ma y  se r i o u s l y  alter the results. 
Their observations were supported by Ney, Colley and Pizzo
(1981) who also noted s p u r iously high results r e l ated to b l o o d  
glucose c o n c e n tration in the sample. In order to overcome 
this pr o b l e m  Kennedy, Mehl and Merimee (1980) emplo y e d  dialysis  
with inter- and i n t r a -batch variation of 8% and 12% r e s p e c t i v e l y .  
Ma, Naughton and Cameron (1981) r e c o m m e n d e d  an a l t e r n a t i v e
technique using t r i c h l oroacetic acid to precipitate proteins 
prior to analysis, with claimed coefficients of variation of 
below 2%.
Details of other methods not based on the t h i o b a r b i t u r i c  
acid reaction have also been published. Schleicher and 
W ieland (1981) have developed a specific and sensitive m e t h o d  
to measure the fructose-lysine linkage in n o n - e n z y m i c a l l y  
g lyc o s y l a t e d  albumin and other proteins. In t h i s ,furosine , 
which is the specific degradation product of the fructose- 
lysine link, is released by hydrolysis in 6M-HCL for 18 hours 
at 95°C. The furosine is then separated on HPLC and its UV 
absorbance compared with that of a series of fr u c t o s e - l y s i n e  
standards. From this, the degree of g l y c o s y l a t i o n  is 
calculated. An o t h e r  approach is to measure seru m - b o u n d 
hexose first using p e r c h l o r i c  acid to precipitate protein, 
and then making alkaline with NaOH before the colour reagent 
is added. The resultant colour is read after 40 m i n u t e s  at 
490nm and the c o ncentration determined using a hexose s t a n d a r d  
curve, (Kennedy, Kandell and Merimee, 1979). Johnson, M e t c a l f  
and Baker (1982) use a m e t h o d  which relies on the a b i lity of 
ketoamines (f r u c t o s a m i n e s ) to act as r e d ucing agents in alkaline 
solutions, to measure s e r u m  g l y c o s y l p r o t e i n . By adding serum to 
a solution of n i t r o b l u e t e t r a z o l i u m  in carbonate b u f f e r  a colo u r  
develops after 15 minutes at 37Qc with an absorbance m a x i m u m  
at 530nm. Lipaemic and h a e m o l y s e d  sera do not affect the 
results unless there is gross contamination. The m e t h o d  p r o duces  
a s ignificant but poor correlation with the TBA c o l o r i m e t r i c
technique (r=0.58), but the authors claim that this is due 
to the p o orer r e p r o d u c i b i l i t y  of the traditional m e t h o d  
(CV=9.3%) compared to their own (CV=6.5%). The color i m e t r i c  
technique which uses f l uorimetric m e a s urement of formaldehyde  
released after periodate oxidation (Gallop e_t a^l. 1981) for 
the meas u r e m e n t  of either g l y c o s y l a t e d  h a e m o globins or 
g lycosylated plasma proteins was discussed earlier in this 
c h a p t e r .
Affinity C h r o m a t o g r a p h y .
Most recently a to t a l l y  new m e t h o d o l o g y  has been d e v e l o p e d  
for the separation and quantitation of g l y c o sylated h a e m o g l o b i n s ,  
using affinity chromatography. Mallia ejt al. (1981) p r o d u c e d  a 
c ross-linked agarose gel activated with carbonyl diim i d a z o l e  
and s u b s e q u e n t l y  coupled to a m i n o phenyl b o r onic acid, to form 
the affinity matrix. The affinity gel, so formed, was 
p i p etted into small chroma t o g r a p h y  columns. After l o a d i n g  a 
sample of h a e m olysate onto the column of gel they w a s h e d  off 
and collected the n o n - g l y c o s y l a t e d  m a t e r i a l  using a b u f f e r  
.containing sodium acetate and m a g n e s i u m  chloride at pH8.5.
The g l y c o s y l a t e d  m a t e r i a l  was s u b s e q u e n t l y  r e m oved with a 
second buffer containing 0.2M sorbitol; this was collected.
This, then is e s s e n t i a l l y  the reverse of the i o n - e xchange  
separation where the g l y c o sylated m a t e r i a l  is eluted from 
the column first. The absorbances of the separated f r a ctions  
were m e a sured at 414nm. and the percentage of the h a e m o g l o b i n  
contained in the sorbitol-eluted, " b o u n d ” fraction was 
c a l c u l a t e d .
Bouriotis j2t al.. (1981) showed that immobilised 
a m i n o -phenyl boronic acid binds s e l e ctively to cis-diols 
and can therefore be used to separate g l y c o s y l a t e d  haemoglobins. 
They used a different b u ffer of 50mmol/l m o r p holine -HC1 and 
10mmol/l KCN for this purpose and only added 0.1mol/l s o r bitol 
for elution.
These initial p u b l i cations s u g g ested that this t e c h n i q u e 
would be a pro m o s i n g  new approach for the measurement, not 
only of g l y c o s y l a t e d  haemoglobins, but also of other g l y c o s y l a t e d  
proteins. At the start of the work for this thesis the af f i n i t y 
gel was not available c ommercially and was obtained for the 
earlier studies from the research laboratories of Pierce 
Chemical Co. in the USA. As the work p r o g r e s s e d  the a f f i n i t y  
gel was ma r k e t e d  in the UK.
AIMS OF THIS T H E S I S .
It was the aim of the work for this thesis; to examine 
the a n a l ytical conditions of the affin i t y  c h r o m a t o g r a p h y  in 
detail and develop a reliable, inexpensive and simple m e t h o d  
for the meas u r e m e n t  of both glyc o s y l a t e d  haem o g l o b i n s  and 
g l y c o sylated plasma proteins in the routine laboratory; to 
compare the newly developed m e t h o d  with those p r e v i o u s l y  
established; to assess its usefulness in m o n i t o r i n g  d i a b e t i c  
control in a variety of clinical situations; to assess any 
additional- advantages that the m e a s u r e m e n t  of g l y c o s y l a t e d  
plasma proteins may confer.
CHAPTER 2.
OPTIMIZATION OF AFFINITY 
CHROMATOGRAPHY METHODS FOR THE 
MEASUREMENT OF BOTH GLYCOSYLATED 
HAEMOGLOBINS AND GLYCOSYLATED 
PLASMA PROTEINS.
INTRODUCTION.
The affinity gel used in this work consists of an 
m - a m i n o p h e n y l b o r o n a t e  ligand attached to an agarose, 
uncharged, gel support. This gel selectively condenses 
with cis-diol groups, such as are present in the glucose 
molecule. In this way any protein which is attached to 
glucose may also condense with the gel, via the glucose 
molecule, with the e limination of two molecules of water 
(Fig. 2.1). If a solution containing g l y c o sylated and 
n o n - g l y c o s y l a t e d  proteins is introduced onto a small column 
of the gel, and this is followed by a buff e r  solution, 
g l ycosylated proteins will be retained and the n o n - g l y c o s y l a t e d  
washed through. For the subsequent removal of the g l y c o s y l a t e d  
material, a buffered solution of sorbitol is employed. This 
competes for the glucose binding site thereby d i s l odging the 
glycosylated molecule. By m e a suring the quantity of p r o t e i n  
in the two fractions thus separated, the p ercentage of 
g l ycosylated m a t erial in the original clinical sample can be 
calculated. This principle forms the basis for both the 
m easurement of g lycosylated haem o g l o b i n  and g l y c o s y l a t e d  
plasma proteins by affinity chromatography.
This chapter provides an account of the e x p e r i m e n t a l  
techniques used throughout this thesis. Initially the 
details of both techniques for the m easurement of g l y c o s y l a t e d  
h a e m oglobin and g lycosylated plasma proteins by affinity  
c h r o m atography are described. The reasons for choosing the 
experimental conditions are then outlined, together with the 
s tatistical analysis of the results. Further details r e l a t i n g
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Fig. 2.1 Schematic r e p r e s entation of the chemical r e a ction 
between glycosylated protein and the m - a m i n o p h e n y l
boronate agarose, Glycogel B .
to different methods or specific samples are described 
separately in the relevant chapters.
The work described in this chapter has been p u b l ished 
(Gould, Hall and Cook,1982, Hall,Cook and G o u l d , 1983, Gould, 
Hall and Cook, 1984).
SECTION 1. 
ROUTINE AFFINITY METHODS FOR THE MEASUREMENT* 
OF GLYCOSYLATED HAEMOGLOBINS AND GLYCOSYLATED 
PLASMA PROTEINS.
SAMPLES.
Clinical M a t e r i a l .
Samples of whole blood were collected from n o n - d i a b e t i c
and diabetic individuals into lithium heparin tubes. These
o
samples were stored at 4- C until use, up to a m a x imum of 7 
d a y s .
Preparation of S a m p l e s .
(1) For g lycosylated h a emoglobins analysis (test h a e m o l y s a t e ).
Erythrocytes were separated from p l a s m a  by
centrifugation at 1200g for 10 minutes. A p p r o x i m a t e l y
100 yml of packed cells were added to 2ml of d e i o n i s e d
w a t e r , a n d  thorough haemolysis was ac h i e v e d  using a
vortex mixer. This diluted haem o l y s a t e  was r o u t i n e l y
o
incubated for 5 hours at 37 C before the d e t e r m i n a t i o n  
of stable glycosylated haemoglobins.
(2) For g l y c o sylated plasma proteins a n a l y s i s .
Plasma was separated from erythrocytes by 
c e ntrifugation at 1200g for 10 minutes. 1 0 0^k1 
of plasma was added to 2ml of deionised w a ter  
and mixed using a vortex mixer. Care was taken 
to avoid contamination of the diluted sample 
with m a t erial from the "buffy" layer. The
o
diluted plasma was incubated for 5 hours at 37 C 
prior to the determination of stable g l y c o sylated  
plasma proteins.
APPARATUS.
Columns used for affinity ch r o m a t o g r a p h y  were supplied by 
Uniscience Ltd., Cambridge, U.K. The dimensions of these 
p olystyrene columns were as follows;
internal diameter = 0.7cm
column length = 6.0cm
total column volume = 2.3ml
reservoir volumn = 5.3ml
Each column had a 7/x filter support and a cap for the
tip of the column. They were claimed to have good chemical
resistance to aqueous solutions of mild acids or weak bases.
The columns were clipped into a p u r p o s e - b u i l t  rack, capable 
of holding a total of 30 columns.
The wash (glycosylated) fractions eluted from the columns 
were collected in 25ml measuring cylinders. These, and all 
other glassware were originally acid-washed, and then t h o r o u g h l y  
washed with deionised water after every use.
The elution (non-glycosylated) fractions were collected into 
5 ml plain glass bottles. (Seward Laboratories., UAC House, 
Blackfriars Road, London, U.K.).
The absorbances of the fractions were m e a sured with a SP1800
S p e c t r o photometer (Pye Unicam Ltd., Cambridge, U.K.), using
disposable cuvettes (Sarstedt Ltd., Leicester, U.K.).
The buffer pH was m e a s u r e d  and adjusted using a Biotech PHM6 pH
meter (V.A. Howe and Co. Ltd., London, U.K.).
+ °
All pH measurements were done at 20 - 1 C.
REAGENTS.
Anticoagulant tubes containing 75IU lithium heparin, and 
preservative tubes containing 2.0mg sodium fluoride, were 
obtained from Seward Laboratories, UAC House, B lackfriars Road, 
London, U.K.
Glycogel B, the affinity gel, an .m-aminophenylboronat e agarose, 
was supplied by Pierce and K a r r i n e r , C h e s t e r , Cheshire, U.K.
Biorad Protein Assay Reagent was o b t ained from Biorad L a b o r a t o r i e s  
Watford, Herts., U.K.
All other chemicals were p u r chased from British Drug Houses,
Poole, Dorset, U.K.
All water used was double deionised to a level of c o n d u c t i v i t y  
below 5Mho per ml.
All reagents u s e d were Analar grade.
Preparation of R e a g e n t s .
(1) Wash b u f f e r .
38.54g ammonium acetate (250mmol/l) and 20.33g 
mag n e s i u m  chloride (50mmol/l) were d i s solved in 
water. The pH was adjusted to either pH8.3 for 
the gl 3'cosylated h a e m oglobin analysis or to pH 
8.9 for the glyco s y l a t e d  plasma protein m e a s urement, 
by the addition of 1M NaOH or 1M-HC1. The b u f f e r  
was then made up to 21 with water. For the 
earliest work, pH8.5 was used for g l y c o s y l a t e d  
h a e m o g l o b i n  measurement.
(2) Elution b u f f e r .
6 .058g tris ( h y a r o x y m e t h y l ) m e t h ylamine (I00mmol/l ) 
and 9.306g disodium e t h y i e n e d i a m i n e t e t r a - a c e t i c  acid 
(50mmoi/l) and 18.22g sorbitol (200mmol/l) were 
dissolved in water. The pH was adjusted to either 
pH 8.3 for the glyco s y l a t e d  haem o g l o b i n  analysis, 
or to pH 8.9 for the glyco s y l a t e d  plasma p r o tein  
measurement by the addition of 1M NaOH or 1M-HC1.
The buffer was then made up to 5 00ml with water.
For the earliest work, pH8.5 was used for g l y c o s y l a t e d  
h a e m oglobin measurement.
(3) Regeneration s o l u t i o n .
3ml of glacial acetic acid was made up to a p p r o x i m a t e l y  
500ml with w a ter (~  0.01M acetic acid).
(4) Protein assay r e a g e n t .
The Coomassie Brilliant Blue protein reagent was
diluted with w a ter and glacial acetic acid in the
ratio 4:5:1 respectively; the quantity p r e pared
depending on the number of samples tested. The
solution was mixed and filtered before use. As
the solution stained glassware, a designated
bottle was used for the reagent. The diluted
acidified reagent was prepared fresh for each
assay. All other prepa r e d  reagents were stored 
o o o
at 4 C, and used at 20 C - 1 C.
(5) S a l i n e .
9.0g of sodium chloride was dissolved in dei o n i s e d 
w a t e r  and made up to 1 litre. This isotonic 
solution (154mmol/l) was used whene v e r  saline was 
required.
(5) Cyanide s o l u t i o n .
0.189g of p o t a ssium cyanide was dissolved in 
d eionised w a t e r  and made up to 500ml to provide 
a solution of 0 . 5 8 m m o l / 1 K C N . This was used in 
the investigation of storage conditions.
I N VESTIGATION OF COOMASSIE BRILLIANT BLUE DYE FOR PROTEIN 
MEASUREMENT IN THE ASSAY FOR G LYCOSYLATED PLASMA PROTEINS.
Choice of Coomassie Brilliant Blue D y e .
At the beg i n n i n g  of this work there were no publications 
using affinity chroma t o g r a p h y  for the measurement of glyc o s y l a t e d  
plasma proteins, and the Glycogel Test Kit from Pierce Chemical 
Co. Ltd., was not marketed. Early work to achieve separation  
of this ma t e r i a l  on m - a m i n o p h e n y l b o r o n a t e  gels was a t t empted 
using similar techniques to those that had been e s t a b l i s h e d  for 
the separation of glyco s y l a t e d  haemoglobins. However, both the 
primary dilution of the sample to add to the column, and the 
separation of "bound" from " u n b o u n d ” m a t e r i a l  with different 
buffers, caused considerable dilution of the original plas m a  
sample. The use of a very sensitive technique was r e q u i r e d  to 
measure the protein content in the collected fractions cont a i n i n g  
ma t erial which did, or did not, bind to the gel. The biuret 
method was found to be too insensitive for this purpose, even 
when the test:dye r a t i o  was increased. Similarly, the direct 
measurement of absorbance at 280nm was found to be inadequate 
at these low protein concentrations. Coomassie Brilliant Blue 
dye was also investigated. This dye, r e c o m m e n d e d  by B r a d f o r d  
(1976) for the q uantitation of microgram quantities of p r o t e i n 9 
appeared to be ideal for the purpose, as it was sensitive to 
protein in very small amounts and had p r e v i o u s l y  been used for
this purpose with cerebrospinal fluid (Hische et_ a_l. 1982) 
and in homogenates. of tumour tissue (Sherwood, 1980). 
Following enquiries, it was found that Biorad Ltd. m a r k e t e d  
a protein reagent containing Coomassie Brilliant Blue G-250 
dye in phos p h o r i c  acid (55%) and methanol. Initial 
experiments using this reagent showed that it was sensitive 
enough to detect protein in the fractions collected after 
affinity chromatography.
A c i d i fication of the Biorad R e a g e n t .
To compensate for the alkaline nature of the buffers 
used for the separation of "bound" and "unbound" material, 
the Biorad Protein Assay Reagent was acidified before use.
It was found that by the addition of glacial acetic acid, 
as described in.the preparation of reagents, this could be 
suitably achieved.
R e generation of G e l s .
In the original literature associated with the a f f i n i t y  
gel, Glycogel B, there was no indication that the a f f i n i t y  
gel could be regenerated for further use. However, i n s t r u c t i o n 
leaflets supplied from another m a n u f a c t u r e r  utilising 
agarose-boronate gels for another purpose, showed that a weak 
acid could successfully regenerate the ligand. This was 
s uccessfully applied to Glycogel B which was r e g e n e r a t e d
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using 5ml of a weak acetic acid solution. Further study 
showed that regeneration was even more successful if the 
columns were washed with 5ml of deionised water before the 
addition of the acid, p r e s umably as this removes the 
remaining alkaline buffer retained in the gel so that it 
does not neutralise the acid solution. Results obtained 
when columns were reused are given later in this chapter.
Linearity of the Protein Concentration Measurement.
To ascertain the linearity of the protein meth o d  in 
the test for g lycosylated plasma proteins, a series of 
plasma dilutions ranging from O.lmg/ml to 0.5mg/ml were 
prepared, these concentrations being consistent with 
those to be found in the column eluates. At a w a v e l e n g t h  
of 595nm. this range of protein concentrations gave a linear 
plot against absorbance (Fig. 2.2) upto an absorbance of 
0.6. To adjust the level of w ash-fraction protein into 
the linear range of this concentration plot, it was n e c e s s a r y  
to dilute this column eluate to 24ml with wash buffer.
Colour Development.
To measure the colour development of the Coomassie 
Brilliant Blue reagent with a protein sample, 500^^1 of an 
elution fraction was mixed with 500yuJ_ of acidified reagent 
in a disposable plastic cuvette, and m i xed by inversion.
The cuvette was immediately placed in a s p e c t r o p h o t o m e t e r
( u i u g e S )  a o u e q j o s q v
and the absorbance at 595nm, m o n itored against air. The 
colour development was very rapid in the first few seconds 
and then gradually increased until a plateau was reached at 
about 25 minutes, after which the absorbance was stable for 
nearly 60 minutes before starting to decrease. This was 
also true when a wash fraction was tested. For this reason 
the measurement of the absorbance at 595nm. was made at 
exactly 30 minutes after mixing. The absorbance of the wash 
and elution fractions were read c oncurrently for each test.
The absorbance maxima of 595nm. was verified by 
m e a s uring the absorbance of a sample mixed with reagent 
between 400nm. and 7 0 0 n m . ( F i g .  2.3).
AFFINITY C H ROMATOGRAPHY
Preparation of Affinity C o l u m n s .
The affinity gel, Glycogel B, was supplied as a 50%
slurry. This slurry was mixed and 2ml tran s f e r r e d  to each
column, which were mounted vertically on a p u r p o s e - b u i l t
rack. When allowed to drain, a 1ml gel column was thus
achieved. Before use, each column was w a shed with 5mL of
d eionised water followed by 5ml of 0.01M acetic acid
(regeneration solution). The columns were then p r i m e d
with 5ml of wash buffer at the correct temperature. When
not in use,the columns were stored v e r t ically in the dark 
o
at 4 C, m  0.01M acetic acid.
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C h r o m a t o g r a p h y .
(1) For g l y c o sylated h a e m o g l o b i n s ,
A volume of I O O m I of test haemolysate was pi p e t t e d  
onto the top of a column and a l l owed to soak into 
the gel. One ml of wash buffer was also added 
and allowed to drain, to ensure that all of the 
ha e m o lysate had soaked into the gel. This was 
followed by a further 7ml. of wash buffer. Both 
elutions of wash buffer were collected in a 25ml 
mea s u r i n g  cylinder and made up to exactly 15ml 
by the addition of further wash buffer. The 
column was then t r a n s ferred to a s upporting rack, 
pos i t i o n e d  over a plain*glass bottle and labelled  
to identify both the sample and wash fraction 
number. E x actly 3ml of elution buff e r  was a l l owed  
to run through the column and this too, was 
collected. A portion of wash sample and a p o r tion 
of elution sample were poured into separate 
cuvettes and their absorbances m e a s u r e d  at m 4 n m . ; 
reading both tests against a wash b u ffer blank.
The absorbance of the elution b u f f e r  blank was 
n o t e d .
(2) For g l y c osylated plasma p r o t e i n s .
The separation of g lycosylated plasma proteins by 
affinity c h r o m a tography was p e r f o r m e d  in an almost 
identical m a n n e r  with the exception that 150yaL of 
diluted plasma was added to the gel, and the wash
fraction was made up to 24-ml before the protein 
concentration was assessed.
For the meas u r e m e n t  of the protein concentration 
in both the wash and elution fractions for each 
test, a portion of each was well mixed with an 
equal volume (0.5ml) of the acidified Coomassie 
Brilliant Blue reagent in disposable microcuvettes. 
The blank was p r e p a r e d  by adding 0.5ml of wash 
buffer to 0.5ml of the acidified Coomassie Brillant 
Blue reagent. After exactly 30min the a b s o r b a n c e s  
of both the wash and elution fractions for each 
sample were mea s u r e d  at 595nm against the wash 
buffer blank. An elution buffer blank was also 
pr e p a r e d  from a mixture of 0.5ml of elution b u f f e r  
and 0.5ml of reagent, and its absorbance m e a s u r e d  
against the wash buffer blank.
To ensure that there was no residual i n t e r f e r i n g  
material on the gel columns, water instead of 
diluted plasma was added to one column in each 
batch and the eluates treated with reagent.
Blank C o r r e c t i o n s .
In the m e a s urement of both g l y c o s y l a t e d  h a e m o g l o b i n s  and 
glyco s y l a t e d  plasma proteins a correction was made to 
compensate for the different effects of the two b u f fers used. 
The basis of the correction depends on the fact that the gel 
bed for every column was 1ml, and that the addition of 3ml 
of elution b u f f e r  served to displace 1ml of residual wash
buffer into the 3ml of collected eluate. To compensate for 
differences between the buffers, a value of two-thirds of 
the absorbance obtained for the' elution b u f f e r  blank was 
subtracted from all of the tests elution absorbances before 
calculations were made.
Calculations .
a l' . i •
The bound m a t erial for each meth o d  was calculated using 
the following equations:
elution
A
% G l y c o s y l a t e d  haemoglobins =  _______ 414  x 100
wash elution
A A
414 x 5 + 414
elution
A
% Glyco s y l a t e d  plasma =_____________5 9 5_________________  x 100
proteins wash elution
A x 8 + A 
595 595
In each case the absorbances for both the wash and 
elution fractions of the separation are used.
A computer programme (Fig. 2.4) was devised under 
instruction from M.P. Bailey, for the calculation of the 
corrected values for each method. The input required for 
the correction was simply the wash and elution absorbances 
for each test, and the absorbance of the elution b u f f e r  
b l a n k .
2.4. A computer programme to calculate the %
g l y c osylated h aemoglobins or % g lycosylated
plasma proteins from the abosorbance v a l u e s .
5 @CHR$ (27); " + "
7 DIM A $ ( 40), B $(40)
10 © ’’E N TER  VOLUME LOADED";
20 INPUT V
30 ©"ENTER BLANK ABSORBANCE";
40 INPUT B 
42 © : ©
45 0 P E N H +  "$LP"
46 ON ESC GOTO 225 
50 B = 2*B /3
60 © " E NTER ABSORBANCE OF WASH";
70 INPUT Al
80 A$ = "Aw = : @ U 4  USING A$,A1
90 ©"ENTER ABSORBANCE OF ELUATE";
100 INPUT A2 
110 A2 =A2-B
120 A$ = "Ae = 4##.###" : ©414USING A$,A2
130 ©+14 
140 K= 5
150 IF V <> 150 THEN 170 
160 K= 8
170 A 3 = A 2+K*A1
180 A$ = "TOTAL ABSORBANCE = : © + 1+ USING A$,A3
190 R$="% G L Y C O S Y L A T I O N  = # # # # . # 4 # "  : © + 1 4 USING B $ , 1 0 0 * A 2 / A  
200 @ + 14 : ©ili 
205 ©
210 GOTO 60 
225 C L 0 S E 4 U  
230 END
When calculating % g l y c o sylated haemoglobins, enter 
100 as the volume loaded.
When calculating % g l y c o sylated p l asma proteins, enter 
150 as the volume loaded.
SECTION 2.
INVESTIGATION OF THE EFFECT OF VARYING 
EXPERIMENTAL CONDITIONS ON THE MEASUREMENT 
OF GLYCOSYLATED PROTEINS BY AFFINITY 
CHROMATOGRAPHY.
To standardise the affinity method for the meas u r e m e n t 
of both g l y c o sylated haemoglobins and g l y c o s y l a t e d  p l a s m a  
proteins, various aspects of the method were examined.
Unless stated otherwise, the methods used were e x actly 
as specified in Section 1 of this chapter. The columns were 
eluted at gravitational pressure, producing a flow-rate of 
0.46 ml/min for the wash buffer and 0.30 ml/min for the 
elution buffer, with the 1ml gel columns used.
S t a t i s t i c s .
Linear correlations were calculated by the least squares 
method, and statistical comparisons were per f o r m e d  by 
Students ft f test.
Elution P r o f i l e s .
Mallia et_ al.. (1981) described the preparation of a 
boronic acid affinity support for the separation and quant i t a t i o n  
of g lycosylated haemoglobins on 1ml columns of gel. They 
recommended removal of "unbound" ma t e r i a l  with 5ml of wash 
buffer followed by removal of the "bound" material with 2ml 
of elution buffer. The work for this thesis was started on 
the basis of this short publication, and initially the pH of 
the buffers used for g lycosylated h aemoglobins was pH8.5, as 
r e c o mmended by these pioneer workers. The buffers used for 
the g l y c o sylated plasma protein assay were at pH8.9. Both 
the assay for g l y c o sylated haemoglobins and that for 
glycosylated plasma proteins were carried.out at room 
temperature. The quantities of wash buffer and elution b u f f e r  
used, in each case, were greater than reco m m e n d e d  by Mallia 
et a l . (1981), to ensure good separation of "bound" from
"unbound" material.
A 1ml gel column of the affinity gel, Glycogel B was 
prepared and e q u i l ibrated with wash buffer. Blood taken from 
a diabetic patient was diluted and incubated in accordance 
with earlier instructions to provide a haemolysate of stable 
g l y c osylated haemoglobin; 1 0 0 jjlI was added to the column and 
allowed to soak in. Nine 1ml volumes of wash buffer were 
then added to the gel and each fraction was collected 
separately. Four 1ml volumes of elution b u ffer were added
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and collected similarly. The absorbance of each fraction at
M-14-nm was recorded and an elution profile plotted (Fig. 2.5A).
The colour of h aemoglobin provides a clear visual
separation of the " u n b o u n d ” material being washed from the
column, leaving a small red band of "bound" material. When
the buffers are changed, this ban d  can be seen to be r e m oved
from the column. This is clearly shown in Fig. 2.6.
To determine the optimum conditions for the separation
of g l y c o sylated proteins diluted plasma from both diabetic
and n o n - d i a b e t i c  individuals was p r e pared and 150^*1 added to
a column. An elution profile (Fig. 2.5B) was prepared for
each by collecting 1ml fractions of wash and elution b u f f e r
in an identical manner to that outlined above. The p r o tein
c o ncentration of each fraction was me a s u r e d  at 595nm after
the addition of acidified Coomassie Brilliant Blue reagent.
As the bulk of the material was in the first wash fractions
these were diluted with wash buffer to ensure an a b s o rbance
within the linear range of the reagent (Fig. 2.2). The
results were calculated accordingly.
Blank values were obtained using an elution profile
scheme for a column to which water rather than diluted p l a s m a
had been added. This p r o duced a h o r i zontal line (i.e. no
profile) with absorbances at 595nm between 0.C01 and 0.002.
On the basis of the elution profile studies for both
methods, the wash volume was increased to 8ml to ensure the
u u
removal of all of the unbound material from the column. The
elution buffer volume was also increased to 3ml to ensure,
I u
that likewise all of the bound material was removed. These
GIXOGEL B AFFINITY CHROMATOGRAPHY 
Progress of haemolysate down column
■
 A fter 1 ml of I  
w ash  b u ffe r  I
After 8ml of 
w ash  b u f fe r
A f te r  1 ml of 
elution  buffer
A fte r  3ml of 
elution buffer
L o a d e d  w ith  
haemolysate
Fig. 2.6 Visual account of the se paration of " b o u n d " 
from "unbound" hae moglob in , using the
affin it y gel, Glycogel B .
volumes are not in agreement with those of Mallia et_ a l . 
(1981), whose recommendations would not seem to provide such 
a clear-cut separation.
jdH .
Mallia et_ a l . (1981) r ecommended the use of both the 
wash and elution buffers at pH8.5 for the separation of 
glycosylated haemoglobins using affinity chromatography.
To investigate the optimum pH to use for the meas u r e m e n t  
of g lycosylated h a e m oglobins or glyc o s y l a t e d  plasma proteins, 
a large quantity of both wash and elution buffers were
+ o
prepared, at 20 - 1 C. Each b u ffer was then s ubdivided and 
each aliquot was adjusted to a different pH value varying 
from pH7.5 to pHlO.O by the addition of either 1M-HC1 or 
1M NaOH. For each pH studied, a group of six columns was 
primed before the assay with the wash buffer of the a p p r o p r i a t e  
pH.
Haemolysate and diluted plasma were pr e p a r e d  from a 
sample of blood taken from a diabetic individual, and these 
were incubated at 37°C for 5 hours before use. Aliquots of 
either the haemolysate (lOOy^l) or the diluted plasma (I50yml) 
were added to each column in a six column group. The assays 
were run as p r e v i o u s l y  detailed, the elution buffer used for 
each group being at the same pH as the wash buffer. I n i t i a l l y  
both the g l ycosylated haemoglobin and glyco s y l a t e d  p l a s m a  
protein assays were studied over the range pH 7.5 to pH 10.0 
in order to gauge the area of optimum pH for each assay. It 
was found that the pH optimum for g l y c o s y l a t e d  haemo g l o b i n s
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7 The effect of pH on the % glyco s y l a t e d  h a e m o g l o b i n s  
( B  ) and % glycosylated plasma proteins ( A ) b o u n d 
to the affinity gel. Each point shows the mean 
(- SD) of the results from 6 columns.
was between pH 8.0 and pH 8.5, and that the optimum for 
glycosylated plasma proteins was n e arer to pH 9.0. On 
the basis of these early studies the pH range studied in 
greater detail for g l ycosylated h aemoglobins was pH 7.5 to 
pH 8.5, whereas for g lycosylated plasma proteins it was 
pH 8.5 to pH 10.0; the results are shown in Fig. 2.7. For 
each pH studied a value was obtained for both the wash b u f f e r  
blank and the elution buffer blank. Compensation for a blank 
value was p a r t i c u l a r l y  important with the g l y c o sylated p l a s m a  
protein study as varying the pH altered the b e h aviour of the 
acidified Coomassie Brilliant Blue reagent, and thereby the 
protein measurement. Blank corrections cancelled this effect.
Fig. 2.7 shows that there is a pl a t e a u  between pH 8.0 
and pH 8.5 for g l ycosylated haemoglobins, and for the 
glycosylated plasma protein m e a s u rement there was a m a x i m u m  
at about pH 8.9. On the basis of this work and later studies 
on storage the pH values routinely adopted for the two methods 
were pH 8.3 and pH 8.9 respectively.
T e m p e r a t u r e .
To investigate the effect of temperature on the assay
for g lycosylated haemoglobins a series of six column groups
were prepared and pos i t i o n e d  in temperature controlled
incubators at 7°C, 10°C, 12.5°C, 15°C, 17.5°C, I9.5°C, 25°C, 
o o
30 C and 37 C. A large quantity of both wash and elution 
buffers were prepared, divided, and these too were incubated 
at the temperatures indicated. Before the test each column 
group was primed with 5ml of wash buffer at the temperature 
to be studied.
Haemolysate was pr e p a r e d  from a blood sample taken from 
a diabetic individual, incubated to remove labile m a t erial 
and lOOytAl was added to each column. The assay was p e r f o r m e d  
as outlined previously, except that the columns and buffers 
were kept at the required temperatures throughout. The effect 
of temperature on volume, if any, was calculated and cor r e c t e d 
for by weighing the elution sample. The whole study was 
repeated using haemolysate prepared from the blood of a n o n ­
diabetic individual. The effect of t emperature was shown for 
both samples by the differences obtained in % g l y c o s y l a t e d  
h aemoglobin calculated for the six column groups at each 
temperature (Fig. 2.8).
The effect of varying the temperature on the g l y c o s y l a t e d
p lasma protein assay was similarly studied by k e e ping the
o o o
column separation stage of the assay at 10 c s 20 c or 37 C.
All eluates were brought to room temperature before their
protein content was measured with the aci d i f i e d  Coomassie
Brilliant Blue Protein reagent.
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Fig. 2.8 shows that altering the temperature affects 
the values obtained for either g l y c o sylated haemoglobins or 
g l y c osylated plasma proteins. In both cases as the 
temperature is increased there is a decline in the p e r c entage 
of "glycosylated" material bound to the column. The extent 
of this decline, r e p r esented by the slopes of the lines, is 
similar for both methods, and in both cases the effect on the 
sample from a diabetic patient was more marked than that for 
the sample from the non-d i a b e t i c  individual.
The e x p e r imental results show that most "glycosylated"
material was retained on the column at the lowest temperature
used. However, one of the principle aims of this project was
to develop a simple, inexpensive and precise technique for
routine use in most laboratories, and there are enormous
practical difficulties in accurately m a i n t a i n i n g  low t e m p e r a t u r e
conditions without a cold room. As the laboratory did not have
such facilities, and many of the clinical laboratories w i s h i n g
to adapt this meth o d  will be similarly placed, it was de c i d e d
to proceed with all future work at room temperature. By
priming the columns with wash buffer before each run it is
° + o
possible to a ccurately maintain 20 C - 1 C against a room
° otemperature back g r o u n d  which varied between 17 C and 24- C 
throughout the year. This degree of temperature control could 
not be achieved by simply priming the columns with b u f f e r  at 
7°C before use at room temperature because the t e m p e rature 
differential which caused a significant increase in column 
t emperature during the run. This was shown e x p e r i m e n t a l l y  
by thrusting a thermometer into the gel bed i mmediately after
u /
1-30
■ Biorad (Mini ion exchange) 
A Affinity Chromatography
1-15-
1-0 0 -
0-70-
18 20 22 26 28
Temperature(0C)
Fig. 2.9 To illustrate the effect of t emperature on the
separation of g l y c o s ylated h a e m o globins by a f f i n i ty 
c h romatography (A) and m i n i - i o n - e x c h a n g e  columns (■) 
from: Glycogel Test Kit: Pierce b i o - r e s e a r c h
products technical bulletin (1981).
By main t a i n i n g  narrow temperature limits (20°C - 1°C) 
the changes in results encountered for affinity c h r o m a t o g r a p h y  
with temperature were minimal, r epresenting changes in 
reprodu c i b i l i t y  in the order of 2%. These precision figures 
look most favorable when compared to the effect of similar 
temperature limits on ion-exchange c h r o m a tography methods 
where similar temperature variation can cause alterations 
in values of upto 13% (Fig. 2.9).
L o a d i n g .
For g l ycosylated h a e m oglobin m e a s urement Mallia ejt a l . 
(1981) reco m m e n d e d  that 100^.1 of a 1 in 20 dilution of p a c k e d  
red cells should be added to each column. The Glycogel test 
kit recommends the addition of 200yul of neat plasma to each 
column for the measurement of g lycosylated plasma proteins, 
and the final measurement of protein concentration in the two 
eluates by m o n i t o r i n g  absorbance at 280nm. The r e c o m m e n d a t i o n s  
of both of these publications were assessed.
(1) Effect of loading different amounts of h a e m o l y s a t e .
Erythrocytes collected from normal and diabetic 
individuals were incubated at 37°C for 5 hours in 20 volumes 
of isotonic saline (154mmol/l NaCl) to remove labile m a t e r i a l ,  
and recovered by centrifugation. These red cells were then 
h a e m olysed by freezing and thawing, and their h a e m o g l o b i n
Table 2.1 Effect of loading different amounts of
NORMAL %
DIABETIC
haem o g l o b i n  onto a 1ml affinity c o l u m n .
Amount of H aemoglobin Loaded (mg)
0.5 1.0
Glyco s y l a t e d  6.43 6.59
Haemoglobins
SD 0.31 0.13
% G l y c osylated 13.64 13.90
Haemoglobins
SD 0.23 0.14
2.0 4.0 7.0 10.0
6.49 5.73 5.29 4.91
0.11 0.18 0.17 0.07
13.63 14.34 12.49
0.44 0.45 0.31
concentration was me a s u r e d  using a Coulter Counter (Coulter 
E lectronics Ltd., Luton, Beds.). The normal h aemolysate was 
then adjusted with w a ter to contain lOg/dl haemoglobin and 
likewise the diabetic sample to contain 7g/dl haemoglobin.
analysed, each different haemolysate being tested four times. 
For those samples containing 4g/dl h aemoglobin or above, an 
extra 3ml of wash buffer and an extra 3ml of elution buffer 
were used to ensure the complete removal of the "unbound" 
and "bound" fractions r e s p e c t i v e l y  from the columns. The 
absorbances of these extra fractions at 414nm were added to 
the values obtained for the original wash and elution samples.
Table 2.1 shows that the value obtained for % 
g lycosylated haemoglobin for both the normal and the diabetic 
samples studied, was independent of loading between 0.5mg 
and 2 . Omg of haemoglobin onto the column. When in excess of 
4 . Omg for the normal sample and 7. Omg for the diabetic, was 
applied, the columns became overloaded. In excess of these 
values the binding of the g l y c o sylated haem o g l o b i n  is impai r e d  
with signi f i c a n t l y  lower results (p 0.001).
(2) Effect of loading different amounts of p l a s m a .
Plasma from a diabetic patient was i n c ubated and 
dialysed against saline for 5 hours to remove any labile 
g lycosylated material.
of each h a e m olysate was added to a gel column and
The concentration of protein in this sample was 
measured using a standard Biuret method whereby 50y<cl of the 
original sample was added to 3ml of Biuret reagent, m i x e d  and 
incubated at room temperature for 15 minutes before the 
absorbance was read at 5 60nm. Quantitation was achieved 
using protein standards of known value.
Once the protein c o ncentration of the sample was known , 
the desired dilutions were prepared in deionised water. Then 
150yul of each dilution was added to each' of a set of four 
p r e pared columns, which was equivalent to adding 2.0, 1.0,
0.5, and 0.25mg protein respectively. Similarly 100y*.l and 
200^1 of undiluted plasma was applied to two groups of four 
columns. This was consistent with the addition of 6.7ing and 
13.4mg of protein to each column. All of the column groups 
were analysed using the standard procedure, but to ensure
1 t' m
that all of the bound and unbound m a t e r i a l  was recovered, two 
additional 3ml volumes of wash buffer were collected and one 
additional 3ml volume of elution buffer. To enable all of 
the eluates to be m e a sured within the linear range e s t a b l i s h e d  
for the protein reagent, appropriate dilutions in wash or 
elution b u ffer were made before the addition of the a c i d i f i e d  
Coomassie Brilliant Blue Protein reagent.
An identical pro t e i n - l o a d i n g  i n v e s t igation was r e p e a t e d  
using plasma from a n o n - d i a b e t i c  individual. This p l a s m a  was 
diluted so as to provide the same loading of protein on to 
the columns as with the diabetic sample. For both the n o n ­
diabetic and the diabetic samples, where neat plasma was l o a d e d
the absorbances of the eluates at 280nm were noted before any 
secondary dilutions were made or acidified Coomassie Brilliant 
Blue Protein reagent was added. Wash buffer or elution buffer, 
as appropriate, were used as blanks.
Table 2.2 shows the % of g l y c o sylated plasma proteins 
for the non- d i a b e t i c  and diabetic samples when different amounts 
of plasma were added to the affinity columns. The values 
obtained were independent of loading when the amount of protein 
loaded was between 0.25 and 2 . Omg per one ml column and when 
protein was me a s u r e d  by the acidified Coomassie Brilliant Blue 
Protein reagent. When larger amounts of neat plasma were 
loaded onto the columns and the proteins were m e a s u r e d  using 
the acidified Coomassie Brilliant Blue Protein reagent there 
was a significant decrease in the percentage of the g l y c o s y l a t e d  
fraction- (p 0.001). At a loading of 13.4mg protein per 
column the decrease was 41% and 33% for normal and diabetic 
samples, respectively. To achieve the optimum c o n c e n t r a t i o n  
to permit the use of the acidified Coomassie Brilliant Blue 
Protein reagent with high column loading it was n e c e s s a r y  to 
dilute the eluates very considerably. This almost cer t a i n l y  
accounts for the wider standard deviation of results. W h e n , 
with neat plasma loading, the protein was m e a s u r e d  at 280nm 
instead of with the acidified Coomassie Brilliant Blue Protein  
reagent, the results were s ignificantly h i g h e r  and had a 
smaller standard deviation. However, the trend of d e c r e a s i n g  
values with increasing load from 6.7mg to 13.4mg per ml of
Table 2.2 Effect of loading different amounts of plasma 
protein onto 1ml affinity gel c o l u m n s .
Amount of Plasma Protein Loaded (mg)
0.25 0.5 1.0 2 .0 6 .7 13 .4 6 . 7 * 1 3 . 4 *
NORMAL
%GPP 6 .95 6 . 93 6 .83 7 .16 5 . 83 4-.20 7 .15 6 .06
SD 0.25 0.33 0.30 0.22 0.19 0.73 0.16 0.05
DIABETIC
%GPP 13.2 13.24 13.25 13.24 8.96 8.77 11.97 11.50
SD 0.34 0.48 0.50 0.19 0.61 0.28 0.17 0.11
Ke£:
%GPP is percentage g lycosylated p l a s m a  proteins
* Value d etermined at 280nm
column was still observed for both the n o n - d iabetic 
(p -<^ 0.001) and the diabetic (p <" 0.01) samples. This 
is important to note for as the test sheet supplied with 
the Glycogel test kit for the measurement of g l y c osylated 
plasma proteins recommends the addition of neat plasma to 
the columns, then different amounts of protein will be 
added depending on the original protein concentration in 
the patients sample. These observations are discussed 
more fully at the end of this chapter, and in chapter 7.
Recovery of Protein from C o l u m n .
Recovery values for both glyco s y l a t e d  h a e m o g l o b i n  and 
the g l y c o sylated plasma protein assays were made. The 
appropriate absorbance in the original sample and the volume 
of material added to each column was noted. The abso r b a n c e s  
of all of the wash and elution fractions were t o t alled after 
making corrections to compensate for the fact that they were 
collected into different volumes. Since the amount of m a t e r i a l  
added to any column could be interpreted in terms of a b s o r b a n c e  
value per ml, and the recovered m a t erial could be s i m i l a r l y  
assessed then a % r e c overy could be calculated. Re c o v e r y  
values between 95% and 98% were obtained.
L a b i l i t y .
Fig. 1. 3 shows that before u n d e rgoing an Amadori 
rearrangement to produce stable g lycosylated haemoglobin, 
glucose and haemoglobin initially combine to form an unstable 
or labile compound. This labile g l y c o sylated haemoglobin 
readily reverts to its original components, and is i nfluenced 
by the glucose concentration at the time of sampling. For 
this reason, if the labile fraction is m e a sured in addition 
to the stable form a higher value will result and this will 
be biased towards recent blood glucose concentrations.
Thus the removal of the labile material is theor e t i c a l l y  
desirable, to provide an accurate m e a s u rement of glycaemic 
history. By diluting a sample in water the e quilibrium  
(Fig. 1.3) is shifted as the free glucose concentration can 
be made so low. as to be virtually removed from the system.
This effect causes the reversion of any labile material 
to the original components, although stable glyco s y l a t e d  
haemoglobin will be u naffected as the Amadori re a r r a n g e m e n t  
is essentially an irreversible process. The m e thod of 
removal of labile material by dilution and incubation, as 
recommended by Compagnucci ejt _al. (1981) was investigated.
A sample of haemolysate was pr e p a r e d  and i m m e diately 
tested in accordance with the r ecommended method. The
o
remainder was divided, and one portion was incubated at 37 C,
o
the other at room temperature (20 C). At intervals of 1,
2.5, 5, 1 6 • and 24 hours r e s p e ctively aliquots of the i n c u b a t e d  
haemolysates were removed and analysed, each being t e s t e d  
five t i m e s .
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The diagram shows the results for incubating a 
normal haemolysate at 20°C ( ■  ) and 37°C ( • ) 
for various time intervals upto 24 hours. Each 
point represents the mean SD) of the results 
from 5 c o l u m n s .
Fig. 2.10 shows that the values of glycosylated
haemoglobin decrease from that achieved with the fresh
o o
sample by incubation at both 37 C and 20 C, this would
be consistent with removal of labile material. After 5
hours at 37°C a p l a teau was obtained. This lower value
o
took 24 hours when incubation was at 20 C.
o
When incubation was continued at 37 C overnight the 
value for % glycosylated haemoglobin apparently increased.
This was originally assumed to be due to the formation of 
met-hae m o g l o b i n  interfering with the method, but the work 
with the storage experiements have shown this not to be 
the case. This phenomenon, if real, remains as yet 
unexplained.
Other experiments were done which showed similar trends
to those outlined; an initial decrease occurring by- i n c u b a t i n g
at 37°C which gave a plateau after 5 hours and then if left
still longer was seen to increase again. However man y  of.
these observations with other diabetic and n o n - d i a b e t i c
s a m ples,although showing similar trends^were not so m a r k e d
as in the given sample. As the amount of labile m a t e r i a l
during these investigations seemed to vary greatly from
individual to individual a larger study was devised to see
if this was the case and if there was any relation between
labile material and the glucose at the time of sampling.
Blood was taken from patients at a diabetic clinic.
Part was put into lithium heparin tubes which were stored 
o
at 4 C until required, up to a ma x i m u m  of one hour, and the 
remainder was put into sodium fluoride tubes for the
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measurement of glucose. This was measured within 10 minutes
of sampling using the Yellow Springs Glucose Analyser, Model
23 AM (Yellow Springs Instrument Co., Yellow Springs, OH 45387,
USA). The whole blood samples were centrifuged and both
haemolysate and diluted plasma were prepared in accordance
with the standard method instructions. These were then
o
tested immediately and after a 5 hour incubation at 37 C by 
the affinity chroma t o g r a p h y  method outlined.
Of the 12 patients studied, all had lower g l y c o sylated 
haemoglobin (Fig. 2.11) values after the incubation, but 
there was no significant correlation with b l ood glucose 
(r = 0.235). Again, a large i n t ra-individual variation was 
observed, with the labile material r e p r e senting between 2.5% 
and 14.5% of the total value obtained for the patient concerned. 
The results of studying lability in g l y c o sylated plasma 
proteins were less clear-cut as 7 patients had decreased  
values after the incubation but 5 gave increased results 
(Fig. 2.11). This may be due to the fact that the m e t h o d  is 
less precise than that for g lycosylated h aemoglobins and so 
the removal of any labile material may not be clearly seen. 
However, other factors should not be d i s c ounted which m ay be 
influencing the results. It may be that the protein m o l e c u l e s  
gradually unwind when diluted in water and this may alter 
their binding characteristics, to the column, with glucose, 
or even with the Coomassie Brilliant Blue reagent. For all 
of these reasons it was decided for the sake of c o n s i s t e n c y  
that diluted plasma should be incubated for 5 hours at 37°C 
prior to the m easurement of g l y c o sylated plas.ma proteins.
haemolysates were routinely incubated for 5 
before the g l y c o sylated haemoglobin assay.
S t o r a g e .
As the methods described were to be routinely used for 
the clinical assessment of diabetic patients, it was n e c e s s a r y  
to determine the effect of storage on samples, many of which 
originated at evening clinics or in general p r a c t i t i o n e r Ts 
surgeries where the immediate measurements of glyco s y l a t e d  
materials were impractical.
A diabetic haemolysate was p r e pared and incubated as 
re c o mmended in section 1 of this chapter. Some of this 
haemolysate was tested immediately, and some aliquots were 
stored at 4°C for analysis after one week. Similarly, a 20 
to 1 dilution of the same sample was p r e pared using cyanide 
solution instead of water to haemolyse the cells. This was 
treated in an identical manner.
The remainder of the red cells from the sample were
o
stored und i l u t e d  at M- C, and the haemolysate was p r e p a r e d  
for analysis after a period of 7 days.
All samples were analysed not only at pH 8.3 but also 
at 8.5, 8.1, 7.8 and 7.5. The pH of the appropriate wash  
and elution buffers was adjusted with 1M-HC1. Four samples 
of each different haemolysate were analysed.
Similarly all 
hours at 37°C
Table 2.3 shows that different storage conditions affect
glycosylated haemoglobin values over the pH range 7.5 to 8.5.
For fresh haemolysate the values obtained for pH 7.8 to 8.5
o
are equivalent. Storage of h aemolysate at 4 C for seven days
causes a decrease in value for pH 7.5 and 8.5 compared to
that at 8.1 and 8.3. A similar trend is found when e rythrocyte
o
are kept for seven days at 4 C before the preparation of the 
h a e m o l y s a t e .
Cyanide increases the values of g lycosylated h a e m o g l o b i n
at all of the pHs studied, and these values increased further
when the haemolysate containing cyanide was stored for seven 
o .
days at 4- C. This is discussed later m  the chapter.
The effect of storage on the estimation of g l y c o s y l a t e d
plasma proteins was also investigated. A 20 to 1 dilution
of plasma from a diabetic patient was pr e p a r e d  and incubated.
The g lycosylated plasma proteins were determined on the same
day and the remainder of the sample was split into five
o
portions. Two of these fractions were stored at 4- C, one to 
be analysed after 4- days and the other after a 7 day incu b a t i o n 
The remaining material was all stored frozen (-10°C) for 
analysis after 1,4- and 7 days respectively. All the samples 
were analysed over a range of pH values; pH 8.5, 8.9, 9.2,
9.5, 10.0. The pH of the appropriate wash and elution b u f f e r s 
being adjusted with 1M NaOH. Each different fraction of the 
diluted plasma was analysed four times.
Table 2.4 shows how different storage conditions affect 
the glycosylated plasma protein values over the pH range from
8.5 to 10.0. The values obtained at pH 8.5, 8.9, and 9.2
. . o
were similar for all samples, both fresh and stored at 4- C
for up to 7 days. However freezing the plasma for up to 7
Table 2.3 Effect of sample storage on % glycosylated
haemoglobin
pH of buffers
7.5 7.8 .1 8 . 3 8 .5
Haemolysate
Haemolysate 
stored 7 days 
at 4°C
Erythrocyte s 
stored 7 days 
at 4°C then 
haemolysed
Haemolysate
containing
cyanide
Haemolysate 
containing- 
cyanide stored 
7 days at 4°C
Mean 16 .74 17.57 17 .09 17 .34
SD 0.12 0 .35 0.31 0.49
Mean 15 .5 0*** 16 .70*** 17.14 NS 17.3 7 NS
SD 0 .45 0.15 0 .30 0 .13
Mean 15 .70*** 16 .50*** 16.65* 17.14 NS
SD 0 .41 0.09 0 .10 0.30
Mean 16.77 NS 17.81 NS 1 8 . 2 4*«* 18 . 2 4«««
SD 0.49 0.17 0.31 0.12
Mean 17 .2 6 — — 18 .6 9*-* 18.6 3**** 19 .13***
SD 0.16 0.29 0,20 0 . 21
17 .18 
0.07
16 .60 
0.22
16 .29 
0.25
17 .64 
0.26
0 .09
The results for stored samples were compared to those for fresh 
haemolysate at the appropriate pH.
NS no significant difference
A s ignificantly different at p = 0.05
* * significantly different at p = 0.02
significantly different at p = 0.01
significantly different at p = 0.001
days causes a significant decrease in values at p H ’s 8.5 
(p = 0.01) and 8.9 (p = 0.05), but not at pH9.2. Freezing 
the diluted plasma sample serves to alter the values, p o s sibly 
by the p r e c i pitation of fibrinogen, or by denaturing the 
protein and thereby altering its binding properties.
The results of these investigations show that for both 
assays the sample m a t erial can be stored in diluted form for 
up to seven days at 4°C without deterioration, p r o v i d i n g  the 
pH of the buffers is correctly adjusted. Red cells can be 
s imilarly stored before the haemolysate is prepared. This 
simplifies the practical difficulties of dealing with samples 
taken at times when immediate assay is not feasible. This 
work further substantiates the original experiments in which 
the optimum pH for the g lycosylated h a e m o globin and 
g lyco s y l a t e d  plasma protein assays was found to be pH 8.3 
and 8.9, respectively.
Table 2.4 The effect of sample storage on the % g l y c o s y l a t e d  
plasma p r o t e i n s .
Fresh plasma Mean
SD
18.77
0.24
19 .01 
0.66
18 .43 
0 .55
16.77 
0 .33
14.62
0.36
Plasma stored 
for 4 days at 4°C
Mean
SD
17.8 0 N S 
0.92
1 8 .82NS
0.23
18.6 7 N S 
0.66
1 7 . 47NS 
0.54
1 5 .IONS 
0 .71
Plasma stored 
for 7 days at 4°C
Mean
SD
1 8 . 51NS 
0.28
19 .48NS 
0.51
1 9 . 24NS 
0 .57
18 . 48*** 
0.97
15 .3 9** 
0.21
Plasma stored 
for 24 hr at - 10°C
Mean
SD
1 8 . 30NS 
0.40
1 8 . 4 INS 
0.32
19 .03NS 
0 .71
1 7 . 74NS 
0 .97
1 5 . 09NS 
0.51
Plasma stored 
for 4 days at -10°C
Mean
SD
18.16* 
0.32
19.38 NS 
0.78
1 9 . 08NS 
0.23
1 7 .49NS 
0.74
15.20* 
0.14
Plasma stored 
for 7 days at -10°C
Mean
SD
17.96*** 
0.29
18.13* 
0.11
1 8 . 3 4NS 
0.45
18.06* 
0 .79
1 5 . 01NS 
0.04
The results for stored samples were compared to those for fresh 
plasma tested at the appropriate pH.
Key:
NS no significant difference
s i gnificantly different at p = 0.05
s i g n i f icantly different at p = 0.02
s i gnificantly different at p = 0.01
Effect of M e t - h a e m o g l o b i n .
As me t - h a e m o g l o b i n  forms during sample storage it was 
considered important to investigate its influence on the 
affinity method for glycosylated haemoglobin m easurement .
Sodium nitrite solution was pre p a r e d  by dissolving 7 . 6mg
of NaNO in 10ml of isotonic saline.
3
M e t h o d .
Haemolysates containing a high proportion of m e t - h a e m o g l o b i n  
were p r e pared by the method of Van Assendelft and Z i j l s t r a 
(1965). Red blood cells (0.5ml) from both a n o r m a l  and a 
diabetic individual were dialysed against isotonic saline 
at 37°C for 5 hours. After c e ntrifugation the saline was 
removed and the packed red cells resuspended in an equal 
volume of fresh saline. This suspension was d i v ided into 
two 1ml portions. To the first, or control portion, was 
added 2ml of saline. To the second, was added 2ml of 
saline containing the sodium nitrite. Both were then 
incubated at 37°C for 15 minutes, and it was n o t e d  that 
the fraction containing the nitrite went very dark brown. 
Both fractions were then centrifuged and washed three 
times with saline to remove any excess nitrite, after 
which lOOyud- of packed red cells from both the test and 
control fractions were added to 2ml' of deionised water.
After vortexing, these haemolysa.tes the percentage of 
g l y c osylated haemoglobin was m e a s u r e d  as p r e v i o u s l y  
described.
Table 2.5 The effect of met - h a e m o g l o b i n  on the
% haemoglobin bound by the affinity method.
% met-ha e m o g l o b i n
(mean ± SD)
Non-diabetic 0 10.22
+
0.12
5 11.17 + 0.62
10 10.47 + 0.10
20 10. 28 + 0.11
+
Diabetic 0 16.63 0.17
5 16 .24
T
-1. 0.18
10 16.23
T
0 .26
20 16 .22
T
0.08
All quoted values are the results of triplicate analysis.
** This was the only value which was s i g n i ficantly different 
(p { .02) from the result at 0%.
It was shown (Table 2.5) that there was no significant 
difference in values obtained for the untreated samples 
or the samples containing varying amounts of met- 
haemoglobin. Only the diabetic sample containing 20% 
m et-ha e m o g l o b i n  had values signi f i c a n t l y  different from 
the untreated sample. This was p r o bably due to the 
very small deviation found in this par t i c u l a r  test 
group (Table 2.5), and it was concluded that m e t - h a e m o g l o b i n  
did not interfere with the method. It was therefore 
u nnecessary to include cyanide in the diluent for the 
p r e p aration of the haemolysate.
Effect of A n t i c o a g u l a n t .
Blood was collected from a diabetic patient and 5ml was 
put into a tube containing 75IU of lithium heparin, and mixed. 
Aliquots of this blood were transferred to other tubes to 
achieve concentrations of 3 times and 6 times the r e c o m m e n d e d  
level of 15 IU/ml. Blood was added to tubes c o n t aining sodium 
fluoride, and in a similar manner different mul t i p l e s  of the 
r e c o mmended concentration of 1.0mg/ml were achieved. Blood 
was collected from a n o n - d iabetic patient and p r e pared in an 
identical manner.
All of the prepared material was then h a e m o l y s e d  and 
incubated in accordance with the routine m e t h o d  for g l y c o s y l a t e d  
haemoglobin measurement and four samples of each h a e m olysate 
were analysed.
There was no significant difference between the two 
anticoagulants used (Table 2.6) and so these tubes could 
be used i n terchangeably for the p r eservation of blood 
samples for this test. Furthermore, the c o ncentration of 
anticoagulant, in both cases, did not appear to be critical. 
Only the n o n-diabetic sample at 6 times the r ecommended  
concentration of sodium fluoride or lithium heparin differed  
s i gnificantly (p 0.05, p 0.05). No such observations 
were made for the diabetic sample (Table 2.6). Although the 
use of sodium fluoride tubes offered the advantage that b l ood  
from the same tube could be tested for blood glucose 
concentration, this m a t erial proved to be less efficient 
than lithium heparin as an anticoagulant and so the latter 
was used routinely for the pres e r v a t i o n  of samples.
Table 2.6 The effect of different anticoagulants, at
varying concentrations, on the % g l y c o sylated  
h a e m o g l o b i n s .
Non-diabetic Diabetic
+ + 
Fluoride 1 6.42 - 0.12 13.52 - 0.45
+ +3 7.19 - 0.93 NS 13.51 - 0.12 NS
+ +
6 6.74 - 0.23 * 13.34 - 0.35 NS
+ +
Lithium 1 6 . 6 6 - 0 . 1 9  1 3 . 3 3 - 0 . 5 3
heparin +
+.
3 6.61 - 0.54 NS 13.38 - 0.14 NS
+ +
6 6.26 - 0.24 * 13.51 - 0.44 NS
Each level of anticoagulant used was tested against the 
recommended level to see if the results differed, s i g n i f i c a n t l y
NS n o n - s i gnificant difference 
* differed at p = 0.05
M is the multiple of the r e c o mmended level 
of anticoagulant.
Column Reuse.
Five groups of columns were prepared, with five columns 
in each group. Each group was used a different number of 
times for the measurement of g l y c o sylated haemoglobin.
The number of times used were 3, 7, 12, 16 and 19 for each 
group, respectively. When not in use the columns were 
stored in the dark at 4°C. After each use the gel was r e g e n e r a t e d  
with acetic acid (0.01M).
When all of the columns had been used for the specified 
number of times (within a period of four weeks), all of them 
were then used for the replicate m e a s urement of g l y c o s y l a t e d  
haemoglobins in a single diabetic haemolysate. Each group 
was s t atistically compared to a fresh set of five columns. A 
small decrease in the amount of bound material was apparent 
with increasing usage (Table 2.7). However, when compared 
to fresh columns this decrease was less than 2% for all groups 
of columns, except those that had been used more than 16 times.
The columns that had been used 19 times showed a significant
+ + 
decrease from 20.24 - 39% to 19.72 - 0.12% (p <  0.05) (Table
2.7). The columns gradually became darker with re-use,
part i c u l a r l y  at the surface of the gel. A single column was
prepared of unused gel which was then stored at room t e m p e r a t u r e
and in the light for three weeks. The percent bound
haemoglobin for this column was compared to unused columns
stored at 4°C and in the dark for the same period of time.
The column kept in the light went a dark purple colour, this
is well illustrated in Fig. 2.12. Although not p r e v i o u s l y
AGEING OF GLYCOGEL B
After -3 weeks  
in daylight
F resh A f t e r
5 u se s
Fig. 2.12 To illustrate the da rke ning of the 
affinity gel when exposed to light
at room t e m p e r a t u r e .
used to analyse samples, this column was shown to have 
reduced capacity to bind g l y c o sylated haemoglobin, and a 
value of 6.22% was observed, compared to 12.11% for the 
same sample using fresh columns.
Similar investigations were done to see how man y  times 
the gel could be r e g e nerated between use, for g l y c osylated 
plasma protein measurements. Again five column groups were 
prepared and each group was used 3, 6 and 9 times for the 
measurement of g lycosylated plasma proteins. When not in 
use the columns were stored in the dark at 4°C. After each 
use the gel was r e g e n erated with acetic acid (0.01M).
When the same diabetic sample was then loaded onto all
the columns only those columns used nine times p r e v i o u s l y
/ "I"showed a significant decrease (p < 0.001) from 15.68 - 0.33
to 14.09 - 0.32%. Again the columns became darker with 
increasing use.
As a result of these investigations the columns were 
regenerated and reused no more than 12 times for the 
m easurement of glycosylated haemoglobins, and no more than 
6 times for the measurement of glyc o s y l a t e d  plasma proteins
Table 2.7 To illustrate the effect of gel reuse on
the measurement of g lycosylated haemoglobins
and g lycosylated plasma proteins by affinity 
c h r o m a t o g r a p h y .
Number % glycosylated % g lycosylated
of uses haemoglobins plasma proteins
+ +
fresh 20.24 - 0.39 15 .68 0.33
+ +
3 19 .85 — 0.24 15 .43 0.2 9
+ +
6 20.16 — 0.27 15 .51 0.27
9 19.92
+
0.20 14.09
+
0.32
+
12 18.9 5 - 1.02
+
16 19.89 - 0 .14
+
19 19 .72 - 0.12 **
Results are the mean result from 5 analysis, together with 
the standard deviation.
Ke^:
NS non-significant 
** differed at p = 0.02
**** differed at p = 0.001
SECTION 3.
PRECISION AND RANGES FOR GLYCOSYLATED 
HAEMOGLOBINS AND GLYCOSYLATED PLASMA 
PROTEINS USING THE AFFINITY METHODS.
The work in this section was done using the conditions 
outlined in section 1 of this chapter. All assays were carried 
out at 20°C — 1 ° C . The pH of the buffers used was pH8.3 for 
glycosylated haemoglobins and pH8.9 for g l y c o sylated plasma 
proteins, except for the precision studies when pH8.5 was 
employed for the g lycosylated haemoglobin assay. All samples 
were collected in lithium heparin and were assayed within 24 
hours of sampling, unless otherwise stated. . Labile ma t e r i a l 
was removed routinely by incubation of the diluted sample for 
5 hours at 37°C. The volume of diluted sample (lOOjnl of sample 
x2ml deionised water) added to the column was 100^1 and 150y^l 
for glycosylated haemoglobins and g lycosylated plasma proteins, 
respectively.
Pre cis i o n .
Using the recommended conditions, experiments were 
carried out to determine the precision of the m easurement  
for both g l y c o sylated h a e m o globins and glycosylated plas m a  
proteins.
Haemolysates were made from blood of both a normal and 
a diabetic individual, and. incubated. Within-.batch pre c i s i o n  
was determined by preparing a series of 20 fresh columns and 
adding lOOyul of the haemolysate to each. The results for 
both normal and diabetic samples are shown in Table 2.8. The 
same samples were stored at 4 ^ a n ^ run on different columns
over a period of a week; a total of 15 runs for each. These 
values were used to calculate the b e t w e e n - b a t c h  p r e c ision of 
the assay (Table 2.8). Table 2.8 shows that the m e t h o d  for 
the assay of glycosylated haemoglobins is h i ghly r e p r o ducible, 
with coefficients of variation of 1.5% to 2.0%.
Values for w i thin-batch and betwe e n - b a t c h  pre c i s i o n  were 
obtained for glycosylated plasma proteins by doing identical 
studies with diluted plasma instead of haemolysate and using 
the affinity method decribed earlier in this chapter for this 
measurement. (Table 2.8). It was ne c e s s a r y  to assess the 
contribution to the observed error made by the additional  
step of adding the acidified Coomassie Brilliant Blue p r o t e i n  
reagent. A sample of diluted plasma was therefore f u rther 
diluted with wash buffer to 27ml, and 500yu-l of this solution 
was put into 20 cuvettes. Fresh acidified protein reagent
Table 2.8 Precision of the affinity neth o d  for
g lycosylated haemoglobins and glycosylated  
plasma p r o t e i n s .
W ithin-batch 
(n = 20)
Between-batch 
(n = 15)
GLYCOSYLATED
H AEMOGLOBINS
Non-diabetic
Diabetic
mean 6.81 
S.D. 0.14- 
mean 2 0.04 
S.D. 0.30
C.V.
2.0
1.5
7 . 00 
0.13 
19 .73 
0 . 30
C . V . %
1.
1.5
GLYCOSYLATED 
PLASMA PROTEINS
Non-diabetic
Diabetic
mean
S.D.
5 .83 
0 .24
mean 13.11 
S.D. 0.51
4.1
3 . 9
5.87
0.45
12.37
0.65
7 . 6
5.2
( 500^1) was then added to each, mixed and the absorbance 
recorded after exactly 30 minutes at 595nm against air.
The mean absorbance value for these 20 assays was 0.351 
with a standard deviation of 0.010, giving a coefficient 
of variation of 2.72%. From these investigations therefore 
it is likely that the wider variation (Table 2.8) found with 
the g l ycosylated plasma protein measurement, as compared 
with that for the g lycosylated haemoglobins, is due almost 
entirely to the additional step required for the protein 
measurement. The contribution of this additional step to 
the total method error can be calculated.
Calculation of the contribution of the Coomassie 
Brilliant Blue Dye measurement to the total error 
in the measurement of glycosylated plasma proteins 
using affinity c h r o m a t o g r a p h y .
The variation that individual components (xj_» etc.)
contribute to the total method error can be calc u l a t e d
through the sum of squares rule:
2 2
Total method error = x^ + X 2 + .....
The total method error for glyco s y l a t e d  plasma p r o teins 
of a n o n - d iabetic was ^ 4.1%, and of a diabetic was.- 3.9% 
(Table 2.8).
The error calculated for the Coomassie B r i l l iant.Blue 
Dye measurement was 2.72%.
By substitution the variation of the affinity step can be 
calculated to be 3.06% and 2.8% for the n o n - diabetic and 
diabetic groups, respectively. These figures are only 
slightly higher than those for the glycosylated h aemoglobin 
assay (1.5% and 2.0%).
Normal R a n g e .
The range of stable g l y c o sylated haemoglobins and
glycosylated plasma proteins found in 62 non-d i a b e t i c s  is
shown in Table 2 . 9 . The range in a group of 138 i n s u l i n - t r e a t e d
diabetic patients is also shown (Table 2^9). These diabetic
patients were all seen as out-patients and were considered
to be clinically in glycaemic control. However, only 15 of
the patients had values within the non-d i a b e t i c  range and
there was a considerable spread of results with values as high
as 21.5% observed. This is clearly seen in Fig. 2.13. The
limitations of a single blood glucose m e a s urement are clearly
illustrated by the fact that 5 patients with g l y c o s y l a t e d
haemoglobins values above 15% had simultaneous glucose b e low
10mmol/l, and conversely3 patients with high blood glucose
levels had glycosylated haemoglobin values below 10%. ( F i g . 2.13).
The normal range was narrower and differed signif i c a n t l y  from
the diabetic group (p -<[ 0.001). The range for n o n - d i a b e t i c
individuals e ncompassed two different populations; norm a l
+
subjects being healthy laboratory workers (6.51 - 0.52%) and
+
non- d i a b e t i c  patients (7.M-5 - 0.90%), which differed signi f i c a n t l y .
(p <  0.001).
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2.13 Histogram showing the d istribution of % g l y c o s y l a t e d
haemoglobins for diabetic and n on-diabetic i ndividuals 
The results include those for individual l a b o r a t o r y
staff (A  ). The diabetic patients with blood glucose 
above 10mmol/l are noted ( •  ).
The ranges shown for 58 n o n - d iabetic and 153 insulin- 
treated, supposedly stabilised diabetic patients for the 
stable g l y c o sylated plasma protein m easurement are also 
given in Table 2.9. Again a wide spread of values for 
diabetic patients was observed (Fig. 2.14), with only 38 
patients having values within the calculated normal range.
Of these, only 4 had high glucose values. Similar to the 
findings with the measurement of g lycosylated haemoglobins, 
of the 35 patients with g l y c o sylated plasma protein values 
of 15% or above, only 14 had simultaneous blood glucose 
levels below 10mmol/l.
Again the normal range was narrower, having within it
the two populations, namely laboratory staff (5.73 - 0.99%)
+
and n on-diabetic patients (6.43 - 2.03%). However, this 
time these groups did not differ significantly. The results 
from n on-diabetic and diabetic groups of individuals did 
differ s i gnificantly (p K 0.001).
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Fig. 2.14 Histogram showing the distribution of % g l y c o s y l a t e d  
plasma proteins for diabetic and n o n - d i a b e t i c  
individuals. The results include those for
individual laboratory staff ( A ). The diabetic 
patients with blood glucose above 10mmol/l are 
noted ( •  ) .
Table 2.9 To ill ustrate the ranges obtai ned for
gly cosyl at ed hae mogl obins  and glycosy la ted  
plasma  proteins with n o n - d i a b e t i c  and diabetic 
p a t i e n t s .
G LYCOS YL ATED G L Y C O S Y L A T E D
HAE MO GL OBINS PLASMA PROTEINS
+ +
N O N-DI AB ET IC (n = 62) 7.31 - 0.92% (n = 58) 6.29 - 1.87%
observed range 5.25% to 9.70% 2.95% to 10.27%
DIABETICS (n = 138 ) 12 . 70 - 2 .88% (n =153)12 . 62 - 3 . 36 %
observed range 6.50% to 21.5% 6.05% to 23.31 o\°
Quality C o n t r o l *
The work for this study was begun in Jan uary 1982 and 
quality control m e asureme nt s were emp lo yed from July 1982, 
for both the glyc osyla te d h a e m o g l o b i n  and g ly co sylate d plasma 
protein assays.
(1) G ly co sylated  h a e m o g l o b i n s .
A large pool of diabetic haemolys ate was pr e p a r e d  
by diluting 5ml of red blood cells from a po orly cont ro lled  
diabetic in 1 litre of deionised  water. After thorou gh 
mixing, aliquots (0.5ml) of this haemo lys ate were stored in 
liquid nitrog en until required. Before use, a sample was 
brought to room tempe ratur e and then incubated at 37°C for 
5 hours to remove labile material. A sample of this qu ality 
control material was run with every batch of columns for the 
glycosy la ted hae mo globin  assay.
The results for the first 20 runs using this qu alit y 
control material were noted  and the mean and b e t w e e n - b a t c h  
variation was cal cul at ed (18.96 - 0.89%). Subsequent qual ity 
control results were compared against these values and each 
had t o b e  within these limits for the results of the rest of 
the batch to be reported.
(2) G ly co sylate d plasm a p r o t e i n s .
The quality control emp lo yed for the g l y c o syl at ed
plasm a pr ote in assay was the W ellc om trol standard (Wellcome
Diagnostics, Dartford, Kent, batch no. K1619), which was
pr epa re d daily from l yo philis ed  ma terial  for use th roughout
the laboratory. After re co nstituti on, lOOywl of the ma t e r i a l
was diluted with 2ml of water and incubated  for 5 hours at
37°C before use. As with the g ly co sylated  haemoglobins,
the first 20 results were used to calculate the mean value
+
and betw e e n - b a t c h  variation (17.51-7 - 1.39%) and all subs eq uent 
quality control values for the assay had. to be within these 
limits to be acceptable.
(3) Changing betw een different b a t ches of af f i n i t y  g e 1 .
Gel of various different batch numbers was suppl ie d 
by Pierce Chemical Co. Ltd. for this aff in ity c h r o m a t o g r a p h y 
work. As well as the quality control scheme, when chang in g 
between batches, the last batch of 20 fre shly p o ured columns 
of the older batch nu mbe r were run in tandem with 20 fresh 
columns from the new batc h and the results were co m p a r e d  to 
check that there was no signi fican t difference. Only uiie batch  
of gel was rejec te d on this basis.
DISCUSSION.
Af fin it y c h ro ma tograp hy  pro vides a very rep rod ucibl e and 
sensitive technique for the m e a s ureme nt  of both glyco s y l a t e d  
h ae mog lob ins (CV. 1 to 2%) and g l y c os ylated  plasma pro tei ns 
(CV. about 5%). There are only two critical volume m e asur em ents; 
the 3ml of elution b u ffer and the adjustm ent of the wash 
fraction to 15ml or 24ml, as appropriate. As the values are 
expressed in terms of perc ent ages, standards are not required, 
which may pa rt ly  account for the high rep r o d u c i b i l i t y  of the 
technique. The slightly wide r vari ation (5%) found with the 
measurem ent of glyc os ylated  plasma proteins can be a c c o u n t e d  
for by the ad di tional step required  to measure the p r ot ein 
content in each fraction.
The methods both give good d i scrimi na tion between 
diabetics (IDDM) and n o n - d iabeti c individuals (Figs 2.13 and 
2.14). The glucose results in both figures show that a 
diabetic patient with either a high gl yco s y l a t e d  h a e m o g l o b i n  
or g ly cosylat ed  plasm a protein, does not nece s s a r i l y  have a 
high simultaneous blo od glucose, and vice versa. This 
implies that the me asureme nt of g l y c o s y l a t e d  m a t eria l is 
more useful for m o n i t o r i n g  long- term glycaernic control. For 
the studies using glycosyl at ed haemo globins, the no rmal range 
had within  it two signif ic antly different populations: norm a l  
subjects (the labo ratory workers) and the n o n - d i a b e t i c  
patients. This is po ss i b l y  a ge -r elated as the labor at ory  
workers were generally between the second and third decades, 
while the patient popu lation  were p r e d o m i n a n t l y  of m i d d l e , t o  
older age. Howe ver other studies desc ri bed later in this
thesis can show no as sociation  between age and control in 
our diabetic clinic. Maybe the difference is due to another 
factor such as the red uced mobil it y of many of the patients.
The removal of labile mater ia l is recommended. This is 
n e c e ssary  as the perc entage  of labile ma t e r i a l  varies 
con sid erab ly  between individuals (Fig 2.11) and is net 
a pp are ntl y rel ated to blo od glucose conce ntration in the same 
sample. These findings do not agree with those of Abraham, 
Perry and Stallings (1383) who suggest that only the stable 
ke toa mine binds to the affin ity gel. However, th e o r e t i c a l l y  
labile materia l should bin d to the gel as the glucose 
attached to haem oglob in  has cis-diol groups. The wide i n t r a ­
in dividual var iation may be due to diss ociatio n cf labile 
material during chr omatog ra phy causing variable results in 
the separation.
The method  is very versatile. S i n c e  either lithium he pari n 
sodium fluoride may be used as anti-c oagulants , it is possibl e 
to do the test on most of the bloo d rec ei ve d routinely. The 
use of sodium fluoride allows the sim ulta neous  m e a s u r e m e n t  of 
glucose and g lycosy la ted hae mogl ob in on the same sample.
However as lithium heparin pr oved to be a much b e t t e r  a n t i ­
coagulant, this was rec omme nd ed for use in the diabetic clinics 
studied. Very little sample is required, enabling g l y c o s y l a t e d  
haem og lobin to be me as ured in blood taken from a f i n g e r p r i c k . 
Th eo retical ly  the me asurement of gl yco s y l a t e d  pl asm a pr o t e i n  
should also require only a small sample of plasma, but in 
practice it was difficult to avoid extensive h ae molysis  in 
small plasma samples.
o r
Bindi ng to the gel column appears to be independent of 
the amount of haemog lo bin betw een  0.5mg and 2.0mg loaded per 
column. This is equivalent to a h a e m o gl obin con centra ti on 
between 5.0g/dl and 20g/dl in the original sample, 
assuming a packed cell volume of 50%. This means that the 
me thod is applicable to almost the whole range of c o nc en tratio ns  
en co unte re d in n o n - d i a b e t i c  and diabetic patients. It must be 
re me mber ed  however, that other features such as re duced red 
cell survival time may affect the g ly cosyla te d h a e m oglo bi n 
result. Similar results were found with the m e a s u r e m e n t  of 
g l y c o syla te d plas ma proteins, where the results were 
independent of loading between 0.25mg and 2.0mg of pr ot ein 
per 1ml gel column.
Storage of both the samples and the gel is important.
The results (Table 2.3) indicate that immediate analysis of
the stable haemolys ate is preferable, but storage at 4°C for
up to a week still enables 96% of the original result to be
obtained. This is not as long as the storage allowed by
Little ejt a l . ( 1983) of upto 21 days. The pH of both buf fers
for the m e a s u r e m e m  of g l yco sy lated h aemog lo bins as r e c o m m e n d e d
by Mallia e_t al. (1981) was 8.5, but the results in this
thesis (Table 23.) show that the pH of 8.3 may be p r e f e r a b l e
since is appears to nu llify the difference in percent
g ly co sylate d hae mo globi n in fresh and stored samples.
o
Similarly, plasma  can be stored s ucce ss fully at 4 C for upto 
a week with little effect on the results. The use of both  
the wash and elution buffers at pH8.9 seems to be o p t i m u m  for 
this assay (Fig. 2.7, Table 2.4).
Met -haem og lobin was shown not to interfere with the me th od  
(Table 2.5) and so it was c on si dered unn ece ss ary to include 
cyanide in the diluent for the p repar at ion of ha em olysate to 
stop its formation. This avoided any potenti al  hazard clue 
to the inclusion of cyanide in the reagent. Also, Middle 
et a l . (1983) have indic ated that the ionicity of the buff ers 
used with this gel is important as inc rea se d h ydroph ob ic 
conditions affects the bo r o n - d i o l  interaction. Therefore the 
inclusion of mat er ial such as cyanide, or indeed saline, in 
any sample added to the column was avoided, as this could 
po te n t i a l l y  alter the column charac teristics . This effect 
was shown in the storage exp eriem en ts (Table 2.3) where the 
presence of cyanide with a fresh sample caused an in creased 
percentag e of h ae mo globin binding to the column, and this 
value in creased still further with s t o r a g e .
At the begin ni ng of this work no s a t i sf ac tory QC scheme 
suitable for general use had been found and the use of 
T i n - h o u s e T quality control was r e c o mm en ded (Boucher e_t a l .
1983) for mo n i t o r i n g  the pe rfo rmance of any individual assay. 
During the work for this thesis various companies sup pl ied 
QC ma teri al  for use with their p a r t i c u l a r  methodol ogy. Ho wever, 
these prov ed uns uc cessful  for use with the aff inity method, 
p re s u m a b l y  as the affini ty me tho d me asu res different m a t e r i a l  
(including G H b A Q ) # an(  ^ so the values for me thods m e a s u r i n g  
other components were not directly applicable. At this time 
Pierce Chemical Co. Ltd. did not supply QC m a t er ial for use 
with  Glycogel B. The use of a pool of ha emolysat e stored at 
-2.0°C prov ed to be sat isfa ctory as a means of qual ity c o n tr ol
for g l y c o sylate d haemog lob ins, as did the use of freshly 
pr epa re d wellc omt rol standar d for the g l y c o sylat ed  plasma 
protein assay. When changing from one batch of affinity gel 
to another, the c onsis te ncy of the results was also checked. 
This, and the quality control schemes were important 
considerations as some of the clinical studies were re l a t i v e l y  
long-term (18 months to 2 years) and so it was ne c e s s a r y  to 
ensure that obser ved effects were not due to diffe rences in 
the gel manufacture.
As described, the metho d is eminently  suitable for 
routine use, as the work may be carried out at room te mp e r a t u r e  
on the labo ra tory bench. There is no requir ement of stri ng ent 
control of either  temperat ure or pH as with the ion-excha ng e  
methods, although the columns must be suitabl y primed be fore  
use. Positi oning the columns in direct sunlight should be 
avoided to prevent a more rapid ageing of the gels. The 
technique is simple to perform, and the affini ty  gels are very 
robust. They may be left to drain for several hours wi th out 
drying out and so 30 samples may be handled in a run, the 
main limiting factor bei ng bench space. Since the m e a s u r e m e n t  
of glyc osylat ed  h a e m oglo bi n only take 40 minutes, it is 
convenient to test 60 samples in a single wo r k i n g  day. The 
measure me nt of g lycos yl ated plasm a pr otein s takes about an 
hou r longer to pe rfo rm  as there is an a d d i ti on al step r e q u i r e d  
for the protei n measurement. Ho wev er with good o r g a n i s a t i o n  
50 to 60 plasma samples may, alternatively, be me asu r e d  w i t h i n  
a wo rking day. All the equipment re quired for eithe r as say  
should be available in any ho spita l laboratory, and by using 
this me thod the need  for expensive equipment is obviated.
Since the gel can be s uc cessfu ll y reused, the price of the 
gel is kept to about 33p per assay, which is highly  
competitive with other techniques such as that ma r k e t e d  
by Corning (53p per test) and the m i n i - i o n - e x c h a n g e  columns 
from Biora d (97p per test). These costs are ca lc ulated  at 
the time of wr it ing this thesis, and do not include V.A'.T.
At the beg inni ng  of the work for this thesis the m a jor  
aim was to develop an affinit y me th od  to provide the 
measureme nt of g l y c o sylated  haemoglob in s for the clinicians 
at a reasonable cost. Ideally this me th o d  should t e c h n i c a l l y  
be within the ca pability of the most junior of l a b o ra to ry 
staff. At the time no suitable inexpensive method was 
ma r k e t e d  and the col ori metri c tec hnique proved difficult to 
do on a day-to-d ay basis. The me th od  de scr ibed in this 
chapter fulfils all of the origi nal aims. It provide s good 
discrimina ti on between diabetics and no n- diabetics,  and has 
been used to mo nitor the progress of diabetic pat ients  over 
a two year pe riod (see later, Chapter 5). Affinity  
chrom a t o g r a p h y  confers the additional advantage that 
gljrcosylated pl asm a proteins may also be m e a s u r e d  using the 
same material. As these are also e x p re ss ed in terms of a 
percentage value this m easure me nt may be dir ect ly com pa r e d  
to that of g l y c o sylated  haemoglobin,  and the usefulne ss of 
each in different clinical situations as ses sed (see later 
Chapters 4, 5 and 6).
CHAPTER 3.
ASSESSMENT OF THE AFFINITY METHODS 
FOR THE MEASUREMENT OF GLYCOSYLATED 
HAEMOGLOBINS AND GLYCOSYLATED 
PLASMA PROTEINS.
INTRODUCTION.
In 1981 Bunn review ed  the techniques then available for 
the meas ur em ent of g ly cosylat ed  hae moglobins . The most 
commonly used me th od was cat ion -e xchange  chrom a t o g r a p h y  
using Biore x 70, generally  p a c kage d in the form of disposab le 
columns. As already discussed  (Chapter 1) this t e c h niq ue  has 
several disadvant ages, a serious one being that it is very 
sensitive to small variation s in temp er ature and pH (Rosenthal,
1979). Also the presence of h a e m oglo bi n variants can e i t h e r  
cause a false increase, e.g. HbF (Simon and Eissler, 1980) or 
a false decrease e.g. HbS, HbC (Aleyassine, 1979). F a l se ly 
high values for HbA^ have been found in patients with ur a e m i a  
(Fluckiger e_t al. 1981), p o s si bly in alc oholics (Stevens et_ a l . 
1981) or those on high doses of asprin (Spicer _et al_. 1979), 
and may be expected  in some young children with lead p o i s o n i n g  
(Charache and Weatherall, 1966). Lactes cent pla sma also causes 
falsely high values, but only if whole blood is an a l y s e d  by  a 
rapid assay (Dix e_t aJL. 1979 ). Some of these i n t e r f e r e n c e s 
are caused by other components at ta ching them se lves to the 
haemogl ob in  molecule; uraemic patients yi eld elevated . levels  
of c arba my la ted haemoglobin, and aspirin .poisoning p r o duces 
ac e t ylated  haemoglobin.  These changes alter the c h a n g e/m as s
ratio of hae m o g l o b i n  A^ causing it to.behave like g l y c o s y l a t e d  
m a t erial when using those methods which are c h a r g e - d e p e n d e n t  
for separation. However, the principle of sepa ration w i t h  
af fin it y c h r o m a togr ap hy depends on the prese nc e of the g l u c o s e
m oie ty and therefore it should not be affected  by these other 
species. This work in ve sti gates this claim and compares the 
a ffi nity tec hnique with another meth o d  rec en tly gain ing in 
po pul arity, that of agar gel e l e ctropho re sis (Menard ejt a l .
1980), which depends on the charge/mass ratio for separat ion.
In this chapter the aff inity techn ique for the m e a s u r e m e n t  
of both g l y c o sy lated hae mogl obins and gly cosy la ted plasma 
proteins has been compare d with e s t a b l i s h e d  techniques; agar 
gel e l ectro ph or esis and the col or imetric  me th o d  respect iv ely. 
The possib le effects of h a e m olysed samples on g l y c o s y l a t e d  
plasm a pr ote in  m e a s ureme nt  was also investigated. P r e l i m i n a r y  
studies of the nature of the ma ter i a l  b i n ding to the gel for 
both the assay of g l y c o sylate d haemogl ob ins and g l y c o s y l a t e d  
plasma proteins, are described.
MATERIALS AND METHODS.
S A M P L E S .
Mater nal  and cord bloods were taken imme di ately  after 
birth from 7 non -d iabetic  and 3 IDDM mothers. Blood was also 
obtained from 8 uraemic patients, 5 patients with ele va ted 
a'GT, 3 cases of aspi rin poisoning, and 2 children with 
lead poisoning. Lithium heparin was used as an a n t i c oa gu lant  
for all blood samples, and each sample was teste d usin g both 
agar gel electr op horesi s and affi nity ch ro ma t o g r a p h y  for the 
me as ur eme nt of g l yc os ylated  hae moglobins.
Samples used for the meas ur ement of g l y c o sylat ed  
hae moglo bi ns  by both agar gel ele ctr op horesis  and af fi nity 
chromatography, and for the comparison of g l y c o syl at ed p l a s m a  
protein mea sure me nt by the colo rim etric me thod and a f f inity 
chromatography, were all obtain ed from the ou t- patient di ab et ic 
clinic at the Royal Sussex County Hospital. No n- d i a b e t i c  
samples used were obtained from la boratory staff. These 
were also the sources of samples for the co mp ariso n of 
g l y c os yl ated haemoglob ins and g l y c o sylate d pl as ma pr otei ns  
both me asured  on the same sample using the af fi nity te chniq ues.  
Blood glucose was rou ti nely me as ured for these patients at the 
time of blood sampling.
(1) Prepar ation  of samples containing different 
amounts of fetal h aemoglo bi n ( H b F ) .
To investigate the interference of HbF, cord blood 
was mixed in various prop or tions with either blood from a 
diabetic or a non-diabetic. The samples used contai ne d 100%, 
80%, 65%, 50%, 35%, 20% and 0% of cord blood in each case. 
Each sample was mix ed  and 100/ui of packe d red cells were 
diluted in 2ml of de ionised water  and incub ated at 37°C for 
5 hours to remove labile material. Each sample was then 
analy sed  in triplicate by the affinity meth od describ ed  in 
Chapter 2 for g ly co sylate d h a e m o gl ob in measuremen t. An 
identical in vesti gation was carried out using a sample 
co nta ining 48% HbS and 48% HbC, instead of cord blood.
(2) Prepar ation  of plasma samples con taining diff er ent 
amounts of h a e m o g l o b i n .
A sample of blood from a poorly c o n t rolled  di abetic  
patient, pr e s e r v e d  in a lithium heparin container, was chosen 
to assess the effect of hae mo lysis on the m e a s uremen t of 
g l ycos yl at ed plasma  proteins. Before these i n v e s t igat io ns 
the sample was analys ed by the usual af finit y met hods to 
give a gly co sylat ed  haem og lobin value of 22.0% and a 
g l y c o s y l a t e d  plasma protein value of 23.1%. The whole b l oo d 
sample was then shaken gently and then re - c e n t r i f u g e d  to 
reveal plasma of a pale pink colour. One aliquot was r e m o v e d
for the est ima tion of haemo gl obin conce ntrat io n and others 
for mi xing with plasm a from a w e l l - c o n t r o l l e d  diabetic 
pat ient which was app are ntly free from haemolysis. The 
pr opo rtions of hae m o l y s e d  plasma used were 100%, 80%, 65%,
50%, 35%, 20% and 0%. The original sample was then remix ed  
and shaken more v ig orousl y to furt her  contaminate the p l a s m a  
with haemoglobin. After cen trifug at ion pl asma of a clear, 
red appearence was obtained. Some of this was also re mo ve d  
to mix with n o n - c o n t a m i n a t e d  plasma in quantities be tween 0% 
and 100%. Again the h ae mo globin  concentrat io n was m e a s u r e d  
and noted. . Fin ally the original blo od sample was r e m ixed  
and furt her haemoly sis ac hie ved using a vortexj^ • After 
centrifuga ti on  the plasma was then found to be grossl y h a e m o l y s e d  
and it was difficult to di stingui sh betw een the plasma and the 
red cell layer. Aliquots were removed from the top of this 
sample to prepare another experim ent as de scribed before, but 
using a more grossly con tami nated  sample. Ha emoglobin 
concen tra tion was noted. All of the pr e p a r e d  pl as ma samples 
were then ana lys ed in triplicate using the aff in ity m e t h o d  
for g l y c o sy la ted plasma proteins.
(3) Pr eparation of samples for i m m u n o e l e c t r o p h o r e s i s  .
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Blood was taken from n o n - d i a b e t i c  patients 
13 heal thy  la bo rat ory staff into lithium hepa rin tubes, 
ce ntrifu gation the plasma (100,ul) from each was diluted 
de ionised w^t er  (2ml) and incubat ed at 37°C for 5 hours 
remove labile material. Each sample was then separat ed  
affinity c h r o m a to gr aphy in a total of 4 runs, the first
freshly poured  gels. The fractions con tai ning materia l which
did not bind to the gel ( " u n b o u n d ” ) in wash buffer, were
o
pooled into a large flask and stored at 4 C. Similar ly the 
fractions co ntaining materi al  which was retain ed by the gel 
("bound") colected in elution buffer, were pooled  in a 
separate flask and stored at 4 ° C . Blood from 91 diabetic 
patients was separated and a pool of "unbound" and "bound" 
material from this source was prepa re d in an ide ntical manner. 
This took a total of 5 runs, again the first run was on 
freshly po ured gel. The whole collect ion took 11 days. All 
samples were stored at 4°C and were then t r a n s p o r t e d  to the 
Universit y of Surrey where they were u l t r a f i l t e r e d  using a 
stirred Diaflo ultra fi l t r a t i o n  cell with a membrane (UM05 ) 
with a cut off at 500 daltons. Each ultrafilt ra te was 
wa shed several times with dei onised w a ter to remove excess 
buffe r constituent s before l y o p h i l i s a t i o n . This part of the 
p rep arative  work was carried out by Dr. B. J. Gould.
Ap prox i m a t e l y  lmg of each sample was r e c o n s t i t u t e d  with 
15^.1 of tr is/ba rb itone buf fer before i m m u n o e l e c t r o p h o r e s i s .
(4-) Pr epa ration of samples for r e c h r o m a t o g r a p h y  
s t u d i e s .
This is descri be d in the methods section of this 
chapter. (
REAGENTS .
For the colori metric m eas ur ement of g ly co sylated  plasma  p r o t e i n s .
0.15 mol/1 sodium chloride (NaC.l), 2.5 mol/1 t r i c h l o r o a c e t i c  
acid (TCA) and 1.0 mol/1 oxalic acid were prepared. A 
satu rat ed solution of thi ob a r b i t u r i c  acid (TBA) was p r e p a r e d  
by adding 0.721g to 100ml of water and incubating at 40°C for 
1 hour. The solution was fi ltere d before use.
Care was taken with the use of the poisonous  reagents  
oxalic acid and t h i o b a rb it uric acid.
For i m m u n o e l ect ro phoresi s and crosse d i m m u n o e l e c t r o p h o r e s i s .
0.05M tri s/b ar bitone b u ffe r was p r e pa red and a d j usted  
to pH8.6. Agarose (HEEO grade) was obt ai ne d from FMC 
Corporation, Marine Colloids Division, Rockland, ME 04-841,
USA, and 1% agarose was pr e p a r e d  in buff er for i m m u n o e l e c t r o p h o r e s i s .
Agarose (Type HSA) was from Litex, Denmark, and 1% agarose  
was p r e pa re d in buffe r and used for the crossed i m m u n o e l e c t r o p h o r e s i s
Antisera;
R a b b i t - a n t i — m a c r o g l o b u l i n  was from 
Behring we rke AG, M a r b u r g - L a h n , Germany. 
R a b b i t - an ti -human  hapt o g l o b i n  was from 
Dako Immunoglob ulins a/s, Denmark.
S h eep- an ti-whol e- human; she e p - a n t i - h u m a n  al bumin ; 
sheep-an ti -human transferrin; s h e e p - a n t i - h u m a n  0 ^ "  
antitrypsin; s h e e p - an ti -human 0(^-acid g l y c o p r o t e i n ;  
sheep- an ti-hum an  IgG, ijA, and IgM; were all 
obtained from Gu ildhay Antisera, Guil dford,  Surrey.
Coomassie Brilliant Blue Stain was pre pa red by adding 
5g of Coomassie Brilliant Blue R250 to one litre of w a ter and 
leaving overnight at room temperature. This solution was 
filter ed and mix ed  with ethanol (96%), water, and glacial 
acetic acid in the ratio 1:9:9:2, respec tivel y, before use. 
Dest ain er was p r e pared  using ethano l (96%), water and glac ial  
acetic acid mix ed  in the pr op ort ions, 9:9:2.
0.15 mol/1 saline was also prepared.
M E T H O D S .
Measu rem ent of Blood G l u c o s e .
Whole bl oo d glucose was m e a su re d using a Yellow ^Springs 
Glucose An alyser  Model 23AM (Yellow Springs Instruments,
Yellow Springs, Ohio, USA.).
Measurement of Glyc o s y l a t e d  Hae mog lo bins and Glyc o s y l a t e d  
Plasma Proteins by A f f in ity C h r o m a t o g r a p h y .
Gl y c o s y l a t e d  h aem og lobins and gl yc o s y l a t e d  pla sma 
proteins were m e a sured by the affinit y methods des cr ib ed in 
Chapter 2, bu f f e r i n g  at pH 8.3 and 8.9, respectively. Labile 
material was rou ti nely remo ved  by incubat ion of the di lu ted  
sample at 37°C for 5 hours prior to analysis.
Measurement of H b A .^ by Agar Gel E l e c t r o p h o r e s i s .
Packed red cells (0.5ml) were added to 10ml of is ot on ic
o
(0.15 mol/1) saline and incubated  at 37 C for 5 hours. Prior 
to elec tro phore sis, the erythro cytes were collected  by 
centrifu gation at 1200g for 10 m i n . Ha emolysis , e l e c t r o p h o r e s i s  
and quantitat ion were carried out acc or ding to the i n s t r u c t i o n s  
provi d e d  by Corning Medical Ltd. (Halstead, Essex, U.K.).
Me asu rement of G l y c o s y l a t e d  Plasma Proteins by the 
Colo rimet ri c T e c h n i q u e .
The manual  me th o d  as describe d by Ma, Nau gh ton and Cameron 
(1981) was chosen for the col orim etric es ti mat ion of 
g ly co sylate d plas ma proteins, with slight m o d i f ica ti ons to 
the volumes used for hydr olysis  and colour development.
Plasma (0.5ml) was diluted with ice-cold 0.15 mol/1 NaCl
(4.5ml) and the pr ot ein  p r e c i p i t a t e d  by the addition of ice-
cold 2.5 mol/1 TCA (0.5ml)'. This was followe d by ce n t r i f u g a t i o n
at 4°C and 1500 g for 15 minutes. The super nat ant was
di sca rded and the pre cipi ta te allowed to drain for 5 min. The
pro tei n was then res u s p e n d e d  in ice-col d 0.15 mol/1 NaCl (4.5ml)
by sonic ation with a micr oprob e (Dawes Instrument Ltd., London
W3, U.K.). These prot ein  p repa ra tions (3.0ml) were m i x e d  with
1.0 mol/1 oxalic acid (1.5ml) in 15ml st oppered glass centrif ug e
tubes, and heated in a boilin g water bath for 4 hours. To
prevent the glass stoppers from bec om ing jammed, each tube had
a piece of card inserted between it and the stopper. The tubes
were cooled in ice for 10 min. Ice-co ld 2.5 mol/1 TCA (1.5ml)
was added and vortex mi xed for 30 seconds. The samples were
o
then c en trifug ed  at 4 C and 1500g for 15 m m .  Colour  was 
de vel op ed by the addition of a fres hly p r e p a r e d  s a t u rated 
solution of TBA (0.5ml) to the superhatant (2.0ml) fo l l o w e d 
by incu bat ion at 40°C for exac tly 30 min. In di vid ual blan k s 
were p r e pa red for each sample by adding 0.5ml of wat er  i n s t e a d  
of TBA solution to 2ml of the appropriate su pernatant, and
o
incu bat ing alongside the test sample at 40 C for 30 min.
The absorb ance of each sample was m e a sure d against its own 
blank at 443nm after all owing 15 min. for e q ui librat io n to 
room t e m p e r a t u r e .
Protein was det ermined in the original soni cated 
pre par atio ns  by taking aliquots (0.5ml) of each, adding 
3ml of Biuret reagent and m e a s u r i n g  absorbance at 560nm 
after 15 min. The results were then calculated  using a 
sta nda rd curve p r e pa red from standards of known pr ot ei n 
c o n t e n t .
A fructose standard  curve was pr e p a r e d  by dis sol ving 
9mg of fructose in 200ml of dei onise d water (0.25mmol/l) 
and diluting this a p p r o pr iately  to provide standards of 0,
0.1, 0.15, 0.2 and 0.25 mmol/1. These were tr ea ted  in an 
iden tic al ma nn er  to the samples (although pr ot ein  p r e c i p i t a t i o n  
was unnecessary,) to check for varia tion p a r t i c u l a r l y  due to 
variati ons  in time and temperature during hydrolysis.
M ea su rement of U r e a .
Urea was me a s u r e d  on the Vickers 300 m u l t i c h a n n e l  
ana ly ser (Vickers Ltd., Medical Eng in eering,  Bas ing stoke ,
Hants, U.K.) using a m e th od ada pted from that descri be d by 
Gutmann and Be rgmeyer (19,74).
Meas urement o f  fc'GT.
^ G T  was mea s u r e d  using a C en tr ifichem  me th od as 
descr ibe d in a ma nua l suppli ed  by the m a nu fa cturer s  
(Bakers Instruments Ltd., Egham, Surrey, U.K.), based on a 
kinetic ph otomet ri c met hod by Szasz (1969).
Measur eme nt of S a l i c y l a t e .
Sa licylate m e a s u rem en t was pe r f o r m e d  m a n u a l l y  as 
d es cribed by Trinder (1954).
Measur eme nt of L e a d .
Blood lead co nc en tration s were me a s u r e d  using graphi te 
furnace atomic ab so rbtion with standards of known v a l u e , on 
an Atomspek H1550 (Rank Hilger, Margate, U.K.).
Measur eme nt of Haemoglobin.
H a e m og lo bin concentr ations were m e a s u r e d  using a Co ul te r 
Counter (Coulter El ectronics  Ltd., Luton, Beds.).
Me asu rement of HbS and H b C .
Samples of blo od  from n o n - d i a b e t i c  patients with sickle 
cell anaemia were recei ved from K i n g s ’ College Hospital, 
London. The per ce nt ag e of HbS and HbC in these samples was 
m e a su re d in the Ha em a t o l o g y  department of K i n g s ' College
Hospital using agar gel electro pho resis  
Halstead, Essex, U.K.).
(Corning Medical Ltd.,
R e c h r o matogra ph y of the Haem oglobin - Fractions P r e v io us ly 
Analyse d by Af finit y C h r o m a t o g r a p h y .
Three different diabetic samples were each a n a ly sed 25 
times, using freshly prep ar ed columns of Glycogel B and the 
recomme nd ed  m e th od  for g l y c o s y l a t e d  haemo gl obins (Ch apt er 2), 
with mean results of 10.5%, 12.5% and 19.5%, res pective ly.
For each sample, after chromatography , all of the h a e m o g l o b i n  
which had not bound to the column (’’u n b o u n d ” ) was c o l l ected  
and pooled. Similarly, all of the h ae mo globin  which had been 
b o u n d  to the column and removed using a b u f f e r  contain in g  
sorbitol ("bound") was po ol ed and col le ct ed in a separate 
container. Using a Diaflo stirred ult ra f i l t r a t i o n  cell and 
a filter ( UM 05) (Amicon Co., Massa chuse tts, U.S.A.) wit h  a
n u K n
cut-off at 500 daltons, each quantity of bo und  or u n b ou nd 
m at er ial was concentrated, as the filter r e t ain ed  the 
h ae mo globin  and allo wed free passage to w a te r and small 
molecules. After concentrating , each u l t r a filtr at e was 
w ash ed sev eral times with deio nised w a te r to ensure all the 
buf fer constituents were removed. When the 6 u l t r a f i l t r a t e s  
from the original  3 samples had been p r e p a r e d  as described, 
each was f reeze -d ried using an Edwards EF03 freeze drier 
(Edwards High Vacuum Inc., Grand Island, New York, U.S.A.).
In the describ ed m e th od for g l y c o s y l a t e d  h a e m o g l o b i n s  
ap pr ox imate ly  1. Omg of hae mog lo bin w as added in the 100/a1 
of ha em olysate added to each column. To be consistent with
this loading, the total amount of hae moglobi n co llected from 
25 columns was diluted in 2500^1 of deion ised wat er before 
rechromatograph y. The distribu ti on of this dilution betwe en  
the "bound" and "unbound" ma terial was calcu la ted di re ct ly 
in accordance with the pe rcentage of haemo gl obin in each 
fraction. After the addition of the water, each fraction 
was t h o r oughl y reco n s t i t u t e d  by vortex mixing  the samples.
After r e c o n s ti tution each sample was checked using the 
method of Van Kampden and Zj ilstr a (1961 ) to ensure that the 
haemoglo bin co ncentrations were com parable to the ori gi na l  
l o a d i n g ,  to avoid o ver lo ading in the rec h r o m a t o g r a p h y  studies. 
The quantities of h a e m o g l o b i n  in the reco n s t i t u t e d  samples 
were found to be betw een  53mg/100m l and 92mg/100ml, co m p a r e d  
with the target values of about lOOmg/lOOml.
Once the ma terial had been recon sti tuted , samples were 
analysed in triplicate with the quantities of r e c o n s t i t u t e d  
ma te ri al bei ng added to the column varying between 50y«.l and 
200^,1 (Table 3.4), to be consist ent with the sort of levels 
of h aemog lo bin typically  loaded onto the affin it y gel. To 
allow for the very small quantities of h a e m og lo bin in the 
wash fractions of the r e c h r o m a t o g r a p h y  exp eriments of samp les 
which had p r e v i o u s l y  bou nd to the gel>the se fractions were 
only diluted to 10ml rather than the r e c o m m e n d e d  15ml. The 
absorbances were mul t i p l i e d  by two-thirds before they were 
in c o r po rated in the usual calculations to obtain p e r c e n t a g e  
values for "bound" material. Alo ngsi de  these r e c h r o m a t o g r a p h y  
experiments two columns were tested adding water, r a t h e r  than 
r e c o n s tituted  haemoglobin.
Im m u n oe le ctrop ho resis .
I m m u n oele ct rophore si s was p e r f ormed  as des cribed by 
Grabar and Willia ms (1952). Moulten agarose (HEEO grade) 
(10ml) was pour ed  onto clean glass plates ( 8 x 8  cm) and 
allo wed  to solidify.' Wells (2mm diabeter) were then 
punched, and troughs cut in the gel as required. Each well 
was filled with  ^  5^ul of sample in t r is /barbit on e buffer.
To some wells a trace of brom o p h e n o l  blue was added as a 
tr ack in g dye. The gels were pl ace d in an e l e c t r op ho resis 
tank ( I m m u no elect ro phoresi s Tank, Medical and Biol og ical 
In str uments Ltd., Ashford, Kent), on a w a t e r - c o o l e d  pla t f o r m  
in contact with filter paper (3MM) wicks. The power pack was 
sx^itched on and adj us ted to appro x i m a t e l y  10V/cm., and this 
was m a i n t a i n e d  until the b r o m o p h e n y l  bl ue - a l b u m i n  tr a c k i n g  
spot had t r a v el led a suitable distance. The gel plate was 
rem ove d from the tank and the gel in the troughs removed. 
A n t is erum was added to the troughs and the gels were then 
left for 24-48 hours in a moist box at room t e m p erature  to 
allow diffus ion to occur.
The gel plates were then wash e d  in saline and their 
surface was p r e ss ed  with absorbent paper  to remove n o n ­
p r e c i p i t a t e d  proteins. This process 'was re peat ed  and then 
the gel was wa shed  with di sti lle d water, before drying  in a 
current of warm air. The gel was then st ain ed  and d e s t a i n e d  
and al lowed to dry before the imm u n o d i f f u s i o n  arcs were 
examined.
Crossed I m m u n o e l e c t r o p h o r e s i s *
Agarose plates were pr e p a r e d  as descr ib ed for the
immu no diff us io n work but this time low endo smotic  agarose
was used. Wells were p u n ch ed  about 1.5cm from one corner
of the gel and filled with sample diluted in buffer. Again
el ec tr ophoresis was carried out as prev i o u s l y  de sc ribed
until the tracki ng  dye had covered a suitable distance.
The gel was then removed from the tank and cut along a line
about 2cm from the edge. Excess gel was removed. Aga rose
o
(8ml) cont ai ning ant iser um  at 57 C was po ur ed to fill the 
space on the glass plate. The plate was then returne d to 
the tank overnight for e l ect ro phoresi s at righ t- angles to 
the original run, at a voltage of about 2V/cm.
The gels were then washed, dried and stai ned as p r e v i o u s l y  
described. The pattern of "rockets" on the gel was examined.
Both the im mu noele c t r o p h o r e s i s  and the cro sse d i m m u n o e l e c t r o p h o r e s i s  
were done by Dr. B. J. Gould.
R E S U L T S .
Comp ari son of Affinit y Ch r o m a t o g r a p h y  with Agar Gel 
Electr op horesi s for the Me asureme nt of G lyco sy lated 
H a e m o g l o b i n s .
Samples were an al ysed from 16 n o n - d ia be tics and 4-2 
diabetics by affinity ch r o m a t o g r a p h y  and the w e l l - e s t a b l i s h e d  
m e thod  of agar gel elect roph oresis.  For both methods the 
labile fractio n was removed  before analysis. Fig. 3.1 shows 
that there is a good co rrelation  (r = 0.95) between the 
results o b t aine d by the two methods. Fig. 3.1 also shows 
that there are only two diabetics with values in the range 
observe d for non-dia be tics when the affinity techn iqu e is 
used. The equivalen t figure for the agar gel e l e c t r o p h o r e t i c  
me t h o d  was nine. The regr ession line with an intercept of 
- 0.43 on the y-axis and a slope of 1.20 indicates that the 
two methods are measuri ng  similar species, but that the 
affinity m e t h o d  measur es add it io nal g l y c o s y l a t e d  material.
Comparison of Aff in ity C h r o m a t o g r a p h y  With the C o l o r i m e t r i c  
Method for the Measurem ent of Gl yc o s y l a t e d  Plasma P r o t e i n s .
Samples were an aly sed from 10 n o n- diabet ic s and 28 
diabetics by affinity ch r o m a t o g r a p h y  and the w e l l - e s t a b l i s h e d  
colorimetr ic me thod for the m e a s u re ment of g l y c o s y l a t e d  p l a s m a  
proteins. For the affini ty method, the labile fraction was 
removed before analysis by incubation. Fig. 3.2 shows that
there is quite a good corr el ation  (r = 0.69) b e t ween the
results ob ta ined by the two methods.
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Fig. 3.1 Correlat ion between g l y c o s y l a t e d  h ae moglo bi ns 
me as ur ed by agar gel e l e ct ro phoresi s and by
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Note: Correlat ion line plotte d by computer.
Relationship Between Glucose with G l y c o sylated Haemoglobins 
and G l y c o sylated Plasma Proteins Measured by Affinity  
C h r o m a t o g r a p h y .
The glucose concentration of whole blttod samples taken 
from 153 diabetic individuals was determined. There was a 
significant correlation between these values and g l y c o s y l a t e d  
ha e m o globin (r = 0.43) in the same samples. There was a 
slightly poorer c orrelation between glucose and g l y c o s y l a t e d  
plas m a  proteins (r = 0.33).
Relationship Between G l y c osylated Haemoglobins and 
G l y c osylated Plasma Proteins Both Measured by Affinity  
C h r o m a t o g r a p h y .
Glyco s y l a t e d  haemoglobins and g l y c o s y l a t e d  plasma 
proteins were me a s u r e d  by affinity ch r o m a t o g r a p h y  on b l o o d  
samples from 16 normals and 153 diabetic patients. Fig. 3.3 
shows that there is a good c orrelation (r = 0.82), with 
the line passing close to the origin and h a ving a slope close 
to unity (0.94).
Fig. 3.3 Correlation between g lycosylated haemoglobins and
glyco s y l a t e d  plasma proteins, both measured by the 
affinity c h romatography method. Normals ( A ) ;
diabetic patients ( *  )_.
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I N T E R F E R E N C E S .
Two types of possible interference with the glyco s y l a t e d  
haemoglobin method are described. The first experiments show 
the effects, if any, that the genetic make-up of the 
h a e m o g l o b i n  molecule has on the method. The investigation 
of the p o s t - t r a n s l a t i o n a l  changes of the haem o g l o b i n  molecule 
and their effects are then described. In most of these 
experiments both affinity chroma t o g r a p h y  and agar gel 
e l e ctrophoresis were used to measure ’’glyco s y l a t e d  h a e m o g l o b i n s ” 
in samples .
The interference of h a e m o globin with the affinity assay 
for g l y c o sylated plasma proteins was also investigated, as 
many of the samples r e c eived for analysis were haemolysed.
Effect of Fetal H aemoglobin on Methods for M e a s uring 
G l y c o sylated H a e m o g l o b i n s .
Fig. 3.4 shows that when cord blood was p r o p o r t i o n a l l y  
mixed with b l ood either from a normal mother, or from a 
diabetic, between 0% and 100% and me a s u r e d  using affin i t y  
chromatography, straight lines were obtained. This indicates 
that h a e m o g l o b i n  F (HbF) and the normal adult h a e m o g l o b i n  are 
given equal w e i g h t i n g  by the affinity method. However, whe n  
samples of cord blood were tested by the agar gel e l e c t r o p h o r e t i c  
method, there was gross interference by HbF (Table 3.1). The 
overall mean value for the m a t ernal samples using the a f f i n i t y  
method was 5.8%, and for the cord samples was 4.0%. The 
corresponding values obtained by the agar gel e l e c t r o p h o r e t i c  
method were 5.7% and 81.5%, respectively. The values for the
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4 Effect on the value of g l y c osylated h a e m o g l o b i n  of 
m i x i n g  cord blood with n o n - d i a b e t i c  maternal blood 
and blood from a diabetic. Increasing amounts of 
cord blood were added to non-d i a b e t i c  mat e r n a l  blood
( A ) and diabetic blood ( #  ) in the proportions 
indicated. The g l y c o sylated haemoglobins were the n  
measured by affinity c h r o m a t o g r a p h y .
the m a t ernal samples of n o n - d iabetic mothers obtained by 
electrophoresis are signif i c a n t l y  higher (p 0.01) than the 
corre s p o n d i n g  values for the affinity method.
Effect of HbS and HbC on the Affinity Method for Mea s u r i n g  
Glyc o s y l a t e d  H a e m o g l o b i n s .
Fig. 3.5 shows that when blood containing 48% HbS and 
48% HbC was mixed in varying proportions with blood from a 
diabetic patient without sickle cell anaemia, a straight line 
was obtained, indicating that HbS and HbC and normal adult 
h a e m o g l o b i n  are all given equal w e i g h t i n g  by the affinity 
method. This is further s ubstantiated by the results listed 
in Table 3.2, showing n o n - d i a b e t i c  patients with different 
quantities of both HbS and HbC, have glyco s y l a t e d  h a e m o g l o b i n  
results within the normal range using the affinity method.
Analysis of the sample containing HbS which had a value 
of 6.16% by affinity chromatography, gave 3,9% by agar gel 
electrophoresis.
Table 3.1 Values for g l y c o sylated h a e m o g l o b i n  in
ma t ernal and cord blood at d e l i v e r y .
Hon Diabetic Mothers 
(n = 7)
Maternal Blood
Cord Blood
Diabetic Mothers 
(n = 3)
Maternal Blood
Cord Blood
% Fast Fraction
(Electrophoretic
Method
+
6.3 4 - 0.9 4 
79.23 t 4.47
+
7.66 - 0.58 
+
86.67 - 1.5
% G l y c o s y l a t e d  Hb 
(Affinity Method)
+
4.92 - 0.70 
4.17 - 0.92
+
7.75 - 3.03 
3.58 ^ 0.91
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Fig. 3.5 Effect, on the value of g l y c o sylated h aemoglobin 
of mixing blood containing HbS- -and HbC with 
blood from a poorly controlled diabetic p a t i e n t . 
The g l y c osylated haemoglobins were then m e a s u r e d  
by affinity c h r o m a t o g r a p h y .
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Table 3.2 Values for g l ycosylated h aemoglobins in samples
containing HbS and, or HbC.
Type of sample % g l y c o sylated haem o g l o b i n s
48%HbS, 4 8 % Hb C 5.2 3
4 9 %HbS 9 4 8 %HbC 8.78
39 % H b S , 39 %HbC 4.92
49 %HbS 8 .14
3 8 %Hb S 6.80
41%HbS 6.10
45%HbS 5 .90
HbS & HbC (% not known) 5 . 44
HbS & HbC (% not known) 6.07
HbS (% not known) 6 .16
HbS (% not k n o w n ) 5 .93
Mean 6 .32
S . D . 1.18
None of the patients in this survey were k n own to 
be diabetic.
Normal range found for glyco s y l a t e d  h a e m o g l o b i n s  by 
affinity c h r o m atography is .5.5% - 9.1%.
Range for these patients is 3.9% - 8.7%.
P o s t - t r a n s l a t i o n a l  changes to the haem o g l o b i n  molecule, 
and their effects are now considered;
Values of G l y c o s y l a t e d  Haemoglobins in Uraemic Patients
The values for uraemics are plotted against their b l ood 
urea nitrogen (EUN) in Fig. 3.6(a). In each case the 
e l e ctrophoretic method gives a higher value than the 
c o r r e sponding value by the electr o p h o r e t i c  m e t h od^but n e i t h e r 
method gives a good correlation against BUN. Some patients 
have values below the normal range for the affinity m e t h o d  
and half have values above the normal range for the 
electro p h o r e t i c  method.
Values of G l y c o s y l a t e d  Haemoglobins in A l c o h o l i c s .
Fig. 3.6(b) shows the values for both methods p l o t t e d  
against the 2^-GT level. Three patients have values above 
the normal range for the ele c t r o p h o r e t i c  method. The only 
value outside the normal range for the af f i n i t y  m e thod is low. 
There is no obvious correlation be t w e e n  g l y c o s y l a t e d  
haemoglobins and ^-GT.
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Values of G l y c osylated Haemoglobin in Cases of Aspirin 
P o i s o n i n g .
The values for the ele c t r o p h o r e t i c  m e thod are well 
above the normal range and this also applies to two of the 
samples with the affinity method (Fig. 3.6(c)). There may 
be some correlation between % glyco s y l a t e d  haemoglobin 
and salicylate concentration.
Values of Glyco s y l a t e d  H a e m oglobin in Cases of Lead 
P o i s o n i n g .
One value was found outside the normal ranges, this was 
a high value by the e l e ctrophoretic m e thod (Fig. 3.6(d)).
Interference in the g l y c o sylated plasma protein assay is now 
considered;
Effect of haemolysis on the measurement of glyco s y l a t e d  plasma 
proteins by affinity c h r o m a t o g r a p h y .
When slightly hae m o l y s e d  plasma containing 0.9g/dl 
h aemoglobin was mixed with plasma containing virtually no 
ha e m o g l o b i n  (0.2g/dl) a straight line was obtained (Fig. 3.7). 
However, as haemolysis within the test sample increased to 
9.8g/dl, and 17.3g/dl in the grossly h a e m o l y s e d  sample this 
linear r elationship was no longer found. Increased h a e m o l y s i s  
caused a reduction in the percentage of g l y c o s y l a t e d  p l a s m a  
proteins and a tendency to plateau (Fig. 3.7), This indicates 
that the presence of excess haem o g l o b i n  w i thin a sample alters 
the results obtained by affinity chroma t o g r a p h y  using the 
method as described. H o w ever samples which are only m i l d l y  
h a e m olysed (i.e. a pale pink colour) can be used.
Fig. 3. 7 Effect on the value of glycosylated plasma proteins
of haemolysis, shown by mixing haemolysed plasma
with non-ha e m o l y s e d  plasma. Increasing amounts of
a diabetic sample with slight haemolysis ( • ) ,
haemolysis of 9.8g/l (A) and gross haemolysis of
17.3g/l (▼) were added in the proportions indicated.
The glycosylated plasma proteins were then m e a sured
by affinity chromatography.
CO
c
CD
o
w.
Q.
CO
E
CO
CO
-o
CD
to
>.
(0
o 
o
>
O
2 4
1 8 -
1 4 -
1 2
1 0
p-
0 2 5 5 0 7 5 1 00
% H a e mo l y s e d  sample
PRELIMINARY INVESTIGATIONS OF MATERIAL BINDING TO GLYCOGE.L B.
Pr e l iminary studies were made to elucidate more fully 
the nature of the fcinding of either g l y c osylated haemo g l o b i n s 
or g l y c o sylated plasma proteins to the affinity gel, Glycogel 
B. Mallia et: a_l. (1981) had used isoelectric focussing to 
analyse the haemoglobin fractions which were retained by the 
affinity gel, and they reported that the "bound" fraction 
contained all the HbA- , and also portions of HbA-, , HbA and
i_ C -L jC.
m e t h a e m o g l o b i n s . The first experiments to be described in 
this thesis show r e c h r o m a t o g r a p h y  of "bound" and "unbound" 
haemoglobin through the affinity gel, to test the effi c i e n c y 
of the primary separation. The other experiments described 
in this section studied the nature of the plasma proteins 
which did, or did not, bind to the gel, by the techniques of 
i m m u n oelectrophoresis and crossed i m m u n o e l e c t r o p h o r e s i s .
R e c h r o matography of the h a e m oglobin fractions prev i o u s l y  
analysed by affinity c h r o m a t o g r a p h y .
The results for the r e c h r o m a t o g r a p h y  of "bound" and 
"unbound" material originating from 3 diabetic samples are 
shown in Table 3.3. It is clear from these results that the 
"unbound" fraction is contaminated in every case with about 
2 - 4% of "bound" material. The "bound" material, which 
should give results of 100%, gave values between 58% and 89%. 
These reduced values may be in part caused by c o n t a m i n a t i o n  
of the "bound" fraction with "unbound" material, and indeed
Table 3.3 Values obtained for r e c hromatography of
h aemoglobin obtained in the " b o u n d ” and 
" u n b o u n d ” fractions from the affinity g e l , 
G lycogel B,
A • B • C•
+ +
5 0 4.05 - 1.1% 2.90 - 0.12% 2.94 - 0 .39%
"Unbound" + + +
100 1.81 - 0.04% 5 .52 - 0.03% 3 .13 0.18%
fraction + 4- +
200 2.14 0.12% 4.02 - 0.19% 2 .90 0.20%
+ ' + +
"Bound." 50 61.2 0 - 3.12% 62.95 - 0.39% 8 6 . 5 7 0.75%
+ +
fraction 100 - 60. 37 - 0.59% 8 6.13 0 .79%
The values shown are the mean results (i SD) from t r i p licate 
assays of r e c h r o m a t o g r a p h y  of material collected after affinity 
c h romatography which had ("bound") and had not ("unbound") 
been retained by the gel. The original haemoglobins t€;sted 
had been obtained from three diabetics A, B and C, with 
gl\7cosylated h a e m oglobin results 10.5%, 12.5% and 19.5% 
respect i v e l y .
(corrected) absorbances of 0.01 and 0.02 obtained for 
the "unbound" fraction with the absorbances of the "bound" 
fraction between 0.57 and 0.65 show this is so. However, the 
loss of material in the p r e p a ration of the material for 
r e c h r o matography may also be part of the explanation. 
Interestingly, the "bound" material studied from a poorly- 
controlled diabetic with the highest original g l y c o s y l a t e d 
haemoglobin result of 19.5%, gave the highest recovery result 
on rechromatography. The "bound" fraction was more difficult 
to study than the "unbound" material, as it was r e c o n s t i t u t e d 
with much smaller volumes of water after freeze-drying. The 
columns used, loading only water, gave m a x imum absorbances 
of C.001 for both "unbound" and "bound" fractions.
Im m u n oelectrophoresis .
Fig. 3.8 shows the i m munodiffusion arcs o b t ained w ith 
material from plasma which did not bind to the a f f inity gel 
(W) and that which did bind (E). Both p o oled sample m a t e r i a l  
from non-d i a b e t i c s  (N) and diabetics (D) were used. Fig. 3.8 
shows the results obtained when the antiserum used was a n t i ­
whole human. The "unbound" (W) fractions show more arcs than 
do the "bound" fractions (E). Both the "bound" fractions (E) 
show 4 arcs. There was no obvious qualitative difference 
between the "bound" material obtained from n o n - d i a b e t i c s  and 
d i a b e t i c s .
Fig. 3.8 Photo gr aph to illustrate the patterns obtained
using i m m u n o e l ectr op horesis  of samples of 
mat eri al colle cte d which did (E) and did not 
(W) bind to the affinity gel, Glyco ge l B .
Material from both n o n - d i ab et ics (N ) and diabeti cs
(D) was examined.
Further studies were also done using specific antisera.
The results are described in Table 3.4 as the bac k g r o u n d  for 
these gels proved too dark to photograph s u ccessfully although 
the arcs were clearly visible. Again the ’’unbound" ma t e r i a l  
was found to be a more complex mixture of proteins, with all 
but IgA and IgM being present. The four m a jor arcs in the 
"bound" fraction were shown to be albumin, o(2 “m ^ c r c g l o b u l i n , 
transferrin and IgG. A very faint arc for haptoglobin was 
also apparent in the same region as that for (X^-niacroglobulin ♦ 
These results were interpreted using the guidelines reported 
by Turner and Hulme (1971).
Crossed Immun o e l e c t r o p h o r e s i s .
The results for the crossed i m m u n o e l e ctrophoresis are 
shown in Fig. 3.9. "'Unbound" material from norm a l  and diabetic 
samples are shown in Fig. 3.9A and C respectively, and "bound" 
material from normals and diabetics in Fig. 3.9B and D. The 
results confirm those shown with the initial i m m u n o e l e c t r o p h o r e  
work. Again the "unbound" (W) fraction is more complex than 
the "bound" fraction (E). When the various ’r o c k e t s ’ are 
examined there are three clear peaks seen with the "bound" 
material; albumin, transferrin and ix^-^^croglobulin. IgG 
does not produce a peak in crossed immunoe l e c t r o p h o r e s i s .
These results were interpreted using the criteria and examples 
illustrated by Moody and Thoioas (1975 ). The height of the 
0(2 -oiacroglobulin peak relative to albumin as shown in Fig.
3.9 appears to be higher for the diabetic sample (D) than
with the normal sample (B).
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Photograph to illustrate the patterns  ob tai ne d 
when pe rf ormin g c r o s s e d - i m m u n o e l e c t r o p h o r e s i s  
of samples of ma terial  collected which did (E) 
and did not (W) bind to the aff in ity gel.
Gfycogel B, Material from both n o n - d iab et ics 
(N) and diabetics (D) was examined.
Table 3.4 Immunodiffusion arcs present with specific
antisera for material which d i d 9 and did not
b ind to the affinity gel, G l y c o g e l B .
Specific antisera "unbound" "bound"
anti- albumin
tX^-glycoprotein 
(X-^-ant itrypsin 
^ “^acro globulin 
h aptoglobin 
transferrin 
IgA 
IgM 
IgG
/
/
/
/
/
/
X
X
/
/
X
X
/
/ (very faint) 
/
X
X
/
The presence (/) or absence (X) of arcs is n o t e d  when m a t e r i a l  
collected after affinity c h romatography which either did 
("bound") and did not ("unbound") bind to the affinity gel was 
allowed to diffuse into specific antisera.
DISCUSSION.
The two methods compared in this study for the 
measurement of g l y c osylated haemoglobins differ in their 
analytical principle which causes the separation b e t ween 
glycosylated and n o n - g l y c o s y l a t e d  material. The agar gel 
el ectrophoretic method, like ion-exchange chromatography, 
separates these haemoglobins on the basis of small charge 
differences. The affinity method relies on the g l y c o s y l a t e d  
portion of the molecule, and in principle should not be 
influenced by the composition of the protein. There was a 
good correlation (r = 0.95) between the agar gel e l e c t r o p h o r e t i c  
method and the affinity technique. The present work shows 
that there is less overlap between the diabetic and the n o n ­
diabetic populations using the affinity m e thod when co m p a r e d  
with the electr o p h o r e t i c  technique. This suggests that the 
affinity m e thod may be more selective, but the numbers s t u d i e d  
would need to be increased for this to be verified. The slope 
of the regression line (Fig. 3.1) indicates that affin i t y  
c h r o m a tography measures material in addition to HbA^. This 
is in accord with Mallia _et aJL. (1981) who showed using 
i soelectric focussing, that the "bound" fraction c o n t a i n e d
all the HbA and also portions of HbA, H b A 2 and m e t h a e m o g l o b i n s .
lc
It is known that a small proportion of HbA, HbA^ and 
methae m o g l o b i n  are glycosylated (Bunn, 1981), and p r e s u m a b l y  
it is these glycosylated molecules which account for the 
higher values observed when using the affinity method. This
increased s ensitivity however, is not reflected in the two 
normal ranges which are s u r p r isingly similar (agar gel 
electrophoresis 5.5%-7.5%, affinity chroma t o g r a p h y  5.5%- 
9.1%). This may be related to the prel i m i n a r y  evidence 
presented in this chapter (Table 3.3) using rechromatography, 
supported by the subsequent p ublication by Fluckiger, Woodtli 
and B e rger (1984), which suggests that using a 1ml affinity 
gel column produces results which are falsely low. The 
details and implications of these findings have been d i s cussed 
fully in Chapter 7.
The results for cord blood illustrate the importance of 
the difference in the principle for separation for the two 
different methods studied, and shows that in the e l e c t r o p h o r e t i c  
method HbF runs with the fast fraction, HbA^. This pro b a b l y  
invalidates the use of this method for the m e a s u r e m e n t  of 
HbA^ during diabetic p r e gnancy since about 17% of the pregnant 
population have concentrations of HbF in excess of 1% of total 
haemoglobin (Pembrey, 1973). This may explain why the n o n ­
diabetic m a t ernal samples had s i g n i ficantly high e r  values 
(p 0.01) when m e a s u r e d  with agar gel ele c t r o p h o r e s i s  c o m p a r e d  
to the affinity method. Fig. 3.4 clearly illustrates that 
fetal h aemoglobin does not interfere with the affinity method.
The result for HbS sample m e a sured by the e l e c t r o p h o r e t i c  
m e t h o d  (8.90%) is higher than when mea s u r e d  by affinity 
c h romatography (6.16%), unlike the low values associated 
with these samples when measured using ion-exchange c h r o m a t o g r a p h y  
(Aleyassine, 1979). On the electr o p h o r e t i c  m e t h o d  4 peaks
Direction of migration
Fig. 3.10 Illustration of 4 peaks obtained 
with a sample from a sickle cell
p a t i e n t « using agar gel e l e c t r o p h o r e s i s .
(S , A , S and A ) are obtained rather than the normal two 
o o 1 1
(A 9 A ) (Fig. 3.10), (Meynard et al. 1980), and the 
o 1
g l y c o sylated haemoglobin, which is the sum of and A^, should 
be normal. However, the separation b e t ween A q and is poor 
after the reco m m e n d e d  40 m i n . electrophoresis and is therefore 
subject to error. Menard ejt al_. (1980) continued their 
electrophoresis of these samples for 50 minutes, but this 
change in methodology, unless applied to all samples, w o uld 
inevitably complicate batch h a n dling and possi b l y  lead to 
extra expense.
The results for investigations of the p o s t - t r a n s l a t i o n a l  
m odifications of h aemoglobin are also important. In u r aemia 
carbamylated h a e m o globins are formed, most of which run in 
advance of the main haemoglobin peak on ion-exchange 
chromatography. The results p r e sented here indicate that 
carbamylated h aemoglobins may be present in the fast fraction 
in the electr o p h o r e t i c  method (Fig. 3.6(a)). The affin i t y  
method gave low values for some uraemic p a t i e n t s . This may 
be e x p lained by the shortened red c e l i s u r v i v a l  time a s s o c i a t e d  
with uraemia (Bruns and Wills, 1984).
Alcoholic patients have been found to have elevated 
amounts of total H b A 1# as m e a sured by ion-exchange c h r o m a t o g r a p h y  
(Hoberman, 1979), probably due to the formation of adducts 
with a c e t a l d e h y d e . The three high results (Fig. 3.6(b)) 
obtained b y  the electr o p h o r e t i c  m e t h o d  are in agreement with 
these findings. The single low value o b t ained with the 
affinity method is in agreement with the low values for H b A ^ c 
in alcoholics reported by Stevens et_ aJ.. (1981) who used
r adioimmunoassay, since the a c e t a l d e h y d e - h a e m o g l o b i n  adduct 
should not bind to the affinity ligand.
A fast h a e m oglobin fraction (HbPb) has been o b s erved in 
about 40% of pre-school children with lead poisoning 
(Charache and Weatherall, 1966) using starch gel e l ectrophoresis 
at pH 8.6. Therefore some children with lead poisoning would 
be expected to have an elevated HbA^ by the ele c t r o p h o r e t i c  
method but HbPb w o uld not be expected to alter the results 
of the affinity method. The limited results obtained (Fig.
3.6(d)) in this work agree with these statements.
Bridges ej: al_. (1975) reported that aspirin, acetyl salicylat 
which is rapidly converted to acetate and salicylate in. v i v o , 
causes the acetylation of HbA _in vivo and iii v i t r o . Spicer 
et a l . (1979) using isoelectric focussing showed that 
acetylated h a e m oglobin focussed near H b A ^ ^ . Therefore patients 
on high doses of asprin may be expected to have elevated H b A 1# 
as was found with the e l e c t r ophoretic m e t h o d  (Fig. 3.6(c).
However the affinity m e thod would not be expected to sense 
a cetylated haemoglobin, so the increased levels found warrant 
further investigation. It may be that alterations in body 
pH due to the salicylate overdose affect g l y c o s y l a t i o n .
Until now the colorimetric method using t h i o b a r b i t u r i c  
acid (TEA) has been the m e thod of choice for the m e a s u r e m e n t  
of g l y c o sylated plasma proteins. Affinity c h r o m a t o g r a p h y  
provides a very attractive alternative as it does not r e q uire 
the removal of glucose, use of poisonous reagents such as TBA 
or oxalic afcid, or sample blanks. In addition the c o l o r i m e t r i c  
method requires much larger samples since 5 - h y d r o x y m e t h y l f u r f u r a l  
is formed, even after p r o l onged acid treatment, in only small
n o n - s t o i c h i o m e t r i c  amounts (Goldstein ejt al.. 1982A).
Furthermore, the colour yield of this m e t h o d  is not the same 
for all proteins (Bunn jet al. 1979 ). Although p rotein-to-  
protein variation also occurs with the Bradford meth o d  
employed with affinity chrom a t o g r a p h y  in this work, it is 
known to have a greater colour yield with albumin than with 
most other proteins (Pierce and Suelter, 1977). The 
prel i m i n a r y  investigations shown here (Figs. 3.8 and 3.9) 
indicate that the bulk of the ma t e r i a l  in both the " g l y c o s y l a t e d ” 
and " n o n - g l ycosylated" fractions, as separated by the affinity 
gel, is albumin. Since this is the case, this source of 
error is minimal.
There was a good correlation (r = 0.7) b e tween the 
colorimetric technique and the affinity meth o d  for the 
m e a s urement of g l y c o sylated plasma proteins, i n d i cating that 
the two methods are m e a s u r i n g  similar moieties. The slope 
of the graph (2.93) may be an indication of the greater 
sensitivity of the affinity method, but it should be n o ted 
that the units of the two axes are quite different (Fig. 3.2).
The cause of the intercept (Fig. 3.2) is not clear, since the 
colorimetric m e t h o d  used takes into account known inter f e r e n c e s 
by glucose and the need for each sample to have an i n d i v i d u a l  
blank. Maybe other material interferes with the c o l o r i m e t r i c  
m e thod which has yet to be identified. The m u l t i p l i c a t i o n  
factor require to produce the colorimetric values however, 
is very large and may obscure the picture. In contrast with 
these results, Fig. 3.7 shows an excellent c o r r elation b e t w e e n  
glycosylated h aemoglobins and glyco s y l a t e d  plasma p r o teins
both me a s u r e d  by affinity c h r o m atography (r = 0.82), with 
a slope close to... unity and the line passing close to the 
origin. The r e l a tively poor correlation of both g l y c o s y l a t e d 
h aemoglobin (r = 0.43) and g l y c o s y l a t e d  plasma proteins 
(r = 0.38) with simultaneous blood glucose is similar to 
other reports (Gonen ejt aJL. 1977, Ma, Naughton and Cameron, 
1981).
In this chapter the interference of hae m o l y s e d  samples 
with the g l y c o s y l a t e d  plasma protein assay using affinity 
c h r o m a tography has been examined. These are important 
studies as many of the samples ro u t i n e l y  received are, to 
some degree, haemolysed, and yet there have been no 
p ublications to date as to wh e t h e r  these samples ma y  be 
used without affecting the results. This work suggests 
that grossly h a e m o l y s e d  samples cause reduced values (Fig. 
3.7). There are two possible explanations. Firstly the 
affinity gel sites for the attachment to the g l y c o s y l a t e d 
molecules may become overloaded when both glyc o s y l a t e d  
haemoglobin and glyc o s y l a t e d  plasma proteins are present 
in the sample material in high amounts. However, a more 
likely e xplanation is that the Coomassie Brilliant Blue 
method for protein m easurement does not give the same 
emphasis to h a e m o g l o b i n  as to albumin and the other p l a s m a  
p r o t e i n s .
The study of plasma proteins which bound or did not 
bind to the affinity gel, has not p r e v i o u s l y  been reported. 
The W ^ - a c i d  glycoprotein, despite h a v i n g  41.4% g l y c o - m a t e r i a l  
(Schultze and Heremans, 1966) was only present in the 
" u n b o u n d ” (W) fraction (Table 3.4). H a p t o g l o b i n  p r o d u c e d
only a very faint band versus specific antisera in the 
i m m u n o e l ectrophoresis studies of the ’’b o u n d ” (E) 
fraction, despite having 19.3% glycoprotein content 
(Schultze and Heremans, 1966). Similarly, cx^-antitrypsin 
has 12.4% glycoprotein content (Schultze and Heremans, 1966A) 
yet does not appear in the ’’bound" fraction. These results
strongly suggest that enzy m i c a l l y  formed glycoproteins do
\
not bind to the affinity gel, Glycogel B. This is supported 
by the earlier observation (Fig. 3.3) that when g l y c osylated 
haemoglobins and g l y c o sylated plasma proteins, as m e a s u r e d  
by affinity chroma t o g r a p h y  are correlated, the line goes 
almost through the origin. If glycoproteins had b o und to 
the gel a significant intercept on the g l y c o s y l a t e d  plasma 
proteins axis w o uld be expected. Pres u m a b l y  glycoproteins 
do not bind as they are hightly branched structures and so 
their cis-diol groups are not accessible for the bi n d i n g 
sites on the gel. Also many of their chains end in 
n e g a tively charged groups such as sialic acid, which w h o u l d  
prohibit binding.
The proteins which are found in the ’’bound" fraction 
include albumin, IgG and transferrin, all of which have 
longer half-lives than the other proteins i n v e s t i g a t e d 
(Scultze and Heremans, 1966B). This is to be expected as 
n on-enzymic g l y c o sylation is prop o r t i o n a l  to both the 
glucose c oncentration and the half-life of the protein 
(Beach, 1979). The most abundant of the immunoglobulins,
IgG, with the longest half-life is found with the "bound"
material. IgA and IgM were not detected in either fraction 
using specific antisera, p o s sibly due to lack of stability  
of these proteins with ul t r a f i l t r a t i o n  and storage. The 
height of the ma c r o g l o b u l i n  peak relative to albumin 
appears to be higher in the "bound" fraction from diabetics 
than from non-diabetics, although the transferrin peaks are 
of comparable heights. The reasons for these findings are 
unclear.
CHAPTER 4.
GLYCOSYLATED HAEMOGLOBINS AND 
GLYCOSYLATED PLASMA PROTEINS IN THE 
DIAGNOSIS OF DIABETES MELLITUS AND 
IMPAIRED GLUCOSE TOLERANCE.
INTRODUCTION.
Keen, Jarrett and McCartney (1982) drew attention to 
the limited ability of clinicians- to predict metabolic  
deterioration in subjects with impaired glucose tolerance.
The extreme ends of the glucose r egulatory spectrum are 
easily defined; there are diabetic patients with charac t e r i s t i c  
symptoms and un e q u i v o c a l l y  high b l ood glucose concentrations, 
and n o n-diabetics with blood glucose levels u n i v e rsally 
recognised as normal. However, be t w e e n  these extremes there 
is a range of considerable diagnostic unce r t a i n t y  with no 
natural cut-off point between normal and abnormal glycaemia.
The Oral Glucose Tolerance T e s t .
In spite of all the advances in research and t e c h n o l o g y  
which have lead to a much deeper u n d e r s t a n d i n g  of the disease 
diabetes mellitus, the clinician still relies largely on the 
measurement of blood glucose for diagnostic purposes.
The concept that early diabetes might be dis c o v e r e d  by 
exposing the patient to a glucose challenge was first 
introduced by Jacobsen in 1913, according to S i p e rstein (1975). 
Since then the oral glucose tolerance test (OGTT), b a sed on 
this concept, has been widely used as a diagnostic aid for 
the diagnosis of diabetes in cases where the clinical features 
or blood glucose c oncentration were equivocal. However, 
because of the lack of uniformity in both the procedure and 
interpretation, there is still sometimes d i f f iculty in 
interpreting results.
In general the OGTT is p e r f o r m e d  by giving an oral 
d ose of glucose to a fasting individual. The blood glucose 
concentration is m e a s u r e d  i m m e diately before, and at intervals 
after the a d ministration of the dose for periods of two to six 
hours. Many factors influence the glycaemic profile such as; 
the pre-test diet of the patient; the quality, strength and 
even the flavour of the glucose solution; the position of the 
patient during the ad m i n i s t r a t i o n  of the dose and the degree of 
m ovement allowed during the test; the source of the b l o o d  sample 
(capillary or venous) and the type of sample used (w h o l e - b l o o d , 
plasma or serum). Even the many different methods for m e a s u r i n g  
glucose influence the results. It is not s urprising therefore 
to find wide differences in the results and their i n t e r p r e t a t i o n  
R eco g n i s i n g  these problems numerous workers have p u b l i s h e d  
detailed protocols and interpretations. M o s e nthal and Barry in 
1950, r e c o m mending a lOOg glucose load concluded that a peak 
glucose exceeding 150 mg / l O O m l  (8.3 mmol/l) and a value of 
l OOmg/lOOmL (5.6 mmol/l) 2 hours after the dose was abnormal. 
Since this work other r e c ommendations have been p u b l i s h e d  by 
Fajans and Conn (1954), Unger (1957) and W i l k erson et a l . (19 60) 
This last group of workers devised a points system for 
i nterpreting the test profile allocating either whole or 
half-points when various time-points of the test had glucose 
values e x c e eding reco m m e n d e d  levels. When a patient had a 
score of 2 or above, diabetes mellitus was diagnosed. Various 
organisations have also made recommendations; The U.S. Public 
Health Service (Sherwin, 1977), the Nat i o n a l  Diabetes Data Group
(1979) and the U n i v ersity Group Diabetes P r o gram (Cooper e_t a l . 
1969). Although the test format in most of these p u b l i c a t i o n s
was similar, opinions varied as to the n o r m a l i t y  of the 
results at different time intervals. Most recently the 
World Health O rganisation (WHO) (1980) have p u b lished a 
report to try and overcome these problems. A dose of 75g 
was chosen as a compromise b e t ween the lOOg dose favoured 
by the Americans and the 50g dose of the Europeans. The 
WHO guidelines for i n terpretation are given later in this 
chapter. In the guidelines is reference to a new category 
of impaired glucose tolerance consisting of those individuals 
whose results lie in the b orderline region between n o n - d i a b e t i c  
and diabetic. The rationale of this category is to detect 
people who are at risk of b e c o m i n g  diabetic, but sparing them 
the social, economic and psych o l o g i c a l  stigma attached to the 
label of diabetes (Keen, Jarrett and Alberti, 1979). However, 
there has been considerable discussion (Mutch and S t o w e r s , 1982) 
as to w h e ther these individuals can be considered to be 
" p r e d i a b e t i c ." Jarrett ejt _al. (1979) noted that m any pa t i e n t s  
with a single OGTT showing impaired glucose tolerance revert 
to normal tolerance when retested. However, Fajans (1981) 
r eported on a symptomatic relatives of m a t u r i t y  onset diabetics, 
both with normal and impaired glucose tolerance. Of the l a tter 
g r o u p ;-S0% p r o g r e s s e d  towards diabetes over the 24 years studied. 
Kadowaki et_ al. (1984) studied 288 subjects with impaired 
tolerance and showed that after 15 years 48 patients had w o r s e n e d  
to overt Type 2 diabetes mellitus with e l e vated fasting b l o o d  
glucose levels. Fuller et_ a_l. (1980) studied 18403 civil 
servants and showed that m o r t a l i t y  with coronary h e art disease  
a p proximately doubled in those individuals with i m p a i r e d  glucose 
tolerance. They therefore emph a s i s e d  the importance of this
category and defined impaired glucose tolerance as involving 
large vessel disease but without the risk of small vessel 
disease as occurs in overt diabetes mellitus. These findings 
are supported by Zammit Maempel (1981) who states that 
m a c r o v a s c u l a r  disease si g n i f i c a n t l y  increases in incidence 
when glucose levels are found beyond a mere 5.3mmol/l at 2 
hours after a 50g oral glucose load.
The c o n t r oversy regarding the significance of impaired 
glucose tolerance continues, as absolute conclusions are 
clouded by the numerous problems which beset the OGT.T.
Siperstein (1975) and Sherwin (1977) are both major critics 
of the OGTT and have detailed many of the problems, some of 
which were m e n t i o n e d  earlier in this chapter. The diet of 
the individual in the days preceding the test must be regulated, 
200 to 300g of carbohydrate a day for 3 days is u s u ally  
necessary. Posture is important, and the p a t ient should be 
ambulatory. Diurnal rhythms have been d e m o n s t r a t e d  with the 
OGTT and so the test is usually started b e t w e e n  9 and 10 am.
Drugs may alter results. Dilantin and adrenergic drugs 
produce glucose intolerance by direct inhibition of i n s ulin 
secretion, and diuretics reduce insulin release i n d i r e c t l y  by 
p ro d u c i n g  p o t a s s i u m  depletion. It may not be p r a c t i c a l  h o w e v e r  
to discontinue the drug for the purposes of an OGTT. There 
are also many medical disorders which affect the test (Table 4.1) 
Unger (1957) n o ted that a r e p eated OGTT done in the same 
individual under similar conditions with respect to all
controllable factors could still y i eld dis s i m i l a r  results.
This may be due to the effect of stress and emotion on the test
( S h e r w i n , 1977).
Table 4.1. Medical Disorders Which May Alter
Glucose Tolerance
chronic renal failure 
cirrhosis
chronic pancreatitis  
starvation
h y p o k a l a e m i a / h y p e r a l d o s t e r o n i s m
C u s h i n g ’s Syndrome
A c r o m e g a l y
p h e o c h r o m o c y t o m a
insulinoma
glucagonoma
acute infection
myoc a r d i a l  infarction
p o s t - s u r g e r y
The Measurement of G l y c osylated Haem o g l o b i n  to Detect
Diabetes M e l l i t u s .
Since g l ycosylated haem o g l o b i n  measures the c umulative
effect of glycaemia over the previous 6 to 8 weeks
(Koenig et al_. 1976), it is c onsequently not as prone to
e n v i r o n m e n t a l  influences as is the OGTT, and so man y  of the
sources of error are avoided. For this reason several workers
have investigated the p o s s i b i l i t y  of using g l y c o s y l a t e d
h aem o g l o b i n  as an indicator of glucose intolerance. Most
published work uses methods b a s e d  on ion-exchange c h romatography.
These include m easurements of HbA by h i g h - p e r f o r m a n c e  liquid
lc
c h r o m a t o g r a p h y  (Santiago, Davis and Fisher, 1978), m e a s u r e m e n t
of HbA by the m e thod of Trivelli (Koenig ejt al. 1976), or the 
lc •
widely available m i ni-columns to measure HbA (Dods and B o l m e y 9
1
1979, Boucher, Welch and Beer,1981). Koenig e_t al. (1976) 
found a correlation be t w e e n  OGTT and the c o r r e s p o n d i n g  
g lyco s y l a t e d  h a e m o g l o b i n  results (r=0.82), but there was 
considerable overlap between the n o n - d i a b e t i c  (3.97% to 5.04%) 
and overt diabetic (4.49% to 11.20%) groups studied. H o w a r d  
(1982) used mac'aca n i g r a  monkeys to study the r e l a t i o n s h i p  
between diabetes mellitus and glyco s y l a t e d  h a e m o g l o b i n  values. 
These monkeys gradually progress towards to diabetes m e l l i t u s  
and their diabetic status can be a s s essed by hormones and 
metabolites. Although he was able to show three d i s tinct 
groups of diabetics, b o r d erline diabetics and normals u s i n g  
both these and g l y c o s y l a t e d  h a e m o g l o b i n  m easurements, the 
numbers he use d  were very small with 6 or less in each group. 
O rchard ejt al. (1982) tried to assess the value of g l y c o s y l a t e d  
h a e m o g l o b i n  for screening early diabetes in 400 r e l a t i v e s  of
diabetic patients using ion-exchange m icro-columns in comparison 
with the OGTT. Using the National Diabetic Data G r o u p ’s 
criteria to interpret the OGTT, they found only 25% of those 
diagnosed as either diabetic or glucose intolerant had abnormal 
glycosylated h a e m oglobin values. They concluded that the 
g lycosylated h a e m o g l o b i n  measurement was too insensitive. 
However, Boucher, Welch and Beer, (1981) reported good 
correlation b e t ween summed glucose values in OGTT and HbA^ 
values for both diabetic and n o n - d i a b e t i c  subjects. This 
encouraging paper was supported by Saibene et_ cil.» (1978), 
who used ion-exchange methods and lOOg glucose load for their 
OGTT, to produce a n o rmal range of 4.2% to 7.8% and a range 
for carbohydrate intolerance of 3.8% to 13.6%. Although 
there was overlap between these two groups, they suggested 
that HbA^ m e a s urement would be useful to improve the s p e c i f i c i t y  
of OGTT.
In this chapter the usefulness of the a f f inity technique 
in the m easurement of g lycosylated haemo g l o b i n s  and g l y c o s y l a t e d  
plasma proteins on b l ood collected during oral glucose 
tolerance tests, is assessed for its ability to detect p a t ients 
with glucose intolerance.
MATERIALS AND M E T H O D S .
Glucose Tolerance T e s t .
Capillary b l ood samples were collected via a fingerprick 
from 53 patients who were referred to the ho s p i t a l  as 
o utpatients for glucose tolerance tests. Each patient had 
been on a 300g carbohydrate diet for each of the previous 3
days and had fasted for at least 12 hours (overnight) p r i o r
to the b l o o d  being collected before the glucose load was 
given. This b l ood was collected into sodium fluoride 
p reservative and the fasting glucose was measured. If this 
exceeded 10mmol/l then the test was discontinued. All OGTT 
were started between 9 and 10am.
An oral glucose load of 50g was given to each p a t ient
using the p r e pared glucose mixture 'Dextran' (Lab Sales UK Ltd. 
Rochdale, Lancs., UK.) made up in 200 ml of water. Re p e a t e d  
blood samples were taken via fingerprick at half hour l y 
intervals up to 2 hours after the glucose dose. All of the 
samples were collected into tubes containing sodium fluoride 
p r eservative and the glucose content was m e a s u r e d  w i t h i n  30 
minutes.
Urine samples were collected while the patient was fasted 
and at hourly intervals after the glucose load until the test 
was complete.
Glucose Measurement.
Whole blood glucose was m e a s u r e d  in each sample using 
the Yellow Springs Glucose A n a lyser Model 23AM (Yellow 
Springs Instrument Co., Yellow Springs, OH 45387, U.S.A.).
A qualitative assessment of the glucose content of 
each urine sample was made using Clinistix (Ames Co.,
Miles Laboratories Ltd., Stoke Poges, Slough, UK.).
I N T E R P RETATION OF ORAL GLUCOSE TOLERANCE TESTS.
The criteria pr o p o s e d  by the WHO Second Report on 
Diabetes (1980) were for a 75g glucose load. It was 
suggested that values obtained using a 50g glucose load 
should be d e c r eased by lmmol/1 at 1 and 2 hours ( h ) after 
the load. On this basis the diagnostic values for the OGTT 
studied w o u l d  be;
(1.) N o r m a l .
At Oh and 2h capillary blood glucose c o n c e n t r a t i o n  
less than 7.0mmol/l was c o n s idered as normal.. A 
fasting value below 6.0mmol/l e x c luded the diagnos 
of d i a b e t e s .
(2.) Impaired glucose t o l e r a n c e .
Impaired glucose tolerance was defined as a Oh 
capillary blood glucose c o n c e ntration lower than 
7.0mmol/l with a concentration at 2h b e t ween 7.0 
and 10.0mmol/l.
(3.) Diabetes m e l l i t u s .
Overt diabetes mellitus was defined in this study 
as a Oh capillary blood glucose c oncentration of 
7.0mmol/l or above, and/or a value of 10mmol/l 
or above at 2h. In the absence of any clinical 
symptoms of .diabetes at least one a dditional  
abnormal blood glucose concentration in the OGTT 
profile confirmed the diagnosis.
Measurement of G l y c o s y l a t e d  H a emoglobins and G l y c o s y l a t e d  
Plasma P r o t e i n s .
After glucose analysis the blood sample taken from a 
fasting patient was c entrifuged at 1200g for 10 minutes.
The erythrocytes were used for the m e a s u r e m e n t  of total and 
stable g l y c o s y l a t e d  h a e m oglobin as described in Chapter 2. 
Similarly the p l asma was prepared and used for the m e a s u r e m e n t  
of both stable and total g l y c osylated plasma proteins.
R E S U L T S .
Total and stable glyc o s y l a t e d  h aemoglobins and g l y c o s y l a t e d  
plasma proteins were d e t e rmined on patients who were referred 
for an OGTT. There were several significant correlations 
between these values and fasting blood glucose, the 2h glucose, 
and the area under the glucose tolerance curve (Table 4.2).
For both glyco s y l a t e d  h a e m o globins and glyco s y l a t e d  plas m a  
proteins the best correlations were found with fasting blood 
glucose. The labile (total minus stable) glyco s y l a t e d  
h a emoglobins and g l y c o s y l a t e d  plasma proteins were c a l c u l a t e d  
for each patient, but perhaps s u r p r i s i n g l y  these values did 
not correlate s i g n i f i c a n t l y  with fasting glucose (r ^  0.3).
Also, urinary glucose did not produce a consistent pattern. 
G l y c osuria was d e m o n strated in 3 patients who had n o r m a l  
glucose tolerance, but was absent for the duration of the test 
from 5 patients with diabetes mellitus.
Of the 53 patients tested, 31 had n o rmal oral glucose 
tolerance tests, 17 had diabetes mellitus and 5 were c l a s s i f i e d 
as having impaired glucose tolerance according to the cr i t e r i a 
p r e v i o u s l y  defined (Table 4.3). In 5 cases the f a s ting b l ood 
glucose was greater than 10mmol/l and so the glucose dose was 
not given. For these patients the range of stable g l y c o s y l a t e d  
haem o g l o b i n  values was from 15.6% to 25.6%, and their values 
for g l y c osylated plasma proteins ranged from 13.9% to 24.4%. 
Comparison of the g l y c o sylated protein values showed that in
all cases these m easurements in those with impaired glucose 
tolerance and diabetes mellitus were s i g n i f i c a n t l y  g r e a t e r  
(p ^  0.001) than in normals.
The discr i m i n a t i o n  between the three classes of patient 
and their values of stable glyco s y l a t e d  proteins are 
i llustrated in Figure 4.1. The diabetic patients had 
stable glyco s y l a t e d  h a e m o g l o b i n  values between 9.4% and 
24.4%. The 5 patients with impaired glucose tolerance had 
stable glyco s y l a t e d  h a e m oglobin values between 8.6% and 
10.0%, which were all greater than the highest values for 
the 31 patients with normal tests (range 5.0% to 8.5%).
Figure 4.1(b) shows that with stable g lycosylated p l asma 
proteins one diabetic patient and two with impaired glucose 
tolerance had values within the n o r m a l  range. The patients 
where overlap occurred were the same when total g l y c o s y l a t e d  
plasma proteins were studied.
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Table 4.2 Summary of the r e l a t ionship between the results 
for the glucose tolerance tests and g l y c o s y l a t e d  
haemoglobins and g l y c o sylated plasma protein values
Fasting Area under
glucose 2h glucose curve (0-2h)
G l y c osylated n = 53 4-8 4-8
haemoglobins (total) r = 0.89 0.75 0.83
slope = 1.34 0.74 0.54
Gl y c o s y l a t e d  n = 53 48 48
h a e m o g l o b i n s (s t a b l e ) r = 0.89 0.74 0.83
slope = 1.28 0.74 0.52
Gl y c o s y l a t e d  n = 52 47 47
plasma proteins r = 0.92 0.72 0.79
(total) slope = 1.35 0.57 0.38
Glyc o s y l a t e d  n = 52 47 47
plasma proteins r = 0.92 0.69 0.75
(stable) slope = 1.27 0.54 0.36
Although 53 patients were studied, for 5 patients the glucose 
load was not given as they had a fasting b l ood glucose ^  lQmmol/1. 
In one case the glyc o s y l a t e d  plasma proteins were not measured.
Table 4.3 Summary of the glyco s y l a t e d  haemoglobins and
g l y c osylated plasma protein values when patient 
results were classified by the WHO criteria
(1980) for a 50g oral glucose l o a d .
Normal
G l y c o s y l a t e d  x 7.2%
h a e m o globins SD 1.3%
(total) n 31
G l y c o s y l a t e d  x 6.6%
haemoglobins SD 1.0%
(stable)n 31
G l y c o s y l a t e d  x 6.2%
plasma proteins SD 1.0%
( t o t a l ) n 31
Glyco s y l a t e d  x 5.9%
plasma proteins SD 1.1%
(stable)n 31
Impaired glucose Diabetes 
tolerance me l l i t u s
9.7% 15.9%
0.4% 4.1%
5 17
9.3% 15.1%
0.6% 3.9%
5 17
8.4% 13.9%
0.7% 5.3%
5 16
8.3% 13.3%
0.9% 4.3%
5 16
DISCUSSION.
The OGTT, as well as being subject to alteration by
numerous factors, as m e n t i o n e d  earlier, is also inconvenient
to the patient and t i m e - c o n s u m i n g  for l a b o r a t o r y  staff.
G l y c o s y l a t e d  h a e m o g l o b i n  is not as prone to e n v i r onmental
influence, and has the additional advantage that only a single
b l ood sample is required with no patient preparation.
Numerous workers have assessed the usefulness of the
meas u r e m e n t  of g l y c o s y l a t e d  h a e m oglobin alongside the more
t r a d i t i o n a l l y  r e c o g n i s e d  OGTT. Two main factors are r e s p o n s i b l e
for the wide discrepancies between different results and
recommendations. The first of these relates to the d i f f erences
in criteria for the i n terpretation of OGTT already m e n t i o n e d  in
the introduction to the chapter. Secondly, the g l y c o s y l a t e d
h a e m o g l o b i n  m e a s u rements may be either HbA or HbA . This
1 lc
r eadily explains why Bolli ejt al. (1980) using a *+0g OGTT and
the Fajans-Conn criteria for i n terpretation obtained a n o r m a l
range of 5,2% to 7.2% and a diabetic range of 6.3% to 18% for
g l y c o sylated haemoglobin. They concluded that the OGTT a p p e a r e d
more sensitive than HbA for m e a s u r i n g  patients with r e d u c e d
1
c arbohydrate tolerance, and yet the Faja n s - C o n n  criteria has 
been shown to overestimate the diagnosis of diabetes ( U n g e r ?1957) 
and so this is more likely to be responsible for the large 
overlap between the ranges. On the basis of this and many 
other studies, S i p e rstein (1975) stated "over the past 20 years 
almost every study using OGTT has re p o r t e d  a pre v a l e n c e  of
' d i a b e t e s 1 that is o b v iously u n r e a l i s t i c a l l y  high." He
r eco m m e n d e d  that diagnosis could only be made on the grounds
of persistent h y p e r g l y c a e m i a . However, if this approach
was adopted then many patients with impaired glucose tolerance
who would later require expensive health care may not be
recognised, and yet early r e c o gnition may allow s uccessful
intervention (Sartor e_t aJL. 1980).
The initial part of this dilemma has been in part solved
by the WHO 2nd. Report (1980) which clearly sets out a
logically b a s e d  criteria for the interp r e t a t i o n  of OGTT for
universal use. The p r o blem of how to measure g l y c o s y l a t e d
h a e m o g l o b i n  remains. In a recent p a per Kesson e_t a^L. (1982)
compared the usefulness of HbA and HbA meas.urenent as ar screening
lc 1
procedure for diabetes mellitus with the conve n t i o n a l  OGTT.
They found in agreement with others (Santiago, Davis and
Fisher, 1978 , Koenig ejt al. 1976) that HbA was not s u f f i c i e n t l y
lc
sensitive in the screening of diabetes. However, the HbA
1
m e a s u rements gave a more consistent comparison with the OGTT, 
which is also consistent with the findings of others 
(Clipson _et al,. 1981, Dods and Bolmey,1979, Boucher, Welch and 
B e e r , 1981). Nevertheless Kesson e_t al. (1982) stressed the 
m e t h o d o l o g i c a l  problems common to all these groups of workers 
who were using methods b a s e d  on i on-exchange c h romatography.
Verrillo et al. ('1-9*8-3) classified patients a c c o rding to the 
WHO criteria (1980) and compared their results with HbA
1
m e asurements and yet they found m a r k e d  overlap be t w e e n  n o r mals 
and those with impaired glucose tolerance.
A f f inity c h r o m atography provides a simple, sensitive
and very precise (CV <( 2%) method for the measurement of
g l ycosylated haemoglobins in the routine clinical labo r a t o r y
(Hall, Cook and G o u l d , 1983), and has none of the m e t h o d o l o g i c a l
problems a s s o ciated with ion-exchange chromatography. It
measures main l y  HbA and g l y c o s y l a t e d  HbA (Klenk ejt a l . 1982 ,
lc 0
Fluckiger, Woodtli and B e r g e r , 1984) ; both fractions are
elevated in diabetes (McDonald ejt <al. 1978), but the latter
fraction may be a more sensitive indicator of h y p e r g l y c a e m i a
(Klenk e_t _al. 1982). As shown with this work, a single
me a s urement using affinity chr o m a t o g r a p h y  appears to d i s t i n g u i s h
between patients with diabetes mellitus (stable g l y c o s y l a t e d
8.5%). There were no false positives r e c orded in the
no n - d i a b e t i c  population, and the two groups were s i g n i f i c a n t l y
different. This clear.-cut separation (Fig 4.1 (a)) is
p o s sibly due to increased sens i t i v i t y  of the affinity m e t h o d
by the c a p a bility of the technique to measure g l y c o s y l a t e d
HbA (usually overlooked by other methods) in addition to 
0
HbA , and this is a substantial p r o p o r t i o n  of the total 
lc
g l y c o s y l a t e d  material. Furthermore, recent work by 
F l u c k i g e r ^ W o o d t l i  and Berger (1984) suggests that this 
sens i t i v i t y  can be further enhanced by m o d i f y i n g  the 
affinity technique to use larger columns and a reduced flow 
rate.
(stable g l y c o s y l a t e d  h a e m o g l o b i n
Those patients who showed impaired glucose tolerance 
also differed si g n i f i c a n t l y  from both the normal and diabetic 
groups. However there was a small overlap between patients 
with impaired glucose tolerance and the overt diabetic 
population, as the highest value for the former was 10%.
This could simply be a r e f l e c t i o n  of the errors in the glucose 
tolerance test for the reasons outlined earlier.
Very similar results were also evident with the total 
g l y c o s y l a t e d  haem o g l o b i n  meas u r e m e n t  (Tables 4.2 and 4.3).
This w o uld imply that the incubation stage for the removal 
of labile ma t e r i a l  is not strictly re q u i r e d  for g l y c o s y l a t e d  
h a e m o globin to be used as a s uccessful s c r eening t e c h nique 
for diabetes mellitus. However, since the prop o r t i o n  of 
labile material is large (mean = 8.5% of the stable fraction), 
and the r e l a t ionship between fasting b l ood glucose and labile 
g lycosylated h a e m o g l o b i n  shows no consistent pattern from 
patient to patient, its removal is recommended.
G l y c o s y l a t e d  plasma proteins were m e a s u r e d  in these 
investigations since it has been shown that they are more 
sensitive to h y p e r g l y c a e m i a  (Kennedy e_t al. 1981), and t h eir 
usefulness in this context had not p r e v i o u s l y  been assessed. 
Tables 4.2 and 4.3 also show that similar conclusions can be 
drawn from the results of both the g l y c o s y l a t e d  plasma p r o tein 
(total and stable). With these m e a s u r e m e n t s  however, most of 
the differences between the different p o p u l a t i o n s  as i n t e rpret 
by the OGTT are slightly less distinct. This may be due to 
the glyco s y l a t e d  plasma protein results being u n e x p e c t e d l y
generally lower than those for glyco s y l a t e d  haemoglobins, or 
due to the fact that the method for g l y c o s y l a t e d  p l asma 
proteins is less precise (C V 5%). In some cases 
haem o l y s e d  plasma may yield falsely low values (see Chapter 
3), and haemolysis did occur in some samples. Sodium fluoride 
was less suitable than lithium heparin as an a nticoagulant and 
the small fingerprick samples obtained were easily haemolysed.
The results in this study, although limited, are very 
e n c o u raging and have been p u b l i s h e d  in full (Hall e_t 
a l . 1984 ). They suggest that the affinity technique is more
suitable for the detection of carbohydrate intolerance than 
other methods using ion-exchange chromatography, as workers 
using other techniques do not show such clear-cut s e p a r a t i o n  
of the different groups. It would be valuable to extend this 
work, with s t a n d a r d i s e d  methodology, to several centres. If 
the enco u r a g i n g  results o b t ained in this limited study are 
more generally applicable, it would be appropriate for the 
meas u r e m e n t  of glyc o s y l a t e d  haem o g l o b i n  by this m e t h o d  to be 
included in future discussion on the diagnostic c r i teria for 
diabetes. The early detection of subject 'at risk' with  
carbohydrate intolerance, as well as those likely to be 
e s p e cially at risk in pregnancy, would seem to be both p o s s i b l e  
and desirable using this technique.
CHAPTER 5.
THE UTILISATION OF GLYCOSYLATED 
HAEMOGLOBINS AND GLYCOSYLATED 
PLASMA PROTEINS FOR MONITORING 
BOTH ACUTE AND CHRONIC CHANGES 
IN GLYCAEMIC CONTROL
INTRODUCTION.
I n s ulin-dependent diabetes mellitus (IDDM) is a well 
rec o g n i s e d  disease. It is a universal health problem 
affecting all human societies.,affecting at least 30 m i l l i o n 
people throughout the world (WHO, 1980). Nowadays, 
treatment is well r e g u lated with numerous clinical facilities, 
although the m a jor emphasis is on the patient himself to 
maintain good glycaemic control. In fact diabetes is an 
excellent example of a chronic disorder where the affected 
person must take the major r e s p o n s i b i l i t y  for his own health. 
Self-m o n i t o r i n g  as well as clinical m o n i t o r i n g  are both an 
integral part of any diabetic care.
Although there is debate r e g arding the direct a s s o c i a t i o n  
of poor glycaemic control and diabetic complications, the 
general medical opinion is that good control is beneficial. 
D isabilities such as ischaemic heart disease, retinopathy, 
glomerulosclerosis, nephropathy, neuropathy, strokes and 
cataracts are 2-3 times higher in diabetics than in the g e neral 
population. Blindness is 20 times higher, and gangrene is 
20-30 times h i gher than in the general population. However, 
there is evidence which challenges the n e c e s s i t y  of close 
g lycaemic control. For example, m i c r o a n g i o p a t h i c  c o m p l i c a t i o n s  
may be the pre s e n t i n g  feature in patients with only m i l d l y  
impaired glucose tolerance, (Pyke and R o b e r t s , 1959), but 
conversly it has been reported (Mur, 1954) that 20% of the 
ketosis-prone patients studied did not develop the usual 
complications of r e t i nopathy and n e u r o p a t h y  even after 25 
years. In spite of these observations, however, there is an
impressive array of evidence to support those who favour 
the view that good glycaemic control is beneficial.
Lesions in the kidney, retina and muscle can be shown by 
chemically inducing diabetes mellitus in rats (Mauer et a l .
1975). These lesions were pre v e n t e d  in smaller groups when using 
insulin therapy good glycaemic control was achieved over 
a period of 5 y e a r s . A later publ i c a t i o n  by these workers 
(Mauer e_t _al. 1976) showed that diabetic vascular lesions 
developed in normal kidneys after they were t r a n s p l a n t e d  
into human patients with diabetes mellitus.
The balance of evidence suggests that there is more 
likely to be a bett e r  prognosis for any diabetic patient 
who maintains good glycaemic control, and therefore it is 
pertinent to consider the criteria for good control and how 
it can be achieved. The definition of diabetic control is 
not clear-cut. Ideally a w e l l - c o n t r o l l e d  diabetic p a t ient 
should be as similar to a non-d i a b e t i c  as possible. In 
practice this degree.of control is v i r tually impossible to 
achieve by insulin injections, and compromises are made.
There are also inherent problems with b l ood glucose 
monitoring, as the concentration will vary with glucose intake, 
not just daily, but from hour to hour. In the past few years 
glyc o s y l a t e d  h a e m oglobin m easurement has been used r o u t i n e l y  
to m o nitor patients with IDDM. As this m e a s u r e m e n t  pr o v i d e s  
cumulative information of a patients glycaemic history, the 
p e r i o d i c i t y  of the change in concentration is much longer 
than for blood glucose.
However, unless the avail a b i l i t y  of the glyc o s y l a t e d  
h aemoglobin m e a s u rement actually influences the attitude 
of the patient to his condition, or alters the clinical 
management, it does not prove itself as a worthwhile test. 
Using affinity ch r o m a t o g r a p h y  (as described in Chapter 2) 
to measure g l y c o sylated haem o g l o b i n  in this study, the 
progress of diabetic patients was followed (Section A).
Those patients a t t e nding an outpatient clinic at the Royal 
Sussex County Hospital, were m o n i t o r e d  over a period of 
about 18 months, starting when the test was first introduced. 
Trends within this patient group have been examined, r e g a r d i n  
age and sex. As well as this r e l a t i v e l y  long term study of 
diabetic control, the combined m e a s u r e m e n t  of g l y c o s y l a t e d  
haemoglobins and g l y c o sylated plasma proteins in the acute 
situation have been assessed (Section B).
SECTION 1.
MONITORING CHRONIC CHANGES IN GLYCAEMIA.
MATERIALS AND M E T H O D S .
Subj e c t s .
This study began in March 1981 and continued until 
September 1983. All of the patients included in this study 
have i n s u lin-dependent diabetes mellitus, and attend an 
out-patient clinic for clinical assessment, a p p r o x i m a t e l y  
once every three months. The age range of those a t t ending 
the clinic was 14 to 71, with a mean age of 36 years and 
5 months. Sequential samples were taken, usually at 3 
monthly i n t e r v a l s , over a duration of about 18 months to 2 
years after the g l y c osylated haem o g l o b i n  assay was introduced.
S a m p l e s .
Venous blood was collected for g l y c o s y l a t e d  h a e m o g l o b i n  
e stimation at each visit. The b l ood was p r e s e r v e d  in l i t h i u m 
heparin containers and stored at 4°C until m e a s u rement, 
within 48 hours.
Measurement of Glyc o s y l a t e d  H a e m o g l o b i n s .
Erythrocytes were separated and used for the measurement 
of glyco s y l a t e d  h aemoglobins as described in C h a p t e r  2.
For some of the earlier samples the pH of the buffers used 
was pH8.5, rather than pH8.3. This should cause slightly 
lower initial results so will not affect o bservations where 
control had improved. Labile m a t erial was removed by 
incubation prior to analysis in all cases.
S t a t i s t i c s .
S tatistical comparisons were p e r f ormed by S t u d e n t ’s 
t-test.
R E S U L T S . I N V E S TIGATION OF CHANGES IN CONTROL
Overall Control C h a n g e s .
A s s e ssment of patient control was made using g l y c o s y l a t e  
haemoglobin results which were close to 12 months apart. 
Overall control for the whole group of 120 patients, as 
m e a s u r e d  by the paired t-test (t=3.121) showed sign i f i c a n t 
improvement (p <  0.01).
Since the method has a b e t w e e n - b a t c h  C.V. of 2%
(Chapter 2), individual change was defined as when the two
values (-2%) did not overlap. Using this criteria 65 patients 
within the group showed improvement, 15 showed no change and 
40 had poorer control.
(1) Control changes in 3 sub-groups, classified 
according to original c o n t r o l .
To determine which type of patient was altering 
its control, the main group was divided into 
sub-groups according to the level of control 
of the individual patients when they were first 
tested. Those patients who had initial levels 
below 9.7% (the top of the normal range) were 
t ermed to be in good control. Patients with an 
initial value b e t ween 9.7% and 14% were c o n s i d e r e d  
as an intermediate control group, and those 
exceeding 14% were c o n s idered as a group 
exhibiting poor control. These values were 
considered to match best the clinical a s s e ssment 
of diabetic patients attending an outpatient  
clinic (Fig. 2.13).
In the w e l l - c o n t r o l l e d  group of 13 patients there 
was no significant overall change in their c o n t r o l  
(t= -1.9). Similarly for the 69 patients in the 
intermediate group there was overall no s i g n i f i c a n t  
change in control (t= -0.12). However, for those 
patients classed as p o orly c ontrolled there was
significant improvement over the year of the 
study (p ^  0.001, t=5.262). These results are 
summarised in Table 5.1. At the b e g i n n i n g  of 
the year 13 patients had values below 9.7% and 
at the end of a years m o n i t o r i n g  using g l y c o s y l a t e d  
h aemoglobin results 17 patients could now be 
included in this group, although 4 of the original  
patients included were rel e g a t e d  to the i n termediate 
group. Of the 38 patients ori g i n a l l y  defined as 
poor control ( } 14%), after 12 months only 17 could 
still warrant this definition. Seven others h o w e v e r > 
were relegated from the intermediate group to poor  
control.
(2) Effect of duration of diabetes on c o n t r o l .
To exclude the effect of new diabetics on the poor 
control group, who should be u n d e r g o i n g  a p e r i o d  
of improved control, any patients (2) who were 
diagnosed as IDDM in the p r e c e d i n g  3 years were 
removed from the poor control group. The r e m a i n i n g  
36 patients however, still show a significant 
improvement in their control (p 0.001, t=5.39). 
These patients have had diabetes for a mean d u r a t i o n  
of 14.7 £ 8.8 years, with an observed range of 
3 - 3 9  years.
To exclude any effect that could be attributed 
to attendance at the outpatient clinic at the 
R o y a l .Sussex County after different clinical 
management elsewhere, any patients who had 
attended the clinic in the study for less than 
3 years were excluded from the poor control group. 
The remaining 28 patients still showed a 
significant improvement in their control 
(p <  0.001, t=4.378) with their mean value of 
16.25 - 1.87% decreasing to 14.03 £ 2.72%.
The r e lationship between age and sex of p a t i e n t 
on diabetic c o n t r o l .
The relationship between age and diabetic control 
is i llustrated in Table 5.2, with the group under 
study being divided according to the different 
decades. The values used in this case were the 
last values obtained in the 12 - 15 month p e r i o d  
that the patient was studied. There is no 
significant difference b e t ween the diabetic control 
as assessed by glyc o s y l a t e d  h a e m o globin in the 
different age groups.
When each age group is divided according to sex 
(Table 5.3), it is clear that the females in this 
study are less w e l l - c o n t r o l l e d  than the males for 
every age g r c u p . 51 women (mean age 35 years and
2 months) and 69 men (mean age 37 years and 5 months) 
were included in this study. As there was no 
s ignificant difference b e t w e e n  the age dist r i b u t i o n 
of the two sexes as shown by lf l and t-tests, the 
two groups could be compared statistically.
The overall mean figures at the beg i n n i n g  of the 
12 month period, d i s r e g a r d i n g  age, of 13.55 - 3.02% 
for females and 12.37 - 2.86% for males support this 
observation. This difference is more marked in the 
overall figures after 12 months when the females 
have a mean glyco s y l a t e d  h a e m o globin value of 13.29 
- 3.04% and the males 11.28 i 1.93%. The first 
values show a significant difference at p <  0.05 
(t=2.16) while the difference after 12 months is 
p <C 0.001 (t=4.14). Table 5.4 shows the p r o p o r t i o n s  
of males and females with improved control, p o o r e r  
control or unc h a n g e d  over the 12 month period, 
depending on their original placement in the various 
groups.
Table 5 . 1 , Trends in diabetic control in relation to 
time of m o n i t o r i n g  using GHb .
Initial Result Result after 1
GROUP 1 
Good Control 
below 9.7% (n = 1 3 )
GROUP 2
Intermediate Control 
9.7% - 14% (n = 69 )
GROUP 3
Poor Control meai: 16.33% 13.88% **
above 14% (n=38) SD 1.86% 2.80%
mean
SD
8 .42% 
1.08%
9.35% NS 
1.7 8%
mean
SD
11.8 6% 
1. 24%
11.8 8% 
1.77%
NS
Year
NS not s tatistically significant
p < 0.001
Table 5 . 2 . The r e l a t ionship between age of patient
and diabetic control.
AGE (y e a r s ) <20 20-30 30-40 40-50 50-60 > 60
n 20 27 22 19 23 9
mean % 12 .68 12.39 11.88 11.62 11. 96 12 .13
SD % 2.69 3 .06 2.04 2 .47 2.69 2 .44
Table 5 . 3 . The relat i o n s h i p  between age and sex of
patient and their diabetic c o n t r o l .
AGE ( y e a r s ) <20 20-30
0
1
oC
O 40-50 50-60 >60
n 12 13 13 9 16 6
mean 9-x> 12.02 10.94 11.07 1 1 . 1 1 1 1 .35 11.13 MALES
SD % 2 . 5 2 1.67 1. 39 2 .04 2.25 1.29
n
mean % 
SD %
8 14 9 10 7 3
13.68 13.74 13.05 12.25 13.35 14.15 FEMALES
3.53 3.47 2.35 2.85 3.28 3.24
Table 5.4.
Males (e 
Females (n
To show the r elationship between sex
of patient and diabetic c o n t r o l .
% Improved control % Poorer control % No change 
i=69 ) 56 .5 29.0 14.5
= 51) 51.0 39 .2 9 .8
TOTAL 54.2 33.3 12 . 5
DISCUSSION.
The major o b s e r vation to be made from this study is
that the patients m o n i t o r e d  in this clinic over a period
of 18 months to 2 years have improved their diabetic control 
in terms of glyc o s y l a t e d  h a e m o globin measurement. Since 
the observation was true for patients who had been diabetic 
and attended the clinic for a period in excess of 3 years, 
then the introduction of this test would appear to be
directly responsible for this change. Ideally, however,
these patients w o uld need to be followed over several years, 
to see if the trend for bett e r  control continued.
These findings may be due to increased patient awareness
or as a direct result of the diabetician altering treatment 
in response to these results. The m e a s u rement of g l y c o s y l a t e d  
haemoglobin should provide the clinician with additional  
information to a single blood glucose concentration, as it 
provides a cumulative index of glycaemic control over a period  
of several weeks (Bunn, 1981). T h e o r e t i c a l l y  this should
lead to a more accurate interpretation of diabetic control and
c onsequently improved clinical management. This trend is 
observed in the results p r e s e n t e d  in this thesis. Although 
there are several p ublications (Gonen e_t a_l. 1977, Dahlquist 
et a l . 1982 , Frazer ejt a_l. 1982) showing a significant 
correlation between g lycosylated h a e m oglobin results and the 
p h y s i c i a n fs rating of diabetic control, Citrin, Ellis and 
Skyler (1980) indicated that the glyco s y l a t e d  h a e m o g l o b i n  
m easurement identified many patients who were e r r o n e o u s l y  
considered to be in good control as they were falsely claiming 
negative results for urinary glucose b e t ween clinic visits.
Similarly, Campbell e_t ajL.(1983) m e a s uring HbA^ by agar gel 
electrophoresis, studied 264 IDDM patients attending a diabetic 
clinic at a district hos p i t a l  and found 73 of those patients 
whose control was c o n s idered s a t i s factory had high HbA^ 
results. They also showed that only 6 of the patients 
considered to have poor control had HbA^ values within the 
normal range. The evidence supporting the a r g ument for 
introducing the glyc o s y l a t e d  haem o g l o b i n  assay into the 
repertoire of b i o c h e m i c a l  tests for diabetic control is 
strong. A f f inity ch r o m a t o g r a p h y  provides a simple, reliable, 
inexpensive and reproducible meth o d  (Chapter 2) of p r o v i d i n g  
this service. The m e thod is suitable for use in most 
laboratories.
The second observation to be made from this study is 
that the females proved to have s i g n i f i c a n t l y  worse control 
than the males (Table 5.3). Oestrogen levels are known to 
cause higher insulin resistance in p r e g nancy (Ciba F o u n d a t i o n  
Symposium 63, 1 9 7 9 ^ and initially it was thought that these 
results might be due to rising oestrogen levels in the 
m e n s trual cycle causing injected insulin to be less effective. 
However, since this poorer control in the females is pr e s e n t 
in every age group this cannot be the u n d e r l y i n g  cause, as 
when menopause is reached this effect should be negated. If 
40 years is chosen as an arbit-ary time for the onset of the 
m e n opause there is no significant difference between those 
patients under 40 years of age (mean = 13.59, SD = 3.14) and 
those who are older (mean = 12.86, SD = 2.92). Oral 
c ontraceptives have been shown to decrease g l y c o s y l a t e d  
haem o g l o b i n  levels (Oakley and Rostron, 1982) so this does
not provide the answer. Possibly the expl a n a t i o n  could lie
in the awareness of the males and the females to their 
treatment. Most of the men in the survey visited the 
evening clinic as they w o r k e d  and so they had to be well- 
m ot i v a t e d  to attend. Many of the women attended the e v e ning 
clinic due to social circumstances rather than day-time 
employment. It is possible that the awareness of the women 
to the diabetic condition and their s e lf-motivation was not 
as positive as the males studied; or a l t e r natively their 
carbohydrate intake was high due to poo r  diet as a result 
of low income .
There are numerous arguments in the literature r e g a r d i n g  
the d e s i rability of diabetic control. Unger (1982A) o u t l i n e d  
how meticulous m a n a gement should delay or prevent the 
complications of diabetes. However, there have been studies 
using subcutaneous, continuous insulin infusions to achieve 
better control which have been shown to accelerate the 
deterioration of retinal function (Lauritzen et_ _al. 1983 ,
Drash, Daneman and Travis, 1980), although these findings 
followed a period of very poor glycaemic control in these 
patients. These workers note h o w ever that there is d i f f i c u l t y  
in a c c u rately defining retinal function and retinal m o r p h o l o g y .  
Although these limited studies cast doubt upon the need for 
close control of blood glucose, the weight of evidence supports 
the view that glycaemic control is important. There seems to 
be no justifiable reason to w i t hold a ther a p e u t i c  option w h i c h  
requires no new drug, but merely the careful m a t ching of 
insulin does to the analogue p r e s e n t a t i o n  of a varying
glucose profile, as achieved with the glyco s y l a t e d  
haemoglobin measurement. However, it is important to note 
that patients may be at increased risk of h y p o g l y c a e m i a  
if the dose of insulin is not correctly m a t c h e d  to the 
patients requirements. This has been d e m o n strated when 
devices for continuous intravenous insulin infusion t h erapy 
(White ejt al_. 1983) have been used for the meticulous 
metabolic control of diabetes mellitus. Unger (1982B) 
drew attention to the poss i b i l i t y  of hypoglycaemia, caused 
by this means of control, causing permanent brain damage.
SECTION 2
MONITORING ACUTE CHANGES IN GLYCAEMIA.
MATERIALS AND M E T H O D S .
. Subj e c t s .
Eight in-patients (A-H) of the Royal Sussex County 
H o s pital were included in this study. Five (A,B,C,D and E) 
were admitted with ketoacidosis, and three (F,G and H) were 
admitted for s t a b i lisation of their diabetes. Their relevant 
clinical details are re c o r d e d  in Table 5.5. P e r m ission was 
obtained from the consultant diabetician for these samples 
to be taken and studied.
S a m p l e s .
Several samples of venous blood were c o l l ected into 
lithium heparin from each patient over the period of t h eir 
hospitalisation; this varied from 4 to 15 days. The first 
sample in the series was taken on admission to hospital, or 
for those patients admitted in coma, as soon as e m e r g e n c y  
treatment was completed.
Table 5.5. Clinical details of those patients (A-H)
admitted to ho s p i t a l  with poor diabetic control
Patient Age Sex Admitted Type Infusions Mode of Other relevant
in coma of control details
coma
A 56 F Y acute S ,D I
B 15 F Y acute , 
severe
S,D,B I cataracts
C 2 3 M Y acute S,D I
D 41 M Y acute S , D I
E 17 M Y sub-
acute
S 9 D I
F 48 F N - - D , I obese, hypothjroid
G 68 F N D , I recent
c e r e b r o v a s c u l a r  
a c c i d e n t , s p r e a d i n g  
cer e b r a l  thrombosis
H 29 M N - - D , 1 , 0 recent i n f e ction
Infus i o n s ;
S : norm a l  saline given with KC1 
D : 5% dextrose 
B : sodium b icarbonate 
Mode of c o n t r o l ;
D : diet 
I : Insulin
0 : Oral hypog l y c a e m i c  agents
M e t h o d s .
The treatment of samples and measurement of glyc o s y l a t e d  
haemoglobins and g l y c o sylated plasma proteins was per f o r m e d 
as outlined in c h a p t e r  2. Labile mater i a l  was removed by 
incubation prior to m e a s u rement in every case.
R E S U L T S .
The changes of g l y c o sylated h a e m o globins and g l y c o s y l a t e d  
plasma proteins in the eight patients (A-H) studied are shown 
in Fig. 5.1. In one instance (Patient H) g l y c o s y l a t e d  
h aemoglobin was still rising during the first day after 
admission, whereas the g l y c o sylated plas m a  protein values had 
already started to decline. The r e m a inder of the patients 
showed that both sets of results started to decline i m m e d i a t e l y  
after admission to hospital.
In most cases (A, B, C, D, E, G and H) g l y c o s y l a t e d  p l a s m a  
proteins have a faster decline than g l y c o s y l a t e d  ha e m o g l o b i n s ,  
and are often higher (A, C, D, E, G and H) on admission. Table 
5.6 shows the first and last result taken for each patient 
during their hospital stay. The percentage decline per day for 
both glyco s y l a t e d  h a e m oglobin and g l y c o s y l a t e d  plasma proteins  
is recorded. The daily percentage decline required for each to 
halve the original result has been c a l c ulated for each pa t i e n t  
and noted. A half-life of 60 days and 20 days (Jones ejt a l .
1983) was assumed for g l y c o sylated haem o g l o b i n  and g l y c o s y l a t e d  
plasma protein respectively. It can be seen that al t h o u g h  
many of the results are in broad agreement with these t h e o r e t i c a l  
values (Table 5 . 6 many (marked w ith an *) decline at a m u c h
and glycosylated plasma proteins in patients (A-H) 
admitted to hospital for stabilization of their
d i a b e t e s .
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For all patients; 
x-axis r e p r esents days 
after admission, 
y-axis represents  
% g l y c o s y l a t i o n .
20
— *
1 0 -
Patient H.
Ke^:
For all patients;
gl y c osylate d 
h a e moglob ins
▲  g l y c o s y l a t e d  
plasma prote i n s
quicker rate .
The calculations were in agreement with those outlined 
by Beach (1979), who showed that any change in g lycosylated 
h aemoglobin c o n c e ntration in a red blood cell was p r o p o r t i o n a l  
to glucose concentration, h a e m oglobin concentration, and the 
life-span of that red blood cell.
Calcula t i o n s .
(1) F or theoretical decrease in glyc o s y l a t e d  h a e m o g l o b i n s  .
initial GHb result x 
2
(2) For theo r e t i c a l  decrease in g l y c osylated plasma 
p r o t e i n s .
initial GPP result x 1 = % decrease per day
2 2 0
(3) For actual decrease in g l y c o s y l a t e d  h a e m o g l o b i n s .
initial - final GHb results = % decrease per day
nu mber of day studied
(4) For actual decrease in g l y c o s y l a t e d  plasma prote i n s  ,
initial - final GPP results = % decrease per day 
number of days studied
1 = % decrease per day
60
Table 5 . 6 . To compare the rate of decline of g l y c osylated 
haemogLobins and g lycosylated plasma proteins 
observed in patients following poor c o n t r o l , 
with the t h e o retical rate.
PATIENT G H b (1) G H b (2) G P P (1) G P P ( 2 ) T GHb(C) GHb(A) GPP(C) G P P (A )
A 20. 3 18.6 22 .8 15.5 11 0.169 0.15 5 0.570. 0.664
B 17 .1 15 .1 13.8 13.0 4 0.142 0.5 00* 0. 3 45 0.2 00
C 15 .8 14.7 17.9 12.5 9 0.132 0.12 2 0 .270) 0.R00*
D 11.3 12.3 13.0 11.4 7 - - 0.325 0.229
E 27.4 20.8 26.8 17.0 15 0.228 0.440* 0.6 70 0.653
F 18 .8 17 .4 22-2 17.6 6 0.157 0.233 0.5 5 5- 0. 767
G 13 .5 12.8 15 .7 13 .0 7 0.113 0.100 0 .39 3* 0.386
H 27.6 21. 7 40.6 23-3 5 0.230 1.18* 1.015' 3.460*
K e y :
GHb(l) represents the first g lycosylated h a e m o g l o b i n  result in 
the series
GHb(2) represents the last g l y c o s y l a t e d  h a e m o g l o b i n  result in 
the series
GPP(l) represents the first g l y c o sylated plasma pr o t e i n  result 
in the series
GPP(2) represents the last glyco s y l a t e d  p l a s m a  protein result 
in the series
GHb(C) is the t h e o r etical % decrease in g l y c o s y l a t e d  h a e m o g l o b i n  
required per day to achieve half the or i g i n a l  value after 
60 days
GHb(A) is the actual % decrease in g l y c o s y l a t e d  h a e m o g l o b i n  per 
day
GPP(C) is the theo r e t i c a l  % decrease in g l y c o s y l a t e d  p l a s m a  
protein required per day to achieve half the o r i g i n a l  
value after 20 days
GPP(A) is the actual % decrease in g l y c o s y l a t e d  plas m a  pr o t e i n  
per day
T is days
A
indicates those results where the % decline in the actual 
results is very much quicker than the t h e o r e t i c a l ,  
expected % decline
DISCUSSION.
For n e a r l y  all of the patients (except H) both g l y c o s y l a t e d 
haemoglobins and g l y c osylated plasma proteins decreased 
i mmediately after admission tc hospital. Other studies have 
shown the decline of g l y c o sylated h a e m o globins after a p e riod 
of poor control. Trovati ejt _al. (1981) studied new juvenile 
diabetics, and found reductions in values within 7 to 10
days after the start of insulin treatment. When labile m a t e r i a l  
was not removed prior to m e a s u r e m e n t  the decrease was o b s e r v e d  
after only one day. However, as labile material in this study 
was removed by incubation (Chapter 2) this cannot be the 
explanation for the immediate decrease observed. Wettre e_t a l . 
(1983) induced poor glycaemic control by w i t h d r a w i n g  insulin, 
and then studied patients through the m e a s u r e m e n t  of g l y c o s y l a t e d  
h a e m oglobin o n c e  insulin treatment was resumed. They did this 
using ion-exchange methods but were unable to show a s i g n i f i c a n t  
decrease in stable H b A ^  within 2 weeks of the improved glycaemia. 
A similar study by Brooks, Nairn and Baird (1980) follo w e d  the 
progress of 7 IDDM patients after a week of poor gly c a e m i c  
control. They used both colorimetric and ion-exchange 
techniques to do this, and found c onsiderable variation in the 
pattern and degree of change in p e r c entage g l y c o s y l a t i o n .
The results in this work show that g l y c o s y l a t e d  h a e m o g l o b i n s  
decrease s i g n i f i c a n t l y  within a few days of treatment, if the 
b e t w e e n - b a t c h  variation for the a f f inity m e t h o d  of about 2% 
(Chapter 2) is considered. This may be due to the s e n s i t i v i t y  
of the affinity technique. Arnquist et_ aJ.. (1982) using  
ion-exchange chromatography, showed that the initial decline
in HbA.. was faster than HbA after a period of poor control; 
a+b 1c
these components d ecreasing in a bi p h a s i c  , f a s h i o n . Since
affinity c h r o m a tography should measure all g lycosylated
material, it may be det e c t i n g  this decrease in HbA. in the
a+b
early days of treatment.
The severity of the k e t o a c i d o t i c  coma for these individuals 
did not relate directly to the extent of their recent poor 
control. Patient E had very high values of both glyco s y l a t e d  
haemoglobins and g l y c o s y l a t e d  plasma proteins and yet was 
admitted in a coma considered to be fsub-acute 1 . In contrast 
patient B had a very severe comatose condition and yet her 
results, though high, were not as high as with patient E.
These findings support those noted by Wieland et_ al_. (1979).
In this study glyco s y l a t e d  plasma proteins decreased at 
a far quicker rate than g l y c o sylated h a e m o g l o b i n s  for most 
of the patients, an observation which is not u n e x p e c t e d  as 
they have a far shorter half-life. Jones et ajL. (1983) 
compared glyc o s y l a t e d  h aemoglobin change as m e a s u r e d  by ion- 
exchange chromatography, with that of glyc o s y l a t e d  albumin 
me a sured by the c olorimetric technique, following a period 
of poor glycaemic control. They found a significant change 
in glycosylated albumin after 4 weeks, but no observable 
change in g l y c o s y l a t e d  haemoglobin in this time. A similar 
study by Dolhofer, Renner and Wieland (1981), again using 
ion-exchange chrom a t o g r a p h y  to measure g l y c o s y l a t e d  h a e m o g l o b i n s  , 
and the c o l o r imetric meth o d  for glyc o s y l a t e d  albumins, s t udied 
patients r e c o v e r i n g  from k e t o a cidotic coma. They showed a 
significant decrease in g l y c o sylated albumins, as m e a s u r e d
by 5-HMF, within the first week of treatment, but no such 
change was noted with the g lycosylated haemoglobins.
Affinity chroma t o g r a p h y  provides an advantage over these 
techniques since it allows the comparison of g l y c o sylated 
haemoglobins and glyco s y l a t e d  plas m a  proteins (or glycosylat 
albumins) using the same technique and expressing results 
in the same units. Other workers have tried to create 
indices of recent changes in control by combining results 
of fasting blood glucose and glyco s y l a t e d  haemo g l o b i n s  on 
a single occasion ( P ecoraro,Chen and Porte, 19 82) but these 
calculations are now shown to be an u n n e c e s s a r y  comp l i c a t i o n  
as the single m e a s u r e m e n t  of glyc o s y l a t e d  plasma proteins by 
affinity c h r o m a tography can provide this information.
Table 5.6 shows that process of g l y c o sylation of 
ha e m oglobin cr protein may not be a simple one. A l t hough  
many of the results decrease at the expected rate, some 
decrease far quicker. The precise temporal r e l a t i o n s h i p  of 
HbA^ to plasma glucose has been q uestioned in the lit e r a t u r e  
(Borsey jet a_l. 1982 , Brooks, Nairn and Baird, 1980). This 
study, although limited, confirms that there is no place 
for c omplacency in the b e lief that the true nature of 
g l ycosylated h a e m o g l o b i n  has fully been elucidated.
CHAPTER 6.
MONITORING NORMAL AND DIABETIC 
PREGNANCIES USING GLYCOSYLATED 
HAEMOGLBINS AND GLYCOSYLATED 
PLASMA PROTEINS.
I N T R O D U C T I O N .
Pregnancy is a diabetogenic condition which confers 
additional problems for the clinical m anagement of the 
diabetic patient. To understand the complications and 
interactions promoted by these two conditions, it is first 
necessary to consider the metabolic changes that occur in 
normal pregnancy. In this way the influence of pregnancy 
on carbohydrate met a b o l i s m  can be defined, the associated 
problems for IDDM mothers clarified, and the circumstances 
which cause some.patients to become diabetic in pregnancy 
(gestational diabetics) 'elucidated.
Metabolic Changes in Normal, Uncom p l i c a t e d  P r e g n a n c y .
Fasting plasma glucose levels decline during pre g n a n c y  
(Bleicher, 0 TSullivan and Frienkelj 1964) whereas there is 
a significant rise in circulating insulin. The glucose 
decline is evident by the tenth week of gestation (Lind, 
Billewicz and Brown, 1973) but the rise in insulin continues 
to a plateau at the 36th week o f  pr e g n a n c y  (Cowett et_ a l . 
1983), so the two cannot be considered in terms of cause and 
effect. The explanation for both observations is the 
influence of the growing conceptus, namely the fetus and the 
p l a c e n t a .
In the non-pregnant condition an individual eats 
intermittently and can be considered at any point in time 
to be in one of two broad categories; the fed or fasted 
state. In the fed state the nutrients are m a x i mally used 
for p r e v a i l i ng.oxidative needs or catabolic repair.
Excesses are stored. These resources can then be used 
for the production of fuel while the fasted condition 
prevails. However, in pregnancy, the fetus functions as 
a continuously feeding boarder within an intermittently  
eating host. Indeed the fetus .has been shown to continue 
growth even in periods of total maternal deprivation 
(Frienkel e t a l .  1970) and p e r s i stently abstracts glucose 
for its needs. This is consistent with the reduced 
maternal glucose levels seen in pregnancy. To do this the 
fetus must modify the maternal response to food deprivation 
and this influence must increase as gestation progresses.
After a brief overnight fast, a pregnant woman will demonstrate 
raised plasma ketones and free fatty acids which are 
characteristic of prolonged starvation in the n o n - p r e g n a n t  
state. This tendency has been labelled "accelerated  
starvation" (Frienkel, 1965) and is thought to be n e e d e d  to 
"spare" circulating maternal glucose for the demands of the 
fetus. Glucose utilisation is 2 to 3 times greater in the 
fetus than the glucose turnover rate in adults (Page, 1969).
Insulin levels have been shown to increase during 
pregnancy (Cowett e_t jal. 1983) yet tissue resistance to 
insulin increases. The main protagonist of this effect is
human placental lactogen (HPL), which is a polypeptide
hormone produced by the placenta. This has been shown
to induce insulin resistance jlii vitro (Beck and Daughaday
1967) and to exert direct lipolytic effects (Turtle and
Kipnis, 1967). However as some pregnancies have p r o g ressed
successfully despite very low levels of;HPL the exact role
of HPL p e r t aining to the maintenance of normal pregnancy
is not clear. Other hormones of pregnancy, progesterone and
oestrogen cause e xaggerated insulin response to stimuli.
A d m i n istration of progesterone to non- p r e g n a n t  individuals
has been shown to enhance their basal and stimulated levels
of insulin secretion (Kalkhoff, Jacobson and Lemper, 1970).
Oestrogens are thought to cause p a n c reatic islet cell
hyperplasia (Redman and Hockaday, 1983). Hence the combined -
effects of all of these, hormones is to increase circulating
insulin whilst reducing its efficacy, and their c o n c e ntration
and effect is in direct proportion to the growing p l a c e n t a l
mass. The overall effect is to produce heightened o x i d ation .
of fat and changes in g l u c o n e o g e n e s i s * This is well
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i llustrated by Cowett et al. (1983) who used D - (U- C) 
glucose in constant infusion studies to investigate the 
glucose turnover rate in pregnancy. They were able to show 
that when f a s t e d 7both n o n - d iabetic and diabetic subjects 
accelerated their glucose turnover rate in p r e g nancy to 
provide for the increased maternal and fetoplacental m e t a b o l i c  
requirements.
Nutrients are t ransferred from the mother to the 
growing fetus, although some are used to maintain the 
placenta. Glucose crosses the placenta by a system of 
facilitated diffusion (Holmberg ejt _al. 1956), and changes 
in fetal blood glucose lag about ten minutes behind 
maternal changes (Redman and H o c k a d a y , 1983). The transfer 
system becomes saturated when maternal levels reach about 
15mmol/l. To maintain this diffusion system the fetal 
glucose has to be lower than maternal levels, and part of 
this gradient is accounted for by the use of glucose by 
the placenta. Amino acids are t ransferred by an active 
process, lipids are t ransferred as free fatty acids, and 
ketones diffuse freely to the fetus. However, neither 
maternal nor fetal insulin crosses the placenta, so the 
two can be considered as separate compartments. As fetal 
insulin response is relatively sluggish to plasma glucose 
the main determinant of fetal glucose at all stages of 
pregnancy is circulating maternal glucose. Fetal insulin 
does have a key role in promoting intra-uterine growth, 
therefore maternal h y perglycaemia causes fetal h y p e r g l y c a e m i a  
with fetal islet cell hyperplasia and h y p e r i n s u l i n a e m i a , 
resulting in excessive fetal growth. There is a whole 
multitude of problems associated with m a t e r n a l  hy p e r g l y c a e m i a  
affecting fetal development and neonatal life. These are 
discussed at length later in this chapter.
Diabetes in P r e g n a n c y .
(1) Gestational diabetes .
The definition of diabetes, even in the non-pregnant 
state is controversial and in the pregnant state is far from 
clear-cut. In pregnancy circulating insulin levels increase 
and this puts extra demands on the J3~cells of the 
pancreas. Any potential inability of these cells to meet the 
additional requirements for insulin will be unmasked in these 
circumstances. For this reason diabetes may be d i a g nosed for 
the first time in pregnancy. If it remits afterwards then 
it can be correctly termed "gestational diabetes". If it 
does not, then it is simply a diagnosis made conc u r r e n t l y  with 
pregnancy. Gestational diabetes cannot therefore be dia g n o s e d  
with certainty until a p o s t partum assessment has been made.
Gestational diabetes is a subset of the category 
"chemical diabetes of pregnancy", which is usually defined 
by an abnormal glucose tolerance test. The effect of chemical 
diabetes upon the fetus is to increase the supply of m a n y  
classes of nutrients and to provoke a relative degree of 
hyp e r i n s u l i n i s m  which may cause macrosomia. Management may 
be by dietary control alone or together with insulin 
administration. The main problem with gestational diabetes 
however is that it may go unrecognised and untreated, 
resulting in an u n e x p lained stillbirth or abnormally large 
b a b y .
( 2) Insulin-dependent diabetes in p r e g n a n c y .
Prior to the discovery of insulin in 1921, the
association of diabetes mellitus and pre g n a n c y  was almost
non-existent. With the advent of insulin the lifespan and
fertility of the diabetic patient i n c r e a s e d■ and pregnancy
became feasible, presenting a whole range of problems for
the obstetrician. The management of pregnancy of overt
diabetics as well as the supervision of diabetes unmasked
by pregnancy, now had to be considered. Before the
availability of insulin m a t ernal mor t a l i t y  was about 45%.
This decreased to about 2% with the use of insulin
(Gugliucci et_ aJ.. 1976), but p e r i natal mor t a l i t y  was still
very frequent. Many of the babies died in utero and were
n oticeably larger than average size. This led Peel (1972)
to suggest that these babies were m a t uring earlier, and he
therefore r ecommended pre-term delivery. This, together
with h o s p i t alisation from 32 weeks gestation (P e d e r s e n ,1954)
decreased perinatal mortality to 25% by the mid 1 9 5 0 ’s
(Gugliucci e_t ajL. 1976). Nowadays this figure has d e c reased
to about 10-15% due to advances in m o n i t o r i n g  fetal w e l l b e i n g
and the a vailability of better hospital facilities. Wheeler,
Gollmar and Deeb (1982) in South Carolina, USA. showed 182
perinatal deaths in every 1000 deliveries to IDDM women,
compared to 25 in every 1000 for non-d i a b e t i c  women. This
figure was slightly lower (102/ ) when all forms of
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diabetes in pregnancy were considered. These figures are 
all u n acceptably high, especially as many deaths no longer 
occur in the uterus but shortly after delivery and are not 
included in these results.
(3) Effect of mater n a l  h y perglycaemia on the
growing f e t u s .
There is a wide range of problems for the fetus or 
newborn thought to be associated with poor diabetic control 
in pregnancy. Congenital abnormalities occur far more 
frequently. Kucera (1971) suggested 4.8% of births to 
diabetic women had congenital anomalies compared with 1.6% 
of births to non-d i a b e t i c  women. These results were s u p ported 
by Watkins (1982) who reported the frequency in diabetics to 
be 2 to 3 times higher than in non-diabetics, and n o ted that 
these anomalies accounted for about half of the observed fetal 
deaths. The types of congenital m a l f o r mations observed  
included caudal regression, anencephaly, spina bifida as 
well as various heart defects such as trans p o s i t i o n  of the 
main vessels, and kidney defects like the ureter duplex.
Mills, Baker and Goldman (1979) suggested that the insult 
causing these malformations occurs before the seventh week 
of gestation. It is unlikely that it is insulin itself 
which causes these effects as mater n a l  insulin does not cross 
the placenta and fetal insulin is not p r o duced until about 
the eighth w e e k o f  gestation, after the critical period of 
t e r a t o g e n e s i s . There are two b i o c hemical effects which 
suggest that it is maternal hy p e r g l y c a e m i a  and not other 
causative factors, which is responsible for the high incidence  
of anomalies observed. Hy p e r g l y c a e m i a  induces low 
intracellular ascorbic acid and high plasma d e h y d r o a s c o r b i c • 
acid, both of which inhibit mitosis (Edgar, 1970).
Interference with mitosis at the very early stages of fetal
development would be expected to cause defects. This
association between maternal h y p e r g l y c a e m i a  earl}/ in'
pregnancy and defects, has been shown using glycosylated
haemoglobin for the retrospective assessment of gljrcaemic
control. Miller jet a l , (19 81) used HPLC to measure H b A ^
in .the first trimester of p r e g nancy for 116 1DDM subjects.
Fifteen infants were delivered in this study with m a jor
congenital abnormalities, defined as a bnormality causing
death or severe handicap. Eight i n f a n t s .h a d ' c o n g e n i t a l
heart defects , three of which were fatal, and four infants
had malfo r m a t i o n s  of the brain, three of which were fatal.
When compared to the group delivering normal infants, this
group with congenital anomalies had s ignificantly h i g h e r
HbA results early in pregnancy. Leslie e_t aJL. (1978)
1C
also showed the associat i o n , u s i n g  ion-exchange c h r o m a t o g r a p h y
to measure HbA . Of the five diabetic women in their study 
1
.with high values early in pregnancy, three p r o duced children  
with fatal congenital abnormalities. No abnormalities were, 
detected in children born to diabetic mothers who were well 
controlled early in pregnancy. The implications are that 
good m anagement of diabetes in the crucial first weeks of 
pregnancy can decrease the incidence of congenital malformations, 
and p r e - p r e g n a n c y  councelling is a d v ocated (Pedersen, 1977).
Steel et_ _al. (1982) r e p orted the results of a p r e - p r e g n a n c y  
clinic over a 5 year period and noted that of the 5 births 
of abnormal babies to diabetic women during this time at 
their hospital, M- did not attend the clinic. The fifth birth 
was to a lady who attended the clinic infrequently, and h ad 
persistent hyperglycaemia.
There are various ante-natal complications observed 
more frequently with diabetic women. These include 
polyhydramnios, pre-eclampsia, and infection (Redman and 
Hockaday, 1983); and their incidence can be reduced by 
adequate glycaemic control. These conditions have adverse 
effects on the growing fetus, contributing to the perinatal, 
mortality and compromising the fetus in terms of nourishment 
and oxygen availability. In these circumstances often 
abnormally small infants are born.
A b n o r m a l l y  large infants are thought to result from 
maternal h y p e r g l y c a e m i a  causing fetal h y p e r g l y c a e m i a  and 
h y p e r i n s u l i n a e m i a , with the resultant excessive growth.
Such macrosomic neonates have typically fat round faces 
with sunken eyes, a short neck, and a lot of head hair.
Many are longer than normal as well as being heavier. 
Macrosomia is seen as a consequence of poor diabetic control 
unless a second pathology such as p l a cental ischaemia 
intervenes. Macrosomia may mean that vaginal delivery is 
impossible and many such infants are born by Caesarian 
section, which confers certain disadvantages. Also the 
large size of these babies in utero may hinder the accurate 
assessment of gestational age by ult r a s o u n d  techniques 
(Ogata e_t a l . 19 79).
Sudden intra-uterine deaths are seen more frequently 
in diabetic pregnancy. Typically these occur suddenly 
between 36 and 38 weeks and are a s s o ciated with macrosomia. 
The actual cause of death is not known but it has been 
p o s t ulated (Redman and Hockaday, 1983) that the fetus dies 
from lactic acidosis which results from an influx of
maternal glucose which exceeds the fetal capacity for its
oxidative metabolism. Again the implication is that sudden
fetal death can be reduced by meticulous maternal glycaemic
control. Madsen and Ditzel (1982) also associated poor
m aternal glycaemic control in terms of HbA with reduced
lc
arterial oxygen saturation and reduced oxygen affinity 
.(P.O at 50% oxygen saturation). They p o s t ulated that poor 
glycaemic control may contribute to fetal hypoxia and i n t r a ­
uterine death.
There are several potential causes of death in the 
neonatal period for infants of diabetic mothers. A frequent 
complication in these infants is r espiratory distress 
syndrome (RDS). This syndrome was discussed by Stubbs and 
Stubbs (1978) who suggest that h y p e r i n s u l i n a e m i a  reduces 
glycerol 3-phosphate and dihydroxyacetone phosphate (DHAP) 
production, and this impairs phosp h o l i p i d  synthesis and 
surfactant production in the lung (Fig. 6 .1 ). A decrease 
of surfactant has been- implicated with RDS (Avery, 1973).
RDS is a m a jor cause of neonatal mortality. In addition 
many babies are born to diabetic mothers by caesarian 
section, which itself augments the risks of deve l o p i n g  RDS 
(Redman and Hockaday, 1983). Other problems such as 
jaundice, h y p o c a l c a e m i a , c a r d i o myopathy and p o l y c y t h a e m i a  
have all been seen to increase in diabetic p r e g nancies 
(Wright et a l . 1982). P o lycythaemia seems to result from 
increased erythropoesis in the liver, and causes inc r e a s e d  
blood viscosity and poor p eripheral perfusion. This 
predisposes to multiple organ thrombosis, of which renal 
vein thrombosis is the most important. Neonatal h y p o g l y c a e m i a
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Fig. 6.1 Glycolysis and the possible effects of h y p e r i n s u l i n a e m i a  
on the production of surfactant in the lung.
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is another complication frequently observed. This is thought 
to result from fetal islet cell h y p e r p l a s i a ,.which produces 
excessive fetal insulin in utero to manage the high levels 
of m a t ernal glucose supplied. When, at birth, this glucose 
supply is abruptly t e r m i n a t e d , h y p o g l y c a e m i a  occurs, as the 
neonate is still p r o d ucing insulin in excess. In addition 
these neonates, seem to have impaired mechanisms for 
compensating for this hypoglycaemia; in par t i c u l a r  the 
secretion of catecholamines and glucagon remains i n a p p r o p r i a t e l y  
low, and the infants can not use their increased reserves.
(4) Management of glycaemic control in diabetic
p r e g n a n c y .
The management of p r e gnancy in IDDM women requires 
great care and attention to detail, although in most cases 
the mother is well motivated. The clinician must gra d u a l l y  
alter the insulin dosage to allow for the progressive insulin 
resistance that occurs. Between 16 and 36 weeks gestation  
the insulin given is, in general, i n c reased by 2/3, but for 
some women insulin requirements will increase by two or 
threefold. The dietary requirements of p r e g nancy needs to 
be carefully b a l anced or ketosis and acidosis may r a pidly 
develop, adversly affecting the fetus. Problems due to 
sickness in early pregnancy, or infection in later p r e g n a n c y  
may upset the delicate balance between carbohydrate intake 
and insulin- administration.
The ultimate aim of management of diabetic pr e g n a n c y  
is to improve perinatal survival and prevent both m a t ernal  
and neonatal complications. The evidence supporting the 
need for good diabetic control is strong, but metabolic  
control is only one factor in the whole spectrum of clinical 
management of the pregnancy. H o w ever as control is 
important, its assessment in b iochemical terms aids the 
obstetrician in his supervision of a successful pregnancy. 
Because of the p hysiological glycosuria that occurs in normal 
pregnancy the usefulness of routine urine checks for glucose 
is limited ( 0 TS h a u n e s s y , Russ and Zuspan, 1979). Frequent 
blood glucose measurements are used instead,but as blood 
glucose fluctuates from hour to hour hyper g l y c a e m r a  may 
easily be missed. For this reason the cumulative assessment 
of glycaemia by g lycosylated h a e m oglobin was i n v e s t i g a t e d  by 
many workers. Also in gestational diabetes, by definition, 
glucose tolerance returns to normal after delivery and so it 
is not possible to confirm the diagnosis r e t r o s p e c t i v e l y  by 
the more t r a d i tional methods for evaluating carbohydrate 
metabolism. G l y c o sylated haem o g l o b i n  measurement, by its 
nature, may provide retrospective information and m ay help 
in the under s t a n d i n g  of, for example, sudden stillbirths or 
the birth of large babies.
Glyco s y l a t e d  haemoglobin measurement in p r e g n a n c y .
There have been many studies on the measurement of
HbA or HbA during pregnancy, most workers using i o n-exchange 
1 1c
chromatography. For these values to be useful to the 
obstetrician, normal ranges in p r e g nancy are essential, 
because the p h y s i ological and b iochemical changes seen in 
pregnancy may affect the usual m e c h a n i s m  of g lycosylation  
and result in different values. However, there has been a 
good deal of discrepancy in the pub l i s h e d  ranges. Some 
workers have reported no significant change between n o n ­
pregnant and pregnant n o n - d iabetic individuals (Kjaegaard 
and Ditzel, 1979, Ylinen, Helaki and Teramo, 1981, Fadel 
ejt al_. 1979 ), whereas others have noted both higher 
(Vintzileos and T h o m p s o n 1980, Davies and Welborn, 1980) 
and lower ranges (O'Shaunessy, Russ and Zuspan, 1979,
McFarland _et ad.. 1981, Lind and C h e y n e , 1979). Schwartz 
et a l . (1976) used Amberiite IRC-50 resin and showed that
HbA levels were elevated slightly in normal p r e g n a n c y 
lc
(from 5.74- 0.42% to 6.97^ 0.69%). However in a later 
publ i c a t i o n  ( S c hwartz, Widness and Schwartz, 1981) they 
refute their earlier evidence. Lind and Cheyne (1979) found 
a progressive decrease in percentage glycosylation to about 
2 0 weeks gestation from when this lower value was maintained.
As fasting blood glucose concentrations fall by about 0 . 3 m m o l / l  
at 10 weeks gestation (Lind, Billewicz and Brown, 1973) these 
observations would be consistent with new erythrocytes b e i n g
exposed to lower t i m e - a v e r a g e d  glucose levels. Also red
cell volume increases p r o g r essively throughout pregnancy due
to increased fluid volume and iron stimulation (Taylor and
Lind, 19 76). This dilutional effect, due to increased
numbers of young erythrocytes would be expected to reduce
the overall percentage glycosylation. Recently Phelps
et a l . (1983) used ion-exchange c h r o m a tography to study
377 non-diabetic p regnancies and suggested that the changes
in HbA. during p r e g n a n c y  were biphasic, r e a ching a m i n i m u m  
lc
value at about 24 weeks gestation and rising again towards 
term. They indicated that this reflects (with the 
appropriate displacement in time) the bi p h a s i c  alterations 
of mean blood sugar concentrations that occur in normal 
pregnancy due to sequential changes in g l u c o r e g u l a t i o n .
Most workers are now in agreement that in IDDM, p r e g n a n c y  
is accompanied by r e d uced g lycosylated h a e m o g l o b i n  values, 
but that these ranges are still higher than observed for 
non-diabetic pregnancies. However, the a ssociation of high 
glycosylated h a e m o g l o b i n  values and m a c r o s o m i a  is in dispute. 
No retrospective correlation between the two using either 
maternal or cord samples could be shown by workers using 
ion-exchange chromatography ( O ’Shaunessy, Russ and Zuspan,
1979 , Brans jet ajL» 1982 , Fadel £jt aJL. 1981), isoelectric 
f ocussin.g( Poon \ Turner and Gillmer, 1981) or the 
t h iobarbituric acid colorimetric technique (Sosenko _et. a l .. 
1982, Worth et a l . 1983). In contrast, other studies have
shown the association. Widness ert al.. (1978) using
cation-exchange c h romatography presented data on 12
diabetic women without vascular disease, and found a strong
correlation between infant birth weight and HbA in the
lc
third trimester (p <^0.05). This correlation improved still 
further when adjustment was made for gestational age 
(p 0.01). Burke _et al.. (1981) used the Fluckiger 
c olorimetric technique to measure g lycosylated haemoglobin 
in the third trimester and found it had some predictive 
capability; detecting 4 out of the 6 m a c r o s o m i c  babies in 
their study. Vintzileos and Thompson (1980) also showed the 
relationship between birth weight and HbA^ and noted the 
additional association between the latter and p l a c ental 
weight. .Mansani et al. (1982) found an association b e t ween 
HbA^ with both ma t e r n a l  weight gain and the size of the 
infants as assessed by their thoracic circumference. R e c ently 
Feldman et_ aJL. (1981!) have used affinity c h r o m a t o g r a p h y  to 
measure g lycosylated haem o g l o b i n  in cord samples. They 
showed that the birth weight ratios (c alculated by dividing  
the birth weight by the 50th percentile weight) were m a r k e d l y  
i ncreased in the cord bloods of the 15 diabetic mothers 
s t u d i e d ,  and eleven of the infants born were above the 90th 
percentile for weight.
Several workers (Steel ejt \al. 1981, Poliak _et aJ^. 1981, 
Coen _et a_l. 1980) have used the m e a s u rement of g l y c o s y l a t e d  
haem o g l o b i n  to investigate ret r o s p e c t i v e l y  the cause for 
babies b e ing born who are la r g e - f o r - g e s t a t i o n a l - a g e  (LGA),
as this tests for abnormal carbohydrate tolerance in 
pregnancy. A s . 1-2% of pregnant woman develop gestational 
diabetes, with the associated risks of neonatal morbidity, 
their i d entification is important for any future 
pregnancies (Shah ejt _al. 19 82). Steel al. (1981) used 
ion-exchange c h r o m a tography to study 50 mothers who had 
produced large babies and 50 who had not. They demon s t r a t e d  
raised hbA^ levels immediately after delivery in 9 of the 
mothers with LGA babies and in only one m o t h e r  with a 
norma l - s i z e d  child. All patients studied had a normal OGTT 
and HbA^ value 6 weeks after delivery. Poliak et al. (1981) 
showed that samples from a group of 50 mothers with LGA 
babies pro d u c e d  s i g n i ficantly higher TBA colour (measured 
in haemoglobin) than in a c orresponding control group.
Coen e_t _al. (1980) found that when the 19 women in their 
study who produced LGA babies were c onsidered as a group, 
their mean g l y c o sylated h aemoglobin value did not vary 
significantly from a group with normal births, however 3 
of the women with LGA offspring had very elevated levels 
of glycosylated haemoglobin.
Many of these discrepancies in results and conclusions 
may be attributable to the methodology, in p articular the 
ion-exchange techniques where minor adult h a e m oglobins have 
been difficult to distinguish from the fetal h aemoglobins/ 
due to coelution. This of course may prove significant 
when i nvestigating ma t e r n a l  and cord b l ood samples. The 
importance of HbF is stressed d ifferently by different 
workers, depending on the actual samples being analysed.
However, although the major problem occurs when m e a s urement 
of glycosylated mat e r i a l  in cord blood is considered, HbF 
levels of 2-3% have.been shown which might have serious 
interference effects on maternal samples when g l y c o sylated 
haemoglobin values of about 6 to 8 % are being .c o n s i d e r e d . 
Svendsen and Sgfegaard (1982) suggest that as most patients 
have HbF values below 1% this p r o blem is of minor importance. 
However, Krause, Stoic and Campbell (1982) stated that the 
relationship between HbF and HbA^ in ion-exchange c h r o m a t o ­
graphy was not a simple one and followed the r e lationship 
as expressed by the equation y= 6.03 + 1.24x. Furthermore, 
they found that 1.5% of the samples with elevated HbA^ levels 
had high ( )> 2.%) HbF levels. Schwartz, Widness and Schwartz 
(1980A.) c ircumvented the coelution problems by u t i lising  
isoelectric focussing and ion-exchange c h romatography using 
DEAE cellulose, which allowed for the separation of the 
minor haemoglobins in cord blood, in the presence of HbF.
However they were unable to demonstrate any d ifference in 
either acetylation or g l y c o sylation in the cords of diabetics  
or non-diabetics. HbF can be acetylated as well as g l y c o s y l a t e d  
(Abraham _et al-. ■ 1979 ) and many methods are unable to 
distinguish between these two types of changes to the 
haemoglobin molecule, and report a combined result. Only 
methods such as the TBA c o l o rimetric technique or i s o e l e c t r i c  
focussing with suitable spacers (Fitzgerald and Cauchi,1980) 
can distinguish between them.
,The ratio of the percentages of glycosylated 
haemoglobin in maternal and cord samples has been calculated, 
by several workers. Caangary, Curran and Malone (1979) used 
the t h i o b arbituric acid method to measure this.ratio. They 
assessed m a t e r n a l  samples to be 1.3 times higher than their 
corresponding cord samples at non-d i a b e t i c  deliveries, 
whereas a higher ratio of 1 . 6  was recorded for diabetics.
Zeller et al. (1983), again using the colorimetric technique 
found that the cord samples for both diabetics and n o n ­
diabetics r e p r esented levels only 60% of the corresponding 
maternal values. Similarly Worth ejt ajL . (19 8 3 ) used this 
method and found a lower percentage of g l y c o sylated 
h aemoglobin in cord samples. Fitzgerald and Cauchi (1980) 
using isoelectric focussing demonstrated that there was no 
difference in the i_n vitro glycosylation rate between fetal 
and adult blood. However there may be many factors which 
account for the lower percentage glycos y l a t i o n  of fetal 
blood observed. Fetal red cell survival is known to be 
slightly decreased (Bratteby e_t al. 1968), which would decrease 
the duration of haem o g l o b i n  exposure to glucose. Also the 
lower plasma glucose concentration in the fetus when 
compared to the mother, would similarly affect the result. 
(Crawford, 1965). As about 15-20% of fetal h a e m o g l o b i n  is 
acetylated at the N-terminal amino group of the Y  chain, 
this blocks the glycosylation site (Schwartz _et aJL. 1980, 
Garlick et_ _al. 1981). Decreased fetal red cell membrane 
perm e a b i l i t y  to glucose could be another c o n t r ibuting f a ctor 
(Widdas 1971).
The aim of the work in this chapter is to use the 
affinity technique to measure glycosylated haemoglobins 
and glycosylated plasma proteins both throughout pregnancy^ 
and at delivery in mater n a l  and cord s a m p l e s . Both 
diabetic and n o n - d iabetic pregnancies will be considered.
The predictive capability of these tests regarding the 
outcome of the pregnancy can be assessed. The role of the 
measurement of g lycosylated plasma proteins in the monitorin 
of diabetic pr e g n a n c y  has never previously been evaluated.
MATERIALS AND METHODS.
Sub jects .
Patients were enrolled for this study from March 1982 
to September 1983. All.patients gave their informed consent 
to this investigation. Non-diabetic women had no family 
history of diabetes and were free from glycosuria during 
pregnancy. All mothers received routine ante-natal care, 
although diabetic mothers were seen weekly in the last 
t r i m e s t e r .
Cl) N o n - d i a b e t i c s .
1 1 0  non-diabetic women were studied at one time- 
point during their pregnancy. 18 had samples taken in the 
first trimester, 37 in the second trimester and 55 in the 
third trimester. The gestational age of the fetus was 
estimated by the mothers menstrual history, clinical 
examination, and ultrasound techniques. Each patient was 
tested for the poss i b i l i t y  of anaemia, by routine h a e m a t o l o g i c a l  
tests'.
Fifty live births to n o n - d i a b e t i c  women were m o n i t o r e d  
19 of the mothers were p r i m i g r a v i d a e . Most of the births were 
normal vaginal deliveries, but there were 4 forceps d eliveries  
and 3 by Caesarian section. No transfusions were given at any 
of the births. Again the gestational age of each fetus was 
based on the mothers m e n strual history, clinical and u l t r a s o u n d  
examinations. All of the births were within 2.5 weeks of the 
pre d i c t e d  date of delivery. The mean age of the mothers was 
28 years (range 19 to 42 years). D e l ivery details, a n t e p a r t u m
complications, placental and birth weights were all noted.
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(2) D i a b e t i c s .
48 diabetics were studied at some time-point 
during their p r e g n a n c y ,many having ante-natal samples 
taken at monthly intervals over several months and more 
frequently towards term. Of these, only 35 had additional 
m a t ernal and cord samples taken at birth; 1 2 were 
p r i m i g r a v i d a e . A further 13 diabetics were studied only 
at delivery.
For the major part of this study only the 35 
diabetics with both full pre-term and delivery assessment 
and full clinical details will be considered. This was a 
t w o - center study with 19 patients being treated at the Royal 
Sussex County Hospital in Brighton, and the remaining 16 at 
Kings College Hospital in London. The group included 28 
diabetics who were e s t a b lished on insulin before pregnancy, 
one diagnosed before p r e gnancy but m a i n t a i n e d  on diet alone, 
and 6 who were gestational diabetics. The diagnosis of 
gestational diabetes was confirmed by the standard criteria 
for oral glucose tolerance tests in pregnancy ( O ’Sullivan and 
Mahan, 1964). The average maternal age of these patients was 
27 years and 8 months (range 21 to 36 years).
Four samples were taken from insu l i n - d e p e n d e n t  
diabetics whose pregnancies had resulted in intra-uterine  
death. The samples were taken at the time, or very shortly 
after the miscarriage.
S t a t i s t i c s .
Statistical comparisons of either pairs or means were 
performed by Students t-test.
S a m p l e s .
Samples of venous blood were taken in pregnancy, w h e t h e r 
diabetic or non-diabetic, usually at routine a n t e -natal visits. 
One part of the b l ood was put into a standard lithium heparin 
tube for glyco s y l a t e d  h a e m o g l o b i n  and glycosylated plasma 
protein a n a l y s i s . The remainder of the blood was p r e s e r v e d  
in a tube containing fluoride oxalate for the m e a s u rement of 
glucose. Non- d i a b e t i c  patients also had blood taken and 
preserved in sodium EDTA for routine haematology.
M a t ernal and cord samples were taken from both n o n - d i a b e t i c  
and diabetic mothers i mmediately after birth, and t r e a t e d  in 
an identical manner. In two instances the cord sample was not 
available, one due to an unexpected still-birth and the other 
when the cord snapped during delivery. In one diabetic patient 
the m a t ernal and cord samples were not taken at delivery, but 
a sample was taken from the mother and infant on the fol l o w i n g 
day.
As this was a two center study, samples from K i n g s 1 College 
Hospital were sent in vacutainer tubes containing l i t hium 
heparin, by first class post for analysis the next day. Any
samples which were h a e m o l y s e d  were excluded from the study.
M e t h o d s .
(1) Glyco s y l a t e d  haemoglobins and glycosylated 
plasma p r o t e i n s .
Measurement of both g l y c o s y l a t e d  h aemoglobins and
g lycosylated plasma proteins were done in accordance with the
techniques outlined in Chapter 2. Labile mater i a l  was r e m o v e d
o
by incubating the sample at 37 C for 5 hours. The stable
o . .
sample was then stored at 4 C until analysis, in most cases
upto a ma x i m u m  of 48 hours. The pH of the buffers used for 
the c h romatography was 8.3 and 8.9 respectively. Three 
different batches of gel were used in the study, and w h e n  a 
new batch of gel was to be used, it was first run in t a n d e m  
with the old batch of gel to ensure that the results o b t a i n e d  
were not signif i c a n t l y  different. By the middle of the study 
quality control was introduced, as outlined in Chapter 2.
(2) Blood g l u c o s e .
Whole blood glucose was m e a s u r e d  using the
Yellow Springs Glucose Analyser Model 23AM (Yellow Springs
Instruments, Yellow Springs, Ohio, USA). This was u s u a l l y
carried out within 30 minutes of sampling, but when this was
o
not possible the sample was stored at 4 C.
r e s u l t s .
Alterations of G l ycosylation of Haemoglobins and Plasma 
Proteins with, the Progress of P r e g n a n c y *
Table 6.1 shows the mean values (-SD) of glycosylated
haemoglobins, g l y c o sylated plasma proteins, and whole blood
glucose for the various, non-diabetic patients studied during
the different trimesters of pregnancy. The trimesters were
defined as three sequential groups, each of 13 weeks, and
the gestational age of the fetus d etermined which trimester,
or group, that a result was considered in. There was a
significant decline in glycosylated haemoglobins from
7.31 - 0.90% for non-pregnant, non-diabetics, to 6.50 - 1.06%
"f"
(p <( 0.001) at the third trimester (Table 6.1) and 6.49 - 1 . 2 2
(p 0.001) for the non-diabetics at term (Table 6.3). Table
6 . 1  well illustrates how the values of both g l y c o sylated
haemoglobins and g lycosylated plasma proteins decrease with
the progress of pregnancy. G lycosylated plas m a  proteins also
decrease s ignificantly (p 0.02) from 6.29 - 1.90% for non-
+
pregnant, n o n - d i a b e t i c s , to 5.61 - 0.93% for n o n - d iabetic
patients at term (Table 6.3), although this decrease was not
significant by the third trimester when values of 5.79 - 0.95%
were obtained. Blood glucose concentrations were s i g n i f i c a n t l y
lower (p X  0.001) at every stage of p r e g nancy (Table 6.1) and
at birth (Table 6.3) when compared to the n o n - p regnant condition.
However, during the progress of pre g n a n c y  the levels rose
s ignificantly (p <  0.001) from 3.48 - 0.43% in the first
+
trimester to 4.11 - 0.62% in the third.
o\
°
Table 6.2 shows the mean values (- SD) of g l ycosylated 
haemoglobins, glycosylated plasma proteins and whole blood 
glucose, for the various diabetic patients studied in the 
different trimesters of pregnancy, again defined as 13 week 
periods. When a diabetic moth e r  had more than one result 
for any of these measurements in a particular trimester, the 
mean value for the trimester was calculated and considered  
as the result for that trimester in this, and later studies.
The diabetics considered in this investigation included the 
35 with a complete set of clinical details, and a further 13 
who only had samples taken during pregnancy, most of whom 
had not delivered before the end of this study. Thirteen 
diabetics were also studied who only had results at delivery. 
Again there was a significant decline (p < 0 . 0 0 1 )  observed 
during pregnancy, from values of glycosylated h aemoglobins  
and g l y c o sylated plasma proteins in n on-pregnant diabetics 
of 12.70 i 2.88% and 12.62 - 3.36% to 9.43 - 2 . 2 5 %  and 8.15 ± 
2.09% in the third trimester (Table 6.2), and 9.67 - 2.57% 
and 7.67 - 1.85% (Table 6.3) at term in these patients.
Table 6.2 shows that both glycosylated h aemoglobins and 
glycosylated plasma proteins decline with the progress of 
pregnancy. For the diabetics in this study the glucose values 
were s i gnificantly lower throughout pre g n a n c y  when co m p a r e d  to 
the ranges observed for the non-pregnant diabetics (Chapter 2). 
However, although glucose values at the third trimester  
(6.13 - 2.28%) were higher than in the first (5.61 - 2.51%) 
(Table 6.2), this rise was not significant.
The results obtained for the diabetics in this study 
were compared.to the non-d i a b e t i c  values in the different 
trimesters. The diabetic patients had significantly higher 
(p >( 0 .0 0 1 ) values for g l y c osylated haemoglobins, g l y c o s y l a t e d  
plasma proteins and glucose at every instance.
Relationship Between Maternal and Cord .Samples.
Table 6.3 shows that g l y c osylated haemoglobins in 
maternal and cord blood were significantly higher (p <  0 .0 0 1 ) 
at diabetic births in this study. The same was true for 
glycosylated plasma proteins in these samples (p <  0 . 0 0 1  for 
maternal blood, p <  0 . 0 1  for cord b l o o d ), but no significant 
difference could be shown for blood glucose, possibly due to 
the wide range of values obtained (Table 6.3).
There was a positive correlation between maternal and 
cord samples for both glycosylated haemoglobins (r = 0.614) 
and g lycosylated plasma proteins (r = 0.424) at deliveries 
to n o n - d iabetic patients. For n o n - d i a b e t i c  deliveries 
g lycosylated haemoglobin values were greater than g l y c o s y l a t e d  
plasma protein values (p <  0 .0 0 1 ) in maternal blood, and 
significantly lower (p <  0.001) in cord blood, (Table 6.3), 
as assessed using the paired t-test. Only 10 out of the 50 
patients studied had lower g l y c o sylated haemoglobins than 
g lycosylated plasma proteins in maternal blood, and only 6 
of the 50 had higher values in cord blood.
Table .6.1 Values for glycosylated h a emoglobins, g l y c o sylated  
plasma proteins and glucose before, and during 
n o n-diabetic p r e g n a n c y .
% G l y c o sylated % G l y c o sylated Whole blood
haemoglobins plasma proteins glucose (mmol/L)
Non'-pregnant 7.31 i 0.90 6.29
+
- 1.9 0 6.49 - 0.51
(n = 62) (n = 58) (n = 13)
1 st trimester 7 .01 - 1.17 5.93 i 0.67 3 .48 i 0.43
(n = 18) NS 
• +
(n = 18) NS (n = 1 8 ) **** 
t
2 nd trimester 6 . 25 - 1.14 5.84 - 0.7 6 3.94 - 0.78
(n = 3 7 ) **** (n = 37) NS (n = 3 7 ) ****
3rd trimester 6.50 - 1.06 5.79 i 0.95 4.11 i 0 . 6  2
(n = 5 5 ) **** (n = 55 ) NS (n = 55) ****
All results are expressed as mean - SD; the results for each 
trimester and the non-pregnant results are compared.
no significant difference 
significant difference at p = 0 . 0 0 1
K e y :
NS
Table 6.2 Values for g l ycosylated h a e m o g l o b i n s ,
glycosylated plasma proteins and glucose.
before, and during diabetic pregnancy
> G lycosylated % G l y c osylated Whole blood
haemoglobins plasma proteins glucose (mmol/L)
Non-pregnant 
diabet ics
12. 70 - 2.88 
(n = 138)
12.6 2 - 3.36 
(n = 15 3)
9.24 
(n =
t 4. 
143)
1 st trimester 10.57 - 2.43
+
9 . 59 - 2.91 5 . 61 
(n =
+
- 2 .
2 0 )(n = 2 8 ) «««« (n = 26)
2nd trimester 9.58 t 1.71 
(n = 3 8 )  ****
8.65 - 1.79 
(n = 3 7 )  ****
6 .14 
(n =
- 2 .
.3 5 )
3rd trimester 9.43 - 2.25 
(n = 46)
8.15 - 2.09 
; (n = 43) ****
6 .13 
(n =
i 2 .
35)
All results are expressed as mean - SD; the results for each 
t rimester and the n on-pregnant results are compared.
K e y :
*'*&* significant difference at p = 0 . 0 0 1
Table 6.3 Values for glycosylated h a e m o g l o b i n s ,
glycosylated plasma proteins and glucose
in maternal and cord blood of n on-diabetic  
and diabetic mothers at d e l i v e r y .
N o n-diabetic Births Diabetic Births
maternal cord m a t ernal cord
+ + + +
GHb 6.49-1.22 3.85-1.01 9.67-2.5 7**** 5.03-1.63**
(%) n= 5 0 . n= 50 n = 48 n = 46
(3.33-9.13) (1.94-7.18) (5.72-16.65) (2.85-9.21)
+ + + ' +
GPP 5.61-0.93 4.75-0.62 7.67-1.85**** 5.54-1.72***
(%) n = 5 0 n= 5 0 n = 47 n = 38
( 3 .47-7 .79 ) ( 3 .25-6.08) ( 3 . 78-14.91) (2 .81-12 .99 )
Blood . 4.53-0.99 3.59-0.82 8.00±5.17NS 4 , 4 2 - 2 . 89NS
glucose. n = 5 0 n = 5 0 n = 18 n = 18
( m m o l / l ) 2 .4-8.7) (1 . 4 - 5 . 6 ) (2.0-24.7) (1.1-11.3)
+
Results are expressed as mean - SD; observed range in 
parentheses. ‘
Results for non-diabetic births and diabetic births are 
compared.
is glycosylated haemoglobins 
is glycosylated plasma proteins 
no significant difference 
significant difference at p = 0 . 0 1  
significant difference at p = 0 . 0 0 1
GHb
GPP
NS
For the diabetics studied, there was also a significant 
positive correlation between maternal and cord samples, for 
both glycosylated haemoglobins (n = 46, r = 0.641) and 
glycosylated plasma proteins (n = 37, r = 0.771) (Figs. 6.2A 
and B). These results include the 35 diabetic patients with 
full clinical details, and a further 13 births to diabetic 
patients who had only blood taken at, and not prior to, 
delivery. This was because either they were delivered very 
early in the study, or were treated elsewhere during pr e g n a n c y  
and only sent to the Royal Sussex County Hospital or 
K i n g s T College Hospital for delivery. Again for these deliveries 
to diabetic patients glycosylated h aemoglobin values were 
s ignificantly greater than those for g lycosylated plasma proteins 
( p X  .0 0 1 ) in maternal blood, but not s i g n i ficantly lower 
(p ) .05) in cord blood (Table 6.3), as assessed by the p a i r e d
t-test. Only 6 out of the 48 patients studied had lower 
glycosylated haemoglobins than g l y c osylated plasma proteins in 
maternal blood, and only 8 of the 48 had higher values in cord 
b l o o d . .
Prediction of Macrosomia Using Glyc o s y l a t e d  Haemoglobins and 
Glycosylated Plasma P r o t e i n s .
The mean birth weight (- SD) for infants of n o n - d i a b e t i c
pregnancies was 3.317 kg - 0.518 kg, whereas that of the
+
diabetic pregnancies was 3.522 kg - 0.713 kg. In the n o n ­
diabetic group there was 23 male and 27 female offspring, and 
in the diabetic group there were 19 male and 16 female infants
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delivered. Only the 35 diabetic patients who were studied 
both during pre g n a n c y  and at delivery were considered. The 
observed range of infant birthweight for the n o n - diabetic 
deliveries was 2.280 kg to 4.360 kg (this baby arrived 2 
weeks late), whereas for the deliveries to the diabetic 
mothers the range was 2.211 kg to 5.180 kg, and none of these 
mothers exceeded their date of delivery.
The mean placental weights (- SD) for the n o n - d iabetic  
pregnancies was 6 6 1 . 33g - 1 4 6 . 84g, and for the diabetic 
pregnancies was 624.17g - 1 8 4 . 60g. The placental weight was 
not recorded at 5 non-d i a b e t i c  births and at 1 1  diabetic 
births .
An infant was considered to be m a c r osomic when their 
birth weight exceeded the 90th centile. (Brans et al. 1982). 
This was determined using the figures from Thompson, Billewicz,. 
and Hytten (1968), who assessed the distribution of fetal 
weight in terms of centiles, where 90% of norm a l  infants have 
a birth weight below the; 90th centile. Their figures also 
allow for the effect of sex of the infant and parity (Figs.
6 .3A and B) on the birth weight. The infants of each of the 
35 diabetic patients considered in this study had their b i rth 
weights interpreted as a centile value using these graphs and 
15 infants were defined as macrosomic (5 males, 10 females). 
These values were then plotted against the g l y c o sylated  
h aemoglobin or g l y c o sylated plasma protein result in the t h i r d  
trimester or in the maternal and cord samples, p r o v i d i n g  6 
centile graphs (Figs. 6.4, 6.5, 6 .6 , 6.7, 6 .8 , 6.9). In this
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way the association between m a c r osomia and these values could 
be assessed.
Fig. 6.4 shows the relationship between the birth weight, 
expressed as a percentile value, and the corresponding 
maternal g l y c o sylated haemoglobin value in the third trimester. 
Of the 35 patients, 15 had infants which had birth weight in 
excess of the ninetieth centile as defined by Thompson, 
Billewicz and Hytten (1968); of these 14 had values for. 
glycosylated haemoglobins in the third t r i mester above the 
normal r a n g e , as defined by the previous studies of non-diabeti< 
pregnancies. Of the remaining 20 diabetics studied, 11 had 
values within this normal range, 8 above and one patient had 
no sample taken at this time. Of these 8 patients, 2 (patients 
D and B) had abnormally small babies with birth weights below 
the tenth percentile v a l u e . This was suggestive of a s e c o n d a r y 
pathology superceeding that of m a c r o s o m i a  yet still po s s i b l y  
linked to diabetes mellitus and reflected in the high 
g lycosylated h a e m o globin values. Indeed patient B has very 
high results throughout the whole period studied, and this 
child had to be delivered by an e m e r gency Caesarian section.
Of the remaining 6 results which w e r e ,falsely positive both 
patients T and V have birth weights very close to the n i n e t i e t h  
percentile, and Patient K had a baby whose weight was only just 
above the eightieth percentile line, yet this infant c l e a r l y  
had the features of a m acrosomic child. It was e x c e s s i v e l y  
fat.with a short neck and a lot of h ead hair. The parents 
of this child were both short, under 5 ft tall, p o s s i b l y
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explaining this result. Fig. 6.5 shows the relationship 
between birth weight, expressed as a percentile value, and 
the corresponding maternal g lycosylated plasma protein value 
in the third trimester. Of the 15 macrosomic babies 11 had 
glycosylated plasma protein results above the normal range, 
one in the normal range and 3 patients did not have results 
for this period. Of the remaining 20 non-ma c r o s o m i c  neonates 
10 had values within the normal range, 1 b e low and 9 above.
Again patients B , D and K were included in this group of false 
positives. Patients V and S had birth weights only just below 
the ninetieth percentile line.
Fig. 6 . 6  shows the relationship between birth weight, 
expressed as a percentile value, and the corresponding 
maternal g l ycosylated haemoglobin result at delivery. Of. the 
15 m a c r osomic infants, 13 had glycosylated haemoglobin results 
above the normal range. Patients Y and R have m a c r osomic 
infants yet have results within the normal range. Of the 20 
infants which were not macrosomic, 14 were within the normal 
range and 6 had g l y c o sylated haemoglobin values above the 
normal range; these include patients B and K. Again patients 
S and V had birth weights very close to the ninetieth centile. 
Similarly, Fig. 6.7 shows the relationship between birth weight, 
expressed as a percentile value, and the corresponding m a t e r n a l  
g lycosylated plasma protein result at delivery. This time the 
discrimination between the non-macrosomic and m a c r osomic groups 
is not as clear-cut with 6 of the m a c r osomic infants h a v i n g
r lO
•
<
•  •
4  4
Eh
4
«■ CQ
4
-
M“ ” ¥ .................." I " " -------------
• •
4
s
•
>H
•
•
\  «
4
4
<
4  •
4
•  V
4
,
O O o
O) lO, f
seiliueo »M6!®M MlJia
N
io
rm
al
 
R
an
gb
! 
! 
(± 
2 
S 
D 
) 
!
values within the normal range (patients Y, A, L, N, G and Z) 
and 6 of the non-ma c r o s o m i c  patients having values above this 
range (patients T, S , V, K 9 W and B). In this latter group 
again patients S, V, B and K are included.
Fig. 6 . 8  shows the relationship between birth weight,
expressed as a percentile value, and the corresponding
g lycosylated haemoglobin result in cord blood. In this 
instance discrimination between the m a c r osomic and non- 
macrosomic individuals in terms of percentage glycosylation 
is very poor. Only 6 of the macrosomic infants have values 
which are above the normal range and 9 have values w i thin it
(patients Y, A, L, E, R, P, J, N and Z). One patient (N) has
a result right at the top of the normal range. Similarly 3 
of the n o n - m a crosomic group have high values (T, K and B), 
although again these include patients K and B. One result 
was not available. When birth weight is similarly assessed  
in terms of the glycosylated plasma protein result from cord 
blood (Fig. 6.9), again there is very poor discrimination.
Of the macrosomic group, 2 have results above the normal 
range, 4 have no result due to obstetric problems or h a e m o l y s i s  
of the sample, and the remainder have values within the n o r m a l  
range. Six of the non-ma c r o s o m i c  group have values which 
exceed the normal range, although these again include p a t i e n t s  
B, D and K. Patients V and T have birthweights very close to 
the ninetieth centile line. There was no result for one 
patient in this latter group.
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The actual birth weight of each infant was divided by 
the appropriate 50th centile value for the corresponding 
week of gestation, as calculated from the intra-uterine 
growth graphs (Figs. 6 .3A and B) to provide a birth weight 
ratio. These birth weight ratios were plotted against the 
glycosylated h aemoglobin or glycosylated plasma protein 
values for the third trimester, or in the maternal and cord 
samples. Fig. 6.10 shows as an example, the graph of 
glycosylated haemoglobin in the third trimester, to illustrate 
the association between this and birth weight ratio. The 
remaining results are not p l o tted individually, but summ a r i s e d  
in Table 6.4-. There was a positive correlation between these 
birth weight ratios and the appropriate maternal and third 
trimester values of g lycosylated haemoglobins and g l y c o s y l a t e d  
plasma proteins (Table 6.4-). There was a poor positive  
correlation between glycosylated haemoglobin and birth weight 
ratio in cord blood, and a poor, negative correlation between 
glycosylated plasma proteins and birth weight ratio in cord 
blood (Table 6.4).
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Table 6.4 Correlation between g lycosylated haemoglobins
Third
trimester
Birth,
maternal
cord
or g l ycosylated plasma proteins in the third 
trimester of p r e gnancy and at birth,-with 
birth weight r a t i o .
% g lycosylated haemoglobins
% glycosylated plasma
proteins
% g lycosylated haemoglobins
% glycosylated plasma
proteins
% glycosylated haemoglobins
% glycosylated plasma
li c o r r e l a t i o n ( r ) slope
34 .463 .043 5
31 .341 ' .0334
35 .348 .030
35 .194 .029
3 3 .08 6 .013
30 -.019 -.032
Of the 35 patients who were studied in this survey, 15 
produced macrosomic babies. The glycosylated h a e m o globin and 
glycosylated plasma proteins of this group were compared to 
the group of 2 0  diabetic mothers whose offsprings were not 
macrosomic. (Table 6.5). Although the mothers of m a c r osomic 
babies had higher results.in all categories except for 
glycosylated plasma proteins in cord blood, only g l y c o sylated 
haemoglobins in maternal blood in the third trimester or in 
cord blood proved to be significantly higher.
When patients D, B and K were included in the "macrosomic" 
group (the first two as they had abnormally small babies, and 
patient K as the baby born was classically macrosomic in 
features, although not above the ninetieth centile) then the 
differences between the two groups becomes clear (Table 6 .6 ). 
For the group containing babies of abnormal birth weight, all 
of the results were significantly higher than in the group of 
non-macrosomic offspring, with the exception of the glycosylate 
plasma proteins in cord blood.
Combined Measurement of G lycosylated Haemoglobins and 
G l y c o sylated Plasma Proteins for the Detection of M a c r o s o m i a .
Table 6.7 shows both the false positive and the false 
negative predictions in the third trimester of macrosomia, 
and the retrospective assessment in maternal and cord samples 
using g lycosylated haemoglobin and g l y c o sylated plasma p r otein 
measurements. These results, when combined, show that the 
number of incorrect predictions or assessments s i m u l t a n e o u s l y  
indicated by both results decreases. In the third t r i m e s t e r
false positives using the combined measurements still include 
patients B, D and K, all of whom could argueably be included 
with the macrosomic group.
Relationship between h aemoglobin concentration and % 
glycosylated haemoglobins in n on-diabetic p r e g n a n c y .
Of the 110 non-diabetic women who were studied at one 
time-point during their pregnancy, 93 had their haemoglobin 
concentration m e a sured by routine h a e m a t ological tests. For 
these patients the mean haemoglobin value was 11.69g/dl with 
an observed range of 8 . 6  to 14.1 g/dl. There was no 
significant correlation (r = 0 . 0 5 3 ,  slope = 0.042) between 
these values and their corresponding g lycosylated h a e m o g l o b i n  
r e s u l t s .
Table 6.5 Values for glycosylated haemoglobins and
glycosylated plasma proteins during the third 
trimester and at delivery (maternal and cord) 
for pregnancies resulting in n o n-macrosomic 
and m acrosomic (weight above 90th centile) b a b i e s .
Non-macrosomic Macrosomic
+ +
THIRD % GHb 8 . 8 2 - 2 . 0 4  (n=20) 11.20 - 2.25 (n=14) **
TRIMESTER + +
% GPP 7.41 - 1.81 ( n = 2 0 ) 9.34 - 2.31 (n=10) NS
+' +
MATERNAL % GHb 8.75 - 2.17 (n=20) 10.90 - 2.61 ( n = 1 5 ) NS
% GPP 6.9 8 - 7.7 3 (n=20) 7.73 - 1.40 (n=15) NS
CORD % GHb 4.56 - 1.32 (n=19) 5.52 —  1.6 9 (n=14) **
% GPP 5.46 - 1.40 (n = 1 9 ) 5.21 ± 0.79 (n=ll) *
Results are expressed as mean " SD; the n o n - m a c r o s o m i c  and 
m acrosomic groups are compared.
NS no significant difference
* significant difference at p = 0.05
** significant difference at p = 0 . 0 2
*** significant difference at p = 0 . 0 1
%GHb is % glycosylated haemoglobins
%GPP is % glycosylated plasma proteins
Table 6.6 Values for g lycosylated haemoglobins and
glycosylated plasma proteins during the third 
trimester and at delivery (maternal and cord) 
for pregnancies resulting in babies of 
abnormal s i z e .
Non-macrosomic Macrosomic (+ Patients
& K)
% GHb 8.40 - 1 . 7 8  (n = 17) 11.20 ~ 2 *1 5 (n = 17-) **
+ +
% GPP 7.14 - 1.82 (n=17) 9.61 - 2.15 (n=14) **
% GHb 8.36 - 1.91 (n=18) 10.91 - 2.54 (n=18) **
% GPP 6.73 - 1.49 (n=17) 7.84 - 1.33 (n=18) *
% GHb 4.28 i 1.14 (n=16) 5.42 - 1.52 (n=17) **
% GPP 5.12 - 1.25 (n = 1 6 ) 5.63 - 1.09 (n=15) NS
■ +
Results are expressed as mean - SD, the n o n - m a c r o s o m i c  and 
"macrosomic" groups are compared.
Key:
NS no significant difference
* . significant difference at p = 0.05
** significant difference at p = 0 . 0 2
significant difference at p = 0 . 0 1
**** significant difference at p = 0 . 0 0 1
%G'Hb is % g lycosylated haemoglobins
%GPP is % glycosylated plasma proteins
THIRD
TR I M E S T E R
MATERNAL
CORD
Table .6.7 Combined measurement of g lycosylated haem o g l o b i n s  
and glycosylated plasma proteins for the detection
of m a c r o s o m i a .
A B C
Third
FALSE trimester 8 9 7
POSITIVES maternal . 6 6 5
cord 3 6 3
Third
FALSE trimester 1 1 ■ 0
NEGATIVES maternal 2 6 1
cord 9 10 3
Column A shows results using only % glycosylated
Column B shows results.using only % glycosylated 
proteins
Column C shows results using the combined m easurements of 
% g lycosylated haemoglobins and. % glycosylated
h a e m o globins
plasma
and Diabetics Insulin-Dependent Before P r e g n a n c y .
Of the 35 diabetic patients studied, 6 were gestational 
diabetics and 29 were insulin-dependent before, and during 
pregnancy. The g lycosylated haemoglobin and g lycosylated 
plasma protein results for each of these two groups was 
assessed and compared (Table 6 .8 ). In all cases the values 
for the g e s t a tionally diabetic group were lower, but only 
g l ycosylated haemoglobins and glyco s y l a t e d  plasma proteins 
in cord blood, and g lycosylated h a e m o g l o b i n s . in m a t e r n a l  b l ood 
were s i g n i ficantly lower (p <C 0 .0 2 ).
Comparison of Gestational Diabetics with Non-diabetics  
During Pregnancy and at D e l i v e r y .
Figure 6.11 shows the results for the 6 gestational  
diabetics for g l y c o sylated h a e m o g l o b i n s , g l y c o s y l a t e d  plas m a  
proteins and glucose, during pregnancy and at delivery, 
compared against the appropriate normal r a n g e s ,(Table 6.9). 
Three of the patients had values within or b e low the normal 
ranges throughout pregnancy and at term. One patient (c), 
only had a high glycosylated h aemoglobin result in the second 
trimester. Patient d had high g lycosylated haem o g l o b i n  at 
delivery, and produced a macrosomic baby. Patient b had high 
results for all three measurements during p r e g nancy and in 
m aternal blood at delivery, and p r o duced a child whose weight 
was only just below the ninetieth c e n t i l e . Two patients, (d 
and e) were diagnosed during the second trimester.

Table 6.8 , Values of glycosylated haemoglobins and
glycosylated plasma proteins in maternal and 
cord blood of insulin-dependent diabetic 
mothers (IDDM) and gestational d i a b e t i c s .
G estational diabetics. 
+
7. 8 2 - 1.7 5 (n = 6 ) ** 
4.26 - 1. 23 (n = 6 ) NS
Insulin-dependent 
d i a b e t i c s .
+
% GHb m a t ernal 10.06 - 2.57 (n=29)
cord 5.00 - 1.48 (n=27)
%GPP maternal 7.64 - 1.22 (n=27) 5.66 - 1.77 ( n = 6 ) **
t
cord 5.57 - 1 . 1 2  (n=25) 4.30 - 1.04 ( n = 6 ) **
+
Results are expressed, as mean - SD; the results for 
insulin-dependent mothers and gesta t i o n a l l y  diabetic 
mothers are compared.
MX- .
NS no significant difference
. significant difference at p = 0 . 0 2
%GHb is % glycosylated haemoglobins
%GPP is % glycosylated plasma proteins
Table 6.9 Normal ranges for g l y c o sylated haemoglobins, 
glycosylated plasma proteins and whole blood 
glucose during the different trimesters of . 
pregnancy and at d e l i v e r y .
Glycosylated
Haemoglobins
(%)
First trimester 4.6 7 to' 9.3 5
Second trimester 3.97 to 8.53
Third t r i mester 4.38 to 8 . 62
Maternal 4.05 to 8.9 3
Cord 1.83 to 5.87
Glyc o s y l a t e d  Whole blood
Plasma glucose
Proteins (%) ( m m o l / I )
4.59 to 7.27 2.62 to 4.34
4.32 to 7.3 6 2.38 to 5.5 0
3.8 9 to 7.69 2.8 7 to 5.3 5
3 . 75 to 7 .47 2 . 5 5 to 6 . 51
3.51 to 5.99 1.9 5 to 5.2 3
+ .
Ranges are calculated from the mean values - 2SD of the 
different trimesters (Table 6.1) and at birth (Table 6.3) 
for n on-diabetic pregnancies.
Abnormalities of Babies Born to Diabetic Mothers in This S t u d y .
Of the 35 diabetic pregnancies in this study, 2 of the 
insulin-dependent diabetic patients produced abnormal babies 
(patients B and G). In both instances the nature of the 
abnormality was only specified as "heart defect". One of 
the other 13 diabetics studied only at delivery (patient DW ) 
also produced an abnormal offspring, this time with spina 
bifida. The results for all these patients at delivery, and 
for patients B and G early in p r e gnancy are given in Table 
6.10, together with some details of the births. The normal  
ranges against which these results are compared are given in 
Table 6.9 and are a summary of the results in Tables 6.1, 
and ,6.3.-; All three patients have maternal g l y c o s y l a t e d 
haemoglobin values which exceed the normal range, although 
only patients B and DW have high glyco s y l a t e d  haem o g l o b i n s  in 
cord blood. Only patient B had glyco s y l a t e d  plasma proteins 
in maternal and cord blood above the normal r a n g e . Inter e s t i n g l y  
both patients B and G had high values for g l y c osylated 
haemoglobins and g l y c o sylated plasma proteins in the first 
trimester. None of the patients had glucose results at delivery, 
but both patients B and G had high glucose values in the first 
trimester with average values of 7.7 and 8.9 mmol/1, r e spectively.
Values Obtained for Diabetic Patients With Intra-Uterine
Deaths .
Four diabetics during the period of this study had i n t r a ­
uterine deaths, and had their g lycosylated haemoglobins and 
glycosylated plasma proteins measured. These patients were 
not included in the group of 35 diabetics which are con s i d e r e d  
throughout this chapter. The results of these four patients  
were 7.18% and 5.36%, 8.93% and 8.63%, 11.73% and 15.79%, and 
9.10% and 10.18% for g l y c o sylated haemoglobins and g l y c o s y l a t e d  
plasma proteins, respectively. The last two patients had 
glycosylated haemoglobin values above the normal range, and 
the last three patients had high g lycosylated plasma proteins. 
In the last two patients the glyco s y l a t e d  plasma proteins were 
higher than the glycosylated haemoglobins.
All of the deaths occurred between 10 and 16 weeks of 
gestation, and a sample was taken within hours of the 
patient being admitted to hospital after miscarriage.
Table 6 .10 Glycos ylated haemoglobin and g l y c osylated
plasma protein results at delivery and in
the first trimester of pregnancy for those
diabetic patients who delivered babies with
abnormalities.
%GHb %GPP Weight and
sex of infant
Mode of 
delivery
Patient B.
maternal 10 .99 3 .85
cord
first
trimester
6.95 
13 . 5 3
7.30 2.170kg Male 
12 .38
Eme r g e n c y
Caesarian
Patient G.
maternal 16.65 6.83
cord 4.87 3.5 4 4.400kg Female F o r c e p s . 
Failure t< 
progress . 
second sti
first 11.82 9 . 5 9
t rimester
Patient DW
maternal
cord
1 2 .07 
9 .21
6.93
5.78 4. 030kg Male C a e s a r i a n
Results for the third trimester are the mean values for each 
patient during that period. Since patient DW was only studied 
at delivery, there were no results for this patient ea r l i e r  in 
p r e g n a n c y ,
DISCUSSION.
In order to assess any relationship between glycosylation 
and the outcome of diabetic p r e g nancy it is first n e c e s s a r y  to 
study non-d i a b e t i c  pregnancy. Previous studies have shown that 
g lycosylated haemoglobin is either unchanged (Ylinen, Helaki 
and Teramo, 1981, Leslie et a l . 1978, Kjaegaard and Ditzel,
1979) or slightly decreased (Lind and C h e y n e , 1979) during 
normal pregnancy. This study is in agreement with these findings 
since there is a significant decrease in maternal glyco s y l a t e d  
haemoglobin during n o n - d iabetic pregnancy (.p'-'C 0.001) (Table 6.1) 
This decrease may be caused by the increase in red cell volume 
and decrease in fasting blood glucose c o ncentration that occurs 
during normal pregnancy (Lind and Cheyne, 1979). M easurement 
of glycosylated plasma proteins during pregnancy and at term 
has not been reported previously. In this study the values, 
not surprisingly, follow a similar pattern to the g l y c o s y l a t e d  
haemoglobins, but with a smaller though significant decrease 
(p s. 0 .0 2 ) between the normal value and that for pregnant 
women at delivery. This is consistent with the. decrease in 
plasma glucose concentration observed in this study when values 
during pregnancy are compared to those of non- p r e g n a n t  patients. 
Glucose levels were shown to increase as pre g n a n c y  progressed, 
but in many cases the samples were taken from patients who were 
not fasted, and this may obscure the results. The c o n c e n t r a t i o n  
of plasma proteins also decreases during pregnancy (Haram, 
Augenseri and Elsayed, 1983) but the decrease is very small, 
and should not affect the g lycosylated plasma protein results.
It is also interesting that there is an inverse ratio
between the percentage of g lycosylated plasma proteins and
glyc o s y l a t e d  haemoglobins in maternal and cord blood. In
cord blood the percentage of g lycosylated plasma proteins is
greater than g lycosylated haemoglobins, and in maternal blood
the opposite is true. This is also the case with the diabetic
pregnancies studied. In maternal blood the concentration of
plasma proteins decreases during the last stages of pre g n a n c y
due to increased body fluids (Lind, 1980). This combined with
the decrease in glucose and the fact that glyco s y l a t e d  plasma
proteins reflect a shorter time p e riod than g lycosylated
haemoglobins,, probably, explains the observation. In cord b l o o d
however, there is an increased concentration of h a e m o g l o b i n
compared with m o t h e r ’s blood which probably alters the b a l ance
so that the concentration of g l y c o sylated plasma proteins is
greater than that of g lycosylated haemoglobins in cord blood.
Only a few previous studies have attempted to m e a sure
glycosylated haemoglobins in both ma t e r n a l  and cord blood.
One group using ion-exchange c h r o m atography (Fitzgerald and
Cauchi, 1980) obtained a value for HbA^ in maternal b l ood of 
+
6.4 - 0.7% and in cord blood of 12.4 - 3.6%. However, two
different c h romatography procedures were used to determine
these values. Using radioim m u n o a s s a y  it was found that the
maternal HbA values were 3.96 - 0.7% compared with 4.56 1 
1 c
1 .8 % in cord blood expressed as a percentage of h a e m o g l o b i n  
A (Peterson ejt aly 1979 ). Another study, (Poon, Turner and 
Gillmer, 1981) this time using isoelectric focusing, quotes
. ■ ' ■ • .j.
maternal H b A lc as 7 . 8 —  1.9% and glyco s y l a t e d  h a e m o g l o b i n  F 
which probably includes acetylated haem o g l o b i n  F, as 7.8 -
1.5%.
Contrary to the findings outlined above, Sosenko
jet _al. (1982), using a colorimetric method, found a
s i g n i ficantly lower value (by 36%) for glycosylated haem o g l o b i n
in cord blood compared with maternal blood. The significant.
decrease reported here from 6 .49 ~ 1 .2 % for m a t ernal b l ood in
non-diabetic pregnancies to 3.85 - 1.0% for cord blood (Table
6.3), is in general agreement with their findings. A similar
trend is shown with the diabetic pregnancies, with a
+
significant decrease from 9,67 - 2.57% in maternal b l ood to 
5.03 - 1.64% in cord blood (Table 6.3). These decreases are 
consistent with the lower blood glucose in cord blood. The 
results for the n o n - d iabetic births show a consistent trend 
with lower glucose, g lycosylated haemoglobins and glyc o s y l a t e d 
.plasma proteins in the fetus when compared with the c o r r e s ponding 
.maternal blood. It has been shown in studies _in vitro that 
fetal h a e m o globin becomes g lycosylated at the same rate and to 
the same extent as adult h a e m oglobin (Fitzgerald and Cauchi.,
1980). It seems l i k e l y  therefore that these lower values in 
the fetal b l ood reflect the rapid u tilisation of glucose by
the fetus (Holmberg et_ al„ 1956). Indeed, although there is
a significant correlation (r = C.641) between the i n d i vidual 
values of m a t ernal and cord blood for the diabetics studied,
the slope of the graph comparing maternal and cord values
(Fig. 6.2A) is 0.418, suggesting that the glucose levels 
c irculating on .the fetal side of the p l a centa are only about 
half those on the maternal side. This is pr o b a b l y  due at
least in part, to the rapid utilisation of glucose by the 
fetus, as well as glucose uptake by the placenta itself.
This is also reflected with the glycosylated plasma p r o t e i n s . 
Again there is a good correlation between maternal and cord 
blood (r = 0.771), but this time the slope of the graph (Fig. 
6.2B) is slightly higher (0.736). This may reflect the. 
increased glucose utilisation, but pre s u m a b l y  other factors 
such as altered protein concentration or turnover rates in 
either fetal or maternal plasma influence the result causing 
the slope to be closer to unity.
Of the diabetic pregnancies studied, a group of 35 were 
considered for most of the work as results were obtained for 
these patients in pre g n a n c y  and at delivery, and their full 
clinical details were a v a i l a b l e . Of these, 6 were g e s t a t i o n a l  
diabetics and, as a group, most of their results for both 
g lycosylated h aemoglobin or glycos^rlated plasma proteins in 
the third trimester or at birth were lower (p 0 .0 2 ) than 
for the group comprising of insulin-dependent diabetic patients. 
(Table 6 .8 ). The results for the gestational diabetics were 
also compared against those ranges obtained for n o n - d i a b e t i c  
pregnancies (Fig. 6.11). Three of these gestational diabetics 
did not have a single high result throughout pregnancy. One 
patient had a single high g l y c o sylated haemoglobin value in 
the third trimester, and two of the others had many high results 
during their pregnancy, all of which may have allowed the 
detection of their gestational diabetes if this had not 
p r e v iously been suspected. Of these two patients with high
results, one produced a macrosomic infant and the other, a 
child whose birth weight was only just below the ninetieth  
centile. These results suggest that diabetes is more 
manageable in gestational diabetics p r o v iding if is recognised, 
as was the case obviously with all of these patients. However, 
since only 6 patients were studied, a larger survey w o u l d  be 
required before any such observations could be confirmed.
Most of the gestat i o n a l l y  diabetic patients were m a i n t a i n e d  
on insulin throughout pregnancy, but one was controlled with 
diet r e s t riction alone.
G l y c o sylated haemoglobins and glyco s y l a t e d  plasma proteins, 
as measured by affinity chromatography, can both be used in the 
third tri m e s t e r  to predict macrosomia. As shown in Table 6.4 
g lycosylated h a e m o g l o b i n  (r = 0.463) and glyc o s y l a t e d  plasma 
proteins (r = C.341) both correlated with birth weight ratio. 
Glycosylated haem o g l o b i n  measured in the third t r i mester 
p redicted correctly 11 out of the no n - m a c r o s o m i c  and 14 out 
of the 15 m a c r osomic births (Fig. 6.4). This represents a 
s ensitivity of 25 correct results out of 34 (73.5%). Indeed 
at least 3 of the patients in the n o n - m a c r o s o m i c  group could 
be considered to be correctly p r e dicted as abnormal (D, B and 
K) as two had very low birth weights (D and B) and one (K) 
had a baby with classical m a c r osomic features. These patients 
could argueably be considered with the m a c r osomic group, as 
glycosylated haemoglobins and g l y c o sylated plasma proteins 
p redicted that these patients too were 'at r i s k 1 . This w o u l d
cSUM-
give an improved sensitivity (85.3%). Patient K had a very 
difficult birth for her baby, although not s t atistically 
macrosomic was very large for the mother, a very small woman, 
to deliver; Two other pa t i e n t s  (T and V) were false positives 
with birth weights just below the ninetieth centile line. All 
of the diabetic patients had ultrasound scans for dating 
purposes early in their pregnancy, usually at 12 - 15 weeks 
gestation. U ltrasound can date the age of the fetus plus or 
minus about one week (Dr. Cawdell, personal communication). 
This being the case, patient V w o uld also be included in the 
m acrosomic group if her dating was a week adrift, increasing 
the s e n s i tivity of the test to 8 5.3%. .
G l y c o sylated plasma proteins can also be used in the 
third trimester to predict the outcome, showing only one false 
negative and nine false positive results (Fig . 6 .5 ). Again 
patients V, K, B and D are included in this latter group.
The sensitivity in this instance is 22 correct p r e d ictions 
out of a total of 32 (6 8 .8 %). When patient S is r e - e v a l u a t e d  
assuming a possible m i s dating by ultrasound of one week, this 
result too can be included in the macr o s o m i c  group. When 
patients V, K, B, D and S are also considered to be c o r r ectly 
predicted to be Tat risk* then the s ensitivity increases to 
84.4%.
The r e trospective analysis of maternal and cord b l o o d  
shows a slightly different picture. Maternal glyco s y l a t e d  
h a e m oglobin valued are in agreement with 14 of the 20 non- 
m acrosomic births and 13 of the 15 m a c r osomic births (Fig. 
6 .6 ). In this case the s ensitivity is still good (77.1%)
although there is a poorer correlation with m a t ernal  
glycosylated haemoglobin and m a c r o s o m i a  (Table 6.4, r = 0.348) 
in terms of birth weight ratio. Maternal g l y c o sylated plasma 
proteins at delivery only agreed with 8 of the m a c r o s o m i c  
births and again there was 6 false negative values (Fig. 6.7). 
Patients W and T remain u n e x p l a i n e d  as false positives. The 
clinical details on patient W indicated that several scans 
showed an abnormally large baby, yet the child was not 
macrosomic. There was a suggestion that the g estational dating 
may have been muddled. The infant had several severe bouts of 
hypogljrcaemia immediately after birth.
The r elationship between glyc o s y l a t e d  h a e m o g l o b i n  in 
cord b l ood was even less selective for macrosomia, agree i n g  
with only 6 of the m a c r osomic (LGA) births (Fig. 6 .8 ). 
Glycosylated plasma proteins in cord blood for the m a c r o s o m i c  
infants only had two values outside the normal range. This 
is a reasonable finding in light of the fetal h y p e r g l y c a e m i a -  
h y p e r i n s u l i n a e m i a - m a c r o s o m i a  theory. If the m a c r o s o m i c  infants 
are p r o d ucing large amounts of insulin in response to high 
maternal glucose levels, their glucose t u r nover and 
utilisation will be very rapid and g l y c o s ylation may not 
occur. This is also r e f l ected in the slopes (0.418, 0.736) 
of the graphs (Figs. 6.2A and B) c orrelating the results from 
maternal and cord samples from the 35 patients in this study, 
which suggests a more rapid turnover of glucose in fetal blood. 
Results for maternal samples at birth show better c o r r e l a t i o n  
with LGA babies (Table .6.4, r = 0.348), but these are less 
satisfactory than the maternal results in the third t r i m e s t e r
(r = 0.463). This is p r e s umably as the maximum growth spurt 
of the fetus occurs at the end of the second trimester (Ogata 
et a l . 1979) so, allowing for the retrospective nature of 
glycosylated haemoglobins this would be best reflected in the 
results of the third trimester. This growth may cause 
macrosomia due to h y p e r g l y c a e m i a  in the second trimester, 
and yet glycaemic control may revert to normal near term when 
these patients are more closely supervised, consequently 
producing normal g l y c o sylation in the birth samples.
The prediction of macrosomia, or* indeed abnormally light 
weight is important as it allows for the better treatment of 
the associated complications (Pettit et: al. 1983) both at 
delivery and during the neonatal period. This work shovrs that 
the m e a s urement of either g l y c o sylated h a e m oglobins or 
glycosylated plasma proteins in the third trimester, can be 
used to predict these conditions. However, the t h ird t r i m e s t e r  
is 13 weeks long and future work to ascertain the time w i t h i n  
this trimester when these measurements are most useful 
clinically, is recommended. The role of glyco s y l a t e d  p l a s m a  
proteins in this study does not appear to confer any 
additional advantage for this purpose, possibly due to the 
method being .less sensitive than that for g l y c o sylated 
haemoglobins, with a b e t w e en-batch variation of about 5% 
(Chapter 2). However, the combined assessment of g l y c o s y l a t e d  
haemoglobins and glycosylated plasma proteins as an i n d i c a t o r  
of possible impending obstetric problems does prove to be 
b e tter than their individual consideration (Table 6.7).
It is interesting and important that with two of the four 
cases of intra-uterine death, the g lycosylated plasma proteins 
were considerably higher than the glycosylated haemoglobins, 
and in one other case the glycosylated plasma protein result 
was abnormal, yet the glycosylated haemoglobin result was 
within the normal range. Glycosylated h a e m oglobin m easurement 
is possibly inadequate in these cases to assess the rapidly . 
changing glycaemic conditions which may be associated with 
intra-uterine death. Recently, Ashby, Deacon and Rinsler (1984) 
recommended that glycosylated plasma proteins should be 
investigated in relation to diabetic pregnancy, as they have 
a faster turnover time; than glycosylated haemoglobins. This 
work suggests that although glycosylated plasma proteins do 
not appear to show any additional information regarding  
macrosomia, they may be of use to detect fetal distress due to 
sudden changes in diabetic control. However, since only four 
such patients were c o n s i d e r e d 'in this study it is not possible 
to draw any major conclusions, as the numbers are too small.
Also it must be noted.that intra-uterine death may occur as a 
result of sudden transient maternal and then fetal h y p o g l y c a e m i a  
This would not affect the glycosylated plasma protein result.
In this study, 3 insulin-dependent diabetic patients were 
included who produced abnormal babies. All of these p a t ients  
had maternal glycosylated haemoglobins above the normal range; 
two had macrosomic babies and one had a baby whose birth weight 
was below the 5th centile. The data available was limited but 
for 2 of these patients studied in the first trimester 
glycosylated haemoglobins, g l ycosylated plasma proteins and 
glucose at this time were all shown to be well above the
appropriate normal range. These few observations are in 
agreement with those of other workers (Miller ejt al_. 1981,
Leslie e_t a l . 1979 ) who were men t i o n e d  earlier in this 
chapter for showing the association between poor glycaemic 
control early in pregnancy and abnormalities in the fetus.
The maintenance of normal glucose profiles in pre g n a n c y 
for IDDM individuals has been shown to be possible with good 
education and regular self-monitoring (Jovanovic et al. 1980). 
However, in this study of 35 patients who were all carefully 
supervised throughout pregnancy, 15 produced macrosomic babies, 
and a further 2 had babies who were 1 at r i s k ’.: Several of
these babies had hypog l y c a e m i a  at birth and were put into 
special care u n i t s . G l y c o sylated haemoglobins and g l y c o s y l a t e d  
plasma protein measurement may help to predict these problems.
In this work these results were available to the clinicians at 
the Royal Sussex County Hospital, but not to those at K i n g s ’ 
College Hospital. Interestingly, 12 of the 15 patients 
producing macrosomic offspring were seen at K i n g s ’ College 
Hospital, as was one patient producing an a bnormally small 
baby. Of these patients, 3 had emergency Caesarian sections. 
These findings may, or may not be related to the absence of 
this b iochemical information. All of the 3 births of a b n ormal 
'babies were also seen at K i n g s ’ College Hospital. Of these,
2 of the mothers had high g lycosylated haemoglobins, g l y c o s y l a t e  
plasma proteins and glucose early in pregnancy. However, it is 
important to note that of the other diabetic mothers studied,
11 had high glycosylated haemoglobins, 13 had high g l y c o s y l a t e d  
plasma proteins and 9 had high glucoses in their first t r i m e s t e r
Affinity chromatography provides a very sensitive 
technique for the measurement of both glycosylated haemoglobins 
and g l ycosylated plasma proteins on the same sample, by the 
same principle, and both expressed in the same units 
(percentages). Fetal h aemoglobin (HbF) has been shown not 
to interfere with the results (Hall jet aJL. 1983 , Chapter 3). 
Unlike ion-exchange chromatography, elaborate combined 
techniques do not have to be employed to make the method 
feasible. Affinity c h romatography makes the routine m e a s u rement 
of both glycosylated haemoglobins and g lycosylated plasma 
proteins available to the clinician manag i n g  a diabetic 
p r e g n a n c y .
The ranges at birth for non-diabetics measured by affinity  
chromatography have been published (Hall et. al_. 1983). T a l w a r  
et a l . (1983) reported the use of affinity chroma t o g r a p h y  for
the measurement of g lycosylated haemoglobins in cord blood.
Their values were 5.2 - 0.3% (range 4.8. to 5.8%), which is 
significantly higher than our reported range (3.85 - 1.01%).
They also used the colorimetric technique to show that the 
extent of glycosylation in cord blood is lower than in m a t e r n a l  
blood. Since this work, Feldman et a l . (1984) have p u b l i s h e d  
details relating glycosylated haemoglobins in cord blood as 
m easured by affinity chromatography, to macrosomia. They used 
1ml colums of Glycogel B for this purpose. They too, n o t e d 
that glycosylated haemoglobin in cord blood was only h a l f  the 
percentage found in adult red cells, and they used iii vitro
incubation studies to show that HbA and HbF were glyco s y l a t e d 
at the same rate. They found a significant correlation 
between the birth weight ratio and glycosylated h aemoglobins  
in cord blood (r = 0 .6 6 ) with 1 1  of the 15 diabetic mothers 
studied producing LGA babies. This is not in agreement with 
the findings in this thesis .which showed this correlation to 
be very poor '(r. = 0.086), and the results of the V,Torth et a l .
(1983) who failed to.correlate birth weight ratio with cord 
or maternal g l ycosylated haemoglobins using the t h i o b a r b i t u r i c  
acid method. This discrepancy may be due to the rel a t i v e l y  
low numbers of diabetic mothers studied by Feldman et a l . (198
It is apparent in diabetic p r e g nancy that nurture, in 
terms of metabolic fuels, affects nature in terms of intrinsic 
genetic expression; and this change can be r e f l ected in the 
glycosylated values obtained. There is evidence that lesions 
at this stage in development, due to improper fuels supplied, 
can persist into later life. A study of Pima Indians by 
Pettit et, al_. (1981) revealed that macrosomia at birth 
p r e d isposed obseity in later, life. . Frienkel (1981) wrote 
"the consequent implications for f uel-mediated teratogenesis 
may have ramifications for developmental b i o logy that e x tend 
far beyond the traditional and more parochial c o n s i derations  
of diabetes in pregnancy".
CHAPTER 7.
GENERAL DISCUSSION.
Binding of G lycosylated Proteins to the Affinity Gel, 
Glycogel B .
Originally Mallia e_t aJL. (1981) produced a cross-linked  
agarose gel activated with carbonyl diimidazole, and 
subsequently coupled this to m - a m i n ophenyl boronic acid 
to form the affinity matrix. At least three commercial 
companies now market versions of this gel; Pierce Chemical . 
Company, Isolab inc. and Amicon, with the respective trade 
names of Glycogel B, Glyc-Affin and Matrix Gel PBA. All 
three gels are similar, and the separation of glyc o s y l a t e d  
material is based on their ability to selectively retain 
cis-diol groups (Fig. 2 .1 ). They therefore bin d  molecules  
containing carbohydrate groups ,, such as glycosylated 
haemoglobins. The work in this thesis shows that other, 
glycosylated proteins may also be separated in this way 
(Gould, Hall and Cook, 1983). The affinity gel is loaded 
into small c h romatography columns and either h aemolysate or 
diluted plasma allowed to soak in. As the n o n - g l y c o s y l a t e d  
material should not be retained by the gel, it may be wash e d
h i
through and collected. The bound g l y c o sylated material can 
be subsequently removed with a second buffer containing 0.2M 
sorbitol, and this may be also collected. Exces's sorbitol is 
added to the elution buffer to compete with the carbohydrate 
groups for the binding sites, and so these molecules are 
removed from the column.
investigate the effect of different parameters on the 
separation process. They used a Matrex Gel PBA, and 
pa r t i c u l a r l y  emphasised the importance of p r e c i s e l y  regulating  
the ligand concentration of the gel. This s t a ndardisation  
is critical, as two-fold increases of ’’g l y c o s y l a t e d  h a e m o g l o b i n ” 
could be achieved by altering the ligand c o ncentration between 
30 and A 0 m m o l / 1 .  Pierce Chemical company claim to standardise 
the manuf a c t u r i n g  process so that the affinity c h r o m a tographic 
support is lot-to-lot reproducible. The sample size was also 
shown to be important (Hall, Cook and Gould, 1983 , Middle Qjt a_l. 198 
to avoid overloading or underloading the column . Middle et_ a l .
(1983) also recommended that mag n e s i u m  chloride should be 
included in the elution buffer for optimum r e s u l t s . Several 
workers have shown that there is a small increase in the 
percentage of the g lycosylated fraction with d ecreasing 
temperature (Gould, Hall and Cook, 1982 , Mallia e_t al_. 1981, Klenk 
e_t a l . 1982) although the temperature dependancy is not n e a r l y  
as m a rked as with ion-exchange chromatography. Clearly then, 
the separation of g l y c o sylated from n o n - g l y c o s y l a t e d  m a t e r i a l  
is dependent on the experimental conditions and, since re c o v e r y  
figures in the order of 98% (Chapter 2) are achieved, this 
dependence is pr o b a b l y  due to the weak affinity of the boron a t e  
ligand for the glycosylated material rather than that the 
buffers are inadequate to remove it from the gel.
The schematic presentation illustrating the binding of
cis-diol groups to the affinity gel, Glycogel B, as shown in
Fig. 2.1 is oversimplified. There has recently been much
discussion in the literature regarding the ring structure
of the carbohydrate in glycosylated materials and its binding
to boronate. Fischer and Wint e r h a l t e r  (19 81) noted that the
carbohydrate moiety in h a e m oglobin A ^ c is present in the ring
form rather than as a linear, open-form attachment. They
argue that the open-form would react with phenylh y d r a z i n e  and
the lack of detectable keto groups by this technique can be
explained if the ketoamine is present as a ring-form. Also
upon periodate oxidation of g l y c o s y l a t e d  haemoglobin (Gallop ejt a l .
1981) only one mol formaldehyde/mol glyco group is formed.
Periodate treatment of an open glucose would liberate two
molecules of formaldehyde. Brownlee, Vlassara and Cerami
(1980) also supported the ring formation of the 1 - d e o x y f r u c t o s y l
derivatives of amino acids and peptides, although their
illustrations suggest a slightly different ring formation to
that of Fischer and W interhalter ( 1 9 8 1)y (Fig. 7.1). Their
ring contained four carbons, and an oxygen joining carbons 2
and 5, whereas that outlined by Fischer and W i n t e r h a l t e r  .
contained five carbons, and an oxygen between carbons 2 and 6 .
Brownlee, Vlassara and Cerami (1980) also suggested the
complex formation between p h e n y l boronic acid in alkaline
solution and the cis-diol groups to be via carbons 2 and 3.
Ferrier (1978) concluded that this b i n ding could occur via
carbons 2 and 3, or carbons 4 and 5. A more recent s t udy by
13
Neglia ert aJ.. (1983) used RNase A as a model protein for C 
NMR studies to characterize the products of n onenzymic 
g l y c o s y l a t i o n . They showed that the initia:! aldimine
Fig. 7.1 Ring formation of the carbohydrate
present in haemoglobin .
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(Schiff's base) cyclizes to a glycosylamine derivative and 
then undergoes a slow Amadori' rearrangement to yield the 
ketoamine adduct. They show (Fig. 7.2) that the ketoamine 
can exist in various tautomeric forms, including both the 
4 and 5 carbons within a ring-form. This is consistent 
with the binding of the boronate ligand to carbons 2 and 
3, 3 and 4, 4 and 5 or 2 and 4 (B.J. Gould, personal 
communication).
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G l ycosylated Material Measured by Affinity C h romatography
At the beginning of this work there had been only a
single publication by Mallia ejt a_l. (1981) who had made a
m-aminoboronate affinity gel and had per f o r m e d  limited
experiments suggesting its use for the measurement of
glycosylated haemoglobins. The work in this thesis, much
of which has been published, substantiates the initial
claims of these workers, showing affinity c h r o m atography
can be very s u c c essfully used to measure glycosylated
haemoglobins in a routine laboratory. The consistently
low coefficients of variation achieved with this technique,
unusual for column methods, probably explain a lot of the
data described in the clinical sections of this work, where
the distinction between diabetics and n o n-diabetics was
well-defined. A further reason for this clear-cut
distinction is that, due to the principle of separation
underlying affinity chromatography, it should be possible
to separate all g lycosylated material. C a t i o n -exchange
ch r o m atography resolves the haemoglobins g l y c o s y l a t e d  at
the amino terminus of the beta-chains (HbA' ), but af f i n i t ya — c
ch romatography should, in addition to t h e s e ,detect h a e m o g l o b i n  
glycosylated at all other sites (GHbAQ ) but which does not 
normally separate from the bulk of haemoglobin with ion-e x c h a n g e  
chromatography. Estimates of the amount of g l y c o sylation 
which is not me a s u r e d  by ion-exchange have been o b t ained by 
incorporating radio a c t i v i t y  from reduction of the ket o a m i n e  
bond with tritiated sodium borohydride (Bookchin and Gallop, 
1968) and.the release of carbohydrate moieties to be m e a s u r e d
as 5-hydroxylfurfural (Gabbay ejt al. 1979). These results
suggest that the additional contribution of this type of 
g l ycosylated haemoglobin ( ”n o n ,,-beta-terminal g l y c o s y l a t i o n ) 
is appro x i m a t e l y  the same as that of H b A l c , although it may 
be even higher (Bunn e_t .al. 1979). However the normal ranges 
achieved with the described affinity method were similar to, 
and not s ignificantly higher than those quoted for ion- 
exchange methods. Also this discrepancy was i n v e s tigated by 
rechro m a t o g a p h y  o f  the original fractions containing m a t e r i a l  
which had bound, or not bound, to the affinity gel. It was 
shown that there was contamination of bound material with 
unbound m a t e r i a l , and vice v e r s a . This finding was also n o ted  
by Middle et_ al.. (1983) and in a recent p u b l ication by 
Fluckiger, Woodtli and Berger (1984), who used larger columns 
of gel (14 x 130mm) .rather than the gel columns used in this 
work (7 x 25mm), and overcame this problem. Indeed with 
these larger columns and a reduced flow rate (0.5 ml/min) 
they were able to demonstrate that there was no c o n t a m i n a t i o n  
of bound^.with u n b o u n d ”m ater i a l  in the final f r a c t i o n s , o r  
vice v e r s a . They also found that the levels of ,,n o n ,,-beta- 
terminal g l y c o sylated haemoglobins were about the same as 
those for H b A l c , as me a s u r e d  by ion-exchange chromatography. 
The affinity gelis expensive to buy, although once it had 
been e stablished that it was possible to regenerate and 
reuse the gel several times (Hall, Cook and G o u l d , 1983), 
the technique became competitive with other more e s t a b l i s h e d  
methods. However, the use of a very large column for this 
work on a routine basis would be p r o h i b i t i v e l y  expensive for 
most laboratories. Production of the gel was difficult as 
the content of ligand in the gel had to be strictly c o n t r o l l e d
(Middle e_t a_l. 1983). In addition the recommendation by 
Fluckiger, Woodtli and Berger (1984-) for working at 4°C 
may also not be practical. The work p u b lished from this 
thesis showed that there was increased amounts of 
"glycosylated molecules" to be found at lower t e m p e r a t u r e s .
The loss of this m a t erial was considered an acceptable error 
for the convenience of working at room temperature.
Recovery from the columns was not affected • Until the 
affinity method can be suitably m o d ified to circumvent 
these problems, affinity chroma t o g r a p h y  as used in this 
thesis appears to provide the best alternative for the 
monitoring of all diabetic patients on a routine basis.
The aim of this work to establish a simple, reproducible, 
reliable and inexpensive technique for the routing m o n i t o r i n g  
of diabetic patients has therefore been achieved.
Garlick e_t aJL. (1983) emphasised that problems r e g a r d i n g  
accuracy also exist with other methods. Peaks isolated by 
ion-exchange chroma t o g r a p h y  or e l e c t r ophoresis were shown to 
be likely to be c ontaminated by n o n - g l y c o s y l a t e d  p r o t e i n s . 
Furthermore, both the t h iobarbituric acid test and the 
b orohydride reduction show variable r e a c tivity depending on 
the site of the k e t o a m i n e - l i n k e d  glucose. Therefore, al t h o u g h  
the affinity method as described in this thesis has been shown 
not to be accurate (Fluckiger, Woodtli and B e r g e r , 1984-) , 
other methods can also be shown to be at fault in this respect. 
However, the p r e l i m i n a r y  work of r e c h r o m a t o g r a p h y  in C h a p t e r  3 
shows that affinity c h romatography using a 1 ml gel column at
gravitational pressure, appears to produce a constant 
percentage of the total g lycosylated m a t e r i a l  b i n ding to 
the column. There was only a very small percentage 
( approximately 2 %) of "bound" material collected with the 
"unbound" material in each experiment.
Since the work described in this thesis was first 
p u b l ished (Gould, Hall and Cook, 1982), affinity 
c h romatography has been r ecognised and used by several 
other workers (Yue £t al. 1982, Klenk et al_. 1982) for the 
measurement of glyc o s y l a t e d  haemoglobins. Very good 
correlations with other methods have been found. C o rrelations 
of r = 0.97 with the t h i o b a rbituric acid method, r = 0 . 9 8  
with the mini ion-exchange columns (Klenk et al. 1982) , 
and r = 0.97 with high pressure liquid c h romatography  
(Little e t a l .  1983) have all been claimed. A good 
correlation (r = 0.95) with the agar gel e l ectrophoretic 
method has been shown in this t h e s i s .
Measurement of Protein in G lycosylated Plasma Protein A s s a y .
G l y c osylated plasma proteins can also be m e a s u r e d  using 
affinity c h romatography (Gould, Hall and Cook, 1983), but 
problems arise when mea s u r i n g  the protein content in the 
wash and elution fractions, since very low levels of p r o tein 
are loaded onto the gel. The recommended m o d i f i e d  Br a d f o r d  
method used here, utilises Coomassie Blue dye which is very 
sensitive to the presence of protein. This affinity m e t h o d  
gave a good correlation (r = 0.69) with the e s t a b l i s h e d
colorimetric method for glyco s y l a t e d  protein estimation.
Since this work began, Glycogel B has become available 
in kit form for the measurement of g lycosylated plas m a  proteins 
and g l y c osylated albumin. A c c o rding to the instructions 
supplied with each kit, a column loading of 2 0 0 y*l of neat 
plasma is used for the assay. This represents an addition 
of 10-15mg of protein per ml of gel, an amount n e eded because  
of the i n s e n sitivity of the direct method for protein 
measurement at 280nm that they recommend. The results in 
this thesis (Table 2.2) show that protein in excess of 2mg 
per ml of gel causes overloading, with cor r e s p o n d i n g l y  lower 
results for the percentage of glycosylated plasma proteins.
The recovery of protein is not altered by different l o a d i n g s ..... 
However, as the loading increases, the binding sites 
available to g l ycosylated molecules pres u m a b l y  become 
saturated. Those in excess are therefore collected in the 
unbound fraction, causing the decrease in the p e r c entage of 
the bound material that was observed when more than 2 mg of 
protein per column was used. This may be an o v e r - s i m p l i f i c a t i o n  
in view of the relatively small decreases found with much 
h igher loadings, and will require further study.
The method for m e a suring protein is critical. The 
modified Bradford m e thod is not only more sensitive than 
m e a suring the absorbance at 280nm, thus allowing a lower 
loading, but also more specific since many compounds other 
than protein absorb at 280nm. There is significant 
p r o t e i n - t o - p r o t e i n  variation with the direct m e t h o d  and w i t h  
the Bradford method. The latter is known to have a gr e a t e r  
colour yield with albumin than with most other proteins 
(Pi e r c e ^ 1977). This p r o t e i n - t o - p r o t e i n  variation p r e s u m a b l y
accounts for the different answers obtained by the two 
methods in the investigations regarding loading of protein 
onto the gel columns (Chapter 2). The variation observed 
with the Coomassie blue dye may be counteracted by the addition 
of sodium dodecyl sulphate to the reagent, which Macart and 
Gerbaut (1982) claim equalises the reactivity of many of the 
proteins in plasma. Further work would be needed to see if 
this could be usefully applied.in the measurement of glyco s y l a t e d 
plasma proteins. ,
Further Investigation Recommended for the Glycosylated Plasma 
Protein A s s a y .
The main objective of this thesis was to set up methods 
using affinity chromatography for the m e a s u rement of g l y c o s y l a t e d  
haemoglobins and glycosylated plasma proteins, and to compare 
their clinical usefulness. The u n d e r l y i n g .principle for the 
separation of g lycosylated from n o n - g l y c o s y l a t e d  mater i a l  should 
be the same for both assays. The main o utstanding p r o blem when 
c onsidering the glycosylated plasma protein assay is to e s t a b l i s h  
what exactly.the method measures. Only recently has this aspect 
of glycosylated haemoglobin measurement using affinity 
chromatography been investigated (Garlick ejt aJ.. 1983 , Fluckiger, 
Woodtli and Berger, 1984).
This thesis has covered several aspects of the m e a s u r e m e n t  
of glycosylated plasma proteins including lability and b u f f e r  
p H ?as well as the precision figures and clinical ranges. The 
study of l a b i l i t y.(Chapter 2) pr o d u c e d  some interesting data 
showing that, in contrast to the findings with g l y c o s y l a t e d  
haemoglobins, incubation of the protein in water caused both
decreases and increases in the r e s u l t s .- This serves to 
emphasise the increased complexity of w o r k i n g  with plasma 
rather than haemoglobin. Buffer pH was shown to be optimum 
at pH 8.9 for the g l ycosylated plasma protein assay, rather 
than at 8.3, as for g l y c osylated h a e m o g l o b i n s . The reasons 
for this are not clear.
As with all research, each avenue of investigation 
indicates many more that heed to be studied. Preliminary 
investigations p ertaining to g lycosylated plasma proteins 
have been reported in Chapter 3, using immuno e l e c t r o p h o r e s i s  
of protein material which bound, or did not bind, to the 
affinity gel Glycogel B. These studies attempted to find, 
out which proteins were g l y c o sylated and which were not..
They showed that enzymically formed glycoproteins did not 
bind to the affinity gel. The implications of this are 
discussed fully in Chapter 3. The other major finding was, 
not surprisingly, that the glycosylated proteins were those 
that had the longest half-lives.
More detailed future work is indicated by these initial 
investigations. studies regarding the efficacy of the 
separation could be achieved.by applying the t h i o b a r b i t u r i c  
acid treatment or r e c h r o m atography to both the "bound" and 
"unbound" material. Problems for both the lines of studies 
suggested may occur however, in obtaining enough m a t e r i a l  to 
study since both the "bound" and "unbound" fractions are 
very dilute and difficulties may occur when trying to
concentrate them. Perhaps a more fruitful i n v e s t i g a t i o n  w o uld
14 , #
be to add tracer amounts of C-glucose labelled serum pr o t e i n
and follow the progress
of the label through the separation procedure. U n f o r t u n a t e l y  
this, and other similar experiments using radioactive 
labelling t e c h n i q u e s :were not possible for this thesis, as 
the .necessary facilities were not readily available. Future 
investigation using the fructosamine method, which is gaining 
in popularity, might be possible.
The method as described in Chapter 2 gave a good 
correlation with the e s t a b lished colorimetric technique. The . 
affinity method for glycosylated plasma proteins also gave a 
v er y  good correlation with that for glycosylated haemoglobins, 
as m e a sured with the same affinity gel, with a line which, 
somewhat surprisingly, went close to the origin. This 
observation implied that the method discriminates between 
enzymically and non - e n z y m i c a l l y  g l y c o sylated protein for if 
e nzymically glycosylated protein was separated with this 
technique this should give a positive intercept on the 
glycosylated plasma protein axis. This was in agreement 
with the studies using immunoelectrophoresis.
Another development of affinity chroma t o g r a p h y  for the 
measurement of glycosylated plasma proteins has been s u g g e s t e d  
(Candiano ejt ad.. 1983) using lectins combined with A-se p h a r o s e  
for the gel matrix.
Clinical Inform ation from G l y c o sylated Haemoglobin and 
G lycosylated Plasma Protein Measurements, Using Affinity 
Ch r o m a t o g r a p h y .
The measurement of glycosylated haemoglobins and 
glycosylated plasma proteins was assessed in a variety of-:, 
clinical situations; the detection of glucose intolerance; 
the mon i t o r i n g  of glycaemic control both in the acute 
•situation and long-term; the m o n i toring of diabetic pregnancy.
Very clear-cut discrimination was shown between diabetic 
and n o n - d iabetic subjects in Chapter 4, with a small, well- 
defined group of subjects who were glucose intolerant. This 
study, although small, indicates that this m e a s u rement should 
be used in a larger population for the detection of glucose 
intolerance. However, it should be noted that the patients 
in this p articular study were to some extent p r e - s e l e c t e d  for 
glucose intolerance as they were sent to the lab o r a t o r y  for 
investigation.
G lyco s y l a t e d  haemoglobins were me a s u r e d  on all samples 
from a diabetic out-patient clinic during the study period.
The results shown in Chapter 5 show that since the test was 
introduced the overall control of the patients attending the 
clinic improved significantly. This suggests that the 
availability of this measurement aids the clinician in the 
assessment of diabetic control. This is consistent with the 
findings of Nathan e_t _al. (1984) who, mea s u r i n g  HbA-^ by HPLC, 
concluded that their assay provided information about the 
degree of long-term glucose control that was not otherwise 
available in the clinical setting. The study of diabetic
out-patients also found significantly higher glycosylated 
haemoglobin results in women compared with men. This is in 
agreement with the findings of Stickland, Paton and Wales
(1984) who used isoelectric focussing in their i n v e s t i g a t i o n s . 
Glycosylated haemoglobins and glycosyl a t e d p i a s m a  proteins were 
both measured in the acute situation (Chapter 5), after the 
admission of patients for stabilisation following a period 
of poor glycaemic control. Most of these patients were admitte 
in c o m a . - As expected, the percentage of g l y c o sylated plasma 
proteins decreased at a faster rate than the percentage of 
glycosylated haemoglobins, p r e s umably as the half-life of 
glycosylated plasma proteins is much shorter (Kennedy jet a l . 
1981). In this situation n e i ther m easurement appears to offer, 
in terms of clinical information, any advantage to regular  
blood glucose measurements. However, as a research tool they 
may prove a convenient way of showing improved control in 
patients during both short and long-term studies. As discussed 
in Chapter 5 the results p r e s ented in this thesis show that 
for some of the patients either g lycosylated h a e m o g l o b i n  or 
glycosylated plasma proteins decreased at a far quicker rate 
than expected. These investigations, suggest that the nature 
of the process of n o n - enzymic glycosylation may. not yet have 
been fully elucidated. A further interesting o b s e r v a t i o n  was 
that some of the patients who were admitted had higher 
glycosylated plasma protein than glycosylated h a e m o g l o b i n  
results on their visit to the clinic less than a month before 
a d m i s s i o n ... This aspect too, may be worth in v e s t i g a t i n g  more
thoroughly in future work, as disparity between the results 
in this way may be able to predict future clinical problems.
In Chapter 6 a two-year, fairly detailed study of diabetic 
patients and non-d i a b e t i c  individuals both during pregnancy 
and at term is described. Ashby, Deacon and Rinsler (1984) 
recently suggested that affinity chromatography would be 
suitable for this purpose and the work in this thesis illustrates 
that this is the case. The results shown in Chapter .3 indicate 
that fetal haemoglobin does not interfere with the method, 
although gross interference with the agar gel electr o p h o r e t i c  
method was demonstrated (Hall et_. a l . 1983 ). This has been 
similarly noted by Talwar ejt aJL. (1983) and is not a s urprising 
finding as the separation process using affinity c h r o m a t o g r a p h y 
should not be affected by the nature of the haemoglobin molecule. 
This lack of interference is of p a r t icular importance when 
studying glycosylation in cord blood to ret r o s p e c t i v e l y  assess 
the glycaemic history of the neonate. However, in this study 
the retrospective analysis did not correlate well with the 
outcome of the births in terms of birth weight. This is 
contrary to the recent findings of Feldman et al/. (1984). They 
also used boronate agarose affinity chr o m a t o g r a p h y  to m e a sure  
glycosylated fetal haemoglobin and showed a significant 
relationship between this and macrosomia, as reflected in the 
birth weight ratios. They noted that g l y c o sylated fetal 
haemoglobin in umbilical cord blood was consistently lower 
than adult values, a finding consistent with the results in 
this thesis. The reasons for this d i s c repancy are, as yet, 
unclear, although it is important to note that both Sosenko 
et a l . (1982 ) and Worth e_t ad. . (1983) using the t h i o b a r b i t u r i c  
acid assay, also failed to find a good correlation between
birth weight ratios and either cord or maternal g l y c o sylated  
haemoglobin levels. Also, Feldman jet al, (1984) studied 
relatively few diabetic pregnancies (n = 15) on which to 
base their conclusions.
Although the results of the study of the diabetic 
pregnancies are discussed in detail in Chapter 6 , there are 
two part i c u l a r  findings wort h y  of emphasis. Firstly, the 
measurement of g l ycosylated haemoglobins and g l y c osylated 
plasma proteins appear to be good predictors of m a c r o s o m i a  
when assessed in blood taken from the moth e r  in the last 
trimester of pregnancy. Considering the many factors which 
must influence the outcome of any pregnancy, this p r e d ictive 
capability of the test is very encouraging; although the 
inclusion of skin-fold thickness measurement in future studies 
should be considered (Sheridan-Pere ira e_t al. 1983). Other 
studies have shown how the retrospective assessment at birth 
can be achieved, but this work suggests that using affin i t y  
c h romatography the biochemist can provide a m e a s u r e m e n t  which 
may alert a clinician managing a diabetic p r e g n a n c y  to future 
birth difficulties. Such information should lead to the 
improved outcome of diabetic pregnancies in general. F u r t h e r  • 
studies involving closer m o n i toring of patients in the third 
t r i mester of pregnancy may pinpoint more accurately when 
fetal problems in terms of glycaemic control are occurring.
This is an exciting possibility.
The second point worthy of mention is that the g l y c o s y l a t e d  
plasma protein assay appears to offer an early w a r n i n g  of 
t hr e a t e n e d  abortion or miscarriage in diabetic pregnancy. In
four of the cases of intrauterine death occurring in this study, 
three had abnormal glycosylated plasma protein results. However 
since the numbers were very small, for any significant 
conclusions a larger study would seem mandatory. It is 
important to note though, that miscarriage may be due to fetal 
distress due to hyperglycaemia, but also may be due to fetal 
abnormality.
Recently there has been a review by Kennedy and Baynes
(1984) which evaluated the speculation that the " b r o w n i n g ” 
reactions of proteins caused by hyperg l y c a e m i a  could have a 
role in the pathogenesis of diabetes m e l l i t u s . Much of the 
evidence supporting these speculations was outlined in C h a pter  
1 of this thesis. More recently a study by the KROC 
Collaborative Study Group (1984) implied by their findings 
that improved control can reverse the progress of a patient 
towards overt nephropathy. This was s ubstantiated by.
Ghiggeri ejt a_l. (1984) who pr o d u c e d  data which showed that 
for both normal and.diabetic patients with normal e x c retion 
rates of albumin, the passage of g l y c osylated albumin was 
facilitated through the glomerular wall of the kidney, in 
contrast to n o n - g l y c o s y l a t e d  albumin. Their results indicate 
that the glycosylation of albumin plays an important role in 
the development of functional nephropathy. These findings 
suggest that the measurement of glyco s y l a t e d  albumin or other 
glycosylated plasma proteins may prove more relevant than 
glycosylated haemoglobin m e a s urement in terms of diabetic 
complications; especially if the alteration of albumin could 
be.shown to compromise its p h y s i o l o g i c a l  functions.
Quality C o n t r o l .
The glycosylated haemoglobin measurement in this thesis 
has been used to assess long-term changes in both the control 
of diabetic patients attending an out-patient clinic, and for / 
the study of diabetic pregnancieis. Glycosylated plasma proteins 
were also used in the. latter investigation. For an}^ conclusions 
to be drawn from these results it was necessary to check on 
b e t w e en-batch precision, especially when the batch n u mber of 
the gel changed. At the beginning of this work no s a t i s f a c t o r y  
quality control (QC) scheme was available, and following the 
recommendations of Boucher et_ a l . (1983) an "in-house" QC 
scheme was set up. This proved very satisfactory for the day- 
to-day check on precision. Over the two years of the research, 
five different batches of gel were ordered from Pierce Chemical 
Co., two with the same batch number. When changing from one 
batch to another, a set of 2 0 columns were pr e p a r e d  from each 
of the different gels and 2 0  diabetic samples were analysed 
concurrently on each set. The results were c a l c u l a t e d  to 
check that there was no significant difference between the two 
batches of gel. On this basis one batch of gel was rejected, 
and it was n o t iced that this p a r t icular gel was pink rather 
than white in appearence, suggesting pro l o n g e d  storage at the 
manufacturers. Precision of  b a t c h - t o - b a t c h  variation of the 
affinity gel has very recently been brought into question by 
Fielden (1984) who found quality control values inc r e a s e d  by 
about 16% when changing from one batch of gel to another.
This was not our findings, although one batch of gel was 
rejected in this study. Perhaps Fielden' also received gel 
which had been stored too long for his first batch of gel, 
which would explain his o b s e r v a t i o n s . This being the case, . 
it is strongly suggested that Pierce Chemical Co. should 
investigate this now, to ensure that an otherwise excellent 
method should not be brought into d i s r e p u t e . Apart from this 
single exception there was no significant variation when 
changing from one batch to another, and this was also found 
by John (personal communication, 1984), who calculated not 
greater than 0.4% variation between the different b a t c h e s - o f  
gel received for use in his laboratory.
Precision figures within batches from a single gel 
batch number, have also been questioned. A variation of 5.6% 
was quoted by, Fielden. (1984) and 13% by Peterson et a l . (19 84) .
In the past year W. G. John has set up a quality control scheme 
for glycosylated haemoglobins with 19 p a r t i c i p a t i n g  l a b o ratories 
8 using affinity chromatography. All of these labo r a t o r i e s  find 
similar precision figures to those quoted in this thesis 
(personal communication, John, 1984).
Future of G l ycosylated Proteins.
The results in this thesis indicate that glycosylated 
haemoglobins are useful for monitoring diabetic patients in 
numerous clinical s i t u a t i o n s , and that affinity ch r o m a t o g r a p h y  
is an extremely promising method for achieving this measurement. 
Future developments may follow the guidelines outlined by 
Fluckiger, Woodtli and Berger (1984) as to the improvement of 
the affinity gel column technique. Other workers (Middle, 
Longstaff and Dean, 1983) have tried to immobilise p h e n y l b o r o n i c  
acid onto paper. This would have obvious a d v a n t a g e s , allowing  
the assay to be done "at the b e d s i d e ” . However, problems o f  
distributing the affinity material evenly over the paper will 
have to be overcome before this mode of assay is a c c e p t i b l e . 
Capillary blood samples have been used s u c c e ssfully with 
ion-exchange c h r o m a tography (Ferrell e_t _al. 1984) and have 
been suggested for use with affinity chrom a t o g r a p h y  (Little 
et al. 1983). This may prove useful in the future."
With these, and similar improvements, affinity c h r o m a t o g r a p h y  
could offer in the future an accurate and sensitive t e c h nique  
for the measurement of g l y c osylated haemoglobins, and in some 
instances g l y c o sylated plasma proteins, which should lead to 
a significant improvement in diabetic control. If, as appears 
likely, g l ycosylation is responsible for man y  of the 
p a t h o p h y s i o l o g i c a l  complications of diabetes mellitus, then 
improved management should ultimately lead to a better pr o g n o s i s  
for the patient.
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Summary
After r e m o v a l  of the labile material, w e  h a v e  m e a s u r e d  the stable glycosylated 
fraction of h a e m o g l o b i n  with a n e w ,  commercially available, p h e n y l b o r o n i c  acid 
affinity gel, Glycogel B. T h e  m e a n  value w a s  established for 61 non-diabetics as 7.31 
( S D ± 0 . 9 2 ) %  a n d  for 108 diabetics as 12.70 ( S D ± 2 . 8 8 ) % .  T h e  m e t h o d  is highly 
reproducible with a coefficient of variation b e l o w  2.0%. T h e  effect of c h a n g i n g  the 
temperature f r o m  7 ° C  to 3 7 ° C ,  a n d  p H  f r o m  8.1 to 8.9 w a s  investigated. F o r  
accurate results the temperature should b e  maint a i n e d  b e t w e e n  2 0 ° C  ±  1°C, a n d  the 
p H  b e t w e e n  8.6 ±0. 1 .  A  poor, b u t  significant correlation (r — 0.43) b e t w e e n  glyco­
sylated h a e m o g l o b i n  a n d  simultaneous b l o o d  glucose w a s  s h o w n .  T h e r e  w a s  a g o o d  
correlation with the agar gel electrophoretic m e t h o d  ( r — 0.95). T h e  slope of the 
regression line w a s  1.20 w h i c h  indicates that this affinity m e t h o d  m e a s u r e s  m o r e  
than just H b A j .  T h e  affinity m e t h o d  appears to offer greater selectivity for diabetics 
t ha n  the electrophoretic m e t h o d .
Introduction
Several m e t h o d s  are use d  to estimate the different glycosylated fractions of 
h a e m o g l o b i n  that are elevated in diabetics. T h e  m o s t  a b u n d a n t  single glycosylated 
fraction, H b A lc, ha s  b e e n  estimated using high pressure liquid c h r o m a t o g r a p h y  [1], 
ion-exchange c h r o m a t o g r a p h y  [2] a n d  isoelectric focusing [3]. Alternatively the fast 
fraction, or H b A , ,  c a n  b e  m e a s u r e d  b y  agar gel electrophoresis [4], high pressure 
liquid c h r o m a t o g r a p h y  [5] or with mi n i  ion-exchange c o l u m n s  [6]. All of these 
m e t h o d s  m e a s u r e  b o t h  the labile a n d  stable f o r m s  of glycosylated h a e m o g l o b i n .  It 
ha s  b e e n  suggested that the labile f o r m  should b e  r e m o v e d  [7] prior to m e a s u r e m e n t .  
O n l y  the colorimetric m e t h o d ,  in w h i c h  the reaction is p r e d o m i n a n t l y  with the 
H b A lc fraction [8], m e a s u r e s  the stable glycosylated h a e m o g l o b i n  without the n e e d
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for a n y  pre-treatment of the haemolysate. All of the m e t h o d s  m e n t i o n e d  a b o v e  h a v e  
b e e n  reviewed [9] a n d  their relative merits a n d  disadvantages discussed.
Preliminary w o r k  o n  a n  alternative m e t h o d  b a s e d  o n  affinity c h r o m a t o g r a p h y  is 
c lai m e d  to h a v e  advantages over other m e t h o d s  [10,11]. B o t h  grou p s  u s e d  phenyl- 
b oro n i c  acid affinity supports w h i c h  b i n d  diols selectively a n d  thus separate glyco­
sylated h a e m o g l o b i n s  f r o m  non-glycosylated h aemoglobins. T h e  technique is claimed 
to b e  highly reproducible a n d  is suggested to b e  relatively unaffected b y  chan g e s  in 
temperature a n d  p H .  W e  h a v e  investigated the effect of these, a n d  other parameters 
o n  the m e a s u r e m e n t  of glycosylated h a e m o g l o b i n  in the clinical laboratory, using a 
c o m m e r c i a l l y  available affinity gel, Glycogel B.
Methods
Sample collection
S a m p l e s  w e r e  collected in lithium heparin tubes f r o m  non-diabetic a n d  diabetic 
individuals. T h e s e  s amples w e r e  stored at 4 ° C  until use, u p  to a  m a x i m u m  of 5 days.
Preparation of the haemolysate
Erythrocytes w e r e  separated f r o m  p l a s m a  b y  centrifugation at 1200 X  g for 10 
m i n .  A p p r o x i m a t e l y  100 ju.1 of p a c k e d  cells w e r e  a d d e d  to 2  m l  of deionised water, 
a n d  t h o r o u g h  haemolysis w a s  achieved using a vortex mixer. This diluted h a e m o l y ­
sate w a s  incubated at 3 7 ° C  for 5 h.
Affinity chromatography
T h e  m e t h o d  u s e d  w a s  that described b y  Mallia et al [10] with m i n o r  modifica­
tions. M i c r o c o l u m n s ,  to w h i c h  1 m l  of Glycogel B  (Pierce a n d  Warriner, Chester, 
Cheshire, U K )  w a s  added, w e r e  equilibrated with w a s h  buffer containing 2 5 0  
m m o l / I  a m m o n i u m  acetate, 50  m m o l / I  m a g n e s i u m  chloride a n d  3 m m o l / I  s o d i u m  
azide. This buffer w a s  adjusted to p H  8.5. H a e m o l y s a t e  (0.1 ml) w a s  a d d e d  to the gel 
a n d  allowed to s o a k  in. T h e  u n b o u n d  h a e m o g l o b i n  fraction w a s  collected b y  passing 
8 m l  of w a s h  buffer t hrough the c o l u m n .  T h e  h a e m o g l o b i n  havi n g  affinity for 
G lycogel B, the b o u n d  fraction, w a s  then eluted with 3 m l  of elution buffer w h i c h  
contained 2 0 0  m m o l / 1  sorbitol, 5 0  m m o l / 1  E D T A  a n d  3 m m o l / 1  s o d i u m  azide in a 
100 m m o l / 1  Tris buffer, final p H  8.5. Elution f r o m  all the c o l u m n s  w a s  carried out 
at r o o m  temperature, 2 0 ° C  ±  1°C, unless otherwise stated. T h e  u n b o u n d  fraction, 
containing the majority of the h a e m o g l o b i n  w a s  diluted to 15 m l  with w a s h  buffer. 
T h e  absorbances of this, a n d  the b o u n d  fraction, w e r e  m e a s u r e d  at 4 1 4  n m  a n d  the 
% h a e m o g l o b i n  b o u n d  calculated.
Removal of labile glycosylated haemoglobin
H a e m o l y s a t e  w a s  prepared as described above. T e n  minu t e s  after preparation 
s a m p l e s  w e r e  loa d e d  o n t o  five columns. Part of the h a e m o l y s a t e  w a s  incubated at 
3 7 ° C ,  while the r e m a i n d e r  w a s  m a i n t a i n e d  at r o o m  temperature, 2 0 ° C .  S a m p l e s  
w e r e  r e m o v e d  a n d  analysed at the times indicated.
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Effect of temperature and p H
T o  investigate the effect of temperature, the c o l u m n s  a n d  b o t h  buffers w e r e  
allowed to equilibrate to the temperature indicated, either in the laboratory w o r k i n g  
area or in temperature controlled incubators. T h e  c o l u m n s  w e r e  rinsed with 5 m l  of 
w a s h  buffer at the required temperature before the run. W h e n  necessary the effect of 
temperature o n  the v o l u m e  of elution buffer w a s  calculated a n d  corrected for b y  
w e i g h i n g  the elution sample.
T o  study the effect of altering p H ,  b o t h  buffers w e r e  adjusted to the required p H  
b y  the addition of either 1 m o l / 1  H C 1  or l m o l / 1  N a O H .  T h e  c o l u m n s  w e r e  
equilibrated with 5 m l  of the appropriate w a s h  buffer before loading the h a e m o l y ­
sate.
N o r m a l l y  six c o l u m n s  w e r e  r u n  at ea c h  temperature a n d  p H .
Measurement of glucose
W h o l e  b l o o d  glucose w a s  m e a s u r e d  within 10 m i n  of s a m p l i n g  using the Y e l l o w  
Springs G l u c o s e  A n a l y s e r  M o d e l  2 3 A M  (Yel l o w  Springs I n strument Co., Y e l l o w  
Springs, O H  45387, U S A ) .
Estimation of HbAj by agar gel electrophoresis
0.5 m l  of p a c k e d  red cells w e r e  a d d e d  to 10 m l  of isotonic (154 m m o l / 1 )  N a C l  
solution a n d  incubated at 3 7 ° C  for 5 h. Prior to electrophoresis, the erythrocytes 
w e r e  collected b y  centrifugation at 1200 X  g for 10 min. Haemolysis, electrophoresis 
a n d  quantitation w e r e  carried out according to instructions prov i d e d  b y  C o r n i n g  
M e d i c a l  Ltd. (Halstead, Essex, U K ) .
Statistics
Linear correlations w e r e  calculated b y  the least squares’ m e t h o d .  Statistical 
c o m p a r i s o n s  w e r e  p e r f o r m e d  b y  Student’s t test.
Results
Removal of labile glycosylated haemoglobin
T h e  total glycosylated h a e m o g l o b i n  is the s u m  of t w o  f o r m s  t e r m e d  labile a n d  
stable. W e  us e d  the m e t h o d  of C o m p a g n u c c i  et al to r e m o v e  the labile fraction [7]. 
T h e  results in Fig. 1 s h o w  that there is a  decrease in the b o u n d  fraction of 
h a e m o g l o b i n  after incubation at b o t h  2 0 ° C  a n d  3 7 ° C .  T h e  greatest decrease 
observed w a s  b e t w e e n  2.5 a n d  5 h  at 3 7 ° C .  T h e s e  results w e r e  b o t h  significantly 
different f r o m  the original value ( p <  0.001), but no t  f r o m  eac h  other. H o w e v e r ,  
w h e n  incubation w a s  continued at this temperature to 2 4  h  a significant increase 
( p < 0 . 0 1 )  w a s  observed, possibly d u e  to the formation of m e t h a e m o g l o b i n .
T h e  results of incubation at r o o m  temperature s h o w  a slower rate of change, a n d  
the value at 2 4  h  is not significantly different f r o m  the value obtained for the s a m e  
s a m p l e  incubated at 3 7 ° C  for 5 h.
T h e  results f r o m  this particular h a e m o l y s a t e  of n o r m a l  b l o o d  w e r e  selected as 
they provide suc h  a clear illustration of the presence a n d  effective r e m o v a l  of the
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Fig. 1. The effect of different incubation times on the % haemoglobin bound by the affinity method.; The 
diagram shows the results for incubating a normal haemolysate at 20°C (■ ) and 37°C ( • )  for various 
time intervals. Each point represents the mean (±SD ) of the results from 5 columns. * *
labile fraction of glycosylated ha e m o g l o b i n .  O t h e r  experiments with n o r m a l  a n d  
diabetic haemolysates s h o w e d  similar trends b u t  these w e r e  not so m a r k e d .  F r o m  
these investigations w e  decided that the labile fraction w a s  best r e m o v e d  b y  
incubation of haemolysates for 5 h  at 3 7 ° C  before estimation of the stable glyco­
sylated h a e m o g l o b i n  fraction.
Effect of temperature on affinity chromatography
A n  increase in the temperature u s e d  for c h r o m a t o g r a p h y  f r o m  7 ° C  to 37° C ,  
c a u s e d  a decrease in the percentage of h a e m o g l o b i n  that r e m a i n e d  b o u n d  to the
20r
4L
i____________ i____________ l____________ i-------!---- 1
0 10 20 30 40
Tem perature (°C)
Fig. 2. The effect of temperature on the % haemoglobin bound to the affinity gel. The diagram shows 
results from normal (■ )  and diabetic ( • )  samples. Each point represents the mean (±SD ) of the results 
from 6 columns.
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affinity gel (Fig. 2). W i t h  the diabetic s a m p l e  this value d r o p p e d  almost linearly f r o m  
1 8.7% to 13.3%, reaching a value of 15.3% at 19.5°C. T h e  values for the n o r m a l  
h a e m o l y s a t e  s h o w  a  similar trend. T h e r e  w a s  a m a r k e d  a n d  significant decrease f r o m  
the 9. 6 %  b o u n d  at 7 ° C  to the 7 . 6 %  b o u n d  at 19.5°C, but further increase in 
t emperature caus e d  n o  further c h a n g e  in binding. W e  decided to w o r k  in the 
t emperature range 20° C ±  1°C, since w e  f o u n d  that it w a s  possible to maintain the 
c o l u m n  within this range despite small fluctuations in a m b i e n t  r o o m  temperature, 
without special apparatus. F u r t h e r m o r e  the variation in %  h a e m o g l o b i n  b o u n d  is 
within the coefficient of variation for the m e t h o d  over this c h o s e n  range.
Effect of p H  on affinity chromatography
Fig. 3 s h o w s  the effect of using different p H  buffers for separating the u n b o u n d  
a n d  b o u n d  fractions of haemog l o b i n .  A s  the p H  w a s  increased f r o m  8.1 to 8.9 there 
w a s  a significant decrease in the percentage of h a e m o g l o b i n  that r e m a i n e d  b o u n d  to 
the affinity gel. F o r  b o t h  the n o r m a l  a n d  diabetic haemolysates there w a s  n o  
significant c h a n g e  in the range p H  8.6 ±0.1.
Normal range and precision
T h e  affinity c h r o m a t o g r a p h y  m e t h o d  is highly reproducible, as s h o w n  b y  the 
results in T a b l e  I. B o t h  within- a n d  betwee n - b a t c h  precision w e r e  d e t e r m i n e d  b y  
analysing replicates of haemolysates p r epared f r o m  n o r m a l  a n d  diabetic individuals. 
T h e  coefficient of variation r a n g e d  f r o m  1.5% to 2.0%. F o r  the b e t w e e n - b a t c h  study 
the haemolysates w e r e  stored at 4 ° C  a n d  w e r e  r u n  o n  different c o l u m n s  over a  
period of a  week. T h e  recovery of h a e m o g l o b i n  f r o m  the c o l u m n s  w a s  a b o u t  9 8 % .
W e  h a v e  studied haemolysates f r o m  61 non-diabetic subjects a n d  108 diabetic 
patients. T h e  m e a n  percentage of glycosylated h a e m o g l o b i n  for the non-diabetic 
g r o u p  w a s  7.31 ( S D ± 0 . 9 2 ) %  (range 5 . 2 5 %  to 9.70%). In contrast, the value for
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Fig. 3. The effect of pH on the % haemoglobin bound to the affinity gel. The diagram shows results for 
normal (■ ) and diabetic ( • )  samples. Each point shows the mean (±SD ) of the results from 6 columns.
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TABLE I
PRECISION OF THE AFFINITY METHOD FOR GLYCOSYLATED HAEMOGLOBIN
Within-batch ( n =  20) Between-batch (n =  15)
% CV% % CV%
Normal mean 6.81 2.0 7.00 1.8
SD 0.14 0.13
Diabetic mean 20.04 1.5 19.73 1.5
SD 0.3 0.3
diabetic patients w a s  12.70 ( S D  ±  2.88%) (range 6.5 %  to 22.5%). T h e  results for these 
t w o  gro u p s  are significantly different ( p <  0.001) wi t h  only 14 of the diabetic 
patients having values within the range q u o t e d  for healthy persons.
Correlation of glycosylated haemoglobin with glucose concentration
T h e  glucose concentration of w h o l e  b l o o d  sam p l e s  taken f r o m  143 diabetic 
individuals w a s  determined. T h e r e  w a s  a  significant correlation b e t w e e n  these values 
a n d  glycosylated h a e m o g l o b i n  in the s a m e  samp l e s  as m e a s u r e d  b y  the affinity 
technique (r  =  0.43).
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Fig. 4. Correlation between HbA, measured by agar gel electrophoresis and % glycosylated haemoglobin 
determined by the affinity method. Normals (■); diabetics (•) .
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Comparison of affinity chromatography with agar gel electrophoresis
W e  h a v e  analysed samp l e s  f r o m  16 non-diabetics a n d  4 2  diabetics b y  affinity 
c h r o m a t o g r a p h y  a n d  the well-established m e t h o d  of agar gel electrophoresis. F o r  
b o t h  m e t h o d s  the labile fraction w a s  r e m o v e d  before analysis b y  incubation at a 2 0  
to 1 dilution for 5 h  at 3 7 ° C .  Fig. 4  s h o w s  that there is a  g o o d  correlation (r =  0.95) 
b e t w e e n  the results obtained b y  the t w o  m e t h o d s .  Fig. 4  also s h o w s  that there are 
only t w o  diabetics with values in the range observed for the non-diabetics w h e n  the 
affinity technique is used. T h e  equivalent figure for the agar gel electrophoretic 
m e t h o d  w a s  nine. T h e  regression line with a n  intercept of —  0.43 o n  the y-axis a n d  a  
slope of 1.20 indicates that the t w o  m e t h o d s  are m e a s u r i n g  similar species, b u t  that 
the affinity m e t h o d  m e a s u r e s  additional glycosylated material.
Discussion
W e  h a v e  u s e d  a n  affinity c h r o m a t o g r a p h y  m e t h o d  similar to that described b y  
Mallia et al [10]. T h e  m a j o r  differences are that in o u r  studies labile glycosylated 
h a e m o g l o b i n  w a s  r e m o v e d  b y  incubation, a n d  a greater v o l u m e  of w a s h  buffer w a s  
used. T h e s e  chan g e s  readily explain w h y  the m e a n  values of glycosylated h a e m o g l o ­
bi n  obtained in this w o r k  for n o r m a l  a n d  diabetic individuals (7.31% a n d  12.70%) 
are lower th a n  theirs (7.65% a n d  15.5%), although this difference could also b e  d u e  
to the smaller n u m b e r  of s a m p l e s  analysed b y  these workers. T h e  m e a n  values 
q u o t e d  b y  Bouriotis et al [11] for non-diabetics a n d  diabetic patients are 5 . 4 %  a n d  
11.0%, respectively. W e  a s s u m e  that this difference is d u e  to the different gels used. 
W e  u s e d  Glycogel B  w h i c h  is a n  a m i n o p h e n y l  boronic acid derivative of agarose, 
w h e r e a s  they u s e d  M a t r e x  G e l  P B A - 3 0  w h i c h  is a similar gel p r o d u c e d  b y  different 
suppliers.
T h e  m e t h o d  described in this p a p e r  is highly reproducible with a  coefficient of 
variation b e t w e e n  1.5% a n d  2.0%. It is simple to perform, a n d  allows analysis of as 
m a n y  as 6 0  samp l e s  a d a y  without difficulty.
C o n t r a r y  to the statement of Mallia et al [10], the m e t h o d  is susceptible to 
c h a n g e s  in p H  a n d  temperature; a n  increase in either causes a  decrease in the 
percentage of h a e m o g l o b i n  b o u n d  to the c o l u m n .  H o w e v e r ,  this affinity m e t h o d  is 
considerably less sensitive to s u c h  changes than is the m e t h o d  using m i n i  ion-ex­
c h a n g e  columns. F o r  instance, the correction factor for a temperature c h a n g e  f r o m  
2 2 ° C  to 2 0 ° C  for the ion-exchange m e t h o d  is 1.33 ( B i o - R a d  Laboratories Ltd., 
W a t f o r d ,  Hertfordshire, U K ) .  U n d e r  similar conditions the appropriate correction 
factor for the affinity m e t h o d  is a b o u t  1.04. T h e  very l o w  coefficient of variation 
f o u n d  with this m e t h o d  requires that the p H  a n d  temperature are m a i n t a i n e d  within 
the limits selected; for p H ,  8.6 ± 0 . 1  a n d  for temperature, 2 0 ° C  ±  1°C.
T h e  correlation b e t w e e n  the percentage glycosylated h a e m o g l o b i n  a n d  the simul­
taneous b l o o d  glucose readings of 143 diabetics is similar to that f o u n d  with other 
m e t h o d s  w h i c h  m e a s u r e  different fractions of glycosylated h a e m o g l o b i n  [12].
T h e r e  w a s  a g o o d  correlation (r =  0.95) b e t w e e n  the C o r n i n g  agar gel electro­
phoretic m e t h o d  a n d  o ur affinity m e t h o d .  T h e  present w o r k  s h o w s  there is less 
overlap b e t w e e n  the diabetic a n d  non-diabetic populations using the affinity m e t h o d
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c o m p a r e d  with the electrophoretic technique. This suggests that the affinity m e t h o d  
m a y  b e  m o r e  selective for diabetics.
T h e  m a i n  outstanding p r o b l e m  with this affinity m e t h o d  is to d e termine exactly 
w h a t  is being measu r e d .  T h e  slope of the regression line in Fig. 4 indicates that w e  
are m e a s u r i n g  glycosylated material additional to H b A j .  This is in accord with 
Mallia et al [10] w h o  s h o w e d ,  using isoelectric focusing, that the b o u n d  fraction 
contained all the H b A lc a n d  also portions of H b A ,  H b A 2 a n d  various m e t h a e -  
moglobins. It is k n o w n  that a small proportion of H b A ,  H b A 2 a n d  m e t h a e m o g l o b i n  
is glycosylated [9] a n d  p r e s u m a b l y  it is these glycosylated molecules w h i c h  account 
for the higher values observed w h e n  using the affinity m e t h o d .  H o w e v e r ,  o u r  results 
investigating the effect of temperature a n d  p H  indicate that s o m e  molecules of 
glycosylated h a e m o g l o b i n  are n ot retained b y  the c o l u m n  as the temperature or p H  
are raised. W e  intend to investigate these cha n g e s  in m o r e  detail.
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An inexpensive, rapid and precise affinity 
chromatography method for the measurement of 
glycosylated haemoglobins
P A U L I N E  M  H A L L ,  J G  H  C O O K  A N D  B  J G O U L D
From the Biochemistry Department, Royal Sussex County Hospital, Brighton, Sussex
s u m m a r y  W e  h a v e  assessed a n  affinity c h r o m a t o g r a p h y  technique, using commercially available 
materials, for the estimation o f  total glycosylated h a e m o g l o b i n  in the routine clinical chemistry 
laboratory. T h e  m e t h o d  gives g o o d  discrimination b e t w e e n  n o r m a l s  (7 -3 1 ^ 0 -9 2 % )  a n d  diabetics 
(1 2 -7 0 it2 -8 8 % )  a n d  ha s  excellent precision ( C V  l- 5 ~ 2 - 0 % ) .  Labile glycosylated h a e m o g l o b i n  is 
no r m a l l y  r e m o v e d  as it is so variable. T h e r e  is n o  significant correlation b e t w e e n  labile glycosylated 
h a e m o g l o b i n  a n d  b l o o d  glucose. I m m e d i a t e  analysis of incubated haemolysates is preferable to 
storage of haemolysates or erythrocytes. T h e  affinity gel c a n  b e  reused a b o u t  16 times, bu t  oxidation 
m u s t  b e  r e d u c e d  b y  keeping the gel at 4 ° C  in the d a r k  w h e n  no t  in use. T h e  cost of  the gel is a b o u t  
7 p  a  test a n d  6 0  samp l e s  c a n  b e  analysed in a  w o r k i n g  day. T h e  m e t h o d  is n o t  affected b y  the 
presence of  u p  to 2 0  %  m e t - h a e m o g l o b i n  a n d  should also give correct values for s amples containing 
genetic variants of haemo g l o b i n .
M e a s u r e m e n t  of glycosylated haemoglobin is well 
docum e n t e d  as a technique for the retrospective 
assessment of carbohydrate metabolism in diabetics. 
However, in recent years doubts have arisen as to 
its usefulness. This is due partly to the large n u m b e r  
of different techniques available for the m e a surement  
of different fractions of haemoglobin a n d  partly to 
the inclusion of the m o r e  variable labile glycosylated 
haemoglobin in a lot of the earlier work.1
Since R a h b a r 2 isolated by  electrophoresis a fast 
running b a n d  whi c h  w a s  elevated in diabetic indivi­
duals, it has been s h o w n  that this fraction, designated 
H b A ! ,  is c o m p o s e d  of a  n u m b e r  of components: 
H bA ia,, H bA ia2 H b A Xb, an d  H b Alc.3 T h e  identity of 
the various carbohydrates that react with H b A  to 
produce these components has been partially 
elucidated,3 a n d  fractions H bAib and H bA ic, 
although present in non-diabetics, have been s h o w n  
to increase in diabetes mellitus.3 Separation, either 
of the fast fraction f r o m  H b A  or of the different 
minor components (H bAib, H bA ic) fr o m  each 
other, has been achieved mainly b y  exploiting small 
charge differences between them. Isoelectric focus­
ing,4 H P L C,5 ion-exchange chromatography,6 a n d  
agar gel electrophoresis7 have all been used. B u n n  
et al,8 have s h o w n  that as well as the fast fraction or 
H b A j, a portion of the H b A  is also glycosylated 
but does not separate fro m  the rest, despite being
chemically different. This portion is also increased 
in diabetics yet it is not included by  the techniques 
previously mentioned. T h e  colorimetric technique9 
assesses all the glycosylated material but does not 
give equal weighting to each type of glycosylated 
haemoglobin,8 has poor sensitivity, a n d  needs a 
correction for haemoglobin concentration.
Affinity chromatography has m a n y  research 
applications but few routine clinical uses. H o w e v e r  
its use for the separation of total glycosylated 
haemoglobins by  exploiting the presence of the 
carbohydrate moiety (the m a i n  point of difference 
between t h e m  a n d  the non-glycosylated molecules) 
should have advantages over the techniques already 
mentioned. Mallia et al.10 synthesised a n  affinity gel 
a n d  claimed that it should be useful for this separa­
tion. W e  have confirmed this a n d  have s h o w n  that it 
correlates well with the agar gel electrophoretic 
m e t h o d  but is simpler to perform. T h e  proposed 
m e t h o d  is relatively insentitive to changes in p H  
a n d  temperature1112, w h i c h  are important c o n ­
siderations for any c o l u m n  method. In this paper 
w e  have assessed this technique for use in a clinical 
laboratory.
Materials and methods
SAMPLE COLLECTION
Samples were collected into lithium heparin tubes
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Table 1 Buffer composition
Wash buffer (p H  8 • 5) Elution buffer (pH  8 • 5)
250 mmol/1 ammonium acetate 200 mmol/1 sorbitol 
50 mmol/1 magnesium chloride 100 mmol/1 tris 
3 mmol/1 sodium azide 50 mmol/1 EDTA
3 mmol/I sodium azide
fr o m  normal a n d  diabetic individuals. These samples 
were stored at 4 ° C  until assayed, u p  to a m a x i m u m  
of seven days.
PREPARATION OF HAEMOLYSATE FOR THE 
DETERMINATION OF STABLE, TOTAL, AND 
LABILE GLYCOSYLATED HAEMOGLOBIN 
Erythrocytes were separated f r o m  plasma by  centri­
fugation at 1 2 0 0 #  for 10 minutes. Approximately 
100 (xl of packed red cells were add e d  to 2 m l  of 
deionised water, a n d  thorough haemolysis w a s  
achieved using a vortex mixer. This diluted h a e m o ­
lysate w a s  divided, a n d  one fraction w a s  incubated 
at 37 ° C  for 5 hours before the determination of 
stable glycosylated haemoglobin.13 T h e  total glyco­
sylated haemoglobin w a s  determined by  analysing 
the unincubated fraction, a n d  the labile material 
w a s  calculated as the difference between the total 
a n d  stable results.
BUFFER COMPOSITION
W a s h  buffer a n d  elution buffer were prepared as 
s h o w n  in Table 1.
ELUTION PROFILE AND AFFINITY 
CHROMATOGRAPHY
C h r o m a t o g r a p h y  columns (Uniscience Ltd, C a m ­
bridge, U K )  containing 1 m l  of affinity gel, Glycogel 
B  (Pierce a n d  Warriner, Chester, Cheshire, U K ) ,  
were prepared, a n d  100 [jlI of haemolysate w a s  
added to the surface a n d  allowed to soak in. Nin e
1-ml volumes of w a s h  buffer were then added to the 
gel a n d  each fraction w a s  collected separately. F o u r
1-ml volumes of elution buffer were added an d  
collected similarly. This gave the elution profile 
(Fig. 1), whi c h  shows that the u n b o u n d  fraction is 
completely r e m o v e d  fro m  the c o l u m n  before the 
elution buffer is used.
After this study the standard procedure adopted 
for clinical samples w a s  to apply 100 fxl of the 
haemolysate to the c o l u m n  a nd allow it to soak in. 
O n e  millilitre of w a s h  buffer w a s  then add e d  to the 
c o l u m n  a n d  allowed to drain in. This w a s  followed 
b y  a further 7 m l  of w a s h  buffer, a n d  the c o m b i n e d  
eluates were collected a n d  m a d e  u p  to 15 m l  with 
buffer. T h e  b o u n d  material w a s  then collected after 
elution with 3 m l  of elution buffer. T h e  absorbances 
of both eluates were measured at 414 n m  ( A ^ a4sh an d  
A|!$ion) using the appropriate buffers as blanks.
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Fig. 1 Elution profile of haemolysate from a 1 ml 
affinity column (Glycogel B).
CALCULATIONS
T h e  per cent b o u n d  material w a s  calculated using 
the following equation:
Glycosylated
haemoglobin
elution 
M14
* wash 
•^414
5 + A--., x 1 W %
REGENERATION OF THE GELS
After use, each c o l u m n  w a s  w a s h e d  with 5 m l  of 
deionised water. followed by 5 m l  of 0-1 m  acetic 
acid a n d  then stored in the dark at 4°C.
Before use, each c o l u m n  w a s  w a s h e d  with 5 m l  
w a s h  buffer, the temperature of which w a s  20rtl°C.
EFFECT OF ANTICOAGULANT
Five millilitres of blood w a s  collected a n d  m i x e d  in 
a tube containing 75 I U  lithium heparin, the anti­
coagulant concentration r e c o m m e n d e d  b y  Seward 
Laboratory ( U A C  House, Blackfriars Rd ,  Lon d o n ,  
U K ) .  Aliquots of this blood were transferred to 
other similar tubes to achieve concentrations of 
3 x  a n d  6 x  the r e c o m m e n d e d  level. Blood w a s  also 
added to tubes containing sod i u m  fluoride, a n d  in a 
similar m a n n e r  different multiples of the r e c o m ­
m e n d e d  concentration of 1 - 0 m g / m l  were achieved. 
All samples were haemolysed a n d  incubated to
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remo v e  the labile fraction before measurement. 
F o u r  samples of each haemolysate were analysed.
EFFECT OF REUSING THE COLUMNS
Five groups of columns were prepared, with five 
columns in each group. E a c h  group w a s  used a 
different n u m b e r  of times for the measurement of 
glycosylated haemoglobin. T h e  n u m b e r  of times 
used were 3, 7, 12, 16, a n d  19 for each group, 
respectively. While not in use the columns were 
stored in the dark at 4°C.
W h e n  all the columns h a d  been used for the speci­
fied n u m b e r  of times (within a period of four weeks), 
all of t h e m  were then used for the replicate measure­
m e n t  of glycosylated haemoglobin in a single 
diabetic haemolysate. E a c h  group w a s  statistically 
co m p a r e d  with a fresh set of five columns.
A  single c o l u m n  w a s  prepared of unused gel which 
h a d  been stored at r o o m  temperature a n d  in the 
light for about three weeks. T h e  percent b o u n d  
haemoglobin for this c o l u m n  w a s  c o m p a r e d  to 
unused columns stored at 4 ° C  a n d  in the dark for 
the s a m e  period of time.
EFFECT OF LOADING DIFFERENT AMOUNTS 
OF HAEMOLYSATE
Erythrocytes collected from normal a n d  diabetic 
individuals were incubated at 3 7 ° C  for 5 hours in 
20 volumes of isotonic saline (154 m m o l / 1  NaC l )  to 
r e m o v e  labile material a n d  recovered by centrifuga­
tion. These red cells were then haemolysed by 
freezing a n d  thawing, a n d  their haemoglobin con­
centration w a s  measured using a Coulter Counter 
(Coulter Electronics Ltd, Luton, Beds). T h e  normal 
haemolysate w a s  then adjusted with water to contain 
10 g/dl haemoglobin a n d  likewise the diabetic 
haemolysate to contain 7 g/dl haemoglobin. E a c h  
w as further diluted to provide haemolysates co n ­
taining 7-0,4-0,2-0,1 -0, a n d  0-5 g/dl haemoglobin.
F o u r  samples of each haemolysate were analysed.
F o r  those samples containing 4 g/dl haemoglobin 
or more, an extra 3 m l  of w a s h  buffer a n d  a n  extra 
3 m l  of elution buffer were used to ensure complete 
removal of the u n b o u n d  a n d  b o u n d  fractions fro m  
the columns.
EFFECT OF STORAGE OF HAEMOGLOBIN
A  20 to 1 dilution of a diabetic haemolysate w a s  
prepared a n d  incubated. S o m e  of this haemolysate 
w a s  tested immediately, a n d  s o m e  aliquots were 
kept at 4 ° C  for analysis after storage for one week. 
Similarly, a 20 to 1 dilution of the s a m e  sample w a s  
prepared using 0-58 m m o l / I  K C N  instead of water 
to lyse the cells. This w a s  treated in a n  identical 
manner.
T h e  remainder of the red cells f r o m  the sample 
were stored undiluted at 4°C, a n d  the haemolysate 
w a s  prepared for analysis after a period of seven days.
All samples were analysed not only at p H  8-5 but 
also at 8-3, 8-1, 7-8, a n d  7-5. T h e  p H  of the appro­
priate w a s h  a n d  elution buffers being adjusted with 
1m  HC1. F o u r  samples of each different haemolysate 
were analysed.
EFFECT OF MET-HAEMOGLOBIN 
CONCENTRATION
Erythrocytes were collected, incubated at 37 ° C  for 
5 hours in 20 volumes of isotonic saline, a n d  re­
covered by centrifugation at 1200 g for 10 minutes. 
Part of the sample w a s  converted to met-h a e m o -  
globin by  incubation with s o d i u m  nitrite solution.14 
Haemolysates containing haemoglobin a n d  met- 
haemoglobin were prepared a n d  mix e d  together in 
k n o w n  proportions. F o u r  columns were tested at 
each met-haemoglobin concentration.
STATISTICS
Statistical comparisons were performed b y  Students 
t test. Linear correlations were calculated b y  the 
least squares method.
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Table 2 Stable and labile glycosylated haemoglobin in normals and diabetics
Hall, Cook and Gould
Stable glycosylated 
haemoglobin ( %)
Labile glycosylated 
haemoglobin ( %)
Labile ( % o f stable)
Normal (n =  12) Mean 6-51 ±0-52 - 0 - 3 4 ± 0 - 4 4 - 5 - 6 5 ± 7 - 3 2
Observed range 5-25 to 7-17 +0-48  to - 1 - 0 4 +  7-22 to -17 -0 6
Diabetic (n =  12) Mean 12-97±2-94 -0 -7 1  ±0-30 - 5 - 9 0 ± 3 -4 0
Observed range 9-81 to 17-28 -0 -3 1  to -1 - 4 2 - 2 - 5 2  to -14 -50
Results
N O R M A L  R A N G E  A N D  P R E C I S I O N
Figure 2 sho w s  the results for 62 normal an d  138 
insulin-treated, supposedly stabilised diabetics. There 
is a wide spread of values for glycosylated h a e m o ­
globin in the diabetic patients, but only 15 h a d  
values within the normal range. Five patients with 
glycosylated haemoglobin values above 1 5 %  h a d  a 
simultaneous blood glucose below 10 mmol/1, 
while three patients with high blood glucose h a d  
glycosylated haemoglobin values below 1 0 % .  T h e  
normal range is m o r e  com p a c t  but has within it 
tw o  different populations: normal subjects, the 
laboratory workers (6-51 ± 0 - 5 2 % ) ,  a n d  the n o n ­
diabetic patients (7 - 4 5 ± 0 - 9 0 % ) .  T h e  t w o  groups 
differ significantly (p <  0 001).
T h e  m e a n  value for 62 normals for glycosylated 
haemoglobin w a s  7-31 ± 0 - 9 2 %  (observed range
5-25-9-70%) a n d  for 138 diabetics 1 2 - 7 0 ± 2 - 8 8 %
(observed range 6-50-21-5%). T h e  tw o  groups are 
significantly different (p <  0-001).
T h e  m e t h o d  w a s  very precise. T w e n t y  replicate 
estimations using a normal sample ( m e a n  value 
6-81 ± 0 - 1 4 % )  a n d  a diabetic sample ( m e a n  value 
20-04 ± 0 - 3 0 % )  gave coefficients of variation of
2 - 0 %  a n d  1-5%, respectively. T h e  recovery of 
haemoglobin, as judged by absorbance at 414 n m ,  
w a s  about 98 %.
L A B I L E  G L Y C O S Y L A T E D  H A E M O G L O B I N
T h e  results of measurement of labile haemoglobin in 
12 normals a n d  12 diabetics are summarised in 
Table 2. Although the labile glycosylated h a e m o ­
globin is subject to greater change in diabetics than 
in normals, w h e n  this change is expressed as a 
percentage of the stable form, both groups s h o w  
changes between 5 %  a n d  6 % .  There are large 
variations in the a m o u n t  of labile material between 
different individuals in both groups, an d  indeed
Table 3 Effect of loading different amounts of haemoglobin onto affinity columns
Amount o f haemoglobin loaded (mg)
0-5 1-0 2-0 4-0 7-0 1 0 0
Normal % Glycosylated 
haemoglobin
6-43 6-59 6-49 5-73 5-29 4-91
SD 0-31 0-13 0-11 0-18 0-17 0-07
Diabetic % Glycosylated 
haemoglobin
13-64 13-90 13-63 14-34 12-49 —
SD 0-23 0-14 0-44 0-45 0-31 —
Table 4 Effect of sample storage on percent glycosylated haemoglobin
p H  o f buffers
7-5 7-8 8-1 8-3 8-5
Haemolysate Mean 16-74 17-57 17-09 17-34 17-18
SD 0-12 0-35 0-31 0-49 0-07
Haemolysate stored 7 days at 4°C Mean 15-50 16-70 17-14 17-37 16-60
SD 0-45 0-15 0-30 0-13 0-22
Erythrocytes stored 7 days at 4°C Mean 15-70 16-50 16-65 17-14 16-29
then haemolysed SD 0-41 0-09 0-10 0-30 0-25
Haemolysate containing cyanide Mean 16-77 17;81 18-24 18-24 17-64
SD 0-49 0-17 0-31 0-12 0-26
Haemolysate containing cyanide stored Mean 17-26 18-69 18-63 19-13 18-46
7 days at 4°C SD 0-16 0-29 0-20 0-21 0-09
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tw o  of the normals s h o w e d  increases rather than 
decreases in the stable glycosylated haemoglobin 
after incubation, although one of these w a s  within 
the variation of the method. There is not a significant 
correlation between labile glycosylated h a e m o ­
globin a n d  glucose.
E F F E C T  O F A N T I C O A G U L A N T  
There wa s  no  significant difference between the t wo 
anticoagulants, lithium heparin a n d  sodi u m  fluoride, 
w h e n  used in blood in which glycosylated h a e m o ­
globin is to be measured. There is n o  significant 
effect w h e n  these t w o  anticoagulants are used at 
their standard concentration or at concentrations u p  
to six times the r e c o m m e n d e d  levels.
R E - U S E  O F A F F I N I T Y  C O L U M N S  
Glycosylated haemoglobin w a s  measured o n  groups 
of columns that h a d  been prepared simultaneously 
but used a varying n u m b e r  of times. T h e  s a m e  
diabetic haemolysate w a s  loaded o n  all the columns 
a n d  this s h o w e d  that there w a s  a small decrease in 
the a m o u n t  of b o u n d  material with increasing usage. 
However, w h e n  c o m p a r e d  with fresh columns, this 
decrease w a s  less than 2 %  for all groups of columns, 
except those that h a d  been used m o r e  than 16 times. 
T h e  columns that h a d  been used 19 times s h o w e d  a 
decrease from 2 0 - 2 4 ± 0 - 3 9 %  to 1 9 - 7 2 ± 0 - 1 2 % ;  
this is a significant difference (p <  0-05).
T h e  columns gradually b e c o m e  darker with re-use, 
particularly at the surface of the gel. W h e n  fresh 
gel is kept in the light it b ecomes dark purple in 
colour. A  c o l u m n  of this material, although not 
previously used to analyse samples, w a s  s h o w n  to 
have a reduced capacity to bind glycosylated 
haemoglobin. A  glycosylated haemoglobin value of 
6 - 2 2 %  w a s  observed c o m p a r e d  to 1 2 - 1 1 %  for the 
s a m e  sample using fresh columns.
E F F E C T  O F  L O A D I N G
Table 3 shows that the value of percent glycosylated 
haemoglobin obtained for normals a n d  diabetics is 
independent of loading between 0-5 a n d  2-0 m g  of 
haemoglobin onto the column. W h e n  in excess of
4-0 m g  for the normals a n d  7-0 m g  for the diabetics 
is applied, the columns b e c o m e  overloaded. In 
excess of these values the binding of the glyco­
sylated haemoglobin is impaired a n d  causes signifi­
cantly lower results ( p  <  0-001).
E F F E C T  O F S T O R A G E ’
Table 4 sho w s  h o w  different storage conditions 
affect glycosylated haemoglobin values over the p H  
range 7-5-8-5. F o r  fresh haemolysate the values 
obtained for p H  7 • 8-8 • 5 are equivalent. Storage of 
haemolysate at 4 ° C  for seven days causes a decrease
in value for p H  7 • 8 a n d  8 • 5 c o m p a r e d  to p H  8 • 1 a n d  
8-3. A  similar trend is found w h e n  erythrocytes are 
kept for seven days at 4 ° C  before preparation of the 
haemolysate. In this case only the value at p H  8-3 
is not different f r o m  the original value of fresh 
haemolysate.
Cyanide increases the values of glycosylated 
haemoglobin at all p H s  studied, a n d  these values 
increased further w h e n  the haemolysate containing 
cyanide w a s  stored for seven days at 4 ° C  (Table 4).
E F F E C T  O F M E T - H A E M O G O L B I N
Haemolysates prepared f r o m  normal a n d  diabetic 
individuals containing u p  to 20 %  met-haemogolbin 
were tested. Despite the very high concentrations of 
met-haemoglobin present, there w a s  n o  significant 
difference in percent glycosylated haemoglobin for 
any of the haemolysates.
Discussion
T h e  met h o d s  for measuring glycosylated h a e m o ­
globin can be considered in t w o  categories. There 
are those that separate parts of the glycosylated
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haemoglobin by m e a n s  of their very small charge 
differences (these include the ion-exchange a n d  
electrophoretic methods) a n d  there are those that 
m a k e  use of the carbohydrate portion of the glyco­
sylated haemoglobin (these include the colorimetric 
a n d  affinity chromatography methods). O f  the t wo 
meth o d s  in this latter category, affinity c h r o m a t o ­
graphy has three important advantages over the 
colorimetric technique. First, it has greater sensi­
tivity; second, all types of glycosylated haemoglobin 
are measured with equal weighting at 414 n m ;  and, 
third, the difficulties associated with blank absor­
bance correction are avoided.
T h e  theoretical basis of the affinity m e t h o d  is 
illustrated in Figure 3. This shows that the m- 
aminophenyl boronate agarose (Glycogel B) has 
an  affinity for cis-diol groups. These are found 
predominantly in carbohydrate or carbohydrate- 
containing molecules. These molecules combine 
with the gel while other molecules pass straight 
through (Fig. 1). T h e  molecules that have c o m b i n e d  
with the gel can then be eluted using a competing 
ligand at high concentration, 200 mmol / 1  sorbitol. 
All forms of glycosylated haemoglobin, including 
H b A x a n d  the forms not normally separated from 
H b A , 8 should be retained by the gel. T h e  specificity 
for haemoglobin a n d  its glycosylated forms is due 
to measurement at 414 n m .
T h e  affinity gel gives a clear-cut separation be­
tween the tw o  fractions (Fig. 1), but if it w a s  co n ­
sidered necessary this separation could be improved 
by using m o r e  w a s h  buffer. T h e  procedure r e c o m ­
m e n d e d  here takes about 40 minutes for a single 
c o l u m n  run, a nd 30 columns can be run by one 
operator at any one time. This is possible because 
the gel does not dry out, even if left to drain for 
several hours. This simplifies the change over from 
w a s h  buffer to elution buffer. T h e  gels can be re­
generated a n d  re-used the s a m e  day, allowing 60 
samples to be completed in a working day.
T h e  m e t h o d  has high precision with coefficients 
of variation for within-batch a n d  between-batch 
samples of 1-5 to 2 - 0 % .  This is possible because 
there are n o  critical small-volume measurements. 
T h e  measurements that affect the precision are the 
adjustment of the w a s h  sample to 15 ml, a n d  the 
accurate pipetting of 3 m l  of elution buffer for 
collection. T h e  m e t h o d  is simplified by the fact that 
the red cells d o  not have to be washed, a n d  the 
pipettings to produce the haemolysate a n d  load the 
c o l u m n  d o  not affect the precision of the m e t h o d  
since the final glycosylated haemoglobin concentra­
tion is expressed in proportional a n d  not absolute 
terms. There is also n o  need for stringent control of 
temperature or p H  as long as these are kept within 
the guidelines indicated.11
T h e  m e t h o d  gives g o o d  discrimination between 
normals a n d  diabetics (Fig. 2). T h e  glucose results 
incorporated in Fig. 2 s h o w  that a diabetic with high 
glycosylated haemoglobin does not necessarily 
have a high simultaneous blood glucose, an d  vice 
versa. This implies that glycosylated haemoglobin 
is the m o r e  useful measurement for monitoring 
long-term diabetic control. T h e  normal range has 
within it tw o  significantly different populations: 
normal subjects (the laboratory workers) a n d  the 
non-diabetic patients. This is possibly age-related as 
the laboratory workers were generally between the 
second a n d  third decades while the patient popula­
tion wa s  predominantly of middle to older age. Since 
only 12 laboratory workers were studied a m o r e  
extensive survey is required to confirm this, although 
a comparable finding w a s  reported by Boucher 
et al.15
T h e  removal of the labile fraction by incubation is 
re c o m m e n d e d .  This is necessary since the percentage 
of labile material varies considerably between 
individuals a n d  is not apparently related to blood 
glucose concentration in the s a m e  sample. T h e  
m e t h o d  is very versatile. Since either lithium 
heparin or sodium fluoride m a y  be used as anti­
coagulants, it is possible to d o  the test o n  most of the 
blood received routinely. T h e  use of sodium fluoride 
allows simultaneous measurement of blood glucose 
a n d  glycosylated haemoglobin o n  a single sample. 
Very little sample is required, so that glycosylated 
haemoglobin can be measured in blood taken fro m  a 
fingerprick. T h e  results in Table 3 s h o w  that the 
binding is independent of the a m o u n t  of h a e m o ­
globin between 0-5 m g  a n d  2-0 m g  loaded per 
column. This is equivalent to a haemoglobin c on­
centration between 5 • 0 g/dl a n d  20 g/dl in the original 
sample, assuming a packed cell v o l u m e  of 5 0 % .  
This m e t h o d  is applicable to almost the entire range 
of concentrations encountered in normals an d  
patients. It should be remembered, however, that 
other features such as reduced red cell survival time 
m a y  affect the glycosylated haemoglobin result.
Storage of both the samples a n d  the gel is i m ­
portant. T h e  results (Table 4) indicate that i m ­
mediate analysis of the stable haemolysate is 
preferable, but storage at 4 ° C  for u p  to a w e e k  still 
enables 9 6 %  of the original result to be obtained. 
T h e  p H  of both buffers w a s  8 • 5 for mos t  of the work, 
as this is r e c o m m e n d e d  by Mallia et al.10; but the 
findings s h o w  that p H  8-3 m a y  be preferable since 
it appears to nullify the difference in percent glyco­
sylated haemoglobin in fresh a n d  stored samples. 
T h e  use of cyanide in the preparation of the h a e m o ­
lysate causes spurious increases in results a n d  is not 
therefore recommended.
W e  have s h o w n  that the columns can be used a t
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least 16 times by  regeneration between use. This is 
important as it effectively reduces the cost of the gel 
to 7p for each test. A  darkening of the gels with 
re-use coincides with a reduction in their binding 
capacity. This is a light-dependent oxidation process. 
F o r  this reason w e  r e c o m m e n d  that between use the 
columns are stored at 4 ° C  a n d  in the dark. T o  
reverse this process w e  have tried various reducing 
substances, such as s o d i u m  borohydride a n d  
ascorbic acid, but as yet without success.
In conclusion, the affinity gel appears to fulfil the 
need for a simple, inexpensive, reproducible tech­
nique for the measurement of glycosylated h a e m o ­
globin in the routine clinical laboratory. It is a 
versatile m e t h o d  which is not affected b y  met- 
haemoglobin a n d  should give correct values even 
for samples containing genetic variants of h a e m o ­
globin.
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A sensitive method for the measurement of 
glycosylated plasma proteins using affinity 
chromatography
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s u m m a r y .  W e  describe a simple, sensitive affinity technique for the routin 
m easurement of glycosylated plasma proteins in clinical laboratories. T h e  c o m  
mercially available phenylboronic acid gel used for the chromatography has recentl 
been marketed as a kit for this purpose (Glycogel Test Kit, Pierce Chemical Co) 
T h e  manufacturers of this kit r e c o m m e n d  loading 200 p.1 neat plasma to each 1 m  
gel column. This high loading is to enable the direct measurement of protein in th 
b o u n d  and u n b o u n d  fractions at 280 nm .  This loading is consistent with 10-15 m  
protein being added per ml gel. O u r  results s h o w  that protein levels greater tha 
2 m g  per ml gel overload the column. Therefore w e  used a modification of th 
m o r e  sensitive Bradford procedure to measure protein. T h e  m e t h o d  discriminate 
between normals (6-29 ±  1-87%) and diabetic patients (12-62 ±  3 - 3 6 % )  and ha 
g o o d  precision ( C V  4-6%). T h e  results obtained correlate with the colorimetri 
m e t h o d  using thiobarbituric acid (r =  0-70) and with glycosylated haemoglobi 
(r =  0-82).
T h e  measurement of glycosylated haemoglobin is 
gaining increasing use in the m a n a g e m e n t  of patients 
with diabetes.1 Other proteins are also glycosylated 
non-enzymically, and it has been s h o w n  that both 
glycosylated albumin an d  glycosylated plasma 
proteins respond m o r e  quickly than glycosylated 
haemoglobin to improvement in glycaemic control.2 3 
T h e  original m e t h o d  for measuring glycosylated 
albumin ,4 which involves isolation of the pure 
protein followed by estimation of the glycosylated 
fraction, is laborious. Glycosylated plasma proteins 
can be estimated directly by a colorimetric m e t h o d 5 
or after protein precipitation.6 F o r  accurate results, 
these methods also require the estimation of protein, 
the removal of glucose,7 an d  correction for back­
ground colour8 o n  each sample. A  specific m e t h o d  
for quantitation of the lysine-bound glucose in 
serum albumin an d  other glycosylated proteins is 
also available.9 This requires isolation of pure 
protein, followed by hydrolysis and then analysis by 
H P L C .
N o n e  of the available methods for measurement 
of glycosylated plasma proteins is suitable for 
routine analysis in the clinical laboratory. There 
have been several recent reports on the use of simple
Reprint requests and correspondence to Dr BJ Gould.
affinity c o l u m n  methods for the measurement o 
glycosylated haemoglobins .10-14 A  similar c h r o m a  
tographic procedure should separate glycosylate 
plasma proteins from their non-glyccsylated counter 
parts. T h e  gel used is a /?/-aminophenylboronat 
agarose, which binds selectively to m-diols .1 
Therefore the b o u n d  fraction measured by thi 
m e t h o d  should detect those proteins in plasma tha 
have free m-diol groups. These will include al 
proteins which have combined non-enzymically wit 
glucose. It is this group, the glycosylated plasm 
proteins, which are k n o w n  to be elevated in diabete
Materials and methods
SAMPLE COLLECTION, PREPARATION OF PLASM 
M E A S U R E M E N T  OF G L U C O S E
Blood samples were collected into lithium hepari 
tubes from normal and diabetic individuals. Thes 
samples were stored at 4 ° C  until assayed u p  to 
m a x i m u m  of seven days. Plasma w a s  separated fron 
erythrocytes by centrifugation at 1200 g for 1 
minutes; 100 p.1 plasma w as added to 2 ml deionise 
water an d  mixed using a vortex mixer. T h e  dilute 
plasma wa s  incubated for 5 hours at 3 7 cC  before th 
determination of glycosylated plasma proteins.
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W h o l e  blood glucose w a s  measured within 10 
inutes of sampling using the Yellow Springs 
lucose Analyser M o d e l  23 A M  (Yellow Springs 
nstrument Co, Yellow Springs, O H  45387, U S A ) .
F F I N I T Y  C H R O M A T O G R A P H Y
hromatography columns (Uniscience Ltd, 
ambridge, U K )  containing 1 ml of affinity gel, 
lycogel B  (Pierce a n d  Warriner, Chester, Cheshire, 
K )  were prepared. T h e y  were equilibrated with 
m l  w a s h  buffer (250 m m o l  /I a m m o n i u m  acetate, 
0 mmol/1 m a g n e s i u m  chloride, a n d  3 mmo l / 1  
o d i u m  azide, p H  adjusted to 8-5) at 20 ±  1°C. 
nitially, 150 jj.1 diluted plasma w a s  applied to the top 
f the c o l u m n  a n d  allowed to soak in. T h e n  1 m l  
ash buffer wa s  added to the surface of the gel an d  
llowed to drain in. This w a s  followed by a further 
m l  w a s h  buffer, a n d  the c o m b i n e d  eluates were 
ollected an d  m a d e  u p  to 24 m l  with w a s h  buffer, 
he b o u n d  material w a s  then collected by  elution 
ith 3 m l  elution buffer (200 m m o l / I  sorbitol, 
0 mmol/1 E D T A ,  3 m m o l / 1  sodium azide, an d  
100 mmol/I tris, p H  adjusted to 8-5) also at 20 ±  
1°C. Preliminary w o r k  s h o w e d  that this procedure 
ompletely separated the u n b o u n d  fraction fr o m  the 
o u n d  fraction. T h e  protein in the b o u n d  a nd 
n b o u n d  fractions w a s  determined by a modification 
of the m e t h o d  of Bradford15 using the Biorad 
Protein Assay reagent (Bio-Rad Laboratories, 
Watford, Herts, U K ) .  T h e  reagent w a s  diluted with 
ater a nd glacial acetic acid in the ratio 4:5:1, 
espectively, filtered, an d  then mixed with an equal 
volume (0-5 ml) of either the b o u n d  or the u n b o u n d  
fractions in disposable microcuvettes. Blank cor­
rections were m a d e  by use of a c o l u m n  to which 
water instead of plasma h a d  been added. After 
30 minutes the absorbances were measured at 
595 n m .  Using this modified reagent it w a s  s h o w n  
that Beer’s L a w  w a s  obeyed for increasing concen­
trations of plasma proteins in either w a s h  buffer or 
elution buffer for absorbances u p  to 0-6. W a s h  
buffer an d  an equal v o l u m e  of acidified Biorad 
Protein Assay reagent w a s  used as a blank. Replace­
men t  with elution buffer gave an almost identical 
blank absorbance. T h e  linearity of the technique 
allowed the absorbances of both eluates ( A 59511 and 
A ^ u5tion) to be measured a n d  the b o u n d  proteins to 
be expressed as a percentage of the total.
T h e  b o u n d  material w a s  calculated using the 
following equation:
Glycosylated plasma proteins % =
A elution
 _ ------------ x 100%
A wash s / 0  . \  elution 
595 ^  °  +  A 595
Fo r  the determination of glycosylated h a e m o ­
globins, erythrocytes were diluted 1 in 20 with 
deionised water, vortex mixed, and incubated for
5 hours at 37 °C. T h e  affinity chromatography used 
conditions identical with those described for plasma 
proteins except that only 100 g.1 of a 1 in 20 h a e m o ­
lysate wa s  added to the column. T h e  absorbances at 
414 n m  of the u n b o u n d  fraction, diluted to 15 m l  
with w a s h  buffer, a n d  b o u n d  fraction were deter­
m i n e d  a n d  the percentage of glycosylated h a e m o ­
globin w a s  calculated. This m e t h o d  has been fully 
evaluated.13
R E G E N E R A T I N G  G E L S  A N D  
R E U S I N G  C O L U M N S
After use, each c o l u m n  w a s  wash e d  with 5 m l  
deionised water, followed by 5 m l  0 • 1 m  acetic acid, 
an d  then stored in the dark at 4°C. T h e  effect of 
reusing the columns w a s  tested with columns, five in 
each group, that h a d  been used three, six an d  nine 
times over a period of four weeks.
L O A D I N G  D I F F E R E N T  A M O U N T S  OF 
P R O T E I N  O N  T O  T H E  C O L U M N  
Plasma fr o m  a diabetic patient w a s  incubated a n d  
dialysed against saline at 3 7 ° C  for 5 hours to r e m o v e  
any labile glycosylated material. T h e  concentration 
of protein in this sample w as then measured using a 
standard biuret method. Different dilutions of this 
plasma in deionised water were prepared. T h e n  
150 (d of each dilution wa s  added to a set of four 
prepared columns, which w a s  equivalent to adding
2-0, 1-0, 0-5, an d  0-25 m g  protein, respectively. 
Similarly, tw o  groups of four columns h a d  100 [d a n d  
200 [d undiluted plasma applied, which w a s  co n ­
sistent with adding 6-7 an d  13-4 m g  protein to each 
column. All of the c o l u m n  groups were analysed 
using the standard procedure, but to ensure that all 
of the b o u n d  and u n b o u n d  material wa s  recovered, 
tw o  additional 3 m l  volumes of w a s h  buffer were 
collected and one additional 3 m l  elution buffer. T o  
enable all the eluates to be measured within the 
linear range of the protein reagent, appropriate 
dilutions in w a s h  or elution buffer were m a d e  before 
the addition of the acidified Biorad Protein Assay 
reagent.
A n  identical protein-loading investigation wa s  
repeated using plasma obtained from a normal 
individual. This plasma w a s  diluted so as to provide 
the s a m e  loading of protein o n  to the columns as 
with the diabetic sample.
Fo r  both the normal a nd the diabetic sample, 
where neat plasma w a s  loaded, the absorbances of 
the eluates at 280 n m  were noted before any 
secondary dilutions were m a d e  or acidified Biorad 
Protein Assay reagent w a s  added. W a s h  buffer or 
elution buffer, as appropriate, were used as blanks.
M E A S U R E M E N T  OF G L Y C O S Y L A T E D  P L A S M A  
P R O T E I N S  U S I N G  T H E  F L U C  K I G E R  A N D  
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T h e  m e t h o d  used w a s  a slight modification of that
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r e c o m m e n d e d  by M a  et a lP  0-5 m l  plasma was 
diluted with 4-5 m l  cold 0-15 mol/1 NaCl, an d  the 
protein w a s  precipitated with 0-5 m l  2-5 mol/1 
T C A  followed by centrifugation at 1200 g for 10 
minutes. T h e  supernatant w a s  discarded a n d  the 
protein resuspended in 4-5 m l  cold 0-15 mol/1 
N a C l  by sonication with a microprobe (Daw e s  
Instruments Ltd, London, U K ) .  A  translucent-to- 
clear stable preparation w a s  obtained. O f  this 
protein suspension 3-0 m l  w a s  put in a stoppered 
quick-fit tube, together with 1-5 ml 1 m oxalic acid 
a nd heated in a boiling water bath for 4-5 hours. 
T h e  tubes were cooled for 10 minutes before 1 - 5 ml 
cold T C A  w a s  added to each tube a n d  mixed using a 
vortex mixer. T h e  samples were centrifuged at 1 2 0 0 g  
for 10 minutes a n d  2 m l  supernatant w a s  transferred 
to a clean tube containing 0-5 m l  freshly prepared 
saturated thiobarbituric acid. After mixing, all 
samples were incubated at 4 0 ° C  for exactly 30 
minutes, and each sample w as read at 443 n m  
against its o w n  blank. A  fructose standard curve 
(0-0-25 mmol/I final concentration) w a s  put through 
with each run to ensure standardisation of the 
procedures.
Protein w a s  estimated in the original sonicated 
preparation by the biuret method, and the degree of 
glycosylation wa s  expressed as absorbance at 
443 n m  per g protein.
S T A T I S T I C S
Linear correlations were calculated by the least 
squares method. Statistical comparisons were 
performed by Student’s t test.
Results
R E U S E  O F A F F I N I T Y  C O L U M N S  
T h e  s a m e  diabetic sample w a s  loaded o n  all the 
columns, an d  this s h o w e d  that only columns used 
nine times s h o w e d  a significant decrease ( p < 0-001) 
from 1 5 - 6 8 ± 0 - 3 3 %  to 1 4 - 0 9 ± 0 - 3 2 % .  Therefore 
columns could safely be reused six times although 
they gradually b e c a m e  darker with reuse.
E F F E C T  O F P R O T E I N  L O A D I N G
Table 1 shows the percentage of glycosylated plasma
proteins for normal a n d  diabetic samples w h e n
different a m o u n t s  of plasma were loaded o n  to th 
affinity columns. T h e  values obtained were indepen 
dent of loading w h e n  the a m o u n t  of plasma protei 
loaded w a s  between 0 • 25 and 2 m g  per 1 m l  col u m 
a n d  w h e n  protein wa s  estimated with acidifie 
Biorad reagent. W h e n  larger amou n t s  of nea 
plasma were loaded on  to the columns and th 
proteins were measured using Biorad reagent ther 
wa s  a significant decrease in the percentage of th 
glycosylated fraction (p<0-001). A t  a  loading o 
13-4 m g  protein per c o l u m n  the decrease w a s  41 ° 
a n d  33 %  for normal and diabetic samples, respect 
ively. T o  achieve the o p t i m u m  concentration o 
protein to permit the use of the Biorad m e t h o d  wit 
high c o l u m n  loading it w a s  necessary to dilute th 
eluate very considerably. This almost certainl 
accounts for the wider standard deviation of th 
results. W h e n ,  with neat plasma loading, the protei 
w a s  measured directly at 280 n m  instead of wit 
Biorad reagent the results were significantly highe 
an d  ha d  a smaller standard deviation. However, th 
trend of decreasing values with increasing load fro
6-7 m g  to 13-4 m g  per ml  of c o l u m n  is still observe 
for both normal (p<0-001) a nd diabetic (p<0-01 
samples.
Recovery experiments gave in excess of 9 7 %  
recovery of protein for both diluted and neat plasma
N O R M A L  R A N G E  A N D  P R E C I S I O N  
Figure 1 shows the results for 58 normal a nd 15 
insulin-treated, supposedly stabilised diabeti 
patients. There is a wide spread of values fo 
glycosylated plasma proteins in the diabetic patients 
a n d  38 h a d  values within the observed normal range 
Also, of the 35 patients with glycosylated plasm 
proteins above 1 5 % ,  14 ha d  simultaneous bloo 
glucose levels below 10 mmol/l. O u t  of 38 patient 
w h o  h a d  glycosylated plasma protein values of les 
than 1 0 % ,  only four ha d  high blood glucose values 
T h e  normal range is m o r e  compact an d  has within i 
tw o  populations: normal laboratory staff (5-73±
0 - 9 0 % )  a n d  non-diabetic patients (6-43 ± 2 - 0 3  %). 
However, the t w o  groups do not differ significantly.
T h e  m e a n  value for the 58 normals for glycosy­
lated plasma proteins w a s  6 - 2 9 ± 1 - 8 7 %  (observed 
range 2-95-10-27%) and for the 153 diabeti 
patients it w a s  12-62 ± 3 - 3 6 %  (observed rang
Table 1 Effect of loading different amounts of plasma protein onto affinity columns {I ml gel)
Sample Amount o f plasma protein loaded (mg)
0-25 0-5 1-0 2-0 6-7 13-4 6-7* 13-4*
Normal % Gycosylated 
plasma protein
6-95 6-93 6-83 7-16 5-83 4-20 7-15 6-06
SD 0-25 0-33 0-30 0-22 0-19 0-73 0-16 0-05
Diabetic % Glycosylated 
plasma protein
13-21 13-24 13-25 13-14 8-96 8-77 11-97 11-50
SD 0-34 0-48 0-50 0-19 0-61 0-28 0-17 0-11
*Value determined at 280 nm.
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Fig. 1 Histogram showing the distribution of %  glycosy- 
ated plasma proteins for diabetic and normal individuals. 
A Results for individual laboratory staff.
•  Results for individual diabetics with blood glucose above 
10 mmol 11.
•05-23-31%). T h e  two groups differ significantly
(p<0-001).
Replicate estimations were do n e  o n  normal an d  
diabetic samples; each gave a coefficient of variation 
of less than 4 % .  Between-batch variation for a 
diabetic sample gave a coefficient of variation of
5 - 3 %  and for a normal 6 - 2 % .
C O R R E L A T I O N  O F G L Y C O S Y L A T E D  P L A S M A  
P R O T E I N S  W I T H  G L U C O S E  A N D  
G L Y C O S Y L A T E D  H A E M O G L O B I N  
T h e  glucose concentration of whole blood samples 
taken from 153 diabetic individuals w a s  determined. 
There wa s  a poor correlation between these values
20 -
a
T>
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20 -
G ly c o sy la te d  p la sm a  p ro te in s  co lorim etric  
m eth od  (A b s^ 3 3  /g  p ro te in )
(°/o) g ly c o s y la t e d  h a em o g lo b in
Fig. 2 Correlation between %  glycosylated haemoglobin 
and % glycosylated plasma protein, both determined by the 
affinity method. Normals (a );  diabetic patients ( • ) .
Fig. 3 Correlation between glycosylated plasma proteins 
measured by the colorimetric method and by the affinity 
method. Normals ( a ) ;  diabetic patients ( • ) .
a nd glycosylated plasma proteins measured o n  the 
s a m e  samples (r=0-38).
Glycosylated plasma proteins a n d  glycosylated 
haemoglobin were measured by the affinity m e t h o d  
o n  blood samples from 16 normals a n d  153 diabetic 
patients. Figure 2 shows that there is a g o o d  
correlation (r=0-82).
T h e  line passes close to the origin an d  has a slope 
close to unity (0-94).
C O R R E L A T I O N  O F  G L Y C O S Y L A T E D  P L A S M A  
P R O T E I N  M E A S U R E D  BY T H E  A F F I N I T Y  
M E T H O D  A N D  T H E  C O L O R I M E T R I C  M E T H O D  
Figure 3 sho w s  that there w a s  a  correlation (r=0-7) 
between glycosylated plasma proteins measured by 
the c o m m o n l y  used colorimetric m e t h o d  a n d  the 
affinity method. T h e  slope of the line w a s  2-93 a n d  
there w a s  a positive intercept of 3-2 A 443 per g 
protein o n  the x-axis.
Discussion
T h e  affinity m e t h o d  described in this paper provides 
a simple an d  sensitive assay for the measurement of 
glycosylated plasma proteins. T h e  separation of n o n ­
glycosylated a n d  glycosylated material is clear-cut 
an d  rapid, allowing u p  to 50 samples to be analysed 
in a working day. Affinity chromatography has three 
m a i n  advantages over the colorimetric m e t h o d  
which has previously been the m e t h o d  of choice for 
the measurement of glycosylated plasma proteins. 
Firstly, it does not require removal of glucose; 
secondly, sample blanks are unnecessary; and, 
thirdly, it does not require poisonous reagents such
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as oxalic acid an d  thiobarbituric acid. Also the 
colorimetric m e t h o d  requires m u c h  larger samples 
since 5-hydroxymethylfurfural is formed, even after 
prolonged acid treatment, in only small non- 
stoichiometric amounts,1 an d  the colour yield of this 
m e t h o d  is not the s a m e  for all proteins.18
Since this w o r k  began, Glycogel B  has b e c o m e  
available in kit f o r m  for the measurement of glyco­
sylated plasma proteins a n d  glycosylated albumin. 
According to the instructions supplied with each kit, 
a c o l u m n  loading of 200 [d neat plasma is used for 
the assay. This represents an addition of 10— 15 m g  
protein per m l  gel, an a m o u n t  that is needed because 
of the insensitivity of the direct m e t h o d  for protein 
measurement at 280 n m .  O u r  results (Table 1) s h o w  
that protein in excess of 2 m g  per m l  gel causes over­
loading with correspondingly lower results for the 
percentage of glycosylated plasma proteins. T h e  
recovery of protein is not altered by  different 
loadings. However, as the loading increases, the 
binding sites available to glycosylated molecules 
presumably b e c o m e  saturated. Tho s e  in excess are 
therefore collected in the u n b o u n d  fraction, causing 
the decrease in the percentage of the b o u n d  material 
that w a s  observed w h e n  m o r e  than 2 m g  protein per 
c o l u m n  w a s  used. This m a y  be an over-simplification 
in view of the relatively small decreases found with 
m u c h  higher loadings an d  will require further study.
T h e  m e t h o d  for measuring protein is critical. T h e  
modified Bradford m e t h o d  is not only m o r e  sensitive 
than measuring the absorbance at 280 nm ,  thus 
allowing a lower loading, but also m o r e  specific 
since m a n y  c o m p o u n d s  other than protein absorb 
at 280 n m .  There is significant protein-to-protein 
variation with the direct m e t h o d  an d  with the 
Bradford method. T h e  latter is k n o w n  to have a 
greater colour yield with albumin than most other 
proteins.19 This protein-to-protein variation pre­
sumably accounts for the different answers obtained 
by the t w o  methods. It is essential for this m e t h o d  
using Bradford reagent that the colour yield of 
plasma proteins is directly proportional to concen­
tration over the range used so that the calculation of 
the ratio of b o u n d  to total protein is valid. W e  have 
s h o w n  that direct proportionality exists up  to 
A = 0 - 6 .  There is a small an d  slow decrease in this 
absorbance with time so that accurate results require 
a constant incubation, in this case 30 minutes.
T h e  cost of the assay is decreased by the fact that 
the affinity gel can be reused about six times although 
for the estimation of glycosylated haemoglobin the 
gels can be reused about 16 times. During reuse the 
gel darkens due to an oxidative process.20
T h e  m e t h o d  has g o o d  precision with a coefficient 
of variation of about 4 %  within batch and 5 - 6 %  
between batch, although this is not as g o o d  as 
reported for estimations of glycosylated h a e m o ­
globin1020 ( C V < 2 % ) .  Also the discrimination
between diabetic individuals a n d  normals is not s 
m a r k e d  with glycosylated plasma proteins (Fig. 1 
as with haemoglobins.20 This could be due to th 
poorer precision or to the m o r e  rapid fluctuations o 
a m o u n t s  of glycosylated plasma proteins that hav 
been reported.2 However, the values for glycosylate 
plasma proteins for non-diabetic subjects (mea
6 - 2 9 ± l -87 % )  a n d  the range for diabetic subject 
(6-05-23-31%) are in g o o d  agreement with th 
values for glycosylated albumin obtained b 
G u t h r o w  et al.21 T h e y  found a m e a n  level of glyco 
sylated albumin of 7 - 0 ± l - 9 %  in non-diabeti 
subjects and a range of 12-8- 2 6 - 0 %  in 22 diabeti 
subjects.
T h e  relatively poor correlation of glycosylated 
plasma proteins with glucose (r=0-38) is similar to 
that in other reports.17 T h e  correlation with th 
colorimetric m e t h o d  (r=0-7) indicates that the tw 
m ethods are measuring similar moieties. T h e  slop 
of this graph (2-93) m a y  be an indication of th 
greater sensitivity of the affinity m e t h o d  but i 
should be noted that the units for the two axes ar 
quite different (Fig. 3). T h e  cause for the intercept on 
the x-axis is not clear since the colorimetric m e t h o  
used17 takes into account the k n o w n  interference b 
glucose an d  the need for an individual blank. It m a  
be that there is s o m e  other interfering material tha 
is yet to be identified. T h e  multiplication facto 
required to produce the colorimetric values is ver 
large a n d  m a y  obscure the picture. In contrast t 
Fig. 3, the correlation s h o w n  in Fig. 2 betwee 
glycosylated plasma proteins an d  glycosylate 
haemoglobin, both measured by the affinity m e t h o d  
has a slope close to unity an d  goes virtually throug 
the origin. These results were not expected since i 
theory the plasma glycoproteins should bind to th 
affinity gel a nd cause a significant positive intercep 
value o n  the y-axis of Figure 2.
W e  have s h o w n  that glycosylated plasma protein 
can be measured by a simple, sensitive affinity 
procedure. T h e  m e t h o d  has been used in a routin 
laboratory, alongside the similar m e t h o d  fo 
glycosylated haemoglobin, a nd is only slightly mo.r 
complex. It should n o w  be possible to assess whic 
of these tw o  measurements is most useful to th 
clinician in particular situations, for example 
diagnosis of diabetes mellitus, following the treat 
m e n t  of patients with hyperglycaemic coma, an 
monitoring diabetic pregnancies.22 A  minor advan 
tage in this respect is that the affinity m e t h o d  unlik 
the colorimetric procedure gives results directly as * 
percentage, as is the case with most methods fo 
glycosylated haemoglobin. However, it is necessar 
that the m e t h o d  r e c o m m e n d e d  by the manufacturer 
for the measurement of glycosylated plasma proteins 
which appears to give incorrect results because th 
columns are overloaded, be corrected as soon a 
possible. Otherwise this potentially useful m e t h o
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ay be disregarded because of doubts concerning its 
liability in the s a m e  w a y  as has already happened 
ith the estimation of glycosylated haemoglobins 
here for a time problems with different method- 
logies m a s k e d  its usefulness as a clinical test.23
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Measurement of Glycosylated Haemoglobins and
Glycosylated Plasma Proteins in Maternal and Cord Blood Using an
Affinity Chromatography Method
P. M. Hall1, G. M. Cawdell2’*, J. G. H. Cook1 and B. J. Gould3
Departments o f1 Biochemistry and 2Obstetrics and Gynaecology, Royal Sussex County Hospital, Brighton, East Sussex and
3Biochemistry Department, University of Surrey, Guildford, Surrey, UK
S u m m a r y .  W e  have used a simple affinity chromatography 
m e t h o d  to measure total glycosylated haemoglobins a n d  gly­
cosylated p l a s m a  proteins in maternal a n d  cord blood at 50 
nor m a l  deliveries. T h e  affinity m e t h o d  gives equal weighting 
to glycosylated haemoglobins including haemo g l o b i n  F  in 
cord blood. T h e  m e a n  values for glycosylated haemoglobins 
in maternal blood (6.49 ±  1.2%) were significantly higher than 
those in cord blood (3.85 ± 1 . 0 % ;  p <  0.001). T h e  difference 
with glycosylated p l a s m a  proteins w a s  less m a r k e d  (maternal 
blood 5.61 ± 0 . 9 %  a n d  cord blood 4.75 ± 0 . 6 % ;  p <  0.001). A  
contributory factor to these differences w a s  the decrease in 
glucose concentration f r o m  4.53 ±  0.99 m m o l / 1  in maternal 
blood to 3.59 ±  0.8 m m o l / 1  in cord blood. T h e  results obtained
at the birth of six children to diabetic mothers s h o w e d  the 
s a m e  trends although the m e a n  values for glycosylated 
haemoglobins (maternal blood 9.27 ± 2 . 3 % ,  cord blood 
4.21 ±0.9%), glycosylated p l a s m a  proteins (maternal blood 
7.44 ± 1 . 6 % ,  cord blood 5.45 ± 1 . 7 % )  a n d  glucose (maternal 
b lood 10.22 ±  7.3 mmol/1, cord blood 5.18 ±  3.4 m m o l / 1 )  were  
higher in all samples than for the deliveries to non-diabetic 
mothers.
K e y  words: Affinity chromatography, cord blood, diabetes, 
diabetic pregnancy, glycosylated fetal haemoglobin, glyco­
sylated fetal plas m a  proteins, glycosylated haemoglobins, gly­
cosylated p l a s m a  proteins.
The measurement o f glycosylated haemoglobins (Gly- 
Hb) is well recognized as a retrospective assessment of 
glycaemic control in diabetic patients [1]. As a clinical 
tool, these haemoglobins are most useful in labile dia­
betes such as occurs in pregnancy where their concen­
tration correlates with mean maternal glycaemia [2]. D e­
spite improvements in the control o f maternal diabetes 
during pregnancy, macrosomia, neonatal morbidity and 
congenital malformations are still frequent in centres 
with low perinatal mortality [3]. Several methods have 
been used to determine glycosylated haemoglobins dur­
ing pregnancy. These include ion-exchange chromatog­
raphy [3-9], high pressure liquid chromatography [10], 
and radioimmunoassay o f HbAic [11].
It is also possible to determine Gly-Hb in cord 
blood and this might be used as an index o f fetal expo­
sure to glucose during the last few weeks o f pregnancy
[12]. The measurement o f glycosylated haemoglobin F 
has been carried out using ion-exchange chromatogra­
phy [13, 14] and isoelectric focusing [12, 15] but both 
techniques probably measure the total o f glycosylated
haemoglobin F and acetylated haemoglobin F [12,14]. 
HbAic has also been measured in cord blood by radio­
immunoassay [16] and may be useful in the future for 
the determination o f gestational age in the third tri­
mester.
A simple, sensitive affinity chromatography tech­
nique which can be used for the measurement o f glyco­
sylated haemoglobins [17,18] is now available commer­
cially. It is rapid and suitable for use in a routine clinical 
laboratory for monitoring all diabetic patients including 
those who are pregnant. In this paper we report the 
ranges for normal pregnancies at term, and show that 
this single technique, with minor modification, can be 
used to determine both glycosylated haemoglobins and 
glycosylated plasma proteins in adult and fetal blood.
Subjects and Methods
Subjects
____________  Fifty live births to non-diabetic women were monitored; 19 of the
* Present address: Department of Obstetrics and Gynaecology, mothers were primigravidae. Most births were normal vaginal deliver-
King’s College Hospital, London, UK ies, but there were four forceps deliveries and three by Caesarean sec-
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Fig.l. Effect on the value of glycosylated haemoglobin of mixing 
cord blood with non-diabetic maternal blood and blood from a dia­
betic. Increasing amounts of cord blood were added to non-diabetic 
maternal blood (A) and diabetic blood ( • )  in the proportions indi­
cated. The glycosylated haemoglobins were then measured by affinity 
chromatography
tion. Gestational age of the fetus was based on the mothers menstrual 
history and ultrasound examinations. Maternal and cord bloods for 
analysis were taken immediately after birth. For the glucose estima­
tion, the sample was preserved using fluoride oxalate; a further sam­
ple of each was taken into a standard lithium heparin tube to prevent 
coagulation. The mean age of the mothers was 28 years (range 19 to 
42 years). The m ean±SD  birth weight was 3.417 ±0.518 kg with the 
observed range being 2.280-4.360 kg. All the births were within 2.5 
weeks of the predicted date of delivery. Six live births to insulin-de­
pendent diabetic patients were also monitored. Maternal and cord 
bloods for analysis were taken immediately after birth, and were treat­
ed in an identical manner to the samples from normal subjects.
Measurement o f  Blood Glucose
Whole blood glucose was measured using the Yellow Springs Glucose 
Analyser Model 23AM (Yellow Springs Instruments, Yellow Springs, 
Ohio, USA). This was usually carried out within 30 min of sampling, 
but when this was not possible, the sample was stored at 4 °C.
Measurement o f  Glycosylated Haemoglobins
Glycosylated haemoglobins were measured by the previously report­
ed affinity chromatography technique [18]. This method uses an 
m-aminophenylboronate agarose gel, Glycogel B (Pierce & Warriner, 
Chester, UK) for the separation of glycosylated from non-glycosylat- 
ed material. The pH of the buffers used for the chromatography was 
8.3.
For each sample, plasma was separated from the erythrocytes by 
centrifugation at 1200 g for 10 min. Then 100 pi of packed red blood 
cells were diluted with 2 ml o f deionised water and incubated at 37 °C 
for 5 h to remove labile material [19]. The stable sample was then 
stored at 4 °C until analysis, in most cases up to a maximum of 48 h.
pH 8.9. The protein in both the unbound fraction (diluted to 24 ml) 
and the bound fraction was measured at 595 nm 30 min after mixing 
with an equal volume of an acidified Bradford reagent [19], This re­
agent was prepared from the Biorad protein assay reagent (Bio-Rad 
Laboratories, Watford, Hertfordshire, UK) diluted with water and 
glacial acetic acid in the ratio 4:5:1. This method is modified from 
that recommended by the suppliers of Glycogel B to avoid overload­
ing the gel columns with protein [20].
Effect o f  Fetal Haemoglobin on Affinity Chromatography 
Method
Packed red blood cells obtained from cord blood were mixed in dif­
ferent proportions with either the appropriate maternal blood or with 
erythrocytes from a diabetic patient. The samples used contained 
100%, 80%, 65%, 50%, 35%, 20% and 0% of cord blood in each case. 
Each sample was mixed and a 100 pi aliquot was diluted in 2 ml of 
deionized water and incubated at 37 °C for 5 h to remove any labile 
material, and then analysed in triplicate using the method outlined for 
glycosylated haemoglobins.
Effect o f  Fetal Haemoglobin on Agar Gel Electrophoretic 
Method
Erythrocytes from cord and maternal blood were diluted 1 in 20 with 
isotonic saline (0.15 mmol/1 NaCl) and incubated at 37 °C for 5 h. The 
erythrocytes were then recovered and the assessment of glycosylated 
haemoglobins in the haemolysed cells was determined by both the af­
finity method and the standard procedure for agar gel electrophoresis 
marketed by Coming (Coming Medical, Halstead, Essex, UK).
Statistical Analysis
Statistical comparisons were performed by Student’s t-test.
Results
Effect o f  Fetal Haemoglobin on Methods for Measuring 
Glycosylated Haemoglobins 
Figure 1 shows that when cord blood was mixed with 
either haemoglobin from a normal mother or haemo­
globin from a diabetic mother in different proportions 
between 0% and 100%, straight lines were obtained. 
This indicates that the haemoglobin F and the normal 
adult haemoglobin are given equal weighting by the af­
finity method. However, when samples o f cord blood 
were tested by the agar gel electrophoretic method there 
was gross interference by haemoglobin F (Table 1). The 
mean value for the maternal samples using the affinity 
method was 5.8%, and for the cord samples it was 4.0%. 
The corresponding values obtained by the agar gel elec­
trophoretic method were 6.7% and 81.5%, respectively.
Measurement o f  Glycosylated Plasma Proteins
Plasma was diluted 1 in 20 with deionised water and incubated at 
37 °C for 5 h. Diluted plasma (150 pi) was added to a 1 ml column of 
Glycogel B. The unbound material was removed with 8 ml of wash 
buffer and the bound fraction eluted with 3 ml of elution buffer. Both 
buffers were as used previously [18], except that they were adjusted to
Values o f  Glycosylated Haemoglobins, 
Glycosylated Plasma Proteins and Glucose in Maternal 
and Cord Blood o f  Normal Pregnancies
Table 2 summarizes the results of glycosylated haemo­
globins, glycosylated plasma proteins and glucose mea-
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Table 1. Glycosylated haemoglobins in cord and maternal samples non-diabetic (A-H) and diabetic (I and J) mothers
Births
A B C D E F G H I J
Maternal blood
Affinity method (%) 6.27 4.40 4.51 5.53 4.64 4.60 4.55 4.40 8.56 10.30
Agar gel electrophoresis (%) 6.0 6.2 6.6 5.4 8.3 5.7 6.2 7.0 8.0 8.0
Cord blood
Affinity method (%) 4.07 5.32 4.96 4.92 3.72 3.25 2.95 2.81 3.33 4.59
Agar gel electrophoresis (%) 72.4 77.3 78.2 86.4 80.8 82.4 77.1 86.6 88.2 85.2
The Affinity Chromatography Method measures glycosylated haemoglobins (%) and agar gel electrophoresis gives the percentage in the fast frac­
tion
Table 2. Values for glycosylated haemoglobins, glycosylated plasma 
proteins and glucose in maternal and cord blood of non-diabetic 
mothers at delivery
Glycosylated Glycosylated Glucose
haemoglobins plasma proteins
(%) (%) (mmol/1)
Maternal blood 6.49 ±  1.22
(« =  50) (3.33-9.13)
Cord blood 3.85 +  1.01
(«=50) (1.94-7.18)
Results are expressed as mean ±  SD ; observed range in parentheses
Table 3. Values for glycosylated haemoglobins, glycosylated plasma 
proteins and glucose in maternal and cord blood of six diabetic moth­
ers at delivery
Patient Glycosylated Glycosylated Blood
haemoglobins plasma glucose
(%) proteins (%) (mmol/1)
1 Maternal 8.56 7.66 5.0
Cord 3.33 4.63 2.6
2 Maternal 12.21 8.99 9.4
Cord 5.25 6.76 1.4
3 Maternal 6.43 7.76 24.7
Cord 4.76 5.32 11.3
4 Maternal 10.30 8.13 8.2
Cord 4.59 5.47 5.8
5 Maternal 7.02 4.35 6.4
Cord 2.85 2.81 5.0
6 Maternal 11.12 7.75 7.6
Cord 4.47 7.70 5.0
Mean ±  SD, Maternal 9.27±2.31 7.44 ±1.59 10.22 ±7.25
Mean ±  SD, Cord 4.21 ±0.92 5.45 ±1.70 5.18 ±3.43
surements for the cord and maternal blood samples o f 
50 live births o f healthy infants to 50 normal mothers. 
The mean value for each parameter was significantly 
lower in the cord sample (/?< 0.001), and therefore the 
infant, than in the mother’s blood. There was overlap 
between the observed ranges for each o f these three pa­
rameters (Table 2), but also a marked trend towards 
lower values in the cord samples for each infant when 
compared with its mother. The glycosylated haemo­
globin values in the cord samples were all lower than 
the corresponding maternal value, but five cord samples 
had higher glycosylated plasma proteins. In three cases, 
the glucose concentration in the cord blood was higher 
than that in the mother, and in one o f these, the glyco­
sylated plasma proteins were also raised.
The mean percentage glycosylated plasma protein 
values for the maternal population were significantly 
lower than those for glycosylated haemoglobins (p <  
0.001). In contrast, in cord blood the glycosylated plas­
ma proteins were higher than the glycosylated haemo­
globin values (p <  0.001).
Results from Diabetic Pregnancies
The values for glycosylated haemoglobins,/glycosylated 
plasma proteins and blood glucose in maternal and 
cord blood samples from six diabetic mothers are 
shown in Table 3. As observed with the non-diabetic 
mothers, the results from cord blood are lower than 
those from maternal blood samples. Comparison o f  
Tables 2 and 3 shows a higher mean value for each mea­
surement in samples from diabetic subjects. Since only 
six results are at present available no further statistical 
analysis has been done.
Discussion
The affinity chromatography method provides a simple, 
sensitive and rapid method for measurement o f both 
glycosylated haemoglobins and glycosylated plasma 
proteins. The separation technique depends on the af­
finity o f the stationary phase (Glycogel B) for the carbo­
hydrate moiety o f either glycosylated haemoglobins or 
glycosylated plasma proteins. For this reason it should 
be independent of the haemoglobin variant and should 
measure the sum o f the glycosylated haemoglobins in­
cluding glycosylated haemoglobin F and haemoglobin 
A. Figure 1 clearly illustrates that fetal haemoglobin 
does not interfere with the affinity method. Other meth­
ods utilising small changes in charge to separate gly­
cosylated and non-glycosylated material may be affect­
5.61 ±0.93 
(3.47-7.79)
4.75 ±0.62 
(3.25-6.08)
4.53 ±0.99 
(2.4 -8 .7 )
3.59 ±0.82 
(1.4 -5 .6 )
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ed by the type o f haemoglobin if this carries a different 
charge. The resulting interference is clearly shown by 
the results of the agar gel electrophoresis method where 
the fetal haemoglobin runs with the fast fraction of 
HbA!.
Glycosylated haemoglobins in cord blood have 
been measured in several ways with results which de­
pend on the degree o f separation and the component 
measured. The resulting literature is confusing and ap­
parently inconsistent. Using isoelectric focusing, results 
for non-diabetic mothers have been reported by two 
groups as 7.8±1.5%  [12] and 6.12±.1.64% [15]. These 
values were claimed to represent the sum o f glyco­
sylated haemoglobin F, HbAlc and acetylated haemo­
globin F. However, Schwartz et al. [13], using a com­
bination o f isoelectric focusing and ion-exchange 
chromatography, separated glycosylated haemoglobin 
F (2.7 ±0.5%) and acetylated haemoglobin F (14.6 ±  
4.8%), which together represent more than twice the val­
ues mentioned above. With two different ion-exchange 
methods, Fadel et al. [14] reported the separation o f two 
fractions; HbAi (2.1 ±0.5%) and what they considered 
to be glycosylated haemoglobin F (14.4 ±  1.9%). The lat­
ter is more than five times greater than the percentage of 
glycosylated haemoglobin F reported by Schwartz et al.
[13]. With all these methods, measurement o f one or 
more glycosylated fractions is rendered inaccurate be­
cause of contamination with non-glycosylated haemo­
globin. Radioimmunoassay has been used for the spe­
cific measurement o f HbAic in cord blood and a value 
of 1.1 ±0.3% was obtained for the babies of non-diabet­
ic mothers [16]. The price o f specificity in this case has 
been the loss o f detection o f a significant amount o f gly­
cosylated haemoglobin. The affinity method used for 
this work provides a means o f isolating and measuring 
all glucose bound fractions o f whatever haemoglobin 
species [18], the results (3.85 ±1.01%) being understand­
ably between the specific value for HbAlc and the 
values obtained by isoelectric focusing which include 
acetylated haemoglobin F.
Prevous studies have shown that Gly-Hb is either 
unchanged [3,6,9] or slightly decreased [22] during nor­
mal pregnancy. This study is in agreement with these 
findings, since the value obtained for maternal glycosy­
lated haemoglobins was 6.49 ±1.2% compared with the 
normal value o f 7.31 ±  0.9% [18]. This significant de­
crease (p <  0.001) may be caused by the increase in red 
cell volume and decrease in fasting plasma glucose con­
centration that occurs during normal pregnancy [22]. 
Measurement o f maternal glycosylated plasma proteins 
at term has not been reported previously. In this study 
we have found, not surprisingly, that it follows a similar 
pattern to the glycosylated haemoglobins but with a 
slightly smaller but significant decrease between the 
normal value (6.29 ±1.9% ; p <  0.02) (unpublished re­
sults) and that for pregnant women at delivery (5.61 ±  
0.9%). This is consistent with the decrease in plasma 
glucose concentration. Although the concentration of
plasma proteins also decreases during pregnancy [23] 
the decrease is very small.
It is also interesting that there is an inverse ratio be­
tween the percentage o f glycosylated plasma proteins 
and glycosylated haemoglobins in maternal and cord 
blood. In cord blood, the percentage o f glycosylated 
plasma proteins is greater than Gly-Hb, and in maternal 
blood the opposite is true. In maternal blood, the con­
centration o f plasma proteins decreases during the last 
stages o f pregnancy due to increased body fluids [23]. 
This, combined with the decrease in glucose and the 
fact that glycosylated plasma proteins reflect a shorter 
time period than glycosylated haemoglobins [24], prob­
ably explains the observations. In cord blood, however, 
there is an increased concentration o f haemoglobin 
compared with the mother’s blood which probably al­
ters the balance so that the concentration o f glycosylat­
ed plasma protein is greater than that o f glycosylated 
haemoglobins in cord blood.
Only a few previous studies have attempted to mea­
sure glycosylated haemoglobins in both maternal and 
cord blood. One group using ion exchange chromatog­
raphy [15] obtained a value for HbA! in maternal blood 
of 6.4 ±0.7% and in cord blood o f 12.4±3.6%. How­
ever, two different chromatography procedures were 
used to determine these values. Using radioimmuno­
assay it was found that the maternal HbAic values were 
3.96 ±0.7% compared with 4.56 ±1.8% in cord blood 
expressed as a percentage o f haemoglobin A [16]. An­
other study, this time using isoelectric focusing [12], 
quotes maternal HbAlc as 7.8 ±1.9% and glycosylated 
haemoglobin F, which probably includes HbAic and 
acetylated haemoglobin F, as 7.8 ±1.5%.
Contrary to the findings outlined above, Sosenko et 
al. [25], using a colorimetric method, found a signifi­
cantly lower value (by 26%) for Gly-Hb in cord blood 
compared to maternal blood. The significant decrease 
reported here from 6.49 ±1.2% for maternal blood, to 
3.85 ±1.0% for cord blood, is in general agreement 
with their findings. This decrease is also consistent with 
the lower blood glucose in cord blood. The results for 
normal births show a consistent trend o f lower glucose, 
glycosylated haemoglobins and glycosylated plasma 
proteins in the fetus when compared with the cor­
responding maternal blood. A similar trend is apparent 
from the preliminary data for diabetic pregnancies. It 
has been shown in studies in vitro that fetal haemoglo­
bin becomes glycosylated at the same rate and to the 
same extent as adult haemoglobin [15]. It seems likely 
therefore that these lower values in the fetal blood re­
flect the rapid utilisation o f glucose by the fetus [26].
The affinity method can offer two measurements for 
any patient at birth, glycosylated haemoglobins and gly­
cosylated plasma proteins. Each of these may be useful 
to the clinician since they reflect different time periods 
of glycaemic control in pregnancy, which is a rapidly 
changing situation both metabolically and physiologi­
cally. Glycosylated haemoglobins reflect the glucose
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history over the previous 6-8  weeks, whereas glyco­
sylated plasma proteins have a much shorter half-life 
and can provide information over a shorter time scale 
[24]. We are at present investigating the predictive ca­
pabilities o f these measurements in relation to the com­
plications associated with diabetic pregnancy.
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Glycosylated Hemoglobins and Glycosylated 
Plasma Proteins in the Diagnosis of 
Diabetes Mellitus and Impaired 
Glucose Tolerance
PAULINE M. HALL, M.Sc., JOHN G. H. COOK, Ph.D., JOANNA SHELDON, M.D., F.R.C.P.,
 ___________________  SHEILA M. RUTHERFORD, A.I.M.L.S., AND BARRY J. GOULD, Ph.D.____________________
Total and stable glycosylated hemoglobins and glycosylated plasma proteins were determined on 53 
patients referred for a glucose tolerance test. Significant correlations were found with fasting blood 
glucose (r >  0.89), 2-h glucose (r >  0.69), and area under the glucose tolerance curve (r >  0.75), 
but the correlations with labile glycosylated proteins were not significant. Thirty-one of the patients 
were normal, five had impaired glucose tolerance (IGT), and seventeen diabetes mellitus (DM) ao  
cording to the WHO criteria. Comparison of the glycosylated protein values showed that, in all cases, 
the values for those with IGT and DM were significantly (P <  0.001) greater than the values for 
normals. The range of values of stable glycosylated hemoglobins for those with DM (9.4-24.4% ), 
those with IGT (8.6-10.0%), and normals (5.0-8.5% ) shows that there was no overlap between overt 
diabetic subjects and normal subjects. This was also found for total glycosylated hemoglobins. The 
results for glycosylated plasma proteins, total and stable, were comparable, but one patient with overt 
DM and two with IGT had values within the normal range. The measurement of glycosylated hemo- 
globins and glycosylated plasma proteins by the simple, precise, affinity'chromatography method is 
potentially a quick, accurate, and simple screening test for patients with DM and IGT and deserves 
consideration as criteria for their diagnosis, diabetes c a r e  7:147-150, m a r c h - april  1984.
For many years the oral glucose tolerance test (OGTT) matography,2 measurement of H bA lc by the method of Tri-has played an important role in the diagnosis of velli,3 or the widely available mini-columns to measure HbAj.4,5
diabetes mellitus (DM ), frequently after the detec- In this article, we report on the use of a simple affinity 
tion of glycosuria. However, the interpretation of technique to measure glycosylated hemoglobins and glyco-
the test is hindered by lack of uniformity in procedures and sylated plasma proteins on blood collected during OGTTs.
by lack of agreement on the criteria for abnormality. Fur- The measurement of glycosylated hemoglobins appears to
thermore, there is day-to-day variation in individuals, despite provide a sensitive screening system for the detection of DM
standardization of methods, and the results are affected by and IGT.
age, many drugs, and diseases.1
The W HO Expert Committee on Diabetes Mellitus, in its 
second report, recommended a standardized test and diag
MATERIALS AND METHODS
nostic criteria.1 Two classes of abnormal response were iden- Glucose tolerance test. Capillary blood samples were collected
tified, DM and impaired glucose tolerance (IGT). The same via a fingerprick from 53 patients who were referred to the
criteria may be used for the diagnosis o f gestational diabetes. hospital as outpatients for glucose tolerance tests (OGTTs).
The cut-off points remain somewhat arbitrary, and individ- Each patient had been on a 300-g carbohydrate diet for each
uals near the limits may require further investigation. o f the previous 3 days and had fasted for at least 12 h (over-
Several workers have investigated the possibility of using night) prior to blood being collected before the glucose load
glycosylated hemoglobin as an indicator in the diagnosis of was given. This blood was collected into sodium fluoride
glucose intolerance. A ll the published work uses methods preservative and the fasting glucose was measured. If this
based on ion-exchange chromatography. These include exceeded 10 mmol/L then the test was discontinued,
measurements o f H bA lc by high-performance liquid chro- A n oral glucose load of 50 g was given to each patient
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using the prepared glucose mixture “Dextran” (Lab Sales UK 
Ltd., Rochdale, Lancashire, United Kingdom) made up in 
200 ml of water. Repeated blood samples were taken via 
fingerprick at half-hourly intervals up to 2 h after the glucose 
dose. A ll of the samples were collected into sodium fluoride 
preservative bottles and kept at room temperature for a max­
imum of 30 min before the measurement of glucose.
Urine samples were collected while the patient was fasted, 
and at hourly intervals after the glucose load until the test 
was completed.
Interpretation of OGTTs. The criteria proposed by the W HO  
Second Report on Diabetes were for a 75-g glucose load. It 
was suggested that values obtained using a 50-g glucose load 
should be decreased by 1 mmol/L at 1 h and 2 h after the 
load. O n this basis, the diagnostic values for our OGTT  
would be (1) Normal. A t 0 h and 2 h capillary blood glucose 
concentration less than 7.0 mmol/L. A  fasting value below 
6 m mol/L excludes the diagnosis of diabetes. (2) Impaired 
Glucose Tolerance. A t 0 h capillary blood glucose concen­
tration less than 7.0 mmol/L and at 2 h between 7.0 and 
10.0 mmol/L. (3) Diabetes Mellitus. A t 0 h capillary blood 
glucose concentration 7.0 mmol/L or above and/or 10 mmol/ 
L or above at 2 h. In the absence of clinical symptoms of 
diabetes, at least one additional abnormal blood glucose con­
centration confirms the diagnosis.
Glucose measurement. W hole blood glucose was measured 
in each sample using the Yellow Springs Glucose Analyzer 
Model 23AM (Yellow Springs Instrument C o., Yellow Springs, 
O hio).
A  qualitative assessment of the glucose content of each 
urine sample was made using Clinistix (Ames C o., Miles 
Laboratories Ltd., Stoke Poges, Slough, United Kingdom).
Preparation of hemolysate for measurement of glycosylated 
hemoglobins. After glucose analysis, the blood sample taken 
from a fasting patient was centrifuged at 1200 X  g  for 10
TABLE 1
Summary of the relationship between the results for the OGTTs and gly­
cosylated hemoglobin and glycosylated plasma protein values
Fasting
glucose 2-h glucose
Area under 
curve (0 -2  h)
Glycosylated N =  53 48 ' 48
hemoglobins r =  0.89 0.75 0.83
(total) slope =  1.34 0.74 0.54
Glycosylated N =  53 48 48
hemoglobins r =  0.89 0.74 0.83
(stable) slope =  1.28 0.74 0.52
Glycosylated N  =  52 47 47
plasma proteins r =  0.92 0.72 0.79 .
(total) slope =  1.35 0.57 0.38
Glycosylated N  ■= 52 47 47
plasma proteins r =  0.92 0.69 0.75
(stable) slope =  1.27 0.54 .0.36
Although 53 patients were studied, for 5 patients the glucose load was not 
given, as they had a fasting blood glucose > 1 0  mmol/L. In one case, the 
glycosylated plasma proteins were not measured.
TABLE 2
Summary of the glycosylated hemoglobin and glycosylated plasma protein 
values when patient results were classified by the WHO criteria1
Normal IGT DM
Glycosylated Mean 7.2% 9.7% 15.9%
hemoglobins SD 1.3% 0.4% 4.1%
(total) N 31 5 17
Glycosylated Mean 6.6% 9.3% 15.1%
hemoglobins SD 1.0% 0.6% 3.9%
(stable) N 31 5 17
Glycosylated Mean 6.2% 8.4% 13.9%
' plasma proteins SD 1.0% 0.7% 5.3%
(total) N 31 5 16
Glycosylated Mean 5.9% 8.3% 13.3%
plasma proteins SD 1.1% 0.9% 4.3%
(stable) N- 31 5 16
min, and a 1:20 dilution of the erythrocytes in water was 
prepared. This hemolysate was thoroughly mixed using a 
vortex mixer, and then divided. One aliquot was kept at 4°C 
for the measurement of total glycosylated hemoglobin while 
the remainder was incubated at 37°C for 5 h to remove labile 
material6 before the measurement of stable glycosylated 
hemoglobin. Both total and stable glycosylated hemoglobin 
were measured using an affinity-chromatography method7 at 
20 ±  1°C and pH 8.3.
Preparation of plasma for measurement of glycosylated plasma 
proteins. After centrifugation, plasma was taken from the 
fasting blood sample, diluted 1:20 with water, and thoroughly 
mixed. As with the hemolysate, half of the diluted plasma 
was kept at 4°C for total glycosylated plasma protein meas­
urement and the remainder incubated for 5 h at 37°C before 
the measurement of stable glycosylated plasma proteins. Both 
total and stable glycosylated plasma proteins were measured 
using an affinity-chromatography method8 at 20 ±  1°C and 
pH 8.9.
Statistics. Linear correlations were calculated by the least- 
squares’ method. Statistical comparisons were performed by 
Student’s t test.
RESULTS ________ ______________ ____________________
T
otal and stable glycosylated hemoglobins and gly­
cosylated plasma proteins were determined on pa­
tients who were referred for an OGTT. The several 
significant correlations between these values and 
fasting blood glucose, the 2-h glucose, and the area under 
the glucose tolerance curve are given in Table 1. For both 
glycosylated hemoglobins and glycosylated plasma proteins, 
the best correlations were found with fasting blood glucose. 
The labile (total-stable) glycosylated hemoglobins and gly­
cosylated plasma proteins were calculated for each patient, 
but these values did not correlate significantly (r <  0.3) with  
fasting glucose. Also, urinary glucose did not produce a con­
sistent pattern. Glycosuria was demonstrated in 3 patients 
who had normal glucose tolerance tests but was absent for 
the duration of the test from 5 patients with DM.
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IMPAIRED D IAB ETE S 
G L U C O S E  MELLITUS 
TO L ER A NC E
IMPAIRED D IAB ETE S 
G L U C O S E  MELLITUS 
TO L ER A NC E
F IG . 1. Distribution of individual values of stable glycosylated proteins 
according to the results of an O G T T . The results of the O G T T  were 
classified according to the W H O  criteria1 and the values for stable gly­
cosylated hemoglobins (A ) and stable glycosylated plasma proteins (B ) 
are represented.
O f the 53 patients tested, 31 had normal OGTTs, 17 had 
DM, and 5 were classified as having IGT according to the 
W HO criteria (Table 2). In 5 cases, the fasting blood glucose 
was greater than 10 mmol/L and so the glucose dose was not 
given. For these patients, the range of stable glycosylated 
hemoglobin values was 15.6-25.6%  and their values of gly­
cosylated plasma proteins ranged from 13.9% to 24-4%. 
Comparison of the glycosylated protein values showed that, 
in all cases, the values for those with IGT and DM were 
significantly (P <  0.001) greater than the values for normal 
subjects.
The discrimination observed between the three classes of 
patients and their values of stable glycosylated proteins are 
illustrated in Figure 1. The diabetic patients had stable gly­
cosylated hemoglobin values between 9.4% and 24-4%. The 
5 patients with IGT had stable glycosylated hemoglobin val­
ues between 8.6% and 10.0%, which were all greater than 
the highest values for the 31 patients with normal tests (range, 
5.0 -8 .5% ). Figure IB shows that, with stable glycosylated 
plasma proteins, one diabetic patient and two with IGT had 
values within the normal range. The patients in whom over­
lap occurred were the same when total glycosylated plasma 
proteins were studied.
D IS C U S S IO N ________________________________________________________________________
The OGTT, although well established, is inconvenient to 
the patient and time consuming for staff. It is prone to en­
vironmental influences, as well as to intraindividual varia­
tion. 1 Glycosylated hemoglobin measures the cumulative ef­
fect of glycemia over the previous 3 -4  wk9 and is consequently 
not as prone to environmental influences. This readily ac­
counts for the several significant correlations found between 
the variables measured in the OGTT, i.e., fasting blood 
glucose, 2-h glucose and area under the glucose tolerance 
curve, and the values for glycosylated proteins.
In this article, we show that there is a clear-cut separation 
of the overt diabetic subjects1 from the nondiabetic subjects 
using glycosylated (stable) hemoglobin measurements (Figure 
1A). O f the overt diabetic subjects, as interpreted by the 
OGTT, all had high glycosylated (stable) hemoglobin values 
exceeding 9.4%- Furthermore, there were no false positives 
recorded in the nondiabetic population, with the maximum 
value being 8.5%. The two groups were significantly differ­
ent. Those patients who showed IGT tests also differed sig­
nificantly from both the normal and diabetic groups. How­
ever, there was a small overlap between patients with IGT 
and the overt diabetic population, as the highest value for 
the former was 10.0%. This could simply be a reflection of 
the errors in the O G TT for the reasons outlined earlier. 
Identification of these patients with IGT is important, as 
they have been shown to be “at risk” of macrovascular disease 
(especially coronary heart disease) and in a significant mi­
nority this diagnosis equates with “early diabetes.”10
Very similar results are also evident with the total glyco­
sylated hemoglobin measurement (TablesT and 2). This would 
imply that the incubation stage for the removal of labile 
material is not strictly required for glycosylated hemoglobin 
to be used as a successful screening technique for DM. How­
ever, since the proportion of labile material is large (mean =  
8.5% of the stable fraction), and the relationship between 
fasting blood glucose and labile glycosylated hemoglobin shows 
no consistent pattern from patient to patient, its removal is 
recommended.
Glycosylated plasma proteins were measured in this in­
vestigation, since it has been shown that they are more sen­
sitive to hyperglycemia.11 Tables 1 and 2 also show that 
similar conclusions can be drawn from the results of both of 
the glycosylated plasma proteins (total and stable). W ith  
these measurements, however, most of the differences be­
tween the different populations, as interpreted by the OGTT, 
are slightly less distinct. This may be due to the glycosylated 
plasma protein results being unexpectedly, generally lower 
than those for glycosylated hemoglobins or due to the fact 
that the method for glycosylated plasma proteins is less pre­
cise (CV — 5% ),8 and in some cases hemolyzed plasma may 
yield false values.
In a recent article, Kesson et a l.12 compared the usefulness 
of H bA lc and HbAj measurement as a screening procedure 
for DM with the conventional OGTT. They found, in agree­
ment with others,2,3 that H bA lc is not sufficiently sensitive 
in the screening of diabetes. However, HbAi measurements 
gave a more consistent comparison with the OGTT, which  
is also comparable to the findings of others.4,5 Nevertheless, 
Kesson et a l.12 stressed the methodologic problems common 
to all these groups of workers who were using methods based 
on ion-exchange chromatography. Verrillo et a l.13 classified 
patients according to the W HO criteria1 and compared their 
results with HbAj measurements. They found marked overlap 
between normals and those with IGT.
Affinity chromatography provides a simple, sensitive, and 
very precise (CV <  2%) method for the measurement of 
glycosylated hemoglobins in the routine clinical laboratory7
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that is not affected by met-hemoglobin7 or hemoglobin F.14 
It measures mainly H bA k and glycosylated HbA015; both  
fractions are elevated in diabetes,16 but the latter fraction 
may be a more sensitive indicator of hyperglycemia.15 We 
have now shown that a single measurement, using affinity 
chromatography, appears to distinguish between patients with 
D M  (stable glycosylated hemoglobin >  10%) and normal 
subjects (stable glycosylated hemoglobin <  8.5%). Patients 
with values between 8% and 10% are most likely to have 
IGT and require further clinical investigation. It would be 
valuable to extend this work, with standardized methodology, 
to several centers. If the encouraging results obtained in this 
limited study are more generally applicable, it would be ap­
propriate for the measurement of glycosylated hemoglobin by 
this method to be included in future discussions on the di­
agnostic criteria for diabetes.
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